Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" ABCC4 "EST170205, MOAT-B, MOATB, MRP4" ENSG00000125257 "ATP binding cassette subfamily C member 4" O15439 13 95019829-95301475 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 35.0" "Group enriched" "Detected in many" 4 "HEL: 60.4;HMC-1: 66.1;RPTEC TERT1: 17.8" "Cancer enriched" "Detected in all" 8 "prostate cancer: 90.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002476 Enhanced Approved "Nucleoli,Golgi apparatus,Plasma membrane" "Nucleoli, Plasma membrane" "Golgi apparatus" "HPA002476: AB_1844434" "unprognostic (8.77e-2)" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (9.89e-4)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (7.45e-3)" "unprognostic (2.40e-2)" "unprognostic (9.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.55e-2)" "prognostic favourable (2.25e-10)" "unprognostic (7.44e-3)" "unprognostic (1.67e-1)" "unprognostic (5.55e-2)" "unprognostic (2.35e-2)" 3.2 1.7 3.8 11.8 4.7 2.9 6.2 1.0 4.6 4.4 11.6 10.3 3.9 4.1 5.8 16.4 3.0 8.6 10.3 3.5 5.7 3.9 19.6 1.9 13.8 7.4 6.6 2.2 7.2 3.5 7.0 2.8 1.8 7.4 35.0 7.3 6.0 3.3 5.2 7.6 4.5 7.4 11.1 6.5 3.8 8.2 3.8 7.0 3.4 6.6 3.1 5.8 25.6 13.4 3.6 4.1 1.0 4.8 4.1 3.6 3.4 4.4 7.8 1.3 2.3 2.4 3.2 0.3 3.6 3.6 3.2 2.8 10.8 3.3 2.5 2.3 4.8 6.0 2.0 1.7 4.0 7.3 3.0 60.4 2.4 2.1 5.0 6.9 66.1 2.4 0.8 2.3 4.7 4.1 6.2 0.1 4.3 1.4 1.2 1.1 1.5 1.9 1.8 3.6 6.5 17.8 10.0 3.2 2.3 1.2 0.2 2.5 0.0 3.7 6.7 3.4 2.2 2.8 4.2 0.0 0.0 1.0 6.5 3.9 1.6 0.6 1.2 0.4 3.2 1.2 2.7 3.6 2.6 3.6 4.1 2.7 1.6 3.5 1.0 4.1 4.8 0.7 3.3 3.4 3.8 4.7 1.0 4.6 5.7 3.9 6.6 2.2 7.4 7.0 ABCC8 "ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2" ENSG00000006071 "ATP binding cassette subfamily C member 8" Q09428 11 17392498-17476879 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Receptor "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.0;pancreas: 25.5;pituitary gland: 26.6" "Group enriched" "Detected in some" 5 "A549: 4.6;AN3-CA: 3.7;SCLC-21H: 6.5" "Cancer enriched" "Detected in some" 9 "pancreatic cancer: 16.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB011451, HPA042318" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "CAB011451: , HPA042318: " "unprognostic (4.30e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (4.73e-2)" "unprognostic (9.48e-3)" "unprognostic (2.23e-1)" "unprognostic (4.46e-3)" "unprognostic (2.53e-3)" "unprognostic (6.04e-2)" "unprognostic (2.34e-2)" "unprognostic (8.72e-3)" "unprognostic (1.13e-1)" "unprognostic (2.22e-2)" "unprognostic (1.96e-2)" "unprognostic (6.88e-5)" "unprognostic (2.72e-2)" "unprognostic (1.85e-1)" 1.3 6.7 4.4 0.8 6.1 0.9 4.0 28.0 12.3 3.0 1.3 2.6 7.7 1.9 3.1 3.7 0.8 1.2 0.9 2.9 5.1 4.8 1.0 0.8 2.9 0.8 3.6 7.2 0.9 25.5 1.0 26.6 1.6 8.5 2.8 1.3 0.7 0.9 8.5 2.3 1.1 1.5 1.3 4.0 0.9 3.5 1.1 2.3 0.0 6.2 0.0 0.8 0.7 0.8 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.0 4.6 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 6.5 0.9 0.0 0.1 0.1 0.1 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 4.4 6.1 28.0 12.3 5.1 4.8 3.6 7.2 8.5 2.3 ABHD14B "CIB, MGC15429" ENSG00000114779 "Abhydrolase domain containing 14B" Q96IU4 3 51968510-51983409 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036444, HPA036642" Supported Approved Nucleoplasm,Nucleoli,Cytosol 2600000 Nucleoli "Nucleoplasm, Cytosol" "HPA036444: AB_10672221, HPA036642: AB_10672225" "unprognostic (8.97e-2)" "prognostic favourable (6.92e-5)" "unprognostic (1.84e-1)" "prognostic favourable (5.42e-5)" "unprognostic (1.07e-1)" "unprognostic (2.21e-2)" "unprognostic (2.06e-3)" "unprognostic (1.35e-3)" "unprognostic (3.95e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (2.95e-2)" "prognostic favourable (2.93e-5)" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (9.70e-2)" "unprognostic (3.70e-2)" 40.0 34.2 6.2 19.8 7.5 11.4 25.2 10.7 7.0 21.9 33.6 8.6 32.1 30.3 19.6 21.7 27.7 22.0 32.9 12.2 6.2 5.8 42.6 78.4 21.5 35.1 7.8 7.3 29.5 45.0 14.2 15.2 11.4 6.7 30.9 20.2 29.1 39.4 35.0 11.7 16.0 58.7 22.6 8.9 23.3 18.7 11.2 6.2 26.0 35.3 15.2 32.5 24.6 16.9 24.9 15.5 12.5 9.4 9.9 27.2 14.0 10.1 8.7 0.7 10.2 28.4 25.3 2.6 4.0 4.8 7.5 8.7 6.4 20.2 11.5 3.2 14.1 5.1 6.3 5.8 5.7 15.6 6.8 18.0 7.5 25.1 15.3 10.1 18.6 32.7 20.1 7.6 10.3 9.1 10.4 18.3 14.4 9.9 4.4 7.7 0.9 22.2 11.4 1.4 51.6 13.6 4.2 4.3 4.6 10.2 19.1 32.6 27.5 6.9 8.5 4.0 18.8 9.0 2.4 23.4 10.9 4.7 8.6 32.3 6.9 12.5 9.4 4.2 18.3 7.6 27.2 24.9 23.0 22.4 15.5 18.7 23.4 21.3 0.8 9.9 4.8 11.3 16.3 14.0 6.2 7.5 10.7 7.0 6.2 5.8 7.8 7.3 6.7 6.2 AC138696.1 ENSG00000264668 8 143247110-143276403 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 2.1" "Low lineage specificity" "Detected in single" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: " "unprognostic (2.24e-2)" "unprognostic (2.10e-1)" "unprognostic (3.56e-3)" "unprognostic (1.87e-1)" "unprognostic (8.68e-3)" "unprognostic (1.14e-1)" "unprognostic (1.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.20e-1)" "unprognostic (3.27e-2)" "unprognostic (1.34e-1)" "unprognostic (1.03e-2)" "unprognostic (2.20e-2)" "unprognostic (3.99e-1)" "unprognostic (2.59e-2)" "unprognostic (4.06e-1)" 3.6 4.8 6.2 2.5 4.4 1.5 2.5 5.8 7.3 3.3 3.8 4.7 2.5 2.6 5.7 2.7 2.8 7.8 2.0 2.7 6.2 4.8 2.6 1.9 2.7 2.5 4.8 3.0 5.8 6.8 4.6 4.5 2.2 4.2 3.0 2.2 3.8 3.6 3.9 4.7 1.8 3.1 3.2 3.7 2.7 2.7 3.5 3.6 1.5 2.7 1.5 2.6 3.6 4.4 0.6 0.6 0.0 0.2 0.9 2.1 0.1 1.3 0.0 0.0 0.8 4.7 0.3 0.5 1.3 3.0 1.5 0.6 0.0 1.8 0.2 0.8 0.3 0.7 0.0 0.6 0.5 0.0 1.4 0.3 0.0 0.0 0.0 0.3 0.6 2.8 1.2 0.0 1.0 0.9 0.0 0.1 0.0 0.0 3.2 0.0 3.0 0.9 1.6 2.8 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.7 0.9 0.9 0.0 0.0 0.7 2.9 0.1 2.2 0.7 1.6 1.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.1 0.0 0.6 0.3 0.0 0.0 0.9 0.2 0.6 0.3 0.1 6.2 4.4 5.8 7.3 6.2 4.8 4.8 3.0 4.2 3.6 AC245033.1 ENSG00000260836 15 82536788-82573194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 11.3" "Cell line enriched" "Detected in some" 5 "U-2197: 18.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA055060 Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum" "Nucleoli, Cytosol" "HPA055060: " "unprognostic (2.91e-2)" 1.5 0.9 5.3 0.9 7.1 0.9 1.3 6.1 11.3 0.9 1.0 1.4 0.0 0.9 0.9 0.9 1.5 0.9 0.9 1.3 3.9 1.6 0.9 1.0 1.1 0.9 3.2 6.1 0.9 1.0 0.9 2.0 1.0 7.3 1.1 1.1 1.9 0.9 0.9 2.0 0.9 1.4 0.9 2.4 1.1 0.9 1.4 1.7 0.0 1.0 0.0 1.0 1.7 0.8 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.7 0.7 18.5 0.3 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.1 6.1 11.3 3.9 1.6 3.2 6.1 7.3 1.7 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621296-88632282 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favourable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 9.4 10.4 6.5 10.2 7.2 14.8 11.2 2.8 5.0 8.0 7.8 4.9 13.4 5.0 9.3 10.2 8.9 7.0 23.0 8.2 4.7 8.5 7.9 17.4 9.1 15.4 13.1 3.1 11.2 18.8 6.7 21.3 11.0 7.8 11.6 9.1 4.3 14.5 9.1 18.8 5.9 8.0 10.6 9.3 14.2 11.1 14.3 4.6 14.0 16.6 10.9 13.7 12.5 5.4 9.3 4.1 0.6 3.6 3.0 15.0 7.6 4.9 22.2 13.9 11.9 6.2 7.5 29.5 17.8 16.3 13.7 16.9 18.2 9.7 21.5 5.7 9.7 7.2 51.2 14.4 11.6 5.2 20.2 11.5 9.0 30.1 15.2 9.5 11.6 9.2 12.7 17.1 14.1 11.4 18.1 12.2 16.7 11.6 11.7 8.0 33.5 12.9 15.4 9.9 15.9 5.7 10.8 11.0 10.1 7.2 8.2 13.7 6.8 10.9 10.4 14.0 19.6 5.7 23.9 23.7 15.9 18.4 12.9 10.7 27.4 0.0 1.8 0.6 5.3 3.1 10.0 9.3 9.1 6.9 4.1 9.3 10.0 8.8 0.4 3.0 3.6 2.4 15.0 7.6 6.5 7.2 2.8 5.0 4.7 8.5 13.1 3.1 7.8 4.6 AGPAT4 "dJ473J16.2, LPAAT-delta" ENSG00000026652 "1-acylglycerol-3-phosphate O-acyltransferase 4" Q9NRZ5 6 161129979-161274061 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.0" "Cell line enhanced" "Detected in many" "AF22: 19.8;HEL: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053287, HPA060525" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoli, Vesicles" "HPA053287: , HPA060525: " "unprognostic (5.69e-2)" "prognostic unfavourable (1.45e-4)" "unprognostic (1.73e-1)" "unprognostic (3.43e-2)" "unprognostic (4.14e-2)" "unprognostic (6.67e-3)" "unprognostic (1.94e-4)" "unprognostic (1.05e-1)" "unprognostic (3.42e-2)" "unprognostic (2.77e-2)" "unprognostic (1.76e-3)" "unprognostic (1.67e-1)" "prognostic unfavourable (4.08e-4)" "unprognostic (1.82e-2)" "unprognostic (8.87e-2)" "unprognostic (3.63e-4)" "unprognostic (5.51e-2)" 5.6 4.2 10.5 3.5 19.1 8.0 4.5 9.6 26.6 5.3 4.2 35.6 1.0 2.6 10.7 4.5 5.2 7.2 8.0 2.9 14.2 11.8 5.2 2.0 6.1 2.0 25.8 12.4 10.0 2.3 1.3 9.8 14.6 27.4 3.7 4.4 0.7 2.7 4.9 2.1 1.9 2.5 8.5 49.0 5.2 3.0 4.2 19.8 0.6 4.8 2.0 2.2 4.0 3.8 1.1 1.9 0.6 3.5 5.8 7.0 2.1 0.3 0.8 19.8 3.9 3.7 7.6 0.8 0.7 0.2 1.5 2.5 1.1 3.5 0.5 1.4 3.1 0.3 3.6 3.0 1.4 2.2 6.2 14.8 3.5 0.0 2.9 0.1 2.1 9.1 1.5 4.0 2.1 4.6 7.3 6.8 1.8 0.0 1.0 1.6 4.7 7.6 0.0 0.9 0.4 4.3 0.3 11.5 4.4 3.0 1.6 0.8 0.8 1.0 5.1 2.1 2.6 1.4 3.3 0.5 0.7 0.0 7.8 0.8 1.3 0.0 3.5 0.0 7.0 2.8 2.3 0.4 3.3 4.1 1.9 1.1 1.7 2.7 0.6 5.8 2.5 1.5 2.9 2.1 10.5 19.1 9.6 15.8 14.2 11.8 25.8 12.4 27.4 19.8 AKAP11 "AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11" ENSG00000023516 "A-kinase anchoring protein 11" Q9UKA4 13 42272153-42323267 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039089 Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoli "HPA039089: AB_10674279" "unprognostic (6.43e-2)" "prognostic unfavourable (9.26e-4)" "unprognostic (4.91e-1)" "unprognostic (6.89e-2)" "unprognostic (1.92e-1)" "unprognostic (7.34e-2)" "unprognostic (1.16e-1)" "unprognostic (1.83e-1)" "unprognostic (7.91e-2)" "unprognostic (2.15e-3)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (7.49e-3)" "unprognostic (7.44e-2)" "unprognostic (1.49e-1)" "unprognostic (6.02e-2)" "unprognostic (1.10e-1)" 11.2 13.6 21.7 10.0 42.3 3.0 11.0 19.9 30.7 17.1 9.1 9.0 5.9 6.9 13.0 15.2 10.2 10.2 9.7 10.4 18.3 17.9 12.9 9.9 10.2 13.4 16.4 22.8 14.6 6.4 11.6 14.5 7.2 20.3 11.1 10.1 6.7 7.6 12.4 5.7 9.1 8.1 13.4 21.4 11.7 9.5 18.1 16.0 5.6 13.3 4.6 12.6 10.4 9.4 3.0 1.6 4.2 1.4 4.8 2.7 0.7 9.2 9.5 11.7 6.9 15.4 18.9 5.1 12.6 10.5 7.6 7.2 10.4 7.7 19.1 4.9 14.1 11.1 10.1 10.5 14.7 20.3 4.7 5.4 6.6 5.1 12.1 13.4 13.3 13.8 10.9 15.5 13.6 11.1 17.7 7.8 15.3 7.0 7.8 4.3 6.9 4.5 6.5 8.2 9.2 7.6 6.9 5.0 7.2 9.6 6.4 4.5 5.5 7.3 15.4 12.9 6.7 19.5 9.5 3.0 3.7 9.9 16.5 6.9 9.0 4.2 0.9 1.2 1.7 1.1 2.1 2.7 2.4 1.6 1.0 3.0 2.1 2.1 0.3 4.8 1.4 1.6 2.7 0.7 21.7 42.3 19.9 24.6 18.3 17.9 16.4 22.8 20.3 16.0 AL136454.1 ENSG00000231767 1 192716132-192716653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 7.4;SK-MEL-30: 6.5;THP-1: 7.6" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA041344, HPA049132, HPA054087" Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA041344: , HPA049132: , HPA054087: " "unprognostic (2.56e-1)" "unprognostic (1.02e-2)" "unprognostic (1.90e-2)" "unprognostic (8.64e-2)" "unprognostic (3.78e-1)" "unprognostic (5.09e-2)" "unprognostic (7.80e-3)" "prognostic favourable (5.72e-4)" "unprognostic (1.59e-1)" "prognostic unfavourable (6.48e-4)" "unprognostic (3.07e-2)" "unprognostic (6.43e-2)" "unprognostic (5.80e-2)" "unprognostic (7.99e-2)" "unprognostic (2.58e-2)" "unprognostic (2.10e-2)" "unprognostic (3.62e-2)" 1.7 0.9 0.3 2.3 0.6 1.9 2.6 0.9 0.9 1.3 0.7 0.0 3.9 2.8 1.8 2.5 0.8 0.7 1.8 0.8 0.5 1.2 0.4 1.3 3.3 1.7 0.2 2.6 7.3 0.0 0.0 0.6 0.8 1.5 0.0 0.4 5.9 4.2 3.4 0.1 1.6 0.6 0.7 3.0 1.2 0.4 1.0 0.2 0.6 2.5 0.8 3.0 2.3 6.1 2.6 1.3 1.9 4.5 7.4 6.4 1.7 0.7 0.5 1.0 0.5 0.0 4.3 0.2 0.9 0.0 0.6 0.0 1.3 0.4 4.3 0.0 1.7 0.3 0.5 0.0 1.4 0.9 0.7 0.9 3.2 0.4 1.2 2.2 0.5 0.8 0.3 0.0 0.3 0.2 1.3 0.0 0.9 1.5 7.4 1.9 0.4 1.7 0.5 1.0 0.6 2.1 1.3 2.7 0.3 2.6 6.5 1.7 7.6 0.8 1.1 2.0 1.4 3.9 2.5 1.8 1.4 1.4 1.2 0.2 1.3 1.4 0.7 3.2 1.9 4.6 6.1 5.7 3.5 2.6 5.8 7.4 7.0 0.4 4.5 1.4 2.4 3.6 6.4 AL162231.1 ENSG00000187186 9 34664163-34666112 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 68.6" "Cell line enhanced" "Detected in many" "HeLa: 27.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069617 Enhanced Approved "Nucleoli,Endoplasmic reticulum,Vesicles" Vesicles "Nucleoli, Endoplasmic reticulum" "HPA069617: " "unprognostic (8.20e-3)" "unprognostic (3.13e-1)" "unprognostic (1.17e-2)" "unprognostic (2.03e-1)" "prognostic unfavourable (6.63e-5)" "unprognostic (2.30e-1)" "unprognostic (2.46e-2)" "unprognostic (9.22e-2)" "unprognostic (2.11e-1)" "unprognostic (2.55e-2)" "unprognostic (5.99e-4)" "unprognostic (8.02e-2)" "unprognostic (1.39e-5)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (7.08e-3)" "unprognostic (2.00e-2)" 3.0 6.9 12.1 2.1 21.6 1.8 2.9 6.9 20.2 2.3 1.8 1.9 1.1 2.8 4.0 13.9 1.8 1.8 2.2 9.1 11.8 9.5 4.9 2.5 2.2 1.4 9.6 12.2 7.8 6.2 3.4 13.1 2.3 7.0 3.7 1.2 1.8 4.6 2.1 21.9 2.2 2.0 3.8 5.0 1.0 1.4 68.6 5.3 0.6 3.5 2.0 0.7 1.5 2.5 4.0 11.8 12.0 2.5 3.5 2.9 1.6 0.3 5.9 5.4 7.0 4.5 2.2 4.9 4.7 1.4 2.9 3.4 0.9 2.3 0.0 0.6 3.1 1.3 3.5 1.6 0.5 12.6 0.6 0.0 27.7 1.7 1.1 2.5 4.4 2.4 1.9 1.8 1.8 0.8 3.1 7.2 2.1 0.0 0.5 2.6 4.5 1.5 0.0 5.2 0.9 5.3 0.0 5.6 9.1 3.3 1.1 7.9 2.8 7.2 1.1 10.4 14.5 3.3 1.1 7.7 2.6 1.0 12.9 1.5 14.3 12.0 2.5 2.6 1.8 1.3 1.7 4.0 2.3 1.0 0.8 1.6 2.9 1.5 3.5 3.5 0.8 11.8 2.0 1.6 12.1 21.6 6.9 20.2 11.8 9.5 9.6 12.2 7.0 5.3 ANKRD49 "FGIF, FLJ20189, GBIF" ENSG00000168876 "Ankyrin repeat domain 49" Q8WVL7 11 94493629-94499583 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040273, HPA048137" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA040273: AB_10674991, HPA048137: " "unprognostic (1.52e-2)" "unprognostic (2.76e-2)" "unprognostic (1.92e-1)" "unprognostic (5.22e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-3)" "unprognostic (1.46e-2)" "unprognostic (7.21e-3)" "unprognostic (1.36e-1)" "unprognostic (1.23e-1)" "unprognostic (4.21e-3)" "prognostic unfavourable (9.96e-4)" "unprognostic (6.32e-3)" "unprognostic (2.82e-1)" "unprognostic (3.40e-2)" "prognostic favourable (6.16e-4)" 9.8 9.0 10.2 10.7 10.8 19.6 12.7 18.6 10.9 15.6 14.8 4.5 9.5 11.2 15.1 19.6 13.2 8.2 7.9 5.7 9.5 6.9 13.3 11.0 10.4 17.5 7.2 8.5 12.3 15.6 9.1 27.9 16.3 7.7 12.6 13.1 7.7 12.1 10.7 7.9 8.8 19.2 9.6 12.5 21.3 12.1 5.3 8.5 22.6 18.0 9.9 19.2 11.9 9.3 20.5 17.7 34.7 15.1 17.3 19.6 10.5 6.4 2.9 7.5 6.5 7.4 9.5 9.1 10.1 9.0 10.6 12.5 14.0 12.6 16.9 15.5 7.1 14.0 9.1 6.9 8.5 13.1 7.4 14.5 11.3 4.7 8.5 12.7 11.6 6.6 17.2 8.2 11.4 8.3 13.7 10.0 7.0 4.4 13.5 23.2 4.3 7.2 11.0 8.4 8.4 10.0 6.8 7.5 7.7 6.9 6.9 6.3 14.1 8.6 5.1 9.6 6.8 10.5 5.0 5.8 13.5 17.9 3.2 15.4 5.5 34.7 15.1 12.6 14.9 12.5 16.3 20.5 15.9 13.1 11.4 19.6 19.6 17.9 27.1 17.3 9.3 17.7 19.1 10.5 10.2 10.8 18.6 10.9 9.5 6.9 7.2 8.5 7.7 8.5 ANKS6 "ANKRD14, FLJ36928, NPHP16, SAMD6" ENSG00000165138 "Ankyrin repeat and sterile alpha motif domain containing 6" Q68DC2 9 98731329-98796965 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008355 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA008355: AB_2058277" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (9.31e-2)" "unprognostic (9.15e-3)" "unprognostic (6.90e-3)" "unprognostic (1.22e-1)" "unprognostic (4.29e-3)" "unprognostic (4.10e-2)" "unprognostic (1.48e-1)" "unprognostic (3.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.94e-2)" "prognostic favourable (3.44e-5)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (3.95e-2)" "unprognostic (2.68e-1)" 5.0 3.7 5.8 4.3 9.9 1.8 4.8 31.2 9.5 7.3 6.5 9.4 2.6 5.9 6.0 7.4 7.5 7.8 7.7 2.9 6.9 6.1 7.7 1.8 7.2 3.4 10.1 4.4 9.6 18.1 10.0 2.8 2.8 11.4 3.6 7.3 4.2 3.1 3.5 3.3 4.4 5.4 8.9 6.1 2.5 7.7 6.1 9.2 1.8 13.4 2.4 4.5 5.4 6.4 0.9 0.0 0.0 0.1 0.0 2.1 0.2 5.4 8.3 7.7 13.4 6.4 5.2 5.2 4.0 6.9 4.5 5.4 4.6 4.0 10.2 3.1 5.7 16.5 5.6 6.8 2.4 14.2 5.8 2.5 5.0 1.9 6.3 1.3 1.7 6.4 8.5 6.2 6.3 5.1 17.2 2.4 3.4 9.1 0.5 2.6 12.1 9.1 6.8 19.1 0.8 8.2 3.4 5.0 5.7 1.7 9.9 4.5 0.0 2.8 5.2 4.8 5.2 12.9 3.9 4.8 8.0 1.7 6.7 4.6 6.8 0.0 0.1 0.0 1.3 0.0 0.7 0.9 0.7 2.1 0.0 0.6 1.8 0.9 0.0 0.0 0.0 0.0 1.1 0.2 5.8 9.9 31.2 9.5 6.9 6.1 10.1 4.4 11.4 9.2 ANXA10 ANX14 ENSG00000109511 "Annexin A10" Q9UJ72 4 168092515-168187690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 33.5;stomach 1: 105.3" "Group enriched" "Detected in some" 6 "PC-3: 41.0;RT4: 55.4" "Group enriched" "Detected in many" 5 "pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA005469 Enhanced Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA005469: AB_1844849" "unprognostic (2.29e-2)" "unprognostic (8.71e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (4.69e-1)" "unprognostic (2.29e-2)" "prognostic favourable (3.64e-6)" "unprognostic (1.18e-3)" "unprognostic (2.88e-1)" "unprognostic (8.61e-4)" "unprognostic (3.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-3)" "unprognostic (8.41e-2)" "unprognostic (4.01e-1)" "unprognostic (2.04e-1)" "unprognostic (8.89e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 1.4 0.1 4.2 0.1 0.1 0.5 0.0 33.5 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 1.5 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.4 0.1 0.1 105.3 0.1 0.1 0.1 0.1 0.1 0.1 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.2 0.0 0.0 55.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 APOC3 ENSG00000110245 "Apolipoprotein C3" P02656 11 116829706-116833072 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism, Lipid transport, Transport" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 714.1" "Group enriched" "Detected in some" 19 "CACO-2: 27.8;Hep G2: 75.2" "Cancer enriched" "Detected in many" 643 "liver cancer: 4021.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065365, HPA073918" Supported Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Secreted to blood" 88520000000 97000000000 Nucleoplasm "Nucleoli, Cell Junctions" "HPA065365: , HPA073918: " "prognostic favourable (3.77e-4)" "unprognostic (2.33e-1)" "prognostic unfavourable (6.87e-5)" "unprognostic (1.60e-2)" "unprognostic (5.21e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 38.7 0.1 0.1 31.7 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.4 714.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 91.3 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 27.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 75.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.6 0.9 0.0 0.0 0.3 1.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 ATP13A3 AFURS1 ENSG00000133657 "ATPase 13A3" Q9H7F0 3 194402672-194498364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029471 Approved Approved "Nucleoli,Plasma membrane,Cytosol" Nucleoli "Plasma membrane, Cytosol" "HPA029471: AB_10600784" "unprognostic (5.07e-2)" "unprognostic (3.53e-2)" "unprognostic (2.94e-1)" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (9.87e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "prognostic unfavourable (1.60e-4)" "unprognostic (2.70e-2)" "prognostic unfavourable (1.63e-4)" "unprognostic (1.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.34e-2)" "unprognostic (3.77e-1)" 27.1 14.4 9.0 20.8 12.7 17.5 22.8 15.3 13.8 12.1 13.4 10.8 17.2 11.4 16.2 13.2 12.4 11.3 17.1 37.8 9.6 8.1 29.7 56.9 22.1 11.6 10.1 8.3 13.2 11.4 37.6 10.6 28.9 10.6 11.8 12.6 12.9 16.7 15.9 11.8 7.7 15.0 12.1 9.0 17.1 16.3 8.8 8.4 18.9 37.1 12.0 12.7 17.8 16.1 1.9 2.4 2.3 2.3 2.2 4.7 1.0 49.9 5.7 10.2 9.7 11.6 18.1 24.8 17.2 18.7 18.7 34.0 31.3 12.2 19.7 51.1 24.7 17.0 9.7 17.1 43.5 65.7 8.5 10.9 7.6 6.7 20.1 35.4 28.6 8.3 7.7 38.8 25.3 9.7 12.5 39.9 22.7 8.5 14.2 7.1 9.7 9.9 13.0 21.9 11.8 15.8 16.0 15.6 8.3 18.2 19.0 12.8 36.3 24.8 12.6 22.8 19.0 45.3 32.0 26.4 47.5 35.1 45.4 21.0 15.8 1.8 1.7 2.3 1.8 2.3 2.2 1.9 1.7 2.8 2.4 1.1 2.5 2.5 0.3 2.2 0.9 1.6 4.7 1.0 9.0 12.7 15.3 13.8 9.6 8.1 10.1 8.3 10.6 8.4 ATXN1 "ATX1, D6S504E, SCA1" ENSG00000124788 "Ataxin 1" P54253 6 16299112-16761491 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 24.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008335, HPA070756" Approved Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA008335: AB_1845129, HPA070756: " "unprognostic (1.01e-1)" "unprognostic (4.77e-2)" "unprognostic (1.23e-1)" "unprognostic (5.64e-3)" "unprognostic (4.54e-1)" "unprognostic (1.95e-2)" "unprognostic (7.74e-2)" "unprognostic (4.51e-2)" "unprognostic (4.06e-1)" "unprognostic (1.11e-2)" "unprognostic (3.87e-2)" "unprognostic (2.69e-2)" "unprognostic (1.41e-3)" "unprognostic (1.67e-3)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (3.29e-3)" 8.1 9.1 17.7 11.9 25.1 5.5 9.1 33.7 29.5 14.8 13.5 12.9 10.3 8.2 20.5 9.8 11.1 11.0 12.1 11.8 18.0 11.0 9.1 10.1 14.8 11.6 21.1 17.7 10.7 10.3 18.4 11.6 10.3 16.4 14.2 8.5 9.8 8.4 14.0 26.3 12.0 8.3 19.1 16.1 11.4 10.3 8.1 25.6 4.6 11.8 12.5 7.4 11.7 11.3 0.4 0.8 4.4 1.7 0.1 2.5 0.8 3.3 2.0 0.7 0.0 3.5 4.8 4.6 3.7 8.6 2.2 2.6 2.1 2.1 0.1 5.0 7.1 3.2 0.2 2.3 3.3 1.9 3.6 0.5 3.2 6.7 5.6 3.1 5.5 3.7 4.4 4.7 4.0 4.6 0.0 4.1 1.9 1.7 0.2 3.6 0.7 3.3 0.2 4.5 3.0 3.1 5.8 0.2 1.9 3.4 4.3 7.0 2.8 5.4 7.0 3.2 4.9 3.7 3.3 24.1 13.8 0.1 2.0 3.2 7.7 0.7 1.7 0.4 2.5 1.3 1.9 0.4 1.7 2.4 0.8 0.1 0.2 1.5 4.4 0.1 0.7 0.4 1.3 0.8 17.7 25.1 33.7 29.5 18.0 11.0 21.1 17.7 16.4 25.6 ATXN3 "ATX3, JOS, MJD, SCA3" ENSG00000066427 "Ataxin 3" P54252 14 92044496-92106625 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB021976, HPA024123, HPA069338" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB021976: , HPA024123: AB_1845133, HPA069338: " "unprognostic (1.06e-2)" "unprognostic (2.93e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-2)" "unprognostic (5.76e-2)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (9.85e-3)" "unprognostic (1.69e-1)" "unprognostic (6.75e-2)" "unprognostic (1.04e-2)" "unprognostic (3.06e-2)" "unprognostic (2.03e-2)" "unprognostic (8.94e-3)" "unprognostic (4.22e-1)" "unprognostic (1.64e-1)" "unprognostic (1.11e-1)" 17.8 10.3 10.2 9.1 11.6 14.3 12.8 18.7 12.1 16.0 11.8 12.2 11.9 6.4 17.9 12.4 17.7 9.5 11.2 10.4 9.0 9.9 9.9 16.0 12.3 11.6 16.3 9.5 14.0 10.3 11.9 17.2 11.7 13.8 15.8 11.7 8.6 11.4 10.2 6.1 21.0 8.7 20.6 16.5 12.6 9.0 14.8 14.3 16.2 11.5 12.0 15.6 15.4 13.6 9.8 14.5 11.4 18.8 7.0 8.5 5.3 5.6 11.1 10.0 9.3 14.6 14.3 19.6 6.4 10.4 8.2 11.4 8.0 15.7 11.5 12.8 10.5 9.8 7.7 14.0 18.1 13.1 2.3 4.9 5.4 11.7 12.1 8.6 8.8 11.6 12.5 14.3 15.0 12.6 6.5 8.6 12.4 21.9 9.0 7.8 7.1 9.2 7.2 18.5 6.5 10.5 12.8 3.4 6.0 15.5 6.6 8.8 12.3 6.0 6.7 8.1 11.9 5.2 3.4 7.5 12.5 10.6 6.0 8.5 4.7 11.4 13.4 9.4 5.9 14.5 7.0 7.1 6.9 6.5 14.5 9.8 7.6 8.5 11.3 7.0 18.8 8.4 6.8 5.3 10.2 11.6 18.7 12.1 9.0 9.9 16.3 9.5 13.8 14.3 ATXN7L2 "FLJ00381, MGC46534" ENSG00000162650 "Ataxin 7 like 2" Q5T6C5 1 109483479-109492804 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029827, HPA054952" Uncertain Approved Nucleoli,Vesicles,Cytosol Nucleoli "Vesicles, Cytosol" "HPA029827: AB_10602390, HPA054952: " "unprognostic (4.53e-2)" "unprognostic (6.55e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (7.65e-4)" "unprognostic (3.90e-2)" "unprognostic (4.61e-5)" "unprognostic (2.40e-4)" "unprognostic (1.75e-1)" "unprognostic (3.53e-2)" "unprognostic (8.07e-2)" "unprognostic (2.77e-4)" "unprognostic (2.85e-2)" "prognostic unfavourable (1.19e-8)" "unprognostic (3.70e-2)" "unprognostic (1.08e-1)" "unprognostic (8.27e-2)" "unprognostic (3.94e-3)" 4.2 5.2 7.5 4.0 9.2 10.2 2.6 15.2 10.9 2.8 2.8 5.1 1.2 2.7 4.4 1.8 2.8 3.3 3.8 2.0 6.5 3.3 3.4 3.0 3.4 3.8 5.7 7.0 7.3 2.4 1.6 9.9 2.5 4.7 2.2 1.4 5.7 1.8 3.2 13.3 3.5 3.1 2.0 3.1 5.4 2.9 8.8 4.8 2.7 4.2 1.0 2.6 3.2 2.4 2.4 1.3 2.4 2.4 2.7 5.6 2.2 2.2 1.7 1.2 4.5 1.6 2.9 3.2 1.6 2.1 3.4 2.2 3.6 1.5 5.8 2.6 2.0 2.5 2.4 2.2 0.4 5.3 3.4 3.2 3.6 1.6 1.0 4.8 7.6 3.1 1.2 3.5 0.0 0.8 5.3 3.3 0.6 7.0 8.4 6.3 7.0 2.5 5.9 2.9 4.1 1.2 2.3 10.6 4.3 1.7 5.7 2.6 1.0 5.0 0.3 2.4 7.0 2.2 6.4 2.1 1.4 5.5 2.8 4.0 6.0 0.0 1.9 2.4 5.4 2.4 5.0 2.3 4.3 5.6 1.3 2.4 4.0 3.8 1.9 2.7 1.6 1.0 3.8 2.2 7.5 9.2 15.2 10.9 6.5 3.3 5.7 7.0 4.7 4.8 BMP7 OP-1 ENSG00000101144 "Bone morphogenetic protein 7" P18075 20 57168748-57266629 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.0;thyroid gland: 44.3" "Cell line enhanced" "Detected in some" "Daudi: 41.5;MCF7: 48.0;RPMI-8226: 18.4;SK-BR-3: 31.3;U-698: 56.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "basophil: 2.4" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057757 Approved Nucleoplasm,Nucleoli,Vesicles "Secreted to blood" 247500 Vesicles "Nucleoplasm, Nucleoli" "HPA057757: " "unprognostic (1.67e-1)" "unprognostic (9.72e-3)" "unprognostic (9.67e-2)" "prognostic unfavourable (2.91e-4)" "unprognostic (2.62e-1)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (6.78e-2)" "unprognostic (4.63e-3)" "unprognostic (4.03e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (4.30e-2)" "unprognostic (1.21e-1)" "unprognostic (5.42e-2)" "unprognostic (1.59e-1)" 1.5 7.2 16.8 2.4 17.5 0.7 2.1 3.8 19.7 9.2 2.3 23.6 6.0 2.7 1.9 17.7 17.2 10.0 1.2 8.5 13.9 9.9 4.5 0.7 1.8 1.6 14.3 11.2 0.8 1.0 0.8 1.9 24.4 12.2 5.0 2.4 37.0 2.6 10.3 1.0 15.5 2.4 1.0 13.8 1.3 4.1 1.4 13.4 1.8 44.3 5.7 4.9 7.8 7.0 0.1 0.1 2.4 0.0 0.0 0.1 0.0 0.0 0.1 5.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 1.6 41.5 10.6 0.0 12.0 1.2 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.0 0.0 3.0 0.0 0.0 0.0 18.4 0.0 0.0 0.1 4.5 1.3 31.3 0.1 0.2 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 56.7 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 16.8 17.5 3.8 12.5 13.9 9.9 14.3 11.2 12.2 13.4 BRWD1 "C21orf107, DCAF19, FLJ11315, N143, WDR9" ENSG00000185658 "Bromodomain and WD repeat domain containing 1" Q9NSI6 21 39184176-39321559 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030943, HPA030944, HPA030945, CAB034184" Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "CAB034184: AB_2243666, HPA030943: , HPA030944: , HPA030945: AB_10670161" "unprognostic (6.00e-2)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (1.31e-1)" "unprognostic (1.27e-1)" "unprognostic (8.39e-3)" "unprognostic (4.94e-2)" "unprognostic (5.01e-2)" "unprognostic (8.90e-2)" "unprognostic (2.26e-1)" "unprognostic (4.82e-3)" "unprognostic (5.45e-2)" "unprognostic (2.58e-3)" "unprognostic (6.48e-2)" "unprognostic (1.19e-1)" "unprognostic (3.88e-2)" "unprognostic (2.56e-2)" 10.9 16.7 33.0 15.4 36.8 13.4 16.3 15.5 40.2 12.3 12.0 14.3 10.5 8.8 13.0 21.1 10.2 11.8 9.9 12.9 29.1 32.9 13.9 21.8 10.0 12.9 24.3 17.7 16.2 17.2 12.8 12.0 15.2 13.4 13.2 11.5 13.0 9.3 11.8 14.6 11.9 9.6 13.1 16.1 9.6 9.9 17.2 10.5 22.4 17.7 9.3 13.2 12.1 11.6 8.5 7.2 11.6 6.1 10.2 11.1 3.8 10.2 4.1 10.1 5.6 6.5 9.8 10.4 5.9 7.0 4.6 5.4 3.9 7.0 33.0 6.2 8.0 5.1 9.4 6.8 7.3 7.6 7.8 22.4 7.2 7.1 8.2 12.3 6.3 6.7 11.3 6.3 16.0 6.8 16.5 16.6 6.4 7.9 8.4 14.6 10.6 5.8 14.9 7.9 10.4 5.6 6.6 8.0 10.3 12.6 15.3 8.8 12.9 17.3 7.5 6.1 2.9 3.5 4.4 18.5 12.7 16.1 7.3 13.2 4.8 4.4 5.2 11.6 10.7 6.1 8.3 8.5 9.2 11.0 7.2 6.3 11.1 9.0 5.7 10.2 3.8 6.8 10.3 3.8 33.0 36.8 15.5 40.0 29.1 32.9 24.3 17.7 13.4 10.5 C10orf67 "bA215C7.4, C10orf115, LINC01552, MGC46732" ENSG00000179133 "Chromosome 10 open reading frame 67" Q8IYJ2 10 23201916-23344845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8" "Cell line enhanced" "Detected in some" "HaCaT: 5.2;SiHa: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 4.2" "Low lineage specificity" "Detected in many" "HPA038130, HPA038131" Approved Approved "Nucleoplasm,Nucleoli,Nuclear speckles" Nucleoplasm "Nucleoli, Nuclear speckles" "HPA038130: , HPA038131: AB_10670658" "unprognostic (4.76e-4)" "unprognostic (2.38e-1)" "unprognostic (3.75e-2)" "unprognostic (2.92e-2)" "unprognostic (9.67e-3)" "unprognostic (1.91e-1)" "unprognostic (1.54e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (2.46e-3)" "unprognostic (3.98e-1)" "unprognostic (3.59e-2)" "unprognostic (3.84e-3)" "unprognostic (9.58e-2)" 0.1 0.1 1.3 1.7 2.6 0.2 0.0 0.1 1.9 0.3 0.5 0.4 1.3 0.5 0.2 4.6 0.1 7.3 0.2 3.2 1.6 1.4 5.0 0.5 4.0 0.3 0.9 0.5 1.8 0.3 0.4 9.0 0.1 1.2 0.1 0.0 0.2 0.1 0.1 0.6 1.9 0.4 0.0 0.7 0.2 0.1 13.8 0.6 0.0 0.6 0.7 0.1 0.1 0.1 1.1 1.1 1.0 0.5 1.1 4.2 0.0 1.5 0.1 1.9 0.2 0.0 0.5 0.4 0.2 0.1 2.0 1.6 0.1 2.4 0.2 0.2 1.5 5.2 0.2 0.7 1.6 0.5 0.4 0.1 0.7 0.3 1.0 0.1 0.0 0.6 1.7 0.6 1.0 0.0 0.2 0.7 0.0 0.3 0.1 0.5 0.9 0.1 0.1 0.2 0.4 1.7 0.3 0.9 0.4 8.4 0.3 0.1 0.3 0.3 0.2 0.4 1.5 0.4 0.1 1.0 0.2 0.1 2.5 0.2 0.1 1.0 0.5 0.6 0.7 0.3 0.6 1.1 1.5 0.8 0.1 1.0 1.1 1.0 0.8 1.1 0.3 1.1 4.2 0.0 1.3 2.6 0.1 1.9 1.6 1.4 0.9 0.5 1.2 0.6 C15orf61 LOC145853 ENSG00000189227 "Chromosome 15 open reading frame 61" A6NNL5 15 67521068-67530143 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 45.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062820 Approved Nucleoli,Vesicles,Cytosol "Secreted - unknown location" "Nucleoli, Vesicles" Cytosol "HPA062820: " "unprognostic (1.35e-1)" "unprognostic (9.42e-3)" "unprognostic (2.11e-1)" "unprognostic (5.41e-2)" "unprognostic (2.40e-1)" "unprognostic (2.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.87e-3)" "unprognostic (8.95e-2)" "unprognostic (4.01e-2)" "unprognostic (1.04e-2)" "unprognostic (8.45e-2)" "prognostic favourable (5.31e-5)" "unprognostic (2.42e-2)" "unprognostic (9.78e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" 9.9 10.0 10.8 4.7 18.1 11.0 17.9 14.5 17.2 5.5 6.0 2.4 5.6 7.5 6.3 5.9 5.5 5.2 5.1 21.0 8.7 7.2 8.4 6.4 7.2 7.5 6.9 10.9 7.9 20.7 8.8 10.9 5.8 7.3 7.2 6.4 5.9 7.0 6.4 45.8 8.4 5.0 7.0 5.8 5.0 6.6 25.2 5.5 3.6 7.7 16.9 3.7 4.6 8.0 7.2 7.2 10.7 6.6 5.1 9.8 5.0 4.3 4.6 1.2 5.1 5.4 7.9 3.3 1.9 3.4 3.6 2.8 3.5 3.1 3.6 4.1 2.1 5.1 4.6 1.3 2.9 2.1 10.9 3.9 3.5 4.6 3.5 4.7 3.2 8.1 3.6 1.2 4.3 1.6 4.3 8.1 1.1 2.4 3.8 7.7 2.0 5.9 5.2 2.6 13.2 2.5 3.0 6.9 5.2 3.3 3.2 5.8 2.8 7.3 1.7 4.8 7.3 5.9 4.9 7.7 11.1 8.8 2.0 9.3 2.4 8.6 6.6 10.7 7.0 5.2 8.0 7.2 9.2 6.9 6.9 5.6 9.8 7.9 0.8 5.1 4.4 7.2 5.6 5.0 10.8 18.1 14.5 17.2 8.7 7.2 6.9 10.9 7.3 5.5 C1orf109 FLJ20508 ENSG00000116922 "Chromosome 1 open reading frame 109" Q9NX04 1 37681570-37692249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027110, HPA027127" Supported Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA027110: AB_10611813, HPA027127: AB_1845628" "unprognostic (1.37e-1)" "unprognostic (3.65e-2)" "unprognostic (2.43e-1)" "unprognostic (3.30e-3)" "unprognostic (1.71e-2)" "unprognostic (7.13e-3)" "prognostic unfavourable (1.76e-7)" "unprognostic (1.93e-1)" "unprognostic (1.48e-2)" "unprognostic (8.38e-2)" "unprognostic (1.73e-1)" "unprognostic (3.79e-3)" "unprognostic (9.96e-2)" "unprognostic (1.66e-2)" "unprognostic (2.25e-1)" "unprognostic (7.96e-3)" "unprognostic (1.69e-1)" 13.8 15.1 12.0 9.3 15.0 9.3 14.5 17.9 20.5 12.9 11.1 11.4 16.2 11.0 15.9 14.3 13.7 13.9 10.5 11.1 13.1 12.9 12.8 12.0 8.8 14.1 13.6 15.0 19.7 19.6 20.5 10.9 14.6 15.9 15.0 7.8 12.9 20.3 14.8 15.2 14.9 8.5 11.6 9.9 10.1 11.1 11.2 12.2 13.1 15.7 9.1 12.6 13.7 12.8 11.4 27.5 3.3 5.0 12.2 16.2 7.5 8.2 9.5 8.2 13.4 7.2 5.2 18.7 9.9 7.1 15.0 11.1 14.4 10.0 11.7 12.0 4.3 12.0 15.1 10.1 15.4 18.7 17.0 13.4 9.6 9.0 13.9 14.5 8.8 7.0 12.5 14.8 19.3 7.5 26.2 14.3 8.5 5.7 14.1 6.4 25.6 18.3 14.0 17.2 32.2 7.9 7.1 24.8 11.9 8.7 13.5 20.1 7.6 6.6 5.0 15.1 9.5 12.1 20.1 11.7 13.0 24.0 7.5 14.3 15.8 1.7 5.0 3.3 10.3 3.9 16.1 11.4 12.4 9.9 5.9 10.3 16.2 13.8 0.9 12.2 4.2 27.5 6.2 7.5 12.0 15.0 17.9 20.5 13.1 12.9 13.6 15.0 15.9 12.2 C8orf34 "vest-1, VEST1" ENSG00000165084 "Chromosome 8 open reading frame 34" Q49A92 8 68330722-68819022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;parathyroid gland: 19.9" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.4;HEK 293: 5.7;LHCN-M2: 4.9;RH-30: 5.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044420, HPA053065" Uncertain Supported "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA044420: AB_10963791, HPA053065: " "unprognostic (1.75e-1)" "unprognostic (2.20e-1)" "unprognostic (3.30e-2)" "unprognostic (5.59e-3)" "unprognostic (3.07e-1)" "unprognostic (2.85e-2)" "unprognostic (3.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.80e-1)" "unprognostic (1.74e-1)" "unprognostic (8.55e-2)" "unprognostic (5.86e-2)" "unprognostic (1.80e-4)" "unprognostic (5.21e-2)" "unprognostic (8.87e-2)" "unprognostic (2.84e-4)" "unprognostic (1.33e-1)" 4.2 0.9 7.4 0.8 10.6 1.1 1.5 9.6 8.4 4.0 0.7 9.6 0.2 0.7 1.5 2.5 2.1 15.3 3.2 1.6 8.9 7.0 1.0 0.7 8.3 0.8 3.7 5.0 1.4 2.1 19.9 2.7 0.9 10.4 3.9 0.9 3.5 1.4 2.2 0.9 1.8 0.8 1.7 3.2 0.8 1.7 1.4 6.7 0.0 1.0 1.1 0.7 1.2 1.1 1.8 2.0 2.9 0.7 1.3 1.8 0.5 0.3 0.0 0.8 0.4 1.2 2.2 0.2 1.4 4.4 0.7 0.6 0.3 0.4 0.2 0.9 1.2 0.3 0.3 0.8 0.2 0.1 5.7 0.7 1.0 0.4 0.2 0.1 0.5 0.1 0.6 0.8 1.5 0.1 0.3 1.0 4.9 0.6 0.1 0.5 2.5 0.1 0.2 5.3 0.1 0.6 0.4 1.1 0.1 0.3 0.3 0.0 2.5 0.2 0.1 1.0 0.6 3.3 0.2 0.8 0.0 0.1 0.4 0.3 0.8 2.1 0.7 1.2 1.4 0.3 1.1 1.0 1.2 1.1 0.3 1.8 1.5 1.8 2.9 1.3 0.5 2.0 0.8 0.5 7.4 10.6 9.6 8.4 8.9 7.0 3.7 5.0 10.4 6.7 C8orf59 ENSG00000176731 "Chromosome 8 open reading frame 59" Q8N0T1 8 85214076-85220421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044805, HPA071903" Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA044805: , HPA071903: " "unprognostic (1.61e-2)" "unprognostic (2.98e-1)" "unprognostic (4.51e-1)" "unprognostic (1.63e-3)" "unprognostic (2.19e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-3)" "unprognostic (1.63e-1)" "unprognostic (1.69e-2)" "unprognostic (2.82e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (2.29e-1)" "unprognostic (3.84e-3)" 28.1 28.2 25.3 25.3 21.9 33.0 46.1 18.9 26.5 33.0 38.4 12.6 36.3 28.1 32.0 45.5 44.8 28.7 25.8 41.5 20.6 24.1 32.3 47.1 20.8 30.7 26.3 27.2 45.1 35.1 19.5 36.0 27.7 24.4 35.5 27.7 14.7 37.8 36.2 43.9 24.8 37.1 33.7 27.0 32.2 36.9 16.7 25.7 39.1 43.5 53.6 32.0 39.1 35.2 33.3 42.7 21.3 25.3 36.5 38.0 23.9 43.6 22.3 33.1 21.5 20.6 39.9 25.9 29.0 27.9 34.0 33.6 25.9 37.8 10.9 24.1 19.2 30.4 23.0 31.9 38.4 30.7 25.1 64.4 21.1 38.3 24.4 24.2 29.2 33.8 37.9 21.9 27.8 28.8 28.9 26.8 28.2 34.4 53.3 45.5 9.5 38.9 22.8 27.7 49.5 33.0 28.0 11.2 24.0 22.0 36.2 40.0 41.8 36.1 22.0 21.7 45.5 24.0 27.5 31.3 36.6 51.2 43.3 31.0 24.1 21.3 20.5 13.4 24.7 25.3 29.5 33.3 32.7 30.1 34.8 29.9 38.0 36.3 5.1 36.5 21.5 42.7 32.1 23.9 25.3 21.9 18.9 26.5 20.6 24.1 26.3 27.2 24.4 25.7 C9orf85 MGC61599 ENSG00000155621 "Chromosome 9 open reading frame 85" Q96MD7 9 71911510-71986054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050767, HPA076627" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA050767: , HPA076627: " "unprognostic (7.81e-2)" "unprognostic (2.80e-1)" "unprognostic (6.21e-2)" "unprognostic (3.04e-1)" "unprognostic (2.89e-2)" "unprognostic (2.87e-2)" "unprognostic (1.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.01e-1)" "unprognostic (3.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.48e-1)" "unprognostic (1.10e-2)" "unprognostic (8.10e-2)" "unprognostic (6.60e-2)" "unprognostic (4.02e-1)" "unprognostic (6.18e-2)" 13.4 12.7 15.5 10.1 26.0 8.9 14.7 11.2 18.8 12.8 12.9 18.2 15.0 19.3 14.1 14.3 18.4 11.6 12.0 10.5 14.9 13.8 12.3 13.1 10.4 13.0 24.5 13.3 16.9 14.7 9.8 16.9 13.9 15.2 13.1 13.7 14.3 14.7 9.8 14.6 18.4 16.3 15.2 21.1 10.7 11.2 9.2 21.9 14.5 14.8 15.9 12.9 18.8 15.5 11.3 13.1 16.1 9.9 17.1 14.6 9.3 7.6 5.1 9.0 7.3 9.4 17.1 9.1 9.9 15.3 7.9 7.8 1.1 4.6 12.5 5.0 8.5 14.0 9.4 9.3 11.0 8.8 4.6 7.6 7.4 6.3 10.1 11.2 6.3 13.8 12.8 8.0 17.5 9.7 9.0 8.4 10.1 3.9 13.5 7.9 8.4 12.4 8.0 15.5 0.3 11.3 11.1 7.4 9.8 4.9 12.5 16.2 4.4 6.5 8.5 7.3 9.4 16.7 7.2 8.5 13.9 5.7 10.0 8.6 4.8 16.1 8.9 12.6 13.4 9.9 13.7 10.9 11.5 11.5 9.3 11.3 14.0 14.6 9.9 17.1 8.3 13.1 10.5 9.3 15.5 26.0 11.2 18.8 14.9 13.8 24.5 13.3 15.2 21.9 CA13 "CAXIII, FLJ37995, MGC59868" ENSG00000185015 "Carbonic anhydrase 13" Q8N1Q1 8 85220587-85284073 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.7" "Cell line enhanced" "Detected in many" "HEL: 16.1;RPTEC TERT1: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024689, CAB025567" Enhanced Uncertain Nucleoplasm,Nucleoli,Vesicles 100000 Nucleoli "Nucleoplasm, Vesicles" "CAB025567: , HPA024689: AB_1846004" "unprognostic (1.12e-2)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (9.16e-5)" "unprognostic (2.21e-2)" "unprognostic (2.08e-1)" "unprognostic (9.39e-2)" "unprognostic (7.90e-3)" "unprognostic (1.97e-1)" "unprognostic (1.34e-2)" "unprognostic (3.58e-2)" "unprognostic (3.13e-1)" "prognostic favourable (9.40e-4)" "unprognostic (7.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.55e-2)" "unprognostic (3.00e-1)" 2.6 2.6 2.0 1.9 3.1 0.5 2.9 2.4 2.4 3.2 18.2 0.8 0.0 14.2 1.8 1.7 6.7 1.4 25.6 5.8 1.6 1.9 10.4 17.1 9.5 2.4 2.0 0.1 2.2 1.6 9.3 6.5 1.0 5.7 2.6 3.7 1.9 7.0 1.0 1.9 7.1 56.7 1.9 5.2 2.2 7.0 0.9 0.9 0.4 10.3 3.9 5.6 2.9 5.2 0.8 2.1 3.2 2.5 0.5 0.5 1.0 0.3 0.4 0.9 0.1 0.6 0.7 0.4 1.1 1.1 0.1 3.1 7.5 5.8 0.4 0.5 1.3 2.4 2.3 3.0 0.2 1.6 1.0 16.1 2.1 6.9 1.6 0.2 0.7 2.4 0.5 0.2 1.3 1.7 4.1 3.2 2.7 0.1 0.3 0.2 0.5 0.5 0.2 2.4 0.2 8.7 0.3 0.3 0.1 0.5 0.0 1.6 0.6 0.8 1.6 3.0 4.3 0.1 1.6 1.3 0.6 2.0 6.3 2.3 2.8 3.2 2.5 1.3 0.4 0.7 0.2 0.2 0.2 0.1 2.1 0.8 0.3 0.5 0.9 0.5 0.8 0.9 0.1 1.0 2.0 3.1 2.4 2.4 1.6 1.9 2.0 0.1 5.7 0.9 CAMLG "CAML, GET2" ENSG00000164615 "Calcium modulating ligand" P49069 5 134738501-134752160 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052636, HPA056472" Approved Approved Nucleoplasm,Nucleoli,Vesicles Vesicles "Nucleoplasm, Nucleoli" "HPA052636: , HPA056472: " "unprognostic (9.23e-2)" "unprognostic (8.54e-2)" "unprognostic (2.95e-1)" "unprognostic (2.21e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (3.68e-2)" "unprognostic (5.41e-3)" "unprognostic (3.07e-1)" "unprognostic (8.54e-2)" "unprognostic (5.34e-3)" "unprognostic (4.58e-2)" "prognostic unfavourable (1.09e-5)" "unprognostic (3.26e-2)" "unprognostic (1.43e-2)" "unprognostic (2.19e-1)" "unprognostic (3.16e-1)" 24.2 29.0 37.6 14.3 32.4 22.7 29.3 28.2 39.3 33.3 32.7 15.5 20.2 26.1 31.7 45.2 21.4 23.0 21.8 22.3 32.4 38.3 20.1 19.7 18.9 18.4 36.2 22.7 53.0 25.7 14.8 21.9 14.0 22.4 27.5 14.3 21.7 15.9 26.2 32.5 19.7 22.2 30.4 26.0 15.1 17.7 36.6 14.0 21.1 21.6 18.5 19.3 40.3 20.0 25.0 16.1 32.1 23.3 16.6 28.6 17.4 9.5 7.4 12.8 23.7 28.4 44.0 5.7 13.6 19.8 10.2 19.3 13.6 14.6 39.1 20.0 9.5 12.4 10.5 16.6 14.5 18.2 19.4 10.4 13.6 11.1 20.9 5.5 32.9 35.6 18.1 12.5 21.6 19.2 6.5 18.2 15.1 10.7 14.5 23.2 6.5 7.5 16.3 16.9 15.1 17.5 9.4 18.9 13.3 9.8 6.2 32.6 17.2 11.5 18.4 9.9 6.1 15.1 12.3 17.2 18.5 15.0 16.7 17.3 5.4 32.1 15.2 32.1 18.3 17.3 24.6 25.0 26.4 22.9 16.1 22.4 27.8 26.8 27.6 16.6 23.3 14.7 28.6 17.4 37.6 32.4 28.2 39.3 32.4 38.3 36.2 22.7 22.4 14.0 CAPS2 ENSG00000180881 "Calcyphosine 2" Q9BXY5 12 75275979-75390928 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.7" "Cell line enhanced" "Detected in many" "A549: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040004 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome Centrosome "Nucleoplasm, Nucleoli" "HPA040004: AB_10794758" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" "unprognostic (7.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.05e-2)" "unprognostic (1.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.36e-1)" "unprognostic (9.61e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-3)" "unprognostic (1.01e-1)" "unprognostic (1.32e-2)" "unprognostic (3.07e-1)" "unprognostic (1.75e-1)" "unprognostic (4.52e-2)" "unprognostic (2.69e-1)" 2.6 4.2 8.0 1.2 5.8 1.6 3.7 15.5 11.2 3.7 2.5 5.5 2.1 1.8 5.0 8.8 3.6 21.7 3.4 5.4 6.3 6.6 6.6 4.2 5.8 1.3 5.4 5.6 4.5 2.6 7.3 15.8 0.9 7.8 5.1 2.0 4.4 5.5 3.6 3.8 2.6 1.9 2.0 8.7 2.6 3.2 8.0 9.5 1.4 9.3 2.2 1.4 2.6 2.0 0.1 0.6 0.0 0.7 1.1 1.8 0.1 1.8 5.0 1.4 0.4 2.5 1.9 0.2 1.0 0.2 2.7 2.9 0.0 2.3 0.5 4.4 0.7 1.1 0.0 2.2 1.9 1.7 0.8 2.1 0.8 0.0 0.0 0.3 0.0 0.8 1.3 2.3 0.5 0.3 0.4 0.8 3.5 0.1 2.4 2.0 0.7 0.7 0.0 0.0 0.2 3.5 0.0 2.9 1.4 0.2 0.1 1.6 1.7 0.7 1.1 2.5 1.1 0.6 0.4 0.2 0.0 0.0 2.2 0.0 2.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.7 0.0 0.0 0.1 0.6 0.9 0.0 1.1 0.7 0.6 1.8 0.1 8.0 5.8 15.5 11.2 6.3 6.6 5.4 5.6 7.8 9.5 CATSPERG "C19orf15, DKFZp434A1022, FLJ46353" ENSG00000099338 "Cation channel sperm associated auxiliary subunit gamma" Q6ZRH7 19 38335775-38370943 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.7" "Cell line enhanced" "Detected in some" "BEWO: 4.1;HMC-1: 5.2;MCF7: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;monocytes: 1.8" "Low region specificity" "Detected in all" HPA052777 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in male reproductive system" Nucleoli "Nucleoplasm, Cytosol" "HPA052777: " "unprognostic (8.50e-5)" "unprognostic (5.12e-2)" "unprognostic (3.57e-3)" "unprognostic (1.51e-1)" "unprognostic (2.63e-1)" "unprognostic (3.18e-1)" "unprognostic (2.60e-1)" "unprognostic (2.87e-3)" "unprognostic (1.00e-1)" "unprognostic (2.92e-2)" "unprognostic (1.06e-1)" "unprognostic (2.50e-1)" "unprognostic (4.37e-4)" "unprognostic (9.99e-2)" "unprognostic (2.01e-1)" "unprognostic (4.61e-2)" "unprognostic (1.07e-3)" 0.9 0.8 2.9 0.8 7.7 1.1 1.3 4.3 5.8 1.2 1.1 6.5 1.9 1.2 1.2 1.8 0.9 1.4 0.9 0.8 3.9 1.0 1.0 1.0 1.1 1.0 7.4 2.2 1.3 1.0 1.0 1.2 0.8 5.2 1.3 1.0 0.4 2.0 1.1 1.0 2.0 1.1 0.9 3.2 0.9 1.0 35.7 6.5 2.2 1.3 0.0 1.0 0.9 3.3 0.1 0.6 4.8 1.8 0.2 0.5 0.2 0.2 0.4 0.2 1.8 0.8 0.0 4.1 0.2 0.0 0.0 0.0 1.3 0.8 0.3 0.0 0.0 0.6 0.5 0.1 0.0 0.9 0.2 0.1 0.2 0.0 0.1 0.3 5.2 0.0 0.8 0.0 0.5 0.1 0.0 1.3 0.0 4.2 0.0 0.0 0.0 0.8 0.1 0.0 0.8 1.9 0.1 0.4 0.5 0.4 0.9 0.2 0.4 0.0 0.3 0.0 1.0 0.6 0.0 0.7 0.9 0.0 0.2 0.2 0.0 0.3 0.8 1.8 0.4 0.9 0.2 0.0 0.1 0.2 0.6 0.1 0.5 0.2 4.8 0.2 1.8 0.4 0.3 0.2 2.9 7.7 4.3 5.8 3.9 1.0 7.4 2.2 5.2 6.5 CCDC175 C14orf38 ENSG00000151838 "Coiled-coil domain containing 175" P0C221 14 59504539-59576831 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.1;pituitary gland: 6.6;testis: 8.2" "Cell line enhanced" "Detected in some" "HDLM-2: 1.5;SCLC-21H: 1.7" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "cerebellum: 17.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA004200 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA004200: AB_1078743" "unprognostic (3.64e-3)" "unprognostic (8.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.21e-1)" "unprognostic (3.83e-1)" "unprognostic (2.02e-2)" "unprognostic (5.98e-2)" "unprognostic (1.27e-1)" 0.2 0.1 0.9 0.2 2.9 0.5 0.2 17.1 3.3 0.2 0.9 1.2 0.0 0.3 0.2 1.0 0.2 1.3 0.5 0.2 0.8 0.5 0.4 0.2 0.5 0.2 0.8 0.9 0.2 0.1 0.3 6.6 0.1 3.0 0.2 1.8 0.6 0.2 0.2 0.2 0.3 0.9 0.2 0.4 0.4 0.2 8.2 1.5 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.1 0.5 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.4 0.9 2.9 17.1 3.3 0.8 0.5 0.8 0.9 3.0 1.5 CCDC24 MGC45441 ENSG00000159214 "Coiled-coil domain containing 24" Q8N4L8 1 43991359-43996528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 6.8" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035424, HPA061710" Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoli, Cytosol" "HPA035424: AB_2674619, HPA061710: " "prognostic favourable (3.06e-5)" "unprognostic (1.47e-1)" "unprognostic (1.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.65e-2)" "prognostic favourable (3.18e-4)" "prognostic unfavourable (1.70e-4)" "unprognostic (1.92e-2)" "unprognostic (6.38e-2)" "unprognostic (2.81e-1)" "unprognostic (7.00e-3)" "unprognostic (3.00e-1)" "unprognostic (1.74e-2)" "unprognostic (6.91e-2)" "unprognostic (1.51e-1)" "unprognostic (7.84e-2)" "unprognostic (2.15e-3)" 1.8 5.5 9.3 2.6 9.8 1.1 5.1 3.0 9.8 7.2 5.0 3.2 18.9 3.7 4.9 6.6 2.6 20.3 13.1 1.5 6.4 8.0 8.9 3.0 3.2 2.6 5.5 9.6 3.4 6.0 9.6 14.5 2.4 5.2 7.2 4.1 6.5 8.4 14.7 1.5 0.9 3.3 3.4 3.3 3.0 4.9 15.4 1.7 0.6 8.8 1.0 2.5 4.7 2.1 6.8 0.8 1.4 4.0 0.5 0.6 0.5 5.1 3.0 1.4 1.5 1.4 0.9 3.1 0.2 2.1 1.6 2.8 2.0 14.8 4.1 5.8 0.6 5.2 0.8 7.3 1.5 4.3 1.8 2.1 1.8 0.6 1.6 0.7 3.6 0.3 0.7 5.2 0.5 1.3 0.9 1.5 2.2 4.4 0.2 1.5 3.1 2.6 1.3 0.0 0.8 6.1 2.0 3.4 3.0 4.5 2.6 2.8 7.6 0.1 0.4 2.4 6.9 1.7 0.7 0.6 1.9 0.9 6.2 0.6 1.9 0.0 0.7 1.4 0.6 4.0 0.3 6.8 0.2 0.2 0.8 3.0 0.0 0.0 0.6 0.5 3.1 0.6 0.0 0.5 9.3 9.8 3.0 9.8 6.4 8.0 5.5 9.6 5.2 1.7 CCDC58 FLJ33273 ENSG00000160124 "Coiled-coil domain containing 58" Q4VC31 3 122359591-122383231 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047777, HPA051965" Approved Approved "Nucleoli,Intermediate filaments,Mitochondria" Mitochondria "Nucleoli, Intermediate filaments" "HPA047777: AB_2680152, HPA051965: AB_2681676" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.53e-4)" "unprognostic (5.64e-2)" "unprognostic (6.98e-3)" "prognostic unfavourable (2.94e-5)" "unprognostic (2.72e-2)" "unprognostic (1.03e-2)" "unprognostic (4.98e-3)" "unprognostic (5.26e-3)" "unprognostic (1.84e-2)" "unprognostic (7.11e-3)" "unprognostic (1.03e-3)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "prognostic favourable (7.29e-4)" 9.5 13.3 8.7 6.8 8.1 7.1 9.2 6.9 12.6 8.2 13.3 7.1 12.4 10.6 7.3 12.4 14.0 5.8 7.7 12.4 7.2 7.0 21.9 23.3 5.4 10.0 8.6 5.3 8.8 9.3 3.1 7.7 6.7 8.5 8.2 14.4 6.5 7.2 6.9 35.2 6.9 10.2 6.3 7.2 8.6 9.1 8.7 9.3 5.5 8.8 24.5 9.6 8.7 7.1 13.9 18.3 1.7 10.2 11.4 16.1 4.6 34.5 11.0 21.0 13.4 7.8 11.0 27.0 13.3 14.4 32.2 31.8 30.9 17.6 25.4 23.0 10.1 24.2 34.0 22.7 38.7 8.7 12.0 29.9 7.8 37.4 13.1 44.4 10.7 9.0 11.8 19.7 21.7 14.8 33.8 11.1 16.9 17.2 28.3 31.8 40.2 20.8 18.8 24.9 31.2 22.2 18.4 21.2 10.4 15.4 16.4 36.9 16.3 29.3 8.5 18.1 23.2 7.6 26.4 8.8 11.7 54.8 20.6 21.6 15.9 0.4 5.0 1.7 10.2 10.2 12.0 13.9 13.6 13.4 10.3 13.5 16.1 14.9 0.9 11.4 8.5 18.3 10.5 4.6 8.7 8.1 6.9 12.6 7.2 7.0 8.6 5.3 8.5 9.3 CCDC59 "BR22, HSPC128, TAP26" ENSG00000133773 "Coiled-coil domain containing 59" Q9P031 12 82223681-82358805 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038555 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA038555: AB_10669543" "unprognostic (1.61e-1)" "unprognostic (6.28e-3)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (1.13e-1)" "unprognostic (6.73e-2)" "unprognostic (1.42e-3)" "unprognostic (1.50e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-2)" "unprognostic (2.62e-1)" "unprognostic (5.56e-2)" "prognostic unfavourable (1.39e-6)" "unprognostic (5.73e-2)" "unprognostic (2.01e-1)" "unprognostic (8.86e-2)" "unprognostic (1.02e-2)" 17.9 10.2 11.3 14.2 16.3 54.9 18.9 14.9 14.7 17.6 16.9 8.9 7.7 7.5 14.8 17.4 17.0 17.2 11.2 14.5 11.5 12.5 16.0 15.4 12.6 13.7 14.8 12.4 18.8 12.5 2.6 18.2 18.7 13.5 18.7 12.5 6.5 12.7 13.3 23.5 12.7 18.9 14.5 16.5 17.3 12.1 18.4 14.9 15.3 19.9 17.9 18.1 21.4 20.9 18.9 18.6 17.9 14.0 13.1 23.6 6.7 11.4 10.8 9.0 6.4 10.0 8.7 14.0 10.4 12.0 18.3 15.0 21.8 6.5 13.4 5.3 10.3 7.3 40.9 19.8 15.6 14.1 21.8 13.2 6.4 14.4 29.5 17.4 7.6 15.1 16.8 19.3 24.4 15.0 24.9 6.9 11.2 20.7 16.0 23.8 14.2 25.2 12.1 13.4 10.9 9.7 11.4 15.3 7.4 11.9 6.4 15.1 13.8 23.1 7.0 9.1 7.0 6.5 19.0 11.0 12.3 25.7 6.5 13.9 12.3 12.7 9.3 16.8 11.6 9.6 19.8 15.2 18.6 16.9 9.6 18.9 22.1 17.6 17.9 13.1 14.0 18.6 23.6 6.7 11.3 16.3 14.9 14.7 11.5 12.5 14.8 12.4 13.5 14.9 CCDC7 "BIOT2, C10orf68, FLJ13031, FLJ32762" ENSG00000216937 "Coiled-coil domain containing 7" Q96M83 10 32446140-32882874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 65.5" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA075536 Approved "Nucleoli,Mitotic spindle,Cytosol" Nucleoli "Mitotic spindle, Cytosol" "HPA075536: " "unprognostic (3.43e-3)" "unprognostic (4.75e-2)" "unprognostic (1.85e-1)" "unprognostic (1.01e-2)" "unprognostic (2.69e-2)" "unprognostic (3.75e-3)" "unprognostic (2.65e-5)" "unprognostic (6.95e-2)" "unprognostic (7.57e-2)" "unprognostic (1.55e-1)" "unprognostic (2.44e-3)" "unprognostic (2.84e-2)" "unprognostic (2.95e-5)" "unprognostic (7.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" 2.1 2.1 3.2 3.8 3.6 2.8 2.2 4.8 3.6 2.3 2.1 4.2 4.3 2.0 3.4 5.1 2.0 1.7 1.9 2.3 2.6 1.9 1.9 1.7 2.0 2.8 4.2 1.5 2.7 2.3 2.1 8.5 1.8 3.0 2.1 2.3 1.8 2.0 3.2 2.0 2.0 1.8 2.1 5.4 2.0 2.0 65.5 3.2 3.4 2.7 0.3 2.2 2.3 2.3 2.4 1.7 0.1 0.6 2.9 5.9 0.5 2.5 2.8 0.8 3.5 2.4 1.9 1.3 2.3 0.8 0.8 2.5 0.6 3.8 1.9 1.2 1.6 1.3 1.3 1.4 3.1 6.6 0.3 1.0 2.0 0.7 4.3 1.0 1.9 1.7 0.7 1.7 0.6 1.0 1.5 6.5 3.2 0.4 0.8 0.6 0.7 2.8 1.6 3.6 0.3 2.3 0.5 1.9 1.9 0.4 0.4 1.5 1.9 1.5 3.8 2.0 2.3 2.6 1.3 2.1 1.4 1.9 2.5 7.3 1.1 0.0 0.6 0.1 3.4 0.3 3.3 2.4 5.3 2.9 0.3 1.2 5.9 3.9 0.1 2.9 0.3 1.7 3.5 0.5 3.2 3.6 4.8 3.6 2.6 1.9 4.2 1.5 3.0 3.2 CDCA7L "JPO2, R1, RAM2" ENSG00000164649 "Cell division cycle associated 7 like" Q96GN5 7 21900900-21946084 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 47.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Region enriched" "Detected in many" 5 "olfactory region: 22.0" HPA027169 Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA027169: AB_1856058" "unprognostic (5.13e-3)" "unprognostic (5.94e-2)" "unprognostic (1.91e-1)" "unprognostic (4.63e-2)" "unprognostic (2.33e-1)" "unprognostic (2.15e-1)" "prognostic unfavourable (4.36e-6)" "unprognostic (4.09e-2)" "unprognostic (2.86e-1)" "unprognostic (3.87e-2)" "unprognostic (3.22e-2)" "unprognostic (2.34e-1)" "prognostic unfavourable (1.98e-4)" "unprognostic (2.00e-1)" "unprognostic (1.60e-1)" "unprognostic (1.73e-1)" "unprognostic (2.83e-3)" 6.2 1.2 3.7 19.9 9.6 24.2 8.0 6.5 4.2 8.4 9.0 7.8 3.9 5.2 11.1 3.6 6.0 7.0 5.4 12.5 3.9 2.5 2.7 4.5 7.3 18.7 6.2 4.0 13.9 17.4 1.0 1.6 2.2 3.7 7.6 10.2 5.8 10.5 8.0 2.7 13.6 8.7 6.6 3.0 9.3 12.7 12.6 5.3 47.9 20.0 5.1 16.5 6.0 9.4 38.5 21.8 11.8 1.3 0.8 9.7 3.3 19.6 6.7 6.3 0.1 3.5 4.4 0.0 16.1 13.9 12.5 17.8 2.5 17.9 41.0 5.3 13.8 12.1 10.0 16.5 25.4 0.0 6.6 9.8 20.0 1.6 4.5 25.8 0.1 8.3 3.0 9.7 28.4 24.7 13.5 0.0 9.7 7.3 32.5 9.3 36.3 8.4 32.7 22.8 27.4 3.5 3.7 23.3 19.0 7.3 4.5 7.3 10.9 11.7 10.4 13.7 16.9 23.8 19.4 21.1 14.5 53.0 13.1 34.8 13.4 0.3 0.6 11.8 0.6 0.9 0.1 28.6 1.9 0.9 4.3 38.5 9.7 3.9 1.1 0.8 1.3 21.8 2.7 3.3 3.7 9.6 6.5 4.2 3.9 2.5 6.2 4.0 3.7 5.3 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692418-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Enhanced "Nucleoplasm,Nucleoli,Cytokinetic bridge" Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavourable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavourable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavourable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.2 1.4 0.9 12.9 1.7 19.0 1.7 0.8 1.6 1.8 6.0 1.1 0.7 5.3 1.4 1.3 9.6 0.7 2.4 0.8 0.9 0.9 1.3 1.5 2.0 12.2 1.8 1.3 0.9 1.0 0.1 0.8 3.7 1.3 1.0 7.7 0.7 2.1 1.0 0.9 4.0 5.4 1.6 1.2 5.4 3.5 44.7 1.7 51.6 0.9 6.5 14.6 1.6 2.9 2.8 1.8 4.5 5.0 6.3 8.9 2.5 28.0 12.3 23.2 16.7 1.0 2.0 15.6 21.2 10.7 37.5 26.6 19.1 21.1 34.1 8.6 13.5 16.0 26.6 14.1 39.9 22.7 11.9 30.7 13.1 15.1 0.2 29.5 15.9 0.7 1.0 21.1 18.7 16.5 25.9 36.7 27.0 12.5 27.2 18.1 26.8 17.0 26.5 31.7 19.5 8.5 11.8 20.7 9.1 23.3 11.0 14.3 16.1 11.2 9.9 18.5 19.6 10.5 33.1 25.0 32.4 46.5 8.7 27.5 21.1 0.0 1.1 1.8 2.5 2.2 4.5 2.8 5.7 3.3 1.0 2.5 1.9 3.8 4.5 6.3 5.0 1.8 8.9 2.5 0.9 1.7 0.8 1.6 0.9 0.9 1.8 1.3 1.3 1.7 CDK5RAP3 "C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114" ENSG00000108465 "CDK5 regulatory subunit associated protein 3" Q96JB5 17 47967810-47981774 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022141, HPA022882, HPA027883" Supported Supported Nucleoli,Vesicles,Cytosol Cytosol "Nucleoli, Vesicles" "HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797" "unprognostic (4.27e-2)" "unprognostic (1.01e-3)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "unprognostic (5.98e-2)" "unprognostic (7.19e-3)" "unprognostic (3.84e-1)" "unprognostic (4.44e-2)" "unprognostic (7.55e-2)" "unprognostic (2.06e-1)" "unprognostic (2.59e-3)" "unprognostic (1.92e-2)" "prognostic unfavourable (3.61e-5)" "unprognostic (8.35e-3)" "unprognostic (2.30e-1)" "unprognostic (9.58e-2)" "prognostic favourable (7.31e-5)" 15.5 19.7 20.8 30.0 38.3 21.2 22.5 35.7 31.9 21.1 21.2 27.1 39.4 24.1 26.2 45.4 20.8 26.1 22.0 14.4 23.2 16.7 23.2 31.0 18.8 22.0 31.3 25.8 28.9 51.9 29.4 41.3 15.4 27.3 24.2 25.5 25.1 44.0 26.4 10.7 16.8 25.8 18.4 18.2 32.3 28.6 40.1 29.5 32.3 29.7 16.5 24.6 20.0 18.5 22.8 26.9 27.2 33.5 22.4 22.3 21.0 22.3 36.0 19.9 35.6 16.7 16.8 35.7 16.3 19.8 16.5 15.2 28.2 21.7 26.9 33.8 17.0 21.9 12.9 18.3 18.5 39.7 17.0 12.8 42.9 38.2 18.7 15.1 14.3 19.1 15.5 14.8 29.1 15.9 15.1 25.0 16.7 42.8 41.1 24.5 12.0 15.6 22.0 33.5 30.5 16.4 28.1 13.6 32.6 12.6 11.3 16.4 25.7 19.8 12.7 13.7 12.2 16.5 20.8 32.9 31.0 16.6 17.1 21.0 16.6 9.1 33.5 27.2 20.9 32.7 22.3 22.1 20.0 18.5 26.9 22.8 18.1 19.9 15.7 22.4 32.5 24.4 19.0 21.0 20.8 38.3 35.7 31.9 23.2 16.7 31.3 25.8 27.3 29.5 CDV3 H41 ENSG00000091527 "CDV3 homolog" Q9UKY7 3 133573730-133590261 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 150.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029761, HPA029762, HPA029763" Enhanced Enhanced "Nucleoli,Plasma membrane,Cytosol" 220000 Cytosol "Nucleoli, Plasma membrane" "HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679" "unprognostic (1.17e-2)" "unprognostic (1.22e-1)" "unprognostic (4.06e-2)" "unprognostic (4.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.52e-1)" "prognostic unfavourable (5.21e-6)" "unprognostic (1.20e-1)" "unprognostic (3.30e-1)" "unprognostic (8.45e-3)" "unprognostic (3.29e-3)" "unprognostic (1.13e-1)" "unprognostic (2.36e-1)" "unprognostic (7.83e-2)" "unprognostic (1.48e-2)" "unprognostic (9.87e-2)" "unprognostic (7.59e-3)" 46.4 26.5 20.7 45.7 22.4 44.9 38.1 13.2 22.3 25.6 29.5 20.2 16.2 18.5 27.0 26.1 34.1 22.0 25.4 50.5 19.0 18.3 26.2 40.2 34.3 47.6 22.5 20.6 32.8 34.4 25.6 22.5 34.8 24.4 24.6 23.9 18.7 24.6 16.7 106.6 23.1 27.7 33.1 25.4 56.6 31.4 38.2 21.5 61.1 33.9 32.5 52.1 43.8 37.2 10.6 14.2 14.7 11.1 5.3 20.8 4.5 49.7 11.6 20.5 13.5 23.7 29.3 24.3 27.5 35.9 27.6 27.4 28.7 20.1 63.7 41.9 30.8 21.5 29.3 27.5 51.8 40.7 11.0 37.6 12.8 17.6 36.9 41.8 24.2 27.8 28.9 24.6 66.5 34.8 27.0 42.8 39.9 14.3 34.2 24.2 20.7 14.9 20.9 27.3 51.0 29.0 20.3 16.3 12.3 26.1 19.5 32.7 63.0 25.7 43.1 29.5 27.9 23.4 27.2 62.5 46.8 150.0 16.5 25.4 17.1 11.5 9.6 14.7 12.2 10.7 12.8 10.6 11.7 12.4 8.5 6.5 9.4 14.4 8.7 5.3 11.1 14.2 20.8 4.5 20.7 22.4 13.2 22.3 19.0 18.3 22.5 20.6 24.4 21.5 CEACAM19 CEAL1 ENSG00000186567 "Carcinoembryonic antigen related cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 13.8;TIME: 17.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: , HPA052865: " "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 1.6 2.9 1.1 0.8 1.9 1.0 2.4 4.3 1.7 3.1 2.4 2.7 2.7 1.4 2.4 4.3 2.1 4.1 1.2 1.8 3.3 4.3 3.8 0.6 0.6 4.0 4.7 1.2 3.9 1.8 4.1 3.3 2.9 3.0 12.5 10.8 2.9 3.0 0.9 1.8 2.0 3.0 3.4 1.7 1.0 4.4 1.7 0.5 1.7 1.0 1.0 0.7 0.6 4.3 8.8 1.3 0.9 3.1 3.6 3.3 2.4 3.6 0.8 1.6 0.3 1.0 0.1 0.8 3.3 5.3 2.2 0.9 0.7 1.2 5.0 0.1 4.7 1.4 3.2 0.2 0.8 1.1 8.8 2.2 5.4 2.1 0.3 0.2 1.2 1.0 0.0 0.5 0.8 1.0 0.0 1.6 0.2 13.8 1.0 1.7 0.4 0.9 0.9 0.8 1.2 0.3 17.8 0.3 6.1 1.3 0.7 0.1 0.3 0.0 0.4 1.7 1.4 1.7 1.0 0.6 0.6 0.4 0.3 0.5 0.3 0.6 0.2 1.7 0.4 0.7 1.6 1.0 0.5 0.5 0.3 0.6 CERCAM "CEECAM1, CerCAM, GLT25D3" ENSG00000167123 "Cerebral endothelial cell adhesion molecule" Q5T4B2 9 128411751-128437351 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.1" "Cell line enhanced" "Detected in many" "ASC diff: 55.3;ASC TERT1: 59.0;fHDF/TERT166: 50.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 5.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021657, HPA051595" Uncertain Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Intracellular and membrane" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA021657: AB_1846507, HPA051595: " "unprognostic (2.87e-2)" "unprognostic (1.37e-3)" "unprognostic (1.89e-3)" "unprognostic (2.19e-1)" "unprognostic (4.68e-3)" "unprognostic (7.79e-3)" "unprognostic (3.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.00e-1)" "prognostic unfavourable (5.22e-4)" "unprognostic (1.59e-1)" "unprognostic (5.93e-2)" "prognostic unfavourable (3.33e-16)" "unprognostic (1.34e-2)" "unprognostic (1.04e-1)" "unprognostic (6.05e-3)" "prognostic unfavourable (3.30e-5)" 12.7 5.1 40.0 7.2 65.5 1.6 9.0 10.0 62.1 19.1 6.9 61.2 5.0 4.8 11.4 10.9 8.2 6.0 17.3 8.8 72.8 34.7 4.9 1.8 5.3 2.3 59.5 28.1 14.1 18.8 15.8 21.6 27.4 31.4 11.1 5.2 3.5 13.2 13.6 4.3 8.9 6.0 27.7 78.1 3.3 5.4 5.2 62.1 0.0 6.7 2.4 2.7 15.1 6.6 0.3 2.0 0.3 1.6 1.1 5.3 2.2 9.4 6.1 6.8 7.3 55.3 59.0 5.9 30.7 29.0 8.0 6.0 2.2 0.4 0.0 12.6 50.1 6.5 3.0 4.0 3.1 2.4 4.8 0.5 5.5 3.3 16.9 1.1 17.2 32.7 2.1 8.7 2.1 9.1 2.7 7.5 10.4 18.0 0.4 11.6 0.4 4.6 0.9 4.8 1.3 3.7 3.6 1.0 1.9 6.9 8.4 3.5 6.8 2.3 10.0 21.4 5.8 29.4 4.7 8.8 6.9 0.1 20.3 3.3 4.2 0.3 1.1 0.1 3.8 1.6 0.3 0.3 0.3 4.7 1.5 0.1 0.1 5.3 0.3 1.1 0.1 2.0 0.0 2.2 40.0 65.5 10.0 24.5 72.8 34.7 59.5 28.1 31.4 62.1 CHD3 "Mi-2a, Mi2-ALPHA, ZFH" ENSG00000170004 "Chromodomain helicase DNA binding protein 3" Q12873 17 7884806-7912760 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043368, HPA076524" Supported Approved "Nucleoplasm,Nucleoli,Centriolar satellite" "Nucleoplasm, Nucleoli, Centriolar satellite" "HPA043368: , HPA076524: " "unprognostic (1.77e-2)" "unprognostic (8.01e-2)" "prognostic unfavourable (2.43e-4)" "prognostic favourable (7.68e-5)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (2.83e-2)" "unprognostic (5.25e-3)" "prognostic favourable (8.36e-4)" "unprognostic (9.11e-2)" "unprognostic (8.31e-2)" "unprognostic (3.98e-2)" "unprognostic (1.50e-1)" "unprognostic (8.90e-3)" "unprognostic (2.20e-3)" 10.4 12.9 31.7 24.3 26.0 18.7 12.5 12.1 28.3 41.1 21.1 4.1 22.5 8.2 46.3 16.1 15.1 25.0 20.0 8.7 30.4 14.2 15.2 2.3 13.1 19.0 8.4 28.4 27.3 15.1 28.5 21.0 8.0 10.7 32.9 11.1 20.7 19.4 23.0 3.3 16.2 14.0 23.3 6.9 14.6 15.8 11.3 5.1 40.6 19.7 7.5 17.7 20.6 28.9 1.6 4.0 4.1 3.5 2.7 7.8 3.6 12.1 30.4 17.8 23.6 21.7 18.2 9.5 14.2 19.1 12.1 12.9 5.9 10.3 34.3 10.8 20.9 16.5 33.4 15.0 15.2 17.4 19.4 16.6 39.4 0.7 11.6 4.7 32.7 24.0 8.0 16.2 10.9 22.3 11.1 0.5 11.2 12.0 13.1 5.5 2.8 11.2 38.4 21.7 5.2 12.0 29.7 12.1 16.4 35.3 13.8 6.9 15.8 7.8 27.9 26.2 20.6 6.3 20.4 2.5 0.4 19.4 13.3 13.5 22.3 0.6 2.7 4.1 7.0 1.7 5.5 1.5 6.7 6.6 2.1 1.6 7.8 5.1 2.1 2.7 3.5 4.0 3.6 3.6 31.7 26.0 12.1 28.3 30.4 14.2 8.4 28.4 10.7 5.1 CKAP5 "ch-TOG, KIAA0097, TOG, TOGp" ENSG00000175216 "Cytoskeleton associated protein 5" Q14008 11 46743048-46846308 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039377, HPA040375" Supported Approved "Nucleoli,Plasma membrane,Centrosome" 460000 "Plasma membrane, Centrosome" Nucleoli "HPA039377: AB_10805477, HPA040375: AB_10794739" "unprognostic (8.00e-2)" "unprognostic (7.35e-2)" "unprognostic (2.35e-1)" "unprognostic (4.12e-2)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "prognostic unfavourable (1.03e-6)" "unprognostic (6.09e-2)" "unprognostic (1.12e-2)" "unprognostic (2.21e-2)" "unprognostic (4.30e-3)" "unprognostic (3.77e-2)" "unprognostic (2.03e-1)" "unprognostic (2.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (4.69e-2)" 13.7 25.5 20.6 11.5 25.7 18.6 12.5 34.6 32.9 11.3 14.6 16.5 7.3 10.2 13.7 10.4 11.7 9.5 10.1 16.6 19.2 19.3 9.7 37.7 8.5 14.1 18.8 21.1 23.8 7.9 20.0 20.8 13.8 33.0 13.5 15.0 9.1 8.7 12.0 26.3 10.7 9.9 16.1 22.5 8.8 12.9 25.4 22.2 28.6 8.0 10.8 14.7 12.6 9.7 8.6 8.4 6.0 8.7 11.7 10.0 3.6 25.9 25.1 53.9 23.1 12.8 20.1 12.5 29.8 18.1 28.4 30.2 20.4 8.8 28.3 10.5 20.0 29.5 38.6 16.9 35.7 25.5 29.5 47.2 20.1 19.6 9.5 36.0 19.8 10.2 9.0 15.9 34.5 21.4 33.3 26.6 23.4 17.9 30.6 9.3 29.0 20.2 32.5 57.4 24.8 9.1 16.0 25.1 21.4 40.5 14.5 14.8 26.7 9.8 18.4 27.6 24.4 46.7 43.9 15.1 32.6 40.8 17.3 17.1 27.0 5.4 5.7 6.0 9.0 8.7 8.8 8.6 6.7 10.0 8.4 8.0 8.2 8.5 0.9 11.7 7.8 5.4 7.5 3.6 20.6 25.7 34.6 31.2 19.2 19.3 18.8 21.1 33.0 22.2 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 75.9;brain: 227.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavourable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 14.7 12.4 61.6 10.7 76.1 11.7 14.1 11.9 77.1 14.1 10.4 100.5 3.3 10.0 16.9 12.6 22.6 10.9 14.3 15.9 85.4 52.3 11.0 14.0 12.2 13.6 133.4 28.9 19.1 5.8 7.0 6.7 20.5 72.7 14.6 13.6 4.9 6.8 15.7 9.7 17.6 9.4 18.5 227.4 11.5 7.5 28.5 95.4 4.3 11.5 4.7 14.8 14.7 11.1 19.9 19.7 28.1 18.6 49.5 75.9 28.6 17.9 7.3 23.0 14.1 27.8 21.7 12.5 14.3 19.6 20.1 27.8 14.8 18.4 9.0 19.3 13.7 24.4 17.6 10.8 35.2 21.2 7.5 18.8 5.2 13.3 22.2 16.9 18.7 25.3 58.5 15.7 16.8 21.8 9.3 27.8 28.2 9.4 12.4 11.2 20.0 15.6 8.4 30.9 11.5 18.7 8.2 8.3 22.9 19.7 6.6 28.2 6.6 14.3 20.1 26.2 24.2 17.8 18.5 36.8 15.7 14.5 43.8 16.3 33.4 28.1 18.6 19.8 21.7 10.7 40.8 19.9 40.9 39.8 19.7 16.4 16.6 16.9 13.8 49.5 10.5 12.7 75.9 28.6 61.6 76.1 11.9 38.8 85.4 52.3 133.4 28.9 72.7 95.4 CLN6 "FLJ20561, HsT18960, nclf" ENSG00000128973 "CLN6, transmembrane ER protein" Q9NWW5 15 68206992-68257211 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066046, HPA066759" Approved Approved "Nucleoli,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum" "Nucleoli, Vesicles" "HPA066046: , HPA066759: " "unprognostic (1.01e-1)" "unprognostic (1.54e-3)" "unprognostic (7.01e-2)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (3.08e-1)" "unprognostic (2.24e-2)" "unprognostic (5.07e-2)" "unprognostic (2.40e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.85e-1)" "prognostic favourable (4.87e-4)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-1)" "unprognostic (6.78e-2)" 21.2 17.8 11.6 16.5 11.8 29.8 13.9 14.9 20.7 14.4 20.2 13.2 11.6 17.1 11.7 14.3 16.7 12.0 17.1 10.4 11.7 10.8 22.0 29.5 18.8 27.0 11.1 12.2 12.4 19.7 11.7 11.5 18.6 14.3 13.4 18.0 28.6 16.0 17.9 16.3 17.0 18.5 12.4 11.6 26.5 15.7 13.8 9.7 27.7 14.5 18.2 21.7 11.0 10.9 2.9 4.6 9.4 13.4 1.8 4.1 2.7 11.4 28.7 7.5 10.5 4.6 3.8 18.1 11.0 5.3 13.5 11.1 22.1 18.7 17.9 5.4 6.5 21.4 21.5 10.6 5.4 11.8 26.3 25.7 20.9 16.4 9.5 28.9 18.4 6.7 3.5 10.8 7.5 9.0 16.9 36.3 10.3 31.4 13.1 20.7 17.9 12.2 12.8 22.9 24.3 11.3 30.0 15.4 6.3 12.3 19.3 10.5 10.3 28.9 5.9 15.2 18.1 11.2 38.7 26.6 28.9 14.6 9.5 35.2 14.7 0.0 7.3 0.4 2.8 11.5 3.8 2.9 2.1 4.1 4.6 2.3 2.7 1.2 9.4 1.8 13.4 3.8 1.9 2.7 11.6 11.8 14.9 20.7 11.7 10.8 11.1 12.2 14.3 9.7 COIL "CLN80, p80-coilin" ENSG00000121058 Coilin P38432 17 56938187-56961054 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 58.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017524, HPA027885, HPA068537, CAB069400" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nuclear bodies" Nucleoplasm "Nucleoli, Nuclear bodies" "CAB017524: AB_1121780, CAB069400: , HPA027885: , HPA068537: " "unprognostic (1.01e-2)" "unprognostic (3.05e-1)" "prognostic favourable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (3.19e-2)" "unprognostic (4.13e-3)" "prognostic unfavourable (1.28e-4)" "unprognostic (1.64e-1)" "unprognostic (4.07e-3)" "unprognostic (3.00e-3)" "unprognostic (2.50e-2)" "unprognostic (2.25e-2)" "unprognostic (1.28e-3)" "unprognostic (2.50e-1)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (7.71e-2)" 8.7 5.6 7.3 5.5 8.1 10.9 8.2 12.6 8.9 8.9 6.4 7.6 4.9 6.7 8.1 8.1 8.5 6.8 4.9 5.3 5.8 5.7 7.0 8.5 5.3 7.7 7.1 6.5 8.6 9.1 8.5 9.7 9.5 8.2 7.8 7.3 5.8 7.5 9.1 7.9 7.8 7.0 5.9 7.2 8.1 6.4 58.8 6.0 12.3 8.7 5.3 8.5 7.7 7.3 22.5 13.7 14.0 13.4 12.7 17.8 8.6 13.0 9.9 20.5 7.9 7.0 8.4 14.2 9.4 8.9 14.4 15.4 13.6 11.3 15.8 19.1 7.5 7.6 13.8 10.9 20.6 18.9 17.5 25.7 9.5 15.3 7.6 21.6 15.7 7.8 13.6 10.8 11.7 12.2 22.2 13.2 13.4 16.5 17.0 13.8 12.0 10.0 8.1 25.2 12.6 9.8 13.2 17.4 17.2 6.3 6.3 15.7 22.7 21.2 8.6 16.8 12.7 8.1 12.1 19.6 24.4 18.5 8.7 12.0 10.2 14.0 11.5 13.9 13.9 10.4 15.6 22.5 15.4 14.6 11.3 21.6 17.8 17.2 6.8 12.7 13.4 13.7 15.2 8.6 7.3 8.1 12.6 8.9 5.8 5.7 7.1 6.5 8.2 6.0 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favourable (4.32e-6)" "prognostic favourable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 8.6 16.6 6.9 9.9 6.9 6.3 15.7 10.5 7.4 19.2 13.3 14.5 6.4 20.4 8.3 10.5 16.7 14.1 13.5 15.5 11.0 14.1 12.1 13.4 16.0 12.2 12.5 11.4 9.1 17.0 12.0 15.3 10.1 16.4 7.0 8.4 10.7 10.6 8.2 10.5 8.6 8.9 23.4 14.4 12.1 16.2 5.2 8.8 10.8 14.4 13.0 8.1 7.1 8.3 8.4 7.0 8.5 13.2 8.5 11.9 9.2 12.6 13.0 10.3 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli, Mitochondria" "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favourable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favourable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.8 3.3 7.7 7.5 6.6 3.9 8.8 4.9 5.0 7.1 6.6 1.6 6.7 13.5 7.5 2.3 7.9 14.3 11.3 6.0 7.4 8.4 7.7 4.5 1.3 9.8 7.3 7.4 8.4 9.7 5.1 4.4 4.8 9.8 4.8 4.4 4.6 5.7 6.0 14.4 8.8 6.6 7.3 14.3 8.8 7.4 11.5 7.7 9.8 12.5 18.5 14.5 15.6 4.7 4.0 3.2 7.0 4.0 14.9 9.1 8.3 5.1 8.4 5.8 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 CRAMP1 "CRAMP1L, KIAA1426" ENSG00000007545 "Cramped chromatin regulator homolog 1" Q96RY5 16 1612325-1677908 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041752 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA041752: AB_10796459" "unprognostic (3.67e-1)" "unprognostic (9.97e-2)" "unprognostic (2.72e-1)" "unprognostic (2.23e-1)" "unprognostic (3.41e-2)" "unprognostic (2.25e-3)" "unprognostic (5.78e-4)" "unprognostic (4.17e-2)" "unprognostic (8.53e-3)" "unprognostic (6.01e-2)" "unprognostic (1.55e-2)" "unprognostic (9.93e-2)" "unprognostic (3.86e-3)" "prognostic favourable (4.93e-4)" "unprognostic (8.57e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" 8.5 6.4 9.2 10.5 9.3 13.9 11.6 24.2 11.0 8.4 8.8 11.1 5.1 7.2 11.4 8.3 8.6 9.9 6.5 7.2 8.6 5.4 6.5 4.7 9.2 8.0 9.7 10.5 12.3 9.2 10.2 10.9 8.4 9.4 9.8 7.1 9.8 8.4 9.5 8.9 13.7 8.4 8.8 7.9 9.4 8.5 21.9 9.8 18.1 11.8 4.4 7.5 10.6 11.7 0.8 2.1 0.5 0.6 2.5 1.9 0.5 5.2 8.6 10.9 10.3 7.3 7.3 12.6 6.2 5.4 8.4 6.0 7.9 9.0 5.3 5.9 7.1 8.9 13.0 6.3 7.7 6.4 13.5 8.3 9.9 4.9 5.3 11.7 13.5 6.3 8.6 10.0 8.1 8.3 11.1 4.1 4.6 8.7 7.7 7.2 8.7 5.3 30.0 5.2 9.2 5.5 5.4 11.4 8.1 9.2 7.6 4.9 6.1 16.2 9.4 8.0 7.8 6.8 7.8 7.0 10.1 13.5 2.7 7.8 7.1 0.4 0.6 0.0 1.9 0.6 0.9 0.8 0.6 0.6 0.3 0.8 0.9 0.9 0.5 2.5 0.2 2.1 0.3 0.5 9.2 9.3 24.2 11.0 8.6 5.4 9.7 10.5 9.4 9.8 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "heart muscle: 180.3" "Cell line enhanced" "Detected in many" "A549: 37.7;EFO-21: 38.6;HUVEC TERT2: 36.1;MCF7: 55.4;SK-BR-3: 43.4;T-47d: 37.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 24.0;T-reg: 29.2" "Group enriched" "Detected in many" 19 "B-cells: 17.9;T-cells: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" 490000 Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 22.8 11.5 27.5 9.1 24.6 1.6 16.9 3.6 30.3 20.2 10.1 9.4 33.7 7.9 15.3 30.6 25.6 29.5 24.5 180.3 22.6 18.7 20.0 6.9 28.5 9.3 13.5 16.9 12.5 12.6 4.3 20.4 29.1 10.4 14.6 3.8 8.8 18.4 28.0 10.7 28.4 9.1 24.9 10.3 13.0 11.3 10.9 7.8 1.0 17.8 23.8 13.3 23.8 17.5 17.9 0.9 0.2 0.5 1.2 29.2 3.4 0.4 37.7 5.5 15.0 0.9 3.9 1.6 1.7 0.4 0.5 0.1 1.1 7.0 0.0 38.6 12.3 21.6 0.7 9.2 0.0 0.2 0.2 0.0 23.7 14.3 4.0 0.0 3.2 1.9 0.8 0.9 5.1 36.1 0.0 0.3 5.4 55.4 0.1 0.1 1.5 22.7 0.0 0.7 1.6 25.4 0.1 8.4 20.9 2.4 43.4 0.3 37.2 0.0 14.0 12.5 5.9 0.3 7.0 0.1 0.1 0.1 3.6 0.0 25.2 0.0 0.5 0.0 2.4 0.2 2.3 14.4 24.0 5.3 0.9 17.9 5.9 1.6 0.2 1.2 0.1 0.1 29.2 3.4 27.5 24.6 3.6 30.3 22.6 18.7 13.5 16.9 10.4 7.8 CUTC CGI-32 ENSG00000119929 "CutC copper transporter" Q9NTM9 10 99702558-99756134 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 122.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038619 Enhanced Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA038619: AB_10672649" "unprognostic (1.25e-2)" "unprognostic (5.92e-2)" "unprognostic (2.70e-1)" "unprognostic (8.66e-2)" "unprognostic (7.39e-2)" "unprognostic (1.39e-1)" "unprognostic (3.55e-3)" "unprognostic (8.67e-2)" "unprognostic (5.36e-2)" "unprognostic (1.81e-1)" "unprognostic (5.87e-2)" "unprognostic (2.06e-1)" "prognostic unfavourable (3.81e-7)" "unprognostic (1.00e-1)" "unprognostic (3.42e-2)" "unprognostic (2.41e-1)" "unprognostic (3.97e-1)" 11.6 4.9 5.7 9.8 8.7 7.9 9.8 3.5 6.5 5.3 5.9 7.2 3.5 4.4 4.9 8.0 6.2 5.1 5.8 13.2 5.9 4.7 5.3 11.0 5.1 7.9 8.6 6.6 4.6 4.5 3.5 3.6 4.5 5.5 6.0 6.4 6.9 5.7 5.4 122.1 5.8 6.2 11.6 7.4 9.2 6.0 14.1 8.3 9.2 4.3 25.1 7.3 13.5 11.4 32.8 24.2 47.1 19.4 25.5 36.3 19.3 9.3 20.2 7.1 21.6 26.4 12.1 3.9 7.7 9.9 7.8 8.8 9.3 7.2 34.2 6.9 13.1 8.1 14.5 12.8 8.7 10.1 13.8 11.3 9.1 14.6 12.2 21.0 5.6 12.5 8.0 12.4 25.8 13.3 10.0 7.6 5.8 6.5 18.8 21.7 7.1 7.6 12.8 8.3 13.1 8.1 3.9 2.3 5.3 3.5 5.6 9.7 9.0 12.0 7.4 3.2 4.4 3.5 10.1 12.5 16.2 24.0 10.6 45.1 2.9 26.5 19.4 47.1 27.2 15.2 28.3 32.8 25.9 25.9 21.0 29.0 36.3 27.8 30.8 25.5 18.5 24.2 24.7 19.3 5.7 8.7 3.5 6.5 5.9 4.7 8.6 6.6 5.5 8.3 CYB5D2 MGC32124 ENSG00000167740 "Cytochrome b5 domain containing 2" Q8WUJ1 17 4143168-4187310 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042299 Approved Approved "Nuclear membrane,Nucleoli,Centrosome" "Secreted - unknown location" "Nuclear membrane" "Nucleoli, Centrosome" "HPA042299: AB_10793879" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (4.16e-2)" "prognostic favourable (6.19e-4)" "unprognostic (1.88e-2)" "unprognostic (1.75e-2)" "prognostic favourable (4.98e-6)" "unprognostic (1.57e-1)" "unprognostic (2.47e-1)" "unprognostic (9.71e-3)" "prognostic favourable (7.76e-5)" "unprognostic (2.04e-1)" "prognostic favourable (2.03e-10)" "unprognostic (2.01e-3)" "unprognostic (8.73e-2)" "unprognostic (1.82e-1)" "unprognostic (2.97e-1)" 13.1 17.3 18.7 5.1 26.4 3.6 15.0 20.6 27.5 15.0 8.1 21.8 14.6 13.3 13.9 27.1 9.8 17.4 14.5 10.3 17.8 21.6 22.9 25.3 8.6 7.4 19.7 26.1 19.5 17.0 28.5 18.5 9.9 19.1 12.0 6.8 17.3 17.5 16.8 12.2 11.7 10.3 7.8 21.7 7.9 12.3 54.1 17.1 4.8 20.6 7.1 6.8 12.0 8.6 9.4 13.0 14.7 12.7 5.9 12.5 9.0 7.8 10.5 6.1 6.4 39.3 11.6 2.5 7.6 16.4 5.5 5.7 3.1 5.2 2.5 6.9 8.8 11.1 2.5 3.5 2.2 8.3 12.6 2.4 6.6 5.2 7.1 1.0 4.8 15.1 8.4 3.0 6.0 10.0 2.5 15.5 4.2 9.6 3.6 1.6 2.2 5.7 4.4 5.4 6.2 12.8 4.1 4.9 4.1 8.5 5.0 11.2 13.2 1.5 13.5 8.1 2.1 7.5 3.9 3.0 2.2 1.9 10.0 2.2 3.1 0.6 12.7 14.7 7.2 10.4 8.1 9.4 11.4 8.8 12.0 9.4 10.8 9.7 11.7 5.9 9.4 13.0 12.5 9.0 18.7 26.4 20.6 27.5 17.8 21.6 19.7 26.1 19.1 17.1 CYB5R1 "humb5R2, NQO3A2" ENSG00000159348 "Cytochrome b5 reductase 1" Q9UHQ9 1 202961869-202967280 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 119.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010641, HPA014147" Enhanced Uncertain Nucleoli,Mitochondria,Cytosol 860000 "Nucleoli, Mitochondria, Cytosol" "HPA010641: AB_1078600, HPA014147: AB_1847370" "unprognostic (6.36e-2)" "unprognostic (8.51e-2)" "unprognostic (1.16e-2)" "prognostic favourable (1.14e-4)" "unprognostic (1.86e-2)" "unprognostic (4.34e-2)" "unprognostic (8.46e-2)" "unprognostic (1.28e-1)" "unprognostic (4.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (2.89e-1)" "unprognostic (1.73e-2)" "unprognostic (2.33e-1)" "unprognostic (6.14e-2)" "unprognostic (2.37e-3)" "unprognostic (1.69e-1)" 9.6 14.5 7.8 5.0 8.4 3.9 16.9 6.2 11.0 11.6 7.5 8.7 10.6 4.4 10.1 32.3 13.7 16.4 9.2 33.9 7.3 9.2 15.5 18.4 10.1 11.7 10.0 9.1 10.8 11.1 16.3 11.1 63.8 11.9 10.5 5.0 15.7 14.4 10.1 119.2 28.5 6.9 10.6 7.4 10.8 18.6 20.1 6.7 11.7 13.5 26.4 10.0 13.6 10.1 20.2 21.9 25.7 33.3 17.2 26.5 28.8 8.3 5.2 4.6 9.4 42.9 9.9 45.1 16.8 15.8 10.9 9.8 4.3 9.9 5.2 14.3 16.7 46.3 3.7 14.4 7.2 7.5 9.5 2.9 6.3 4.9 15.5 2.5 7.4 15.8 47.6 12.0 6.6 7.2 8.8 9.4 39.4 9.8 3.2 2.2 3.0 10.0 5.3 22.2 11.1 10.3 10.0 3.9 4.8 9.4 31.4 13.6 14.5 5.7 7.0 12.5 5.3 4.7 9.3 8.8 10.4 2.4 13.8 3.9 9.3 11.6 33.3 25.6 16.7 24.2 22.2 13.6 19.3 17.8 21.9 20.2 26.5 18.8 25.7 17.2 15.7 15.1 19.1 28.8 7.8 8.4 6.2 11.0 7.3 9.2 10.0 9.1 11.9 6.7 DCTN6 WS-3 ENSG00000104671 "Dynactin subunit 6" O00399 8 30156297-30183640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024049, HPA024558" Approved Supported "Nucleoli,Plasma membrane,Cytosol" "Nucleoli, Cytosol" "Plasma membrane" "HPA024049: AB_1847524, HPA024558: AB_1847525" "unprognostic (1.28e-1)" "unprognostic (8.32e-3)" "unprognostic (1.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.69e-1)" "unprognostic (7.50e-2)" "prognostic unfavourable (5.51e-4)" "unprognostic (1.26e-1)" "unprognostic (7.84e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-2)" "unprognostic (9.26e-2)" "prognostic favourable (5.42e-4)" "unprognostic (1.06e-1)" "unprognostic (3.10e-1)" "unprognostic (7.54e-2)" "unprognostic (1.43e-1)" 29.5 34.6 41.4 15.6 39.4 23.3 32.6 23.6 43.6 21.0 20.6 27.4 15.4 14.2 24.1 27.2 24.1 18.0 20.0 44.5 37.7 35.2 32.8 27.5 20.3 15.3 42.3 36.3 26.3 19.5 31.0 27.7 32.7 41.4 21.9 22.5 16.5 20.3 23.7 20.4 17.5 15.6 26.0 46.2 16.8 19.3 13.9 30.3 15.4 33.7 18.2 17.9 25.7 18.8 7.4 19.8 9.5 15.9 10.2 11.2 6.9 18.9 18.2 23.0 12.1 21.0 28.9 14.8 25.8 29.9 25.2 26.4 11.8 12.6 14.1 27.7 27.0 14.1 15.9 21.8 29.7 11.3 12.4 20.2 15.6 18.5 16.2 11.4 17.2 24.4 31.2 18.0 19.3 22.5 22.6 15.6 26.7 14.4 21.1 16.4 18.8 11.6 11.3 17.3 12.3 35.8 18.6 37.8 21.4 15.0 18.5 25.6 17.8 16.2 21.6 13.7 47.8 11.2 18.3 6.6 7.4 18.2 25.2 13.1 23.8 9.5 14.1 4.9 8.6 15.9 9.8 7.4 7.8 10.1 16.8 5.5 9.0 11.2 4.5 10.2 15.1 19.8 8.7 6.9 41.4 39.4 23.6 43.6 37.7 35.2 42.3 36.3 41.4 30.3 DDAH1 DDAH ENSG00000153904 "Dimethylarginine dimethylaminohydrolase 1" O94760 1 85318481-85578363 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.6" "Cell line enhanced" "Detected in many" "SH-SY5Y: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 1.3;naive B-cell: 1.0" "Lineage enhanced" "Detected in single" "B-cells: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006308 Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" 140000 "Plasma membrane, Cytosol" Nucleoli "HPA006308: AB_1847532" "unprognostic (1.44e-2)" "unprognostic (2.43e-1)" "prognostic favourable (5.99e-4)" "unprognostic (6.82e-2)" "unprognostic (1.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.55e-1)" "unprognostic (3.85e-2)" "unprognostic (2.57e-1)" "unprognostic (1.02e-2)" "unprognostic (3.62e-2)" "unprognostic (1.56e-1)" "prognostic favourable (5.21e-6)" "unprognostic (5.37e-2)" "unprognostic (9.06e-2)" "unprognostic (5.81e-2)" "unprognostic (1.56e-2)" 4.3 14.3 43.9 5.8 44.9 0.7 6.6 14.4 37.2 7.7 22.1 20.7 4.3 21.1 6.0 33.8 4.9 18.4 12.2 6.4 29.5 24.1 61.6 39.9 11.8 1.1 24.9 37.0 3.4 13.8 13.0 7.2 3.1 13.8 13.1 21.4 4.1 8.5 6.2 13.8 2.8 19.9 7.4 8.1 4.1 15.6 9.3 11.0 0.0 14.1 1.0 1.2 6.0 3.0 1.3 0.4 0.0 0.0 0.0 0.0 0.0 18.7 2.3 6.6 1.2 11.1 9.4 0.8 22.1 13.4 7.9 8.4 26.6 5.0 0.0 9.2 25.0 5.4 23.9 4.6 10.1 0.0 9.2 0.0 6.3 9.2 4.0 17.0 1.0 7.8 0.4 6.6 4.2 12.5 0.0 1.9 20.2 1.5 0.9 0.0 7.9 6.9 0.0 15.5 0.2 33.7 14.0 18.7 36.3 2.9 16.8 2.7 9.1 1.3 24.4 6.9 5.6 1.7 15.4 0.0 0.0 0.0 0.3 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 43.9 44.9 14.4 37.2 29.5 24.1 24.9 37.0 13.8 11.0 DDX28 "FLJ11282, MDDX28" ENSG00000182810 "DEAD-box helicase 28" Q9NUL7 16 68021274-68023442 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041911, HPA053585" Approved Supported Nucleoli,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoli "HPA041911: AB_10794161, HPA053585: " "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-2)" "unprognostic (8.46e-2)" "unprognostic (9.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.63e-2)" "unprognostic (8.14e-3)" "unprognostic (8.53e-2)" "prognostic favourable (2.07e-10)" "unprognostic (1.58e-2)" "unprognostic (6.21e-2)" "unprognostic (2.23e-1)" "unprognostic (2.47e-1)" 9.8 12.7 6.2 6.7 8.3 19.7 7.1 6.0 12.9 8.3 7.2 6.4 6.8 5.2 7.5 7.3 9.7 7.1 7.0 9.2 5.2 5.9 8.9 12.4 5.8 18.4 6.4 5.1 8.6 13.3 6.8 4.6 17.1 6.6 6.1 6.0 7.8 6.3 5.2 16.2 9.9 7.9 5.3 3.0 11.1 7.0 11.5 2.7 14.6 10.2 7.3 10.6 8.0 4.8 17.8 18.0 22.9 19.1 17.0 22.9 16.6 6.1 9.1 4.5 5.4 6.3 3.5 10.5 4.2 6.2 10.6 7.6 8.8 9.8 23.0 6.5 5.2 11.1 6.4 10.2 6.3 3.1 10.5 8.3 4.8 9.1 8.5 13.0 9.0 6.8 11.1 8.7 8.0 5.9 14.8 3.6 4.7 13.7 13.6 18.3 11.0 6.8 13.4 4.2 24.6 7.4 7.1 9.4 6.3 17.1 4.9 9.3 9.4 14.3 4.2 4.7 4.0 6.7 6.9 8.1 9.8 22.1 5.8 10.1 6.3 17.7 19.1 22.9 15.7 18.8 17.3 12.6 14.6 16.9 18.0 17.8 22.9 16.9 6.3 17.0 18.5 9.0 13.8 16.6 6.2 8.3 6.0 12.9 5.2 5.9 6.4 5.1 6.6 2.7 DDX31 "FLJ13633, FLJ14578, FLJ23349, PPP1R25" ENSG00000125485 "DEAD-box helicase 31" Q9H8H2 9 132592997-132670401 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020891 Supported "Nucleoli,Golgi apparatus,Vesicles" Nucleoli "Golgi apparatus, Vesicles" "HPA020891: " "unprognostic (5.71e-2)" "unprognostic (1.76e-2)" "unprognostic (2.56e-1)" "unprognostic (7.91e-2)" "unprognostic (5.79e-2)" "unprognostic (9.94e-2)" "prognostic unfavourable (1.68e-7)" "unprognostic (1.34e-1)" "unprognostic (2.02e-2)" "unprognostic (1.66e-1)" "unprognostic (3.90e-2)" "unprognostic (9.57e-3)" "unprognostic (4.57e-3)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.03e-1)" 6.8 6.9 8.2 15.3 11.2 6.0 12.3 18.4 8.5 7.5 6.6 9.4 12.6 5.0 8.9 8.8 9.8 8.8 7.5 5.4 6.3 6.3 8.4 9.2 12.0 15.1 9.1 5.7 16.9 17.3 10.0 8.8 5.8 9.8 9.2 8.0 7.4 12.7 12.6 12.9 14.0 7.2 12.7 12.9 8.7 6.8 15.2 8.3 6.8 22.7 10.8 13.8 7.2 12.6 5.0 4.5 1.9 2.7 3.1 6.9 3.0 7.1 13.2 6.5 8.9 7.9 7.2 12.7 7.6 7.5 12.1 9.2 14.7 14.7 17.8 7.0 7.1 20.0 20.3 8.9 9.7 10.9 7.5 9.6 11.8 7.7 9.6 17.1 7.9 6.3 12.2 12.3 17.4 7.9 17.7 7.0 10.0 15.3 11.9 9.3 16.0 13.6 12.6 11.5 20.5 11.0 6.8 11.7 8.3 14.0 12.4 10.6 26.0 5.0 6.6 20.5 9.3 11.6 11.8 3.4 10.7 13.9 7.4 10.9 15.4 0.0 1.9 1.9 5.7 2.7 4.7 4.2 5.5 4.4 4.5 5.0 6.9 5.1 0.3 3.1 1.9 2.8 3.6 3.0 8.2 11.2 18.4 8.5 6.3 6.3 9.1 5.7 9.8 8.3 DDX51 ENSG00000185163 "DEAD-box helicase 51" Q8N8A6 12 132136594-132144335 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039503 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA039503: AB_10796328" "unprognostic (2.84e-3)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" "unprognostic (2.84e-1)" "unprognostic (8.66e-2)" "unprognostic (4.00e-2)" "prognostic unfavourable (4.73e-4)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (4.88e-1)" "unprognostic (3.05e-3)" "unprognostic (5.31e-2)" "unprognostic (3.97e-2)" "unprognostic (2.48e-1)" "unprognostic (4.69e-2)" "unprognostic (3.28e-1)" "unprognostic (1.65e-3)" 10.5 8.5 12.7 12.7 17.1 17.2 10.3 23.5 18.9 8.8 8.4 11.8 10.6 7.8 11.5 12.2 8.5 12.4 10.0 8.1 11.6 9.9 9.5 7.2 8.9 11.1 10.5 16.9 19.6 14.8 10.1 9.8 7.2 11.8 9.3 7.3 8.9 10.7 12.4 13.8 18.0 8.2 10.4 10.5 10.6 9.3 6.7 12.0 9.5 9.9 7.1 10.4 9.3 8.6 2.5 2.3 2.6 2.1 1.6 2.0 1.0 6.2 10.1 4.2 5.3 4.0 3.9 8.0 4.8 2.9 7.1 3.0 6.2 3.1 10.9 4.2 2.9 6.6 10.4 7.7 3.5 2.6 10.1 12.9 5.4 2.0 4.8 9.0 7.5 3.4 5.7 4.0 3.6 3.8 9.5 3.6 2.1 6.1 10.9 18.4 7.4 17.3 13.0 5.7 12.1 4.8 4.9 10.3 5.4 5.2 7.5 5.3 6.6 8.3 6.6 2.7 8.2 6.6 11.0 10.1 5.9 12.7 5.6 6.8 6.3 1.1 2.1 1.2 2.0 1.0 0.7 1.5 1.3 0.9 0.6 2.5 1.2 1.6 2.6 1.6 1.0 2.3 0.6 1.0 12.7 17.1 23.5 18.9 11.6 9.9 10.5 16.9 11.8 12.0 DDX53 "CAGE, CT26" ENSG00000184735 "DEAD-box helicase 53" Q86TM3 X 22999961-23003589 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 11.5" "Cell line enhanced" "Detected in some" "K-562: 6.2;RPMI-8226: 3.2;U-2197: 2.1;U-266/84: 14.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003186 Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA003186: AB_1078637" "unprognostic (5.76e-1)" "unprognostic (1.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.4 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DDX54 "APR-5, DP97, MGC2835" ENSG00000123064 "DEAD-box helicase 54" Q8TDD1 12 113157174-113185479 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028244, HPA070786" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA028244: AB_10603885, HPA070786: " "unprognostic (1.61e-2)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (8.54e-2)" "unprognostic (8.57e-2)" "unprognostic (6.39e-2)" "prognostic unfavourable (1.39e-4)" "unprognostic (2.23e-2)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.83e-2)" "unprognostic (1.15e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" 17.2 17.6 9.2 20.7 12.8 25.4 17.2 9.9 13.6 17.9 16.4 12.4 18.1 20.3 18.0 19.4 19.5 17.2 17.9 20.1 8.8 7.9 22.3 28.6 14.0 19.9 8.1 9.4 22.4 27.0 18.3 7.4 22.6 10.0 16.6 9.0 13.4 17.4 13.9 45.4 18.7 19.4 14.8 8.1 22.2 16.1 11.4 8.6 26.6 23.1 21.6 22.2 16.7 17.5 12.1 13.3 8.0 15.2 11.9 13.0 10.0 26.4 27.7 10.3 19.0 6.9 8.3 26.7 14.4 13.4 19.7 10.8 28.5 12.9 34.3 16.9 12.0 19.7 18.3 18.7 7.5 19.7 22.5 20.6 14.9 19.4 12.2 34.3 24.4 13.7 14.8 19.0 11.8 16.1 29.8 12.3 10.1 24.5 29.5 49.0 24.1 19.7 21.9 15.3 35.0 10.7 27.7 13.4 12.2 20.4 31.3 13.0 26.8 26.9 11.9 16.7 18.7 19.8 30.0 18.0 20.5 38.6 14.7 19.2 17.5 8.0 10.0 2.3 12.4 15.2 13.0 11.6 11.4 12.2 13.3 12.1 11.8 12.5 0.6 11.9 9.8 10.0 9.4 10.0 9.2 12.8 9.9 13.6 8.8 7.9 8.1 9.4 10.0 8.6 DEPDC7 ENSG00000121690 "DEP domain containing 7" Q96QD5 11 33015864-33033582 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 51.8;liver: 42.2" "Cell line enhanced" "Detected in many" "LHCN-M2: 26.7;RH-30: 20.2;SiHa: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 9.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015800 Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA015800: AB_1847610" "unprognostic (2.34e-1)" "unprognostic (5.57e-2)" "unprognostic (1.27e-1)" "unprognostic (2.27e-1)" "unprognostic (2.66e-2)" "unprognostic (7.26e-2)" "prognostic favourable (7.26e-4)" "unprognostic (1.80e-1)" "unprognostic (1.22e-1)" "unprognostic (2.92e-1)" "unprognostic (1.17e-3)" "unprognostic (8.99e-2)" "unprognostic (1.89e-2)" "unprognostic (9.30e-2)" "unprognostic (8.09e-3)" "unprognostic (2.64e-1)" "unprognostic (2.94e-2)" 0.6 0.5 2.0 1.4 4.1 0.9 2.0 0.5 2.6 1.7 15.3 4.3 1.2 14.1 1.2 1.4 3.1 0.8 3.1 0.9 2.6 1.4 10.9 42.2 0.7 0.4 4.0 1.5 1.3 2.7 3.5 0.8 1.2 2.8 1.4 3.1 1.2 1.7 1.0 3.3 3.4 51.8 1.0 3.2 0.5 2.2 15.6 3.3 1.8 0.6 2.0 0.9 0.9 2.4 0.0 4.4 9.0 0.7 3.0 3.1 0.6 4.5 2.5 3.7 1.6 1.9 1.9 2.4 8.0 2.7 4.9 6.6 6.5 0.4 0.0 1.8 7.9 4.6 5.3 1.9 5.8 0.0 7.4 1.2 7.8 9.2 1.6 4.3 5.5 2.3 2.9 2.8 2.1 0.0 2.9 0.0 26.7 0.5 0.0 7.0 2.4 0.0 0.0 20.2 0.0 1.6 0.6 0.8 2.1 18.4 3.3 15.9 0.8 2.3 0.0 3.2 5.3 17.1 5.1 0.0 0.0 0.0 1.1 0.0 15.6 4.0 0.7 9.0 0.3 0.2 0.0 0.0 0.6 0.3 4.4 0.0 2.9 3.1 0.0 3.0 0.0 1.8 0.0 0.6 2.0 4.1 0.5 2.6 2.6 1.4 4.0 1.5 2.8 3.3 DIAPH2 "DIA, DIA2, POF, POF2" ENSG00000147202 "Diaphanous related formin 2" O60879 X 96684663-97604997 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Oogenesis" "Developmental protein" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005647, CAB015461, CAB068183, CAB068184" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Vesicles" "Endoplasmic reticulum, Vesicles" Nucleoli "CAB015461: AB_831223, CAB068183: , CAB068184: , HPA005647: AB_1078657" "unprognostic (5.75e-2)" "unprognostic (4.13e-3)" "unprognostic (1.48e-1)" "prognostic unfavourable (2.16e-5)" "unprognostic (1.58e-1)" "unprognostic (6.48e-2)" "unprognostic (4.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.41e-1)" "unprognostic (1.43e-2)" "prognostic unfavourable (2.12e-4)" "unprognostic (3.39e-2)" "prognostic unfavourable (3.90e-4)" "unprognostic (6.44e-2)" "unprognostic (3.11e-2)" "unprognostic (6.99e-3)" "unprognostic (6.08e-3)" 25.3 5.7 8.2 16.5 13.6 19.9 12.0 1.6 4.6 17.8 18.5 2.9 15.1 5.5 10.7 9.1 16.3 10.4 12.6 13.0 6.6 3.0 6.1 15.7 16.8 6.9 4.1 4.4 14.2 6.6 8.7 5.5 37.2 7.1 16.0 11.4 4.7 9.4 17.2 19.9 9.3 12.0 18.5 7.3 9.8 9.9 12.3 5.1 9.4 7.5 12.0 4.9 19.8 26.9 2.7 4.3 5.7 5.8 1.4 2.8 1.0 0.0 4.0 1.9 3.9 11.0 18.4 0.0 6.9 7.3 3.7 7.9 3.3 7.6 11.3 5.5 5.9 0.0 10.3 1.1 4.9 0.3 5.9 0.0 4.8 3.5 9.2 14.5 5.2 9.2 3.7 5.0 15.7 7.2 0.0 9.3 6.9 3.2 5.4 5.9 15.3 5.9 0.0 10.4 0.0 2.1 6.0 0.0 4.0 0.0 2.0 5.5 1.7 8.0 9.1 8.1 3.7 6.6 4.4 0.1 0.0 9.5 6.8 14.8 4.7 0.0 5.8 5.7 2.3 5.4 1.8 2.7 2.4 2.8 4.3 2.4 1.6 1.5 0.6 1.4 4.5 4.1 1.3 1.0 8.2 13.6 1.6 4.6 6.6 3.0 4.1 4.4 7.1 5.1 DIMT1 "DIMT1L, HSA9761" ENSG00000086189 "DIM1 dimethyladenosine transferase 1 homolog" Q9UNQ2 5 62387254-62403939 "Enzymes, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042944 Approved Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA042944: " "unprognostic (1.58e-1)" "unprognostic (2.27e-1)" "unprognostic (6.02e-3)" "unprognostic (7.16e-2)" "unprognostic (8.95e-3)" "unprognostic (1.73e-2)" "prognostic unfavourable (6.93e-4)" "unprognostic (8.88e-2)" "unprognostic (1.18e-2)" "unprognostic (1.62e-1)" "unprognostic (5.31e-2)" "unprognostic (3.70e-1)" "prognostic unfavourable (8.90e-12)" "unprognostic (8.89e-2)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (5.15e-2)" 16.7 14.0 18.9 16.7 17.0 10.6 18.9 11.5 23.5 18.6 11.8 12.4 11.8 11.0 16.2 11.9 20.1 14.2 15.3 19.7 19.1 17.0 11.9 16.3 11.7 22.5 18.8 8.5 17.8 28.4 8.9 13.4 16.7 12.3 18.8 9.5 10.0 16.1 18.3 17.9 12.2 11.9 24.6 20.2 22.1 10.2 10.7 9.8 16.3 19.0 19.0 19.2 21.7 13.2 7.9 7.7 5.0 5.6 7.0 13.2 6.1 14.4 8.7 15.9 20.8 11.8 15.7 15.9 18.6 7.0 14.4 15.3 14.1 15.5 29.8 17.0 13.8 11.3 10.7 11.0 18.3 21.2 18.7 20.5 11.4 11.7 14.2 16.8 15.8 13.6 8.9 14.0 13.7 12.5 20.7 13.8 14.6 14.5 24.7 25.9 15.4 18.4 16.0 16.1 41.1 13.0 13.4 17.9 15.6 15.9 14.9 15.9 12.0 15.8 13.8 9.9 10.4 14.0 25.4 18.2 18.9 26.9 15.1 30.2 14.6 5.0 3.1 2.3 7.7 5.6 11.7 7.9 10.4 9.3 5.0 6.6 13.2 11.0 0.8 7.0 4.3 7.7 9.3 6.1 18.9 17.0 11.5 14.7 19.1 17.0 18.8 8.5 12.3 9.8 DLK2 "EGFL9, MGC2487" ENSG00000171462 "Delta like non-canonical Notch ligand 2" Q6UY11 6 43450352-43456632 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 19.3" "Cell line enhanced" "Detected in many" "HaCaT: 16.2;HBEC3-KT: 8.8;hTCEpi: 26.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA061223, HPA068672, HPA070955" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA061223: , HPA068672: , HPA070955: " "unprognostic (4.65e-5)" "unprognostic (1.27e-1)" "unprognostic (1.69e-1)" "unprognostic (9.68e-4)" "unprognostic (2.87e-1)" "unprognostic (3.80e-1)" "unprognostic (4.19e-3)" "unprognostic (1.65e-1)" "unprognostic (2.65e-3)" "unprognostic (4.04e-1)" "unprognostic (1.88e-2)" "unprognostic (1.88e-1)" "unprognostic (9.27e-12)" "unprognostic (7.71e-4)" "unprognostic (8.92e-2)" "unprognostic (1.55e-1)" "unprognostic (6.43e-2)" 1.0 1.1 4.5 1.4 7.9 1.7 4.3 12.2 8.2 2.2 0.7 0.9 6.4 1.1 1.4 3.8 10.5 1.1 0.9 1.8 4.1 4.6 0.7 0.7 1.1 1.7 1.5 4.8 1.7 1.5 0.4 0.5 1.3 0.9 10.4 0.5 0.3 12.4 13.0 0.7 19.3 1.0 0.6 1.5 1.5 1.1 1.1 1.2 1.3 0.8 4.7 3.9 2.2 5.3 0.8 1.8 1.0 0.5 2.5 3.2 0.3 5.1 1.8 0.5 7.7 0.0 0.4 1.7 1.9 2.1 2.1 1.0 1.8 0.2 0.9 1.2 0.3 16.2 5.4 8.8 0.4 1.0 2.0 0.4 0.9 2.7 0.5 0.3 1.1 0.9 26.6 0.6 5.0 0.0 0.4 0.7 0.8 1.9 0.4 0.4 0.7 1.9 1.0 0.9 0.5 0.3 1.8 5.7 0.5 0.6 0.2 0.3 0.5 1.6 0.5 0.8 2.5 0.6 3.7 1.2 0.3 1.7 0.1 0.7 0.5 0.9 0.4 0.4 0.7 0.3 3.2 0.6 2.2 2.2 0.1 0.8 0.9 0.4 1.0 2.5 0.5 1.8 0.3 0.3 4.5 7.9 12.2 8.2 4.1 4.6 1.5 4.8 0.9 1.2 DNAJA2 "CPR3, DNAJ, DNJ3, HIRIP4" ENSG00000069345 "DnaJ heat shock protein family (Hsp40) member A2" O60884 16 46955362-46973788 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049789, HPA060538" Approved Approved "Nucleoli,Intermediate filaments,Cytosol" 31000 "Nucleoli, Cytosol" "Intermediate filaments" "HPA049789: , HPA060538: " "unprognostic (7.68e-3)" "unprognostic (1.05e-2)" "unprognostic (4.77e-2)" "unprognostic (3.67e-2)" "unprognostic (4.46e-2)" "prognostic unfavourable (2.81e-4)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.53e-2)" "unprognostic (5.41e-2)" "unprognostic (2.12e-1)" "prognostic favourable (1.19e-9)" "unprognostic (9.22e-2)" "unprognostic (2.28e-1)" "unprognostic (9.22e-2)" "unprognostic (4.69e-2)" 25.0 29.2 32.3 18.0 36.5 23.6 22.8 29.8 44.2 21.7 21.1 17.1 20.3 22.3 25.6 33.6 23.4 20.3 18.9 37.9 30.5 27.1 31.2 39.0 17.7 21.4 25.5 27.6 26.1 18.9 29.0 18.9 22.1 31.5 25.6 21.9 18.4 19.1 24.9 43.7 22.3 23.8 26.9 21.2 24.1 20.3 33.0 18.7 20.8 25.4 31.8 23.2 24.5 23.5 13.6 10.5 14.5 14.0 14.3 18.9 10.2 10.9 13.1 13.2 11.2 18.1 17.5 20.1 14.3 17.3 21.6 10.3 11.4 11.5 17.7 11.6 15.4 17.1 21.0 14.8 25.1 4.2 17.6 13.0 6.4 24.0 21.7 19.7 18.2 18.6 17.2 12.5 11.9 14.9 14.9 6.0 18.2 12.0 14.1 27.5 20.1 19.5 16.4 24.2 21.0 26.0 11.7 18.1 11.6 17.0 25.8 15.6 10.0 15.4 15.3 12.8 8.1 9.2 12.0 14.8 10.1 23.7 13.5 17.0 10.7 13.0 11.5 14.5 11.9 14.0 15.4 13.6 16.1 13.3 10.5 10.4 16.0 15.7 12.1 14.3 12.0 7.4 18.9 10.2 32.3 36.5 29.8 44.2 30.5 27.1 25.5 27.6 31.5 18.7 DOC2A ENSG00000149927 "Double C2 domain alpha" Q14183 16 30005509-30023270 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 49.0;testis: 12.6" "Cell line enhanced" "Detected in many" "BEWO: 9.6;REH: 7.8;SCLC-21H: 26.1;U-937: 12.5" "Cancer enhanced" "Detected in many" "renal cancer: 5.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 4 "amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4" HPA065676 Uncertain "Nucleoplasm,Nucleoli,Cell Junctions" "Cell Junctions" "Nucleoplasm, Nucleoli" "HPA065676: " "unprognostic (1.46e-3)" "unprognostic (3.39e-1)" "unprognostic (2.30e-2)" "unprognostic (1.31e-1)" "unprognostic (4.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.66e-2)" "unprognostic (9.14e-2)" "unprognostic (3.90e-2)" "unprognostic (2.89e-2)" "unprognostic (1.28e-3)" "unprognostic (5.13e-2)" "unprognostic (8.29e-3)" "unprognostic (1.71e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" "unprognostic (2.61e-1)" 1.2 2.7 18.5 1.0 17.5 3.9 2.3 24.0 49.0 1.3 3.1 0.9 0.3 1.7 1.6 2.4 1.1 3.3 1.8 1.0 15.3 8.3 1.6 1.4 3.5 1.4 2.8 27.4 5.7 1.0 1.3 3.2 1.2 13.1 2.5 2.4 0.0 1.6 1.4 1.1 2.0 2.3 1.8 4.2 3.1 1.7 12.6 1.8 0.0 1.6 0.0 1.2 1.4 0.6 0.6 1.1 1.0 0.4 0.2 0.5 0.3 0.7 1.5 1.0 0.8 0.3 0.0 9.6 0.4 0.7 0.5 0.3 3.9 2.7 0.0 0.9 0.4 0.2 4.9 2.0 0.2 0.1 0.5 0.7 0.5 0.3 0.7 0.9 2.8 1.1 0.8 0.1 1.1 0.0 0.3 0.0 0.0 7.6 2.0 3.5 1.5 4.1 7.8 0.1 0.4 0.5 0.8 26.1 2.0 0.5 2.7 0.2 2.6 1.6 0.8 0.3 1.5 0.3 0.3 0.4 0.1 0.1 0.3 12.5 0.3 0.8 0.4 0.0 0.0 0.3 0.1 0.5 0.1 0.3 1.1 0.6 0.5 0.5 1.0 0.2 0.0 0.0 0.1 0.3 18.5 17.5 24.0 36.2 15.3 8.3 2.8 27.4 13.1 1.8 DOHH "HLRC1, MGC4293" ENSG00000129932 "Deoxyhypusine hydroxylase" Q9BU89 19 3490822-3500940 "Enzymes, Predicted intracellular proteins" "Hypusine biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041953, HPA076271" Approved Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA041953: AB_10795386, HPA076271: " "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (8.63e-2)" "prognostic favourable (2.24e-4)" "unprognostic (3.66e-1)" "unprognostic (2.01e-2)" "unprognostic (9.45e-2)" "unprognostic (7.26e-2)" "unprognostic (4.65e-2)" "unprognostic (1.13e-1)" "prognostic favourable (3.58e-4)" "unprognostic (9.87e-3)" "unprognostic (1.14e-3)" "unprognostic (4.35e-2)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" "unprognostic (3.76e-3)" 8.1 6.5 10.5 6.6 13.0 9.3 3.4 5.5 13.0 3.9 5.5 6.9 2.6 18.9 3.7 4.1 4.1 3.1 4.9 5.1 14.9 9.1 6.0 6.4 4.0 4.5 18.2 6.2 3.8 7.6 3.8 3.9 3.8 8.4 5.1 2.0 3.2 6.0 4.0 23.1 7.0 12.3 2.4 25.5 5.9 7.3 4.2 6.1 4.7 2.9 7.8 4.5 3.1 4.7 11.6 11.0 1.8 6.6 6.9 12.3 4.4 9.1 11.0 1.7 3.6 0.9 1.0 7.3 8.7 1.8 4.3 3.4 15.2 3.8 7.2 6.8 1.3 9.5 2.7 3.0 0.9 10.5 12.3 7.5 6.2 18.1 3.5 9.9 10.4 1.2 3.0 4.1 1.8 2.2 16.2 8.5 1.7 10.4 10.8 11.3 9.7 14.8 12.2 4.0 10.3 2.6 5.1 10.4 7.7 6.1 5.4 8.7 7.5 5.5 5.0 5.4 7.4 14.2 15.9 11.3 8.1 9.5 6.4 22.6 6.4 1.1 5.3 1.8 6.2 6.2 8.1 8.1 8.5 12.3 8.7 11.6 12.3 10.4 0.3 6.9 6.6 11.0 9.6 4.4 10.5 13.0 5.5 13.0 14.9 9.1 18.2 6.2 8.4 6.1 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947619 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Enhanced Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA066767: , HPA068706: " "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favourable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favourable (6.88e-5)" "unprognostic (6.13e-3)" 11.0 20.2 7.9 7.8 13.8 1.4 9.5 7.0 18.6 9.8 8.6 14.9 7.1 8.8 12.4 16.8 10.9 10.8 10.8 12.0 7.6 9.9 17.5 22.0 10.6 10.6 8.1 6.7 13.2 16.9 19.2 8.0 19.5 16.3 12.3 8.0 14.2 15.5 12.8 7.9 11.4 10.9 11.1 5.9 11.6 12.4 22.4 6.0 12.5 11.0 11.9 12.1 10.4 7.3 9.4 14.2 5.6 16.4 9.8 13.7 9.0 5.1 19.1 6.8 10.0 20.1 10.6 9.2 10.7 17.4 13.2 9.8 15.0 8.1 2.8 5.7 15.5 36.4 9.2 13.4 6.8 4.7 8.1 3.5 13.1 10.8 20.3 3.8 6.3 14.6 12.4 14.2 7.8 12.8 8.5 4.5 14.2 25.2 3.1 3.2 8.7 11.9 3.1 9.0 11.1 11.8 7.7 6.2 7.0 14.2 11.7 6.3 20.5 5.0 10.6 11.9 4.3 14.9 8.8 4.3 10.7 2.8 11.2 3.5 9.0 2.3 13.5 5.6 10.2 13.3 9.1 9.4 9.2 11.2 14.2 9.2 12.1 12.3 2.1 9.8 16.4 8.1 13.7 9.0 7.9 13.8 7.0 18.6 7.6 9.9 8.1 6.7 16.3 6.0 DPPA4 FLJ10713 ENSG00000121570 "Developmental pluripotency associated 4" Q7L190 3 109326141-109337572 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.3;lymphoid tissue: 35.8" "Group enriched" "Detected in some" 5 "HAP1: 22.7;NTERA-2: 83.5" "Cancer enriched" "Detected in single" 218 "testis cancer: 59.0" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 10.3" "Lineage enriched" "Detected in single" 11 "dendritic cells: 10.3" "CAB020678, HPA035249, HPA035250" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB020678: , HPA035249: , HPA035250: " "unprognostic (2.07e-2)" "unprognostic (2.53e-2)" "unprognostic (3.80e-1)" "unprognostic (2.53e-1)" "unprognostic (8.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.52e-1)" "unprognostic (9.83e-2)" "unprognostic (2.02e-2)" "unprognostic (6.60e-2)" "unprognostic (2.48e-2)" "unprognostic (3.03e-8)" "unprognostic (5.28e-2)" "unprognostic (5.04e-2)" "unprognostic (5.56e-2)" "unprognostic (3.85e-2)" 0.1 0.1 0.2 0.3 1.0 8.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.6 0.1 0.2 1.3 0.6 0.8 0.3 0.0 0.0 0.0 0.0 2.2 4.2 0.4 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 8.1 0.0 35.8 0.1 0.0 1.0 0.4 0.1 0.9 10.3 0.0 0.0 0.7 0.2 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 83.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.2 0.0 0.7 0.0 10.3 0.0 0.1 0.2 1.0 0.1 0.3 0.6 0.1 0.3 0.0 0.4 0.0 DRGX "DRG11, PRRXL1" ENSG00000165606 "Dorsal root ganglia homeobox" A6NNA5 10 49364181-49396016 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 8 "adrenal gland: 13.9;brain: 8.0" "Cell line enhanced" "Detected in some" "RH-30: 8.1;SH-SY5Y: 36.6;U-2197: 13.2" "Low cancer specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "pons and medulla: 4.1" "Low region specificity" "Detected in all" HPA043978 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA043978: AB_10961154" "unprognostic (1.42e-2)" "unprognostic (5.68e-2)" "unprognostic (3.92e-2)" "unprognostic (1.23e-2)" "unprognostic (1.74e-3)" "unprognostic (1.58e-1)" "unprognostic (4.54e-2)" "unprognostic (3.74e-2)" "unprognostic (8.91e-2)" "unprognostic (1.60e-1)" "unprognostic (4.09e-2)" 0.2 13.9 0.0 0.4 0.2 0.3 0.1 0.4 3.3 0.0 0.4 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.5 0.1 2.0 0.6 0.0 0.0 0.0 0.9 0.0 4.8 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.3 0.0 8.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 3.3 0.2 0.3 2.0 0.6 4.8 0.0 DTL "CDT2, DCAF2, L2DTL, RAMP" ENSG00000143476 "Denticleless E3 ubiquitin protein ligase homolog" Q9NZJ0 1 212035553-212107400 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "memory CD8 T-cell: 1.5;T-reg: 5.2" "Lineage enriched" "Detected in single" 7 "T-cells: 5.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028016, HPA032023, HPA032031" Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA028016: AB_10611958, HPA032023: , HPA032031: " "unprognostic (7.61e-2)" "unprognostic (1.01e-3)" "unprognostic (2.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.19e-1)" "unprognostic (5.31e-2)" "prognostic unfavourable (4.41e-5)" "unprognostic (8.96e-3)" "unprognostic (2.45e-3)" "unprognostic (8.83e-3)" "unprognostic (2.52e-3)" "unprognostic (2.83e-2)" "prognostic unfavourable (1.71e-9)" "unprognostic (5.93e-2)" "unprognostic (2.01e-1)" "unprognostic (1.96e-2)" "unprognostic (2.82e-1)" 1.3 0.7 0.4 5.4 0.6 10.8 1.3 0.4 0.5 1.2 2.8 0.3 0.1 1.7 1.0 0.6 4.0 0.4 1.5 0.6 0.4 0.4 0.8 1.0 1.6 4.4 0.4 0.1 0.6 0.5 0.6 0.7 5.4 0.2 0.6 4.2 0.2 1.1 0.1 0.4 1.6 3.3 1.4 0.4 4.6 1.1 37.2 0.1 41.2 0.9 5.7 7.5 0.9 1.6 0.7 0.3 0.0 0.4 0.6 5.2 0.7 12.5 10.7 18.4 9.2 1.1 2.3 9.0 15.8 9.8 14.9 22.3 6.6 11.1 9.5 5.9 6.0 9.8 24.2 13.3 21.6 11.5 11.6 15.2 14.1 8.1 0.0 19.9 9.5 1.0 0.4 24.2 12.9 6.8 18.1 19.4 17.2 5.0 26.6 9.1 21.2 12.4 21.1 32.4 18.4 4.2 8.7 11.5 18.0 15.0 14.4 6.5 12.2 9.1 3.7 15.0 11.2 15.4 17.7 7.1 11.1 22.0 7.6 13.2 14.5 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.8 1.5 0.3 0.1 0.0 0.3 0.0 0.6 0.0 0.0 5.2 0.7 0.4 0.6 0.4 0.5 0.4 0.4 0.4 0.1 0.2 0.1 DTWD1 "MDS009, MGC111207" ENSG00000104047 "DTW domain containing 1" Q8N5C7 15 49620980-49656232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042214 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA042214: " "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (3.00e-1)" "unprognostic (3.70e-4)" "unprognostic (8.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.82e-1)" "unprognostic (9.87e-2)" "unprognostic (4.44e-3)" "unprognostic (4.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (1.02e-1)" "unprognostic (7.85e-2)" "unprognostic (2.80e-2)" "unprognostic (2.35e-1)" 19.1 12.6 15.7 11.3 27.5 4.2 17.5 16.7 16.0 24.5 20.1 10.9 9.4 6.9 25.2 15.8 11.7 17.0 19.9 12.0 11.5 9.3 10.3 9.9 11.6 10.4 12.9 12.2 21.6 28.5 8.7 22.1 11.2 11.9 19.2 11.2 11.6 18.0 14.2 10.7 10.8 8.9 22.4 11.7 9.4 15.6 8.2 13.1 12.1 15.5 11.8 8.7 21.5 17.2 8.6 21.6 5.4 11.9 11.1 11.5 5.2 4.4 5.2 9.6 5.1 19.1 37.4 7.6 12.9 12.9 17.2 12.7 1.6 3.6 7.0 9.7 16.1 8.0 6.8 6.8 16.7 4.7 4.8 6.1 10.6 6.2 12.8 7.9 5.3 18.0 9.1 10.7 13.2 7.0 11.3 7.5 18.0 8.9 5.3 6.4 6.0 7.1 7.7 19.8 27.7 5.5 3.1 8.6 6.5 15.6 5.3 12.0 5.3 11.5 4.6 20.4 8.1 11.4 14.3 6.0 9.1 4.2 17.9 22.7 12.6 5.4 8.6 4.2 6.5 9.8 8.9 8.6 9.6 10.4 10.8 8.6 11.5 10.6 2.1 11.1 11.9 21.6 7.5 5.2 15.7 27.5 16.7 16.0 11.5 9.3 12.9 12.2 11.9 13.1 DTX3 "FLJ34766, RNF154" ENSG00000178498 "Deltex E3 ubiquitin ligase 3" Q8N9I9 12 57604622-57609804 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Cancer enhanced" "Detected in all" "glioma: 54.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 2.0;T-cells: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059654 Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli" "Golgi apparatus" "HPA059654: " "unprognostic (2.31e-2)" "unprognostic (8.80e-2)" "unprognostic (2.06e-2)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.58e-2)" "unprognostic (6.91e-2)" "prognostic favourable (9.87e-4)" "unprognostic (1.84e-1)" "unprognostic (4.26e-2)" "prognostic favourable (1.44e-4)" "unprognostic (8.62e-2)" "unprognostic (5.44e-3)" "unprognostic (7.99e-2)" "unprognostic (8.81e-2)" "unprognostic (9.51e-2)" "unprognostic (3.48e-2)" 7.2 18.8 22.7 9.0 35.2 3.5 9.4 47.8 53.6 17.6 22.8 23.7 11.0 6.7 29.7 30.6 9.7 31.8 14.1 20.5 23.8 19.8 11.4 2.4 12.2 11.0 18.3 28.4 36.3 12.0 23.9 32.7 16.0 22.5 21.1 10.1 20.4 13.2 29.5 10.9 7.9 9.4 28.7 16.9 11.2 11.2 7.8 21.6 6.8 16.8 5.1 8.8 11.8 13.5 0.3 0.6 0.0 0.0 2.0 5.5 1.8 3.1 8.4 25.0 0.0 0.0 0.0 0.1 5.1 13.3 11.3 11.5 4.3 13.6 4.5 7.9 11.1 5.2 0.0 0.6 8.0 11.3 1.5 2.6 13.0 4.5 19.3 0.0 0.0 9.5 6.3 8.6 0.1 12.6 0.0 15.4 8.6 7.0 13.7 0.1 19.7 0.7 0.0 20.9 0.2 1.0 8.4 18.2 28.8 4.0 1.2 2.4 14.4 6.9 0.0 14.8 5.9 6.8 7.3 25.2 18.9 0.0 9.5 0.0 7.7 0.0 0.0 0.0 5.5 0.0 1.3 0.3 2.1 2.5 0.2 0.3 1.9 3.5 0.0 2.0 0.0 0.6 4.2 1.8 22.7 35.2 47.8 53.6 23.8 19.8 18.3 28.4 22.5 21.6 E2F5 ENSG00000133740 "E2F transcription factor 5" Q15329 8 85177225-85217158 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cilium biogenesis/degradation, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 27.0;Daudi: 53.1;U-698: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 13.3;naive B-cell: 7.6" "Lineage enriched" "Detected in many" 9 "B-cells: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055723, HPA065441" Enhanced Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA055723: , HPA065441: " "unprognostic (8.73e-2)" "unprognostic (3.45e-1)" "unprognostic (3.15e-2)" "unprognostic (1.02e-3)" "unprognostic (6.73e-3)" "unprognostic (1.62e-1)" "unprognostic (3.36e-5)" "unprognostic (1.23e-1)" "unprognostic (9.53e-2)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.87e-2)" "prognostic unfavourable (1.89e-6)" "unprognostic (2.88e-2)" "unprognostic (3.25e-2)" "unprognostic (3.64e-1)" "unprognostic (2.95e-3)" 3.0 9.0 6.4 22.2 8.1 1.5 5.9 2.6 5.3 5.0 5.9 4.0 3.4 4.6 5.4 7.4 4.7 7.2 6.6 3.2 5.6 5.6 9.0 4.5 5.1 22.4 4.6 2.7 8.3 14.6 12.7 10.6 4.3 3.8 5.1 7.2 3.4 5.7 5.9 1.1 1.7 7.3 3.8 4.5 9.9 5.1 10.5 3.2 13.6 10.2 3.0 26.0 6.0 7.6 13.3 1.4 0.0 0.0 1.1 0.6 0.6 4.8 5.2 27.0 10.0 0.5 0.7 8.7 0.9 2.1 0.8 2.3 3.1 5.7 53.1 3.8 1.1 1.0 15.7 1.3 1.0 5.5 7.2 5.3 2.9 7.3 4.3 1.6 0.0 1.0 2.1 1.0 3.8 0.8 11.2 0.4 1.4 3.1 5.4 3.5 8.7 4.6 4.3 1.1 5.7 8.7 3.4 3.3 10.4 0.6 1.8 8.0 11.3 1.7 0.0 1.3 1.0 1.5 3.5 10.0 6.7 25.4 1.5 1.3 2.6 0.0 0.0 0.0 0.1 0.0 0.0 13.3 0.0 0.0 0.1 7.6 0.2 0.4 0.0 1.1 0.0 1.4 0.6 0.6 6.4 8.1 2.6 4.5 5.6 5.6 4.6 2.7 3.8 3.2 E2F8 FLJ23311 ENSG00000129173 "E2F transcription factor 8" A0AVK6 11 19224063-19241620 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 30.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.9" "Lineage enriched" "Detected in single" 24 "T-cells: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA064882, HPA076614" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA064882: , HPA076614: " "unprognostic (5.62e-2)" "unprognostic (5.24e-2)" "unprognostic (3.17e-2)" "unprognostic (6.99e-3)" "unprognostic (2.86e-2)" "unprognostic (1.66e-2)" "unprognostic (1.29e-5)" "unprognostic (1.94e-2)" "unprognostic (3.90e-3)" "unprognostic (2.41e-1)" "unprognostic (7.29e-4)" "unprognostic (1.16e-2)" "unprognostic (9.13e-8)" "unprognostic (1.02e-3)" "unprognostic (1.37e-1)" "unprognostic (3.81e-1)" "unprognostic (4.28e-3)" 1.0 0.4 0.4 7.2 0.2 11.5 0.3 0.2 0.4 1.6 3.6 0.2 0.2 3.3 1.2 1.4 8.2 0.9 2.0 3.4 0.2 0.2 0.4 0.5 0.8 6.1 0.2 0.2 0.7 0.3 0.0 0.2 4.0 0.2 0.6 4.8 1.2 1.8 0.9 11.5 2.6 4.6 0.7 0.2 2.4 5.1 4.7 0.2 30.3 0.3 8.0 12.5 3.4 2.1 0.0 0.1 0.0 0.0 0.0 2.9 0.4 14.2 4.3 4.4 6.1 0.2 0.6 18.9 7.9 2.2 9.3 10.1 14.7 4.7 14.1 3.3 2.5 12.6 10.8 1.0 8.5 9.5 8.7 4.9 2.4 4.0 0.0 7.5 11.9 0.2 0.0 1.9 0.6 13.1 10.3 13.7 3.7 6.9 14.6 9.3 4.1 6.0 15.9 8.3 9.6 4.0 9.7 3.8 4.3 3.5 7.0 0.8 4.8 8.0 2.5 4.5 5.6 11.0 7.1 4.7 9.5 17.9 5.7 14.7 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 0.4 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2 ECEL1 "DINE, XCE" ENSG00000171551 "Endothelin converting enzyme like 1" O95672 2 232479827-232487828 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;ovary: 57.1" "Group enriched" "Detected in some" 6 "AN3-CA: 29.4;HeLa: 15.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.9" "Region enriched" "Detected in many" 5 "hypothalamus: 28.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA067560, HPA069756, HPA077424" Approved Supported Approved "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA067560: , HPA069756: , HPA077424: " "unprognostic (1.21e-2)" "unprognostic (1.06e-2)" "unprognostic (4.39e-1)" "unprognostic (4.62e-3)" "unprognostic (2.80e-1)" "unprognostic (9.96e-4)" "unprognostic (7.56e-3)" "unprognostic (1.22e-1)" "unprognostic (9.89e-3)" "unprognostic (8.49e-2)" "unprognostic (1.54e-1)" "unprognostic (2.89e-1)" "unprognostic (1.24e-5)" "unprognostic (3.09e-2)" "unprognostic (3.68e-1)" "unprognostic (7.84e-2)" "unprognostic (5.45e-2)" 0.9 2.6 0.5 0.9 4.0 0.2 0.4 0.7 1.2 0.3 0.4 0.5 0.1 0.3 0.6 4.9 0.3 1.7 1.0 1.1 0.1 28.6 1.0 0.7 0.2 1.2 0.3 0.1 57.1 0.6 0.3 8.9 0.4 5.5 0.3 0.2 11.5 0.3 1.2 1.8 0.3 0.3 1.1 4.5 2.0 0.3 0.8 1.6 0.1 0.5 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.3 0.0 0.0 0.4 0.0 0.0 0.0 2.6 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.0 0.7 1.2 0.1 28.6 0.3 0.1 5.5 1.6 EDN1 ET1 ENSG00000078401 "Endothelin 1" P05305 6 12290363-12297194 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 107.5;HUVEC TERT2: 71.2;T-47d: 22.0;TIME: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.9" "Lineage enriched" "Detected in many" 6 "monocytes: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031976, CAB032500, CAB037291" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted to blood" 1085 "Nucleoli, Golgi apparatus" Nucleoplasm "CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "unprognostic (9.72e-2)" "unprognostic (3.40e-1)" "unprognostic (1.91e-1)" "unprognostic (6.24e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (8.92e-2)" "unprognostic (4.19e-2)" "unprognostic (3.17e-1)" "unprognostic (8.02e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (3.47e-1)" 35.7 1.5 8.4 6.2 30.8 3.6 19.2 3.2 22.0 8.2 9.2 4.2 1.1 9.0 7.2 15.3 10.8 8.6 11.9 5.2 19.0 6.2 5.7 2.8 25.1 6.7 10.9 5.5 4.3 8.2 1.6 1.0 16.0 25.1 5.4 12.9 6.9 9.7 8.5 25.6 8.2 6.7 9.7 13.5 10.2 6.8 4.8 5.6 0.2 2.9 3.8 2.1 5.3 4.1 0.2 0.2 1.2 7.9 0.0 0.2 0.0 1.5 9.0 0.1 0.0 0.0 0.0 0.0 2.8 2.5 2.4 2.0 11.6 1.3 0.0 107.5 1.1 0.8 0.0 1.6 1.7 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 1.0 0.4 0.3 71.2 0.0 0.0 9.0 0.2 0.0 0.0 0.1 0.1 0.0 0.8 0.0 5.6 1.4 0.1 0.0 0.2 8.5 0.0 22.0 0.1 52.7 6.0 4.8 0.1 3.6 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 7.9 0.1 0.0 0.0 8.4 30.8 3.2 22.0 19.0 6.2 10.9 5.5 25.1 5.6 EFCAB14 KIAA0494 ENSG00000159658 "EF-hand calcium binding domain 14" O75071 1 46675159-46719064 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 107.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011224, HPA011938" Approved Approved "Nucleoli,Golgi apparatus,Cytosol" 58000 Cytosol "Nucleoli, Golgi apparatus" "HPA011224: AB_1852314, HPA011938: AB_1852317" "unprognostic (2.44e-1)" "unprognostic (5.90e-2)" "unprognostic (7.53e-2)" "unprognostic (2.36e-1)" "unprognostic (7.34e-2)" "unprognostic (4.55e-2)" "unprognostic (1.39e-2)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (1.66e-1)" "unprognostic (1.21e-2)" "unprognostic (3.00e-1)" "unprognostic (1.13e-3)" "unprognostic (1.00e-2)" "unprognostic (5.77e-2)" "unprognostic (1.94e-1)" "unprognostic (2.46e-1)" 29.4 17.4 29.4 14.3 29.5 6.7 22.5 16.2 24.8 25.3 26.0 40.6 15.6 17.2 23.7 27.3 30.0 22.0 19.7 20.2 27.2 20.5 27.8 24.9 24.0 16.4 31.0 15.2 25.2 16.0 107.1 17.2 25.2 27.3 24.4 24.0 23.0 19.9 24.9 24.7 20.4 26.9 22.5 36.1 24.0 36.4 21.9 30.6 28.7 30.1 13.2 20.2 25.7 20.0 16.6 16.0 30.3 21.1 17.1 28.5 18.3 14.3 8.2 7.0 11.1 33.5 21.1 16.1 15.5 23.0 17.2 17.8 9.8 9.7 11.5 16.3 21.1 17.4 12.0 17.2 23.5 21.9 7.7 14.4 9.1 4.0 11.5 18.6 28.4 18.6 28.7 13.7 11.4 21.0 8.9 16.5 17.8 5.6 12.2 8.4 10.0 9.3 9.3 19.6 10.1 18.2 29.1 3.6 5.0 19.2 27.2 14.6 12.2 16.2 19.3 14.8 7.2 17.1 15.7 16.9 23.5 9.3 18.9 16.0 10.9 15.6 18.6 30.3 23.6 21.1 28.5 16.6 20.6 20.2 16.0 16.2 18.0 19.5 12.5 17.1 18.3 12.9 17.8 18.3 29.4 29.5 16.2 24.8 27.2 20.5 31.0 15.2 27.3 30.6 EIPR1 "EIPR-1, TSSC1" ENSG00000032389 "EARP complex and GARP complex interacting protein 1" Q53HC9 2 3188925-3377882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031231, HPA031232, HPA031233, HPA031234" Approved Supported "Nucleoplasm,Nucleoli,Intermediate filaments" "Nucleoplasm, Nucleoli" "Intermediate filaments" "HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: " "unprognostic (2.16e-1)" "unprognostic (2.22e-1)" "unprognostic (2.71e-1)" "unprognostic (1.66e-1)" "unprognostic (4.27e-2)" "unprognostic (1.22e-1)" "prognostic unfavourable (3.67e-7)" "unprognostic (1.94e-1)" "unprognostic (1.57e-1)" "unprognostic (7.83e-2)" "unprognostic (2.10e-1)" "unprognostic (2.50e-1)" "unprognostic (1.78e-1)" "unprognostic (1.02e-2)" "unprognostic (3.43e-1)" "unprognostic (2.24e-2)" "unprognostic (3.83e-2)" 7.3 12.3 20.1 17.3 24.4 14.2 9.0 26.0 22.9 8.3 11.9 12.1 10.0 10.7 7.7 18.4 14.5 12.0 7.9 10.3 17.7 19.3 12.4 11.4 7.9 15.2 15.1 14.5 5.8 11.6 14.2 20.8 8.0 13.6 7.7 10.9 10.5 9.9 7.4 10.9 9.2 9.3 9.4 12.4 12.0 9.3 9.9 11.5 14.5 20.4 15.5 15.3 11.1 7.7 15.7 23.4 13.9 13.3 16.3 16.9 14.0 11.1 20.9 11.2 12.6 7.1 9.6 25.3 11.7 12.1 14.1 10.8 13.9 14.1 19.4 20.7 11.8 11.4 8.7 16.8 7.8 15.1 16.5 17.2 13.0 32.2 13.5 16.8 21.5 8.7 15.3 14.2 18.5 17.8 19.1 13.5 12.9 20.7 15.5 24.5 12.9 16.7 18.2 11.8 26.1 17.4 15.4 24.4 28.3 8.2 13.8 12.7 12.8 15.7 12.4 11.3 5.9 9.3 15.6 15.5 37.5 16.1 13.4 17.5 10.4 13.9 11.8 9.4 16.1 13.3 16.3 13.9 13.4 16.8 21.3 15.7 14.7 15.8 5.0 16.3 11.9 23.4 16.9 14.0 20.1 24.4 26.0 22.9 17.7 19.3 15.1 14.5 13.6 11.5 ELAVL1 "Hua, HuR, MelG" ENSG00000066044 "ELAV like RNA binding protein 1" Q15717 19 7958579-8005659 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005256, HPA046298" Approved Supported Nucleoplasm,Nucleoli,Cytosol 210000 Nucleoplasm "Nucleoli, Cytosol" "CAB005256: AB_2096342, HPA046298: " "unprognostic (1.19e-1)" "unprognostic (9.66e-3)" "unprognostic (2.46e-2)" "unprognostic (3.98e-1)" "unprognostic (1.04e-1)" "unprognostic (6.37e-3)" "unprognostic (1.81e-2)" "unprognostic (8.44e-2)" "unprognostic (3.75e-2)" "prognostic favourable (4.93e-4)" "unprognostic (2.09e-1)" "unprognostic (1.59e-2)" "unprognostic (7.23e-2)" "unprognostic (6.14e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 19.7 23.8 28.0 22.4 34.1 17.2 22.4 35.4 28.0 23.1 21.4 21.2 19.6 17.9 27.5 19.7 24.4 25.7 16.9 25.2 23.6 17.6 20.8 21.4 19.4 26.5 27.5 22.2 25.7 20.4 29.4 25.4 23.3 26.5 20.4 20.2 19.7 21.2 23.0 27.6 19.2 18.4 30.4 17.7 21.9 19.7 46.7 26.5 40.4 20.6 18.7 30.7 23.4 32.2 17.1 17.6 24.3 14.7 23.2 19.6 9.4 35.6 23.7 39.8 29.9 15.6 15.7 22.4 26.6 22.4 39.7 31.1 34.2 20.8 43.0 37.5 29.2 24.9 44.3 30.5 33.6 38.4 41.2 37.7 17.4 31.8 22.9 35.7 30.2 19.4 18.3 27.6 16.8 30.3 38.7 32.3 27.3 26.5 59.6 28.8 35.5 30.2 67.1 26.0 28.3 25.2 26.4 28.6 20.9 25.2 25.5 20.1 29.1 28.2 22.7 37.2 26.1 34.4 45.8 33.0 31.8 45.2 20.8 43.0 32.0 16.4 13.0 24.3 12.2 11.7 12.9 14.0 17.8 19.6 17.6 17.1 16.1 12.4 3.8 23.2 14.7 8.8 13.5 9.4 28.0 34.1 35.4 28.0 23.6 17.6 27.5 22.2 26.5 26.5 ELMOD2 MGC10084 ENSG00000179387 "ELMO domain containing 2" Q8IZ81 4 140524158-140553770 "Predicted intracellular proteins" "Antiviral defense" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047600 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA047600: " "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (6.70e-3)" "unprognostic (2.10e-3)" "unprognostic (4.91e-2)" "unprognostic (3.93e-1)" "unprognostic (1.66e-2)" "unprognostic (1.26e-1)" "unprognostic (1.76e-1)" "unprognostic (7.93e-2)" "unprognostic (1.05e-2)" "unprognostic (3.65e-1)" "prognostic favourable (1.17e-8)" "unprognostic (3.17e-1)" "unprognostic (4.03e-1)" "prognostic unfavourable (6.35e-4)" "unprognostic (1.82e-2)" 11.6 20.8 9.2 11.9 14.0 8.5 16.7 14.0 10.6 13.8 17.9 10.4 24.7 14.4 15.4 15.8 13.9 13.9 10.9 18.0 10.4 11.2 20.6 19.3 14.5 13.9 13.6 9.2 13.0 17.2 20.2 24.1 17.3 13.6 15.5 15.2 12.1 13.5 21.2 8.4 10.5 31.0 12.4 14.4 11.6 12.1 9.1 12.3 18.2 19.6 10.5 11.2 12.1 11.6 6.0 10.6 17.0 7.8 7.8 8.6 4.8 6.5 7.3 14.9 11.4 15.7 18.1 9.6 15.5 14.8 8.6 10.4 7.1 14.0 10.7 6.9 9.7 6.0 14.1 9.8 10.7 10.4 8.4 8.8 5.8 9.3 14.2 13.4 7.8 12.4 16.4 7.3 7.6 9.4 11.3 17.7 14.8 4.8 14.5 4.6 7.9 6.0 17.1 11.5 6.9 12.5 10.5 7.1 26.4 10.2 10.4 11.1 10.2 5.6 9.4 19.9 7.2 9.3 16.0 18.6 26.4 13.6 14.5 10.6 15.0 2.6 7.2 8.7 7.5 7.8 8.6 3.8 6.9 8.3 6.1 6.0 7.1 7.0 17.0 7.8 5.9 10.6 8.0 4.8 9.2 14.0 14.0 10.6 10.4 11.2 13.6 9.2 13.6 12.3 ELOC "SIII, TCEB1" ENSG00000154582 "Elongin C" Q15369 8 73939169-73972287 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078113 Approved "Nucleoli,Vesicles,Cell Junctions" 250000 Vesicles "Nucleoli, Cell Junctions" "HPA078113: " "prognostic unfavourable (6.48e-4)" "unprognostic (1.60e-1)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" "unprognostic (2.46e-2)" "unprognostic (8.02e-3)" "unprognostic (5.84e-3)" "unprognostic (2.19e-2)" "unprognostic (1.77e-1)" "unprognostic (6.99e-3)" "unprognostic (4.02e-3)" "unprognostic (3.33e-2)" "unprognostic (2.77e-3)" "unprognostic (3.84e-2)" "unprognostic (5.33e-2)" "unprognostic (1.67e-1)" "unprognostic (8.95e-2)" 27.0 29.5 39.1 19.2 37.6 35.4 24.2 25.6 43.3 17.5 19.6 12.2 21.0 13.4 18.2 31.7 24.5 17.2 17.9 50.1 33.9 29.5 28.2 36.1 21.2 35.2 32.5 28.4 17.9 25.5 17.6 20.0 25.7 27.3 19.2 20.6 12.1 16.3 21.0 62.5 16.6 14.5 24.4 33.9 18.7 18.5 51.0 18.8 19.7 19.6 31.9 27.9 19.3 16.7 38.9 55.3 51.7 35.4 32.5 44.9 26.4 44.6 36.6 33.6 24.3 25.7 33.6 24.1 44.4 36.3 43.6 44.8 32.5 39.0 22.8 36.0 39.3 32.1 37.0 44.3 57.7 26.2 30.7 39.7 39.1 51.5 33.6 25.4 29.8 34.0 35.6 39.4 51.0 40.5 34.9 30.6 57.2 33.1 65.3 45.7 30.5 59.3 23.8 21.1 21.6 47.5 39.2 31.7 30.0 18.6 101.5 41.4 37.4 27.4 30.9 31.7 35.8 34.6 44.5 34.8 42.4 42.0 38.1 27.8 38.4 51.7 32.2 38.2 31.2 35.4 34.0 38.9 37.5 34.8 34.2 34.0 34.3 34.4 37.7 32.5 33.8 55.3 44.9 26.4 39.1 37.6 25.6 43.3 33.9 29.5 32.5 28.4 27.3 18.8 ERGIC2 "Erv41, PTX1" ENSG00000087502 "ERGIC and golgi 2" Q96RQ1 12 29337352-29381189 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049695 Approved Supported "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoli "HPA049695: " "unprognostic (1.62e-2)" "unprognostic (3.50e-2)" "unprognostic (5.53e-2)" "unprognostic (3.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.19e-3)" "prognostic unfavourable (8.06e-6)" "unprognostic (3.70e-2)" "unprognostic (2.32e-2)" "prognostic favourable (8.18e-4)" "prognostic unfavourable (7.02e-6)" "unprognostic (2.67e-1)" "prognostic unfavourable (3.76e-6)" "unprognostic (6.02e-2)" "unprognostic (2.08e-1)" "unprognostic (3.19e-2)" "unprognostic (2.64e-1)" 26.6 21.0 24.4 21.9 32.8 5.5 29.9 28.1 36.1 25.4 22.7 14.6 25.8 21.2 23.1 33.1 32.5 16.6 21.2 33.7 25.3 22.6 27.7 36.2 18.6 18.9 29.8 24.2 24.9 32.6 27.3 40.1 40.9 31.2 29.5 21.4 12.1 28.8 23.8 29.2 15.6 24.3 31.4 31.0 25.6 21.1 32.8 30.7 25.7 28.6 21.6 25.8 33.4 20.6 27.0 39.0 59.2 30.1 22.1 40.8 27.5 24.6 22.7 18.6 12.5 26.9 31.7 45.4 40.2 33.9 25.2 27.3 29.9 41.7 13.6 40.1 31.9 25.9 17.7 26.6 40.4 29.1 19.1 22.1 32.5 17.3 15.8 30.7 18.7 22.4 21.4 31.8 32.2 19.5 18.0 38.7 33.6 13.3 15.3 33.3 26.2 64.2 14.2 51.3 27.6 21.4 36.2 7.1 11.6 20.5 23.3 23.8 45.0 25.2 21.6 34.4 29.3 45.4 43.3 28.5 36.0 27.2 28.7 23.0 27.8 24.2 17.0 22.1 29.7 25.3 35.8 27.0 38.1 34.8 17.8 22.3 38.4 32.3 59.2 22.1 30.1 39.0 40.8 27.5 24.4 32.8 28.1 36.1 25.3 22.6 29.8 24.2 31.2 30.7 EXOC4 "KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p" ENSG00000131558 "Exocyst complex component 4" Q96A65 7 133253073-134066589 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031443, HPA031444" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA031443: AB_10602496, HPA031444: " "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (2.05e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (8.63e-2)" "unprognostic (2.33e-1)" "unprognostic (4.40e-1)" "unprognostic (2.04e-1)" "prognostic unfavourable (6.19e-4)" "unprognostic (9.78e-3)" "prognostic favourable (6.85e-5)" "unprognostic (5.91e-2)" "unprognostic (2.18e-1)" "unprognostic (3.37e-1)" "unprognostic (3.35e-2)" 21.2 23.7 18.5 17.7 22.3 10.5 19.4 25.7 24.4 20.8 17.0 19.7 22.2 11.2 25.8 20.6 21.5 24.2 16.8 16.5 14.7 15.4 15.6 15.2 16.5 12.6 14.2 19.3 27.7 26.5 28.5 31.2 16.4 22.0 16.9 18.8 19.3 20.5 18.8 50.7 24.4 13.7 20.8 18.7 17.9 16.3 17.2 17.3 34.7 22.9 18.3 22.1 26.3 20.6 8.3 16.3 8.1 12.7 18.4 12.4 10.4 17.7 14.6 20.2 19.9 23.7 24.7 7.0 13.0 21.7 11.8 15.6 8.4 25.0 13.3 9.4 24.4 11.3 10.8 17.7 19.7 20.2 12.9 10.7 15.4 8.9 26.1 14.0 11.7 24.0 22.2 16.8 31.2 20.1 15.4 13.3 21.9 11.6 25.5 15.5 15.1 13.7 11.4 17.9 23.9 19.1 15.9 15.8 24.9 19.5 18.0 20.8 11.9 13.2 21.8 13.2 6.9 13.9 14.1 21.1 12.8 12.8 38.9 16.5 20.1 8.1 12.0 6.9 11.8 12.7 10.5 8.3 12.3 12.4 16.3 8.0 10.1 10.4 4.0 18.4 10.5 7.3 12.4 10.4 18.5 22.3 25.7 24.4 14.7 15.4 14.2 19.3 22.0 17.3 EXOSC10 "p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p" ENSG00000171824 "Exosome component 10" Q01780 1 11066618-11099881 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028470, HPA028484, CAB037141" Supported Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250" "unprognostic (1.23e-2)" "unprognostic (3.46e-2)" "unprognostic (1.85e-2)" "unprognostic (1.62e-1)" "unprognostic (6.88e-2)" "unprognostic (6.37e-2)" "prognostic unfavourable (2.49e-6)" "unprognostic (3.36e-1)" "unprognostic (4.66e-2)" "unprognostic (2.52e-1)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (7.68e-3)" "unprognostic (3.43e-1)" "unprognostic (9.03e-2)" "prognostic favourable (5.27e-4)" "unprognostic (1.33e-1)" 28.2 21.8 30.4 22.1 31.9 30.8 27.9 58.8 34.7 24.8 22.0 31.9 22.4 18.5 27.0 22.9 27.6 22.7 18.3 18.3 27.8 16.2 22.4 18.2 20.8 26.0 31.5 26.3 31.2 24.2 23.1 32.1 23.5 24.3 22.1 25.9 20.4 24.6 20.5 27.3 33.2 22.7 25.6 23.2 26.0 25.2 20.3 32.7 28.2 20.8 12.5 29.9 23.6 24.6 21.0 21.6 24.8 26.4 27.5 25.9 22.3 23.1 14.8 31.1 12.0 16.6 18.4 17.8 22.9 16.9 40.4 36.8 21.8 33.9 23.4 14.9 21.7 23.1 34.3 25.5 37.2 26.2 34.4 34.0 29.1 22.2 16.3 27.6 27.1 14.4 22.1 39.6 23.4 25.1 35.6 21.6 22.2 13.1 27.1 25.5 20.6 17.8 28.0 26.5 20.4 23.7 11.9 20.1 19.6 24.7 21.4 27.4 18.7 25.5 22.7 21.6 22.5 19.3 26.8 13.1 20.5 46.3 22.0 41.2 25.8 24.8 18.2 14.6 22.2 23.4 25.9 21.0 23.1 22.1 21.6 19.9 19.8 22.0 3.6 27.5 26.4 11.0 21.8 22.3 30.4 31.9 58.8 34.7 27.8 16.2 31.5 26.3 24.3 32.7 FAM131C "C1orf117, FLJ36766" ENSG00000185519 "Family with sequence similarity 131 member C" Q96AQ9 1 16057769-16073632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.1" "Cell line enhanced" "Detected in some" "A549: 10.7;HEK 293: 6.9;PC-3: 7.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031046 Uncertain Approved "Nucleoli,Intermediate filaments,Cytosol" "Nucleoli, Intermediate filaments, Cytosol" "HPA031046: " "unprognostic (4.69e-3)" "unprognostic (4.98e-2)" "unprognostic (7.26e-2)" "unprognostic (2.46e-4)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.63e-2)" "unprognostic (4.67e-4)" "unprognostic (2.82e-1)" "unprognostic (1.93e-2)" "unprognostic (1.75e-1)" "unprognostic (1.68e-1)" "prognostic favourable (9.33e-6)" "unprognostic (1.93e-1)" "unprognostic (2.29e-1)" "unprognostic (2.82e-2)" "unprognostic (1.44e-1)" 0.7 7.8 5.6 0.6 4.0 0.5 1.1 41.1 9.1 1.1 1.0 7.7 0.0 0.7 1.0 1.4 1.2 1.1 1.4 5.2 5.0 6.5 10.4 2.2 0.6 0.5 10.7 3.8 1.2 7.1 2.0 5.6 0.7 8.7 0.8 0.6 0.8 6.3 1.6 0.6 3.2 0.8 0.9 17.7 0.6 1.6 1.3 4.9 0.0 1.7 0.0 1.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.2 10.7 0.4 0.6 0.0 0.0 0.0 1.0 0.9 1.2 2.7 0.2 2.3 0.0 0.4 0.5 1.2 1.4 0.3 0.3 0.0 6.9 0.0 2.4 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.9 0.7 0.0 0.0 0.1 2.2 0.0 0.0 0.4 7.9 0.0 0.0 4.5 0.8 0.0 1.5 3.1 0.4 1.3 0.3 0.3 0.0 1.7 0.2 3.8 0.0 0.0 1.7 0.1 0.0 3.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 4.0 41.1 7.1 5.0 6.5 10.7 3.8 8.7 4.9 FAM13A "ARHGAP48, FAM13A1, KIAA0914" ENSG00000138640 "Family with sequence similarity 13 member A" O94988 4 88725955-89111398 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2" "Low region specificity" "Detected in all" "HPA038108, HPA038109" Uncertain Approved "Nucleoli,Cell Junctions,Cytosol" "Cell Junctions, Cytosol" Nucleoli "HPA038108: , HPA038109: AB_10672619" "unprognostic (1.14e-1)" "unprognostic (1.53e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (3.20e-1)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.81e-1)" "unprognostic (8.20e-2)" "unprognostic (1.75e-1)" "unprognostic (1.46e-3)" "unprognostic (6.36e-2)" "unprognostic (4.71e-1)" "unprognostic (3.49e-3)" "unprognostic (1.90e-2)" "unprognostic (7.44e-2)" "prognostic favourable (4.28e-4)" 58.6 10.8 9.1 11.0 9.3 6.5 19.0 17.9 18.5 15.5 41.0 3.7 7.4 30.5 10.9 12.0 9.3 14.8 10.7 8.8 9.6 5.7 14.0 22.9 13.3 5.3 10.0 6.8 17.8 23.5 45.5 11.2 20.7 11.4 15.9 9.3 11.5 13.3 8.0 8.4 17.5 30.5 15.6 19.4 4.9 13.4 11.1 12.9 3.2 20.4 16.1 4.0 30.4 23.8 0.1 5.7 1.4 6.5 0.7 5.2 2.6 2.4 3.7 5.5 7.2 32.2 13.3 9.1 5.7 6.9 2.2 2.1 3.1 5.7 0.1 2.3 4.0 1.5 8.1 4.1 5.1 0.3 5.6 4.0 5.1 0.4 9.4 3.3 0.5 12.7 3.3 5.7 2.1 3.8 10.5 0.4 4.9 0.1 0.3 1.5 6.8 3.8 5.5 9.4 2.1 4.2 12.0 14.0 3.7 1.4 4.4 5.4 3.1 0.1 1.4 6.4 3.5 3.1 3.2 1.9 1.1 0.0 9.5 0.3 3.3 0.1 6.5 0.1 1.8 3.2 1.3 0.1 4.7 0.6 5.7 0.1 5.2 1.3 1.4 0.7 1.0 1.9 2.5 2.6 9.1 9.3 17.9 18.5 9.6 5.7 10.0 6.8 11.4 12.9 FAM229B "C6orf225, DKFZp586F0922, LOC619208" ENSG00000203778 "Family with sequence similarity 229 member B" Q4G0N7 6 112087599-112102790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 118.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036068 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA036068: AB_10673495" "unprognostic (1.65e-1)" "unprognostic (9.41e-2)" "unprognostic (4.29e-2)" "unprognostic (4.67e-3)" "unprognostic (3.17e-2)" "unprognostic (2.00e-2)" "unprognostic (2.71e-2)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-3)" "unprognostic (4.74e-2)" "prognostic favourable (8.76e-4)" "unprognostic (3.74e-3)" "unprognostic (1.36e-1)" "unprognostic (1.80e-2)" "unprognostic (2.06e-2)" 4.7 7.4 18.4 2.1 16.8 2.0 7.7 5.8 14.8 8.2 4.2 17.3 4.3 2.2 9.6 17.0 3.8 23.7 8.8 16.8 15.7 16.2 11.6 11.0 5.2 2.0 20.7 11.2 10.7 4.3 10.0 15.4 5.2 15.3 7.3 3.1 8.6 3.9 11.0 5.9 1.9 2.3 8.6 21.7 2.3 4.3 118.9 13.6 1.6 9.7 2.6 2.0 4.6 2.6 4.0 3.4 2.7 0.3 5.4 8.1 2.8 1.6 4.2 17.5 8.5 15.4 15.4 0.8 6.4 24.6 9.3 19.6 0.7 4.1 1.3 19.1 11.8 1.0 3.6 9.3 14.8 0.4 12.0 1.5 2.0 6.6 9.6 3.4 0.8 9.3 6.3 15.3 2.6 9.0 2.0 3.4 11.3 0.4 6.2 5.4 4.5 10.1 9.7 4.4 1.4 13.6 0.2 16.3 6.8 5.1 0.6 9.9 8.3 3.1 5.1 7.7 3.3 29.5 8.5 2.6 0.1 11.8 12.3 2.8 10.2 0.1 0.1 2.7 4.2 0.0 5.3 2.5 3.7 3.3 0.5 4.0 8.1 7.2 0.4 5.4 0.3 3.4 0.4 2.8 18.4 16.8 5.8 14.0 15.7 16.2 20.7 11.2 15.3 13.6 FAM98C FLJ44669 ENSG00000130244 "Family with sequence similarity 98 member C" Q17RN3 19 38403135-38409088 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040930, HPA041730" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA040930: AB_10795484, HPA041730: AB_10804114" "unprognostic (3.01e-2)" "unprognostic (6.44e-3)" "unprognostic (5.15e-2)" "unprognostic (1.94e-1)" "unprognostic (3.18e-1)" "unprognostic (8.10e-3)" "unprognostic (3.06e-1)" "unprognostic (2.15e-2)" "unprognostic (2.95e-1)" "prognostic unfavourable (8.51e-5)" "unprognostic (2.82e-2)" "unprognostic (8.91e-3)" "unprognostic (1.01e-1)" "unprognostic (2.37e-3)" "unprognostic (2.43e-1)" "unprognostic (2.96e-1)" "prognostic favourable (5.53e-4)" 10.8 8.9 18.3 9.3 16.9 11.0 9.8 17.0 19.9 8.7 14.2 12.8 9.0 19.6 9.9 7.2 14.3 13.8 9.1 11.6 16.0 13.1 9.1 13.4 8.7 9.5 12.3 16.9 10.2 22.4 10.6 8.1 7.6 13.0 12.5 7.0 8.2 17.7 9.5 2.5 17.0 22.2 6.8 12.7 10.1 19.2 5.4 9.7 5.3 11.8 7.7 11.2 9.4 9.5 6.0 3.2 12.6 3.4 3.3 5.6 1.6 11.7 12.8 1.5 7.4 1.6 5.6 6.5 6.8 5.8 6.8 7.2 2.1 8.6 10.7 7.7 4.0 5.7 2.9 4.9 1.1 17.2 6.0 3.5 2.1 4.9 7.3 3.0 6.4 5.3 10.3 3.4 6.3 4.0 9.6 11.8 4.0 13.0 4.3 2.3 1.1 13.8 8.9 3.1 6.3 8.2 6.2 2.6 7.6 6.9 12.2 4.0 9.3 9.4 5.1 3.1 8.3 9.4 8.2 12.7 6.4 4.5 7.9 7.0 4.9 0.0 2.3 12.6 3.1 3.3 4.2 2.6 5.6 4.6 3.2 6.0 4.3 3.4 2.0 3.3 3.4 1.2 4.4 1.6 18.3 16.9 17.0 19.9 16.0 13.1 12.3 16.9 13.0 9.7 FANCG "FAG, XRCC9" ENSG00000221829 "Fanconi anemia complementation group G" O15287 9 35073835-35080016 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Cancer-related genes, Disease mutation, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008105, HPA045335" Approved Supported "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoli "CAB008105: AB_2231542, HPA045335: " "unprognostic (9.41e-2)" "unprognostic (2.62e-2)" "unprognostic (1.82e-1)" "unprognostic (1.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.83e-3)" "prognostic unfavourable (2.02e-4)" "unprognostic (8.92e-2)" "unprognostic (1.42e-2)" "unprognostic (2.27e-3)" "unprognostic (9.01e-2)" "unprognostic (5.62e-2)" "prognostic unfavourable (2.38e-7)" "unprognostic (1.14e-2)" "unprognostic (1.59e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" 5.8 5.0 4.4 7.1 6.5 14.9 7.5 13.9 8.5 6.2 5.9 5.3 8.4 6.7 6.8 3.2 9.2 8.6 4.7 5.9 7.6 4.0 5.2 4.5 5.1 9.9 8.7 4.4 9.2 17.0 6.7 4.8 7.6 6.6 7.0 5.5 3.5 8.7 9.7 2.9 8.9 6.5 6.4 4.2 8.6 5.8 8.9 7.6 25.6 9.3 4.8 9.2 6.8 6.9 6.8 4.8 8.9 2.5 8.8 9.2 3.4 15.7 19.5 14.3 13.2 3.2 5.1 12.0 11.1 8.0 21.8 20.9 9.3 9.9 15.6 7.7 3.5 9.7 11.9 10.2 8.3 18.2 7.2 11.1 20.9 5.7 0.9 11.3 12.9 4.2 2.0 19.0 8.6 11.1 7.3 21.0 10.9 14.0 19.1 15.5 14.9 15.1 19.8 16.9 11.0 5.1 6.7 6.9 12.6 7.3 10.4 4.1 13.5 8.1 6.7 10.3 20.7 13.2 14.9 5.7 10.8 9.4 9.2 8.4 14.1 8.9 0.8 7.7 7.4 2.5 6.5 6.8 6.1 5.7 2.2 6.5 4.8 5.0 1.3 8.8 2.3 4.8 9.2 3.4 4.4 6.5 13.9 8.5 7.6 4.0 8.7 4.4 6.6 7.6 FAU "asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30" ENSG00000149806 "FAU, ubiquitin like and ribosomal protein S30 fusion" "P35544, P62861" 11 65120628-65122473 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059015 Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA059015: " "unprognostic (1.81e-3)" "unprognostic (3.47e-2)" "unprognostic (2.89e-1)" "unprognostic (2.91e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-3)" "unprognostic (1.97e-1)" "unprognostic (5.40e-2)" "unprognostic (1.26e-1)" "unprognostic (7.06e-3)" "unprognostic (7.77e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-2)" 79.7 95.0 90.6 84.9 76.2 186.7 95.4 50.9 80.9 103.6 134.8 77.6 63.4 77.8 84.0 80.5 115.2 100.0 87.2 133.9 70.0 58.9 88.0 162.9 77.5 182.6 78.9 40.8 176.0 202.8 27.5 56.1 73.2 46.6 123.5 53.0 67.8 97.3 76.7 190.8 86.8 93.8 97.5 72.4 130.9 79.2 53.6 53.2 126.8 121.5 83.6 149.5 122.0 136.6 291.3 169.7 90.9 119.0 116.3 253.8 346.5 78.1 51.5 45.5 72.1 44.6 66.6 62.4 44.6 43.5 62.6 39.7 58.2 78.5 93.1 121.2 38.4 69.1 42.2 59.5 26.1 68.3 64.6 75.1 54.1 79.9 82.0 89.0 82.8 82.1 99.1 53.7 73.2 48.2 70.0 110.4 33.1 97.7 102.7 179.6 125.2 85.8 100.0 36.4 182.7 57.6 44.2 63.4 63.6 34.7 100.3 139.4 89.7 123.4 45.6 56.6 65.3 87.3 71.3 120.1 114.1 158.5 68.6 69.3 64.0 90.9 119.0 70.6 128.9 107.0 176.1 291.3 212.1 165.5 132.1 281.7 253.8 198.1 78.9 116.3 92.8 169.7 153.8 346.5 90.6 76.2 50.9 80.9 70.0 58.9 78.9 40.8 46.6 53.2 FBXL2 "FBL2, FBL3" ENSG00000153558 "F-box and leucine rich repeat protein 2" Q9UKC9 3 33277025-33403662 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061783 Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA061783: " "unprognostic (5.73e-2)" "unprognostic (4.47e-2)" "unprognostic (7.92e-2)" "unprognostic (7.21e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.10e-2)" "unprognostic (2.09e-1)" "unprognostic (3.16e-1)" "unprognostic (2.00e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "prognostic favourable (3.35e-4)" "unprognostic (3.30e-3)" "unprognostic (9.72e-2)" "unprognostic (4.28e-2)" "unprognostic (5.90e-2)" 3.2 5.2 8.0 2.2 15.0 1.9 4.1 7.2 18.1 3.7 2.9 4.1 1.8 3.2 5.2 8.2 2.3 6.0 3.0 2.7 8.7 11.3 5.5 1.4 4.6 1.8 6.6 13.4 4.5 3.5 7.7 16.1 5.5 13.1 4.3 1.5 6.4 3.1 6.5 1.5 2.9 2.0 3.5 4.5 2.3 2.5 4.3 2.8 0.0 8.6 0.6 1.5 2.6 2.5 1.3 0.9 2.8 1.0 0.9 1.1 0.1 4.0 1.1 1.7 1.9 2.4 4.0 0.6 3.2 2.6 2.9 4.3 0.8 4.9 0.2 1.0 2.1 1.1 1.4 3.6 2.0 0.4 2.0 0.7 3.4 0.8 2.9 0.3 0.8 1.6 2.6 1.8 1.4 5.2 1.0 0.4 9.9 0.4 0.8 0.7 1.2 1.0 0.1 1.0 0.1 7.4 1.2 2.1 2.1 1.4 0.8 2.4 2.3 1.2 4.0 1.5 1.4 1.1 1.8 0.4 0.2 0.2 1.3 0.3 1.0 1.5 1.0 0.7 0.9 0.5 0.7 0.5 0.7 0.9 0.3 1.3 1.1 1.1 2.8 0.9 0.7 0.9 0.4 0.1 8.0 15.0 7.2 18.1 8.7 11.3 6.6 13.4 13.1 2.8 FEZ2 ENSG00000171055 "Fasciculation and elongation protein zeta 2" Q9UHY8 2 36531805-36646087 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 13.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035978 Uncertain Approved "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "HPA035978: AB_10672235" "unprognostic (1.42e-1)" "unprognostic (5.02e-3)" "unprognostic (2.89e-1)" "unprognostic (1.15e-2)" "unprognostic (2.91e-2)" "unprognostic (1.94e-3)" "prognostic unfavourable (7.79e-6)" "unprognostic (1.09e-1)" "unprognostic (7.05e-2)" "unprognostic (2.42e-1)" "unprognostic (1.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.65e-2)" "unprognostic (7.82e-3)" "unprognostic (7.07e-2)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" 31.7 23.4 28.7 12.0 25.3 8.1 18.6 20.1 31.2 18.3 17.2 28.0 6.0 13.1 20.4 13.1 20.4 13.1 14.6 28.5 26.1 22.6 21.4 18.4 16.5 13.1 27.6 21.6 18.3 6.8 14.2 8.5 29.6 29.3 15.6 18.4 19.0 9.7 22.1 51.0 9.1 18.7 26.9 33.8 17.8 12.2 12.6 25.4 9.4 14.8 12.2 12.1 15.5 13.5 1.7 13.6 4.7 3.5 3.1 1.5 0.7 15.3 9.2 12.6 5.3 24.9 33.0 9.9 39.1 20.0 24.0 15.2 6.4 5.0 9.5 24.0 50.6 6.1 10.6 13.5 26.2 2.2 5.8 7.7 3.3 10.6 11.9 7.7 1.9 31.6 11.6 14.8 17.8 34.2 8.3 3.0 44.2 5.4 4.7 6.7 6.6 14.5 3.1 11.4 3.2 19.0 15.0 0.3 11.4 9.6 7.9 9.3 2.8 9.7 39.7 15.0 8.0 8.2 22.7 2.2 2.6 6.5 14.9 5.4 21.1 2.4 3.5 4.7 1.5 3.3 1.0 1.7 1.1 0.8 3.6 1.0 1.3 0.5 4.0 3.1 1.9 13.6 1.3 0.7 28.7 25.3 20.1 28.8 26.1 22.6 27.6 21.6 29.3 25.4 FOXM1 "FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident" ENSG00000111206 "Forkhead box M1" Q08050 12 2857681-2877155 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.5;testis: 40.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" CAB017832 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB017832: " "unprognostic (3.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.22e-2)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (3.75e-2)" "prognostic unfavourable (1.95e-6)" "prognostic unfavourable (2.92e-4)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "prognostic unfavourable (3.03e-5)" "unprognostic (6.09e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.80e-2)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (1.94e-1)" 1.7 1.7 1.0 9.3 0.9 13.8 2.4 0.4 1.2 2.0 6.5 0.4 1.1 6.0 1.2 2.1 13.5 0.4 4.1 1.2 0.8 0.6 1.3 1.6 2.8 6.6 0.8 0.3 0.8 0.6 0.0 0.5 3.9 0.9 0.9 8.2 0.6 2.6 1.1 0.7 3.7 7.1 4.4 1.2 5.0 3.2 40.1 0.4 47.5 0.6 11.4 11.6 2.0 3.7 0.7 0.6 1.0 0.6 0.4 1.9 0.1 28.6 29.1 22.6 20.7 3.4 4.5 28.8 18.7 18.5 38.1 34.5 36.7 25.7 18.5 4.0 26.8 22.3 33.8 17.2 37.3 34.6 18.1 20.9 27.9 15.7 0.5 16.8 17.1 2.3 1.9 35.3 24.9 26.8 11.7 41.7 29.9 26.9 22.8 8.0 49.8 21.7 16.6 34.3 9.7 9.0 18.4 12.7 20.2 24.0 20.1 11.0 19.7 18.8 10.7 30.9 47.0 36.1 65.0 5.5 9.1 26.8 14.3 16.1 32.7 0.4 0.6 0.1 0.4 0.2 0.4 0.7 0.5 0.4 0.2 0.7 0.9 0.3 1.0 0.4 0.1 0.6 1.9 0.1 1.0 0.9 0.4 1.2 0.8 0.6 0.8 0.3 0.9 0.4 FPR1 "FMLP, FPR" ENSG00000171051 "Formyl peptide receptor 1" P21462 19 51745172-51804110 "G-protein coupled receptors, Predicted membrane proteins" Chemotaxis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.3;lymphoid tissue: 64.4" "Cell line enriched" "Detected in some" 5 "U-87 MG: 34.2" "Cancer enhanced" "Detected in all" "glioma: 23.0" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "neutrophil: 213.3" "Lineage enriched" "Detected in many" 6 "granulocytes: 213.3" "Not detected" "Not detected" "HPA046550, HPA061744" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA046550: , HPA061744: " "unprognostic (5.54e-2)" "unprognostic (4.16e-2)" "unprognostic (1.88e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (1.15e-1)" "unprognostic (5.48e-3)" "unprognostic (4.59e-2)" "unprognostic (8.34e-2)" "prognostic unfavourable (2.21e-4)" "unprognostic (6.03e-2)" "unprognostic (4.52e-3)" "unprognostic (1.54e-2)" "unprognostic (1.70e-3)" 22.6 3.7 5.2 52.2 12.4 54.5 2.9 1.1 6.3 2.6 2.4 5.9 0.0 1.1 2.3 2.3 3.3 8.4 9.6 11.2 15.7 4.3 6.0 7.5 28.8 58.4 15.5 0.8 1.9 3.5 0.8 2.3 13.0 9.7 1.8 1.2 2.4 2.4 0.9 3.2 1.1 2.2 12.8 14.3 64.4 3.2 2.9 10.1 0.9 2.7 0.7 3.2 7.9 4.6 0.0 8.9 213.3 36.3 0.0 0.0 16.9 0.3 0.5 0.2 0.3 0.4 1.1 0.3 0.2 0.0 0.3 1.0 0.2 0.3 0.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.6 2.7 0.2 0.4 2.4 0.1 0.8 0.8 0.0 0.1 0.3 6.9 0.5 0.1 0.2 0.2 0.4 0.2 0.4 0.0 0.6 0.3 0.1 0.2 0.4 0.0 0.3 0.6 0.6 0.5 1.1 0.2 0.0 1.6 0.1 0.0 0.3 34.2 0.8 0.1 13.0 36.3 10.0 0.0 15.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 213.3 0.0 9.5 0.3 0.0 16.9 5.2 12.4 1.1 6.3 15.7 4.3 15.5 0.8 9.7 10.1 FRMD8 "FKSG44, FLJ90369" ENSG00000126391 "FERM domain containing 8" Q9BZ67 11 65386599-65413525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002861, HPA005506" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA002861: AB_1078878, HPA005506: " "unprognostic (1.54e-1)" "unprognostic (4.07e-1)" "unprognostic (6.28e-2)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "prognostic unfavourable (9.94e-5)" "unprognostic (9.12e-3)" "unprognostic (1.51e-2)" "unprognostic (6.36e-3)" "unprognostic (1.90e-2)" "unprognostic (6.41e-3)" "unprognostic (4.19e-3)" "unprognostic (1.47e-2)" "unprognostic (7.36e-3)" "unprognostic (3.34e-1)" "unprognostic (2.91e-2)" 14.6 11.9 7.8 18.5 12.1 13.1 15.2 8.9 10.3 12.5 15.1 11.4 6.9 13.6 10.5 12.2 23.9 14.6 17.4 10.0 8.0 5.4 10.5 12.0 15.1 17.3 17.0 8.5 8.9 20.9 5.7 8.2 12.2 11.7 10.7 8.2 7.8 18.6 10.9 12.0 24.3 16.5 8.1 8.9 29.0 11.7 11.3 14.6 16.6 12.4 16.6 21.8 11.0 18.1 10.9 11.4 19.7 14.9 6.5 14.3 9.0 6.8 8.8 3.6 8.3 9.6 5.1 6.3 7.7 7.3 6.7 5.3 8.4 11.5 8.5 16.8 11.0 12.1 4.5 6.8 2.9 14.1 4.1 11.7 8.0 4.6 5.2 6.5 18.3 6.3 5.4 6.4 3.4 10.8 9.7 9.5 7.4 9.3 9.9 9.6 3.9 11.5 13.2 6.6 9.6 5.5 8.6 7.6 5.3 6.0 24.4 18.6 8.9 5.4 9.4 7.6 7.9 10.2 4.8 16.4 8.4 8.0 6.6 4.1 52.2 0.8 9.7 13.4 11.5 11.0 12.7 10.9 8.4 14.3 9.1 9.2 7.8 8.4 19.7 6.5 14.9 11.4 8.9 9.0 7.8 12.1 8.9 10.3 8.0 5.4 17.0 8.5 11.7 14.6 FXYD1 PLM ENSG00000266964 "FXYD domain containing ion transport regulator 1" O00168 19 35138808-35143109 "Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8" "Cell line enhanced" "Detected in some" "ASC diff: 30.3;ASC TERT1: 8.8;HSkMC: 12.5" "Cancer enhanced" "Detected in many" "liver cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 11.7" "Group enriched" "Detected in many" 5 "B-cells: 11.7;T-cells: 7.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026873 Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA026873: AB_1855471" "unprognostic (5.58e-3)" "unprognostic (6.60e-2)" "unprognostic (3.37e-2)" "unprognostic (1.31e-2)" "prognostic unfavourable (6.91e-4)" "unprognostic (1.54e-2)" "unprognostic (1.72e-2)" "unprognostic (3.54e-3)" "unprognostic (8.13e-2)" "unprognostic (5.11e-2)" "unprognostic (8.64e-2)" "unprognostic (2.66e-1)" "prognostic unfavourable (7.59e-8)" "unprognostic (9.97e-3)" "unprognostic (2.25e-1)" "unprognostic (1.65e-1)" "unprognostic (1.92e-2)" 28.2 8.1 35.7 5.2 40.7 2.0 21.8 16.8 34.7 46.5 16.9 25.5 7.1 5.0 26.3 17.9 18.8 31.1 14.8 134.1 23.8 19.9 4.5 137.1 14.1 3.0 36.1 23.7 34.0 6.2 2.1 4.3 8.6 21.5 21.6 7.9 14.1 6.4 20.7 299.8 5.8 7.5 27.7 19.0 6.2 8.4 7.5 14.8 0.0 3.9 29.0 3.5 12.7 23.7 11.7 0.7 1.2 0.7 2.0 7.1 0.7 0.7 0.0 0.0 0.1 30.3 8.8 0.8 3.6 0.1 0.0 0.0 0.0 0.2 2.4 0.9 0.0 0.6 0.7 0.4 0.0 2.1 0.8 0.4 0.0 1.1 3.5 0.2 0.2 12.5 0.0 0.1 0.3 0.1 0.6 2.5 0.1 0.0 0.0 0.5 0.1 0.4 0.0 0.1 0.6 0.0 0.0 0.2 0.1 0.4 0.1 1.0 0.1 3.9 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.6 0.4 5.0 1.2 0.3 0.0 1.4 0.7 0.9 11.7 4.1 1.7 0.3 6.6 0.8 1.0 0.6 2.0 0.7 0.7 7.1 0.7 35.7 40.7 16.8 34.7 23.8 19.9 36.1 23.7 21.5 14.8 GCLC "GCS, GLCL, GLCLC" ENSG00000001084 "Glutamate-cysteine ligase catalytic subunit" P48506 6 53497341-53616970 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glutathione biosynthesis" Ligase "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.2" "Cell line enhanced" "Detected in all" "A549: 54.7;Hep G2: 46.7;RT4: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009569, HPA036359, HPA036360" Approved Approved Nucleoplasm,Nucleoli,Cytosol 3600000 Nucleoplasm "Nucleoli, Cytosol" "CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789" "unprognostic (8.41e-2)" "unprognostic (1.27e-2)" "unprognostic (5.65e-2)" "unprognostic (2.42e-1)" "unprognostic (1.58e-1)" "unprognostic (2.76e-1)" "unprognostic (2.60e-1)" "unprognostic (7.50e-2)" "unprognostic (9.94e-3)" "unprognostic (4.67e-3)" "unprognostic (1.30e-1)" "unprognostic (5.23e-2)" "prognostic favourable (3.83e-6)" "unprognostic (3.78e-2)" "unprognostic (8.91e-2)" "prognostic unfavourable (8.24e-4)" "unprognostic (2.30e-2)" 15.8 11.1 12.9 9.0 16.0 14.4 13.0 5.4 15.1 6.8 16.2 21.6 8.2 18.9 9.2 5.3 20.0 29.1 14.9 7.4 13.1 10.6 15.4 69.2 12.9 10.1 21.6 12.2 6.2 12.4 6.6 5.4 6.2 13.0 13.0 12.2 5.2 11.2 10.1 7.0 8.6 14.8 11.9 13.6 16.8 14.8 5.2 17.5 3.1 14.1 32.4 10.6 34.4 12.3 1.6 4.2 2.2 1.9 8.0 2.3 0.6 8.1 54.7 4.5 10.6 5.4 2.4 6.0 4.1 6.7 3.1 3.7 8.0 19.0 15.5 7.9 3.7 11.6 13.7 30.1 4.2 12.2 8.4 10.4 10.6 46.7 6.2 13.6 6.4 3.8 12.8 3.5 15.7 4.7 5.7 4.9 1.5 8.6 11.7 5.4 8.3 5.1 3.9 2.7 13.7 10.1 50.4 13.0 6.4 6.9 11.1 7.2 7.6 6.5 6.5 2.8 9.8 7.1 6.1 6.6 10.1 9.0 7.0 9.8 4.7 2.2 1.1 0.6 1.2 1.9 0.8 1.6 1.0 2.3 4.2 1.0 0.6 1.3 0.5 8.0 1.8 3.0 1.6 0.6 12.9 16.0 5.4 11.9 13.1 10.6 21.6 12.2 13.0 17.5 GDE1 MIR16 ENSG00000006007 "Glycerophosphodiester phosphodiesterase 1" Q9NZC3 16 19501689-19522145 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074747 Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA074747: " "unprognostic (1.69e-1)" "unprognostic (5.13e-2)" "prognostic favourable (3.12e-4)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (4.10e-3)" "prognostic unfavourable (7.52e-5)" "unprognostic (2.10e-2)" "unprognostic (1.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.60e-3)" "unprognostic (9.92e-2)" "prognostic favourable (3.12e-5)" "unprognostic (8.36e-2)" "unprognostic (9.69e-3)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" 20.3 18.5 30.6 11.7 34.3 17.5 23.9 13.5 32.2 18.1 31.0 24.5 23.0 22.7 15.0 22.6 19.0 13.4 17.5 40.7 31.1 17.5 21.1 21.3 22.1 13.1 29.2 20.6 9.9 28.3 35.3 13.9 15.5 20.8 21.4 32.5 12.5 20.4 24.9 42.4 18.5 20.8 27.2 25.3 10.1 22.8 14.8 23.8 9.6 17.9 21.7 12.7 22.8 12.4 4.6 7.4 23.9 12.4 3.7 7.4 4.6 14.6 17.6 9.7 11.5 46.8 17.4 13.9 15.1 26.0 11.8 14.7 10.0 26.2 11.0 19.5 22.0 12.7 13.5 17.8 14.4 11.9 20.8 9.2 17.3 21.6 28.4 12.1 8.6 18.3 28.9 12.6 14.8 15.8 5.1 11.4 12.8 26.4 10.5 11.2 11.3 13.7 15.2 17.8 15.9 29.2 22.5 11.3 10.3 14.7 17.6 13.9 18.0 14.5 16.6 10.0 9.0 13.2 9.2 10.7 10.1 7.6 15.4 18.0 8.9 23.9 11.8 6.4 5.7 10.5 7.3 4.6 6.8 6.6 7.4 3.7 3.6 5.7 19.8 3.7 12.4 4.6 7.4 4.6 30.6 34.3 13.5 32.2 31.1 17.5 29.2 20.6 20.8 23.8 GEMIN2 SIP1 ENSG00000092208 "Gem nuclear organelle associated protein 2" O14893 14 39114223-39136973 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015426, HPA046570, HPA057114" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nuclear bodies" Nucleoli "CAB015426: AB_629517, HPA046570: , HPA057114: " "unprognostic (4.53e-1)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (3.52e-2)" "prognostic unfavourable (3.88e-6)" "unprognostic (8.62e-3)" "unprognostic (3.05e-2)" "unprognostic (1.99e-3)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (4.53e-3)" "unprognostic (1.52e-1)" "unprognostic (1.58e-1)" "unprognostic (3.95e-1)" "unprognostic (6.78e-2)" 10.0 8.2 13.2 8.1 16.9 15.2 13.3 15.7 15.2 10.1 9.5 10.9 5.2 11.4 9.3 12.5 10.2 9.9 7.2 12.4 13.8 10.1 8.2 9.2 9.1 14.1 11.0 13.8 11.3 8.5 4.3 16.1 9.0 13.4 8.4 10.9 8.9 7.7 7.7 18.9 10.4 8.0 12.6 12.4 9.5 8.4 13.2 12.8 11.9 9.8 9.9 13.3 11.3 9.6 17.1 15.8 8.9 12.6 11.6 15.5 8.7 11.4 16.5 16.3 11.9 5.7 6.7 8.4 5.5 4.4 14.7 14.7 14.4 13.6 17.0 11.5 4.7 8.8 21.8 9.3 15.5 8.7 12.7 9.9 10.1 35.8 11.7 15.0 6.5 3.6 8.9 9.3 13.4 12.8 11.8 12.5 8.2 22.8 16.4 14.5 11.4 18.6 15.4 17.8 10.7 8.2 7.6 16.0 3.2 11.5 8.9 6.0 20.3 6.6 5.2 6.8 10.1 6.6 8.9 13.1 20.3 24.9 3.3 16.0 9.5 8.1 12.3 8.9 14.3 12.6 10.1 15.4 13.2 14.0 15.6 17.1 14.9 15.5 3.4 11.6 10.4 15.8 11.4 8.7 13.2 16.9 15.7 15.2 13.8 10.1 11.0 13.8 13.4 12.8 GET4 "C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35" ENSG00000239857 "Golgi to ER traffic protein 4" Q7L5D6 7 876552-896436 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019765 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA019765: AB_1845750" "unprognostic (2.80e-2)" "unprognostic (2.40e-2)" "unprognostic (2.10e-2)" "unprognostic (9.66e-4)" "unprognostic (9.86e-2)" "unprognostic (8.64e-2)" "unprognostic (4.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.59e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-1)" "unprognostic (1.21e-1)" "unprognostic (7.65e-2)" "unprognostic (8.18e-2)" "unprognostic (1.26e-1)" "unprognostic (5.93e-2)" "unprognostic (9.47e-2)" 13.7 39.8 22.4 14.8 21.4 28.5 15.3 22.1 23.5 10.3 15.5 20.9 19.0 21.8 12.3 23.8 18.8 14.6 12.8 18.7 16.4 15.4 27.8 37.5 12.2 15.1 22.9 21.5 16.5 32.6 11.3 32.9 21.7 18.9 16.8 9.9 15.2 25.0 21.9 53.7 29.7 20.9 12.6 18.9 16.9 22.2 32.0 22.7 12.5 16.0 21.8 12.5 14.3 17.3 23.3 31.5 28.9 30.7 24.9 27.3 21.9 26.0 12.8 9.0 13.3 4.6 3.2 28.5 7.3 5.1 9.3 9.3 34.9 32.6 9.6 7.6 4.1 16.6 10.1 7.9 4.0 3.9 17.3 5.3 10.1 19.7 10.3 9.0 9.8 4.9 9.5 8.1 5.3 7.3 34.1 8.9 5.2 19.8 6.8 21.7 32.3 19.3 14.4 1.5 10.3 8.2 15.4 16.3 17.6 6.7 24.6 10.5 18.7 16.0 7.3 6.9 15.4 15.8 9.9 13.5 8.4 12.4 7.1 15.5 17.3 16.8 27.4 28.9 24.2 24.7 23.7 23.3 26.5 24.0 27.7 23.2 26.0 27.3 21.1 24.9 30.7 31.5 24.5 21.9 22.4 21.4 22.1 23.5 16.4 15.4 22.9 21.5 18.9 22.7 GJC1 "CX45, GJA7" ENSG00000182963 "Gap junction protein gamma 1" P36383 17 44798448-44830816 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071788 Uncertain "Nucleoli,Cell Junctions,Cytosol" "Nucleoli, Cytosol" "Cell Junctions" "HPA071788: " "unprognostic (1.84e-2)" "unprognostic (2.04e-1)" "unprognostic (2.13e-2)" "unprognostic (1.35e-1)" "unprognostic (1.75e-1)" "unprognostic (2.22e-1)" "unprognostic (7.02e-2)" "unprognostic (4.01e-1)" "unprognostic (1.60e-2)" "unprognostic (1.11e-1)" "unprognostic (3.02e-1)" "unprognostic (1.64e-1)" "prognostic unfavourable (3.55e-8)" "unprognostic (5.18e-2)" "unprognostic (2.20e-1)" "unprognostic (8.52e-2)" "prognostic unfavourable (7.83e-4)" 7.3 0.8 2.2 4.1 3.4 1.0 4.7 8.2 4.2 14.8 23.0 2.8 7.0 1.6 24.2 3.1 3.2 5.0 5.4 10.0 3.3 1.8 1.5 0.9 6.5 2.3 2.5 4.0 2.2 1.3 2.6 0.7 28.5 3.4 8.2 2.8 3.7 1.7 17.0 5.4 1.9 4.8 27.5 2.2 0.9 7.8 8.0 2.9 1.4 5.3 2.9 1.7 12.6 10.4 1.2 1.0 4.7 1.0 1.9 1.0 0.4 17.6 9.1 23.0 7.9 3.0 4.7 9.0 19.6 15.5 21.1 22.7 5.3 9.8 0.1 1.0 18.3 4.6 11.9 6.1 29.8 0.1 8.9 0.1 4.9 0.6 1.9 0.1 0.8 3.3 0.6 16.1 5.3 7.2 0.8 0.2 12.2 0.1 2.8 1.8 10.3 7.8 16.7 29.2 0.1 5.1 7.4 4.4 10.0 2.2 0.1 6.6 4.8 2.8 6.0 18.7 18.1 8.5 16.6 0.1 4.6 13.1 6.5 0.1 17.5 4.7 1.0 1.1 0.9 0.6 0.8 0.9 0.7 0.6 0.3 1.2 0.9 1.0 3.9 1.9 0.7 1.0 0.6 0.4 2.2 3.4 8.2 4.2 3.3 1.8 2.5 4.0 3.4 2.9 GLOD4 "C17orf25, CGI-150, HC71" ENSG00000167699 "Glyoxalase domain containing 4" Q9HC38 17 757097-783390 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021623, HPA023246, HPA023248" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol 3800000 Cytosol "Nucleoplasm, Nucleoli" "HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (1.99e-1)" "unprognostic (2.11e-1)" "unprognostic (2.88e-1)" "unprognostic (3.35e-1)" "unprognostic (3.13e-2)" "unprognostic (6.27e-2)" "unprognostic (4.86e-2)" "unprognostic (1.96e-2)" "prognostic favourable (2.18e-6)" "unprognostic (6.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.46e-1)" "unprognostic (3.02e-1)" 21.7 29.5 31.3 16.7 35.6 10.2 19.1 26.0 36.2 17.8 37.1 21.5 16.5 43.0 22.3 23.3 23.6 24.9 20.9 19.7 26.1 38.5 41.6 40.4 16.8 22.8 23.0 34.8 22.9 32.3 13.9 19.4 28.1 28.6 21.1 26.6 21.9 29.2 20.9 21.4 27.5 42.5 24.7 18.2 23.8 43.4 17.9 18.2 22.7 26.0 19.2 24.0 25.2 17.5 27.5 17.9 17.8 24.6 22.8 36.7 26.0 40.3 36.6 42.2 23.3 18.6 18.5 25.8 32.4 19.9 26.3 20.0 29.6 29.0 48.2 35.3 14.5 29.3 36.8 20.5 27.5 35.3 31.4 23.2 20.3 38.7 18.5 23.9 30.7 12.9 28.6 26.4 23.2 24.2 37.9 31.4 27.7 24.9 41.0 18.4 30.9 12.5 41.1 17.1 22.1 25.9 27.6 19.3 32.4 25.7 18.6 41.5 23.1 25.4 31.5 25.1 20.1 35.1 40.5 17.7 32.2 29.6 29.8 26.9 26.2 9.2 19.8 17.8 27.7 24.2 30.2 27.0 33.6 33.3 17.5 27.5 28.7 31.3 2.7 22.8 24.6 17.9 36.7 26.0 31.3 35.6 26.0 36.2 26.1 38.5 23.0 34.8 28.6 18.2 GNAI1 ENSG00000127955 "G protein subunit alpha i1" P63096 7 80133955-80219402 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transport" Transducer "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "NK-cell: 20.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022449, HPA042141" Approved Supported Nucleoplasm,Nucleoli,Centrosome 9000000 Centrosome "Nucleoplasm, Nucleoli" "CAB022449: , HPA042141: " "unprognostic (2.29e-1)" "unprognostic (2.83e-2)" "unprognostic (2.64e-2)" "unprognostic (1.54e-1)" "unprognostic (7.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.92e-2)" "unprognostic (2.08e-2)" "prognostic unfavourable (5.09e-4)" "unprognostic (9.78e-2)" "unprognostic (1.26e-1)" "unprognostic (4.48e-1)" "unprognostic (9.41e-3)" "prognostic unfavourable (6.47e-4)" "unprognostic (1.12e-1)" "unprognostic (1.94e-2)" "unprognostic (1.53e-1)" 33.2 23.4 17.2 5.4 26.2 1.5 14.4 14.4 33.7 9.4 10.5 36.9 3.0 6.9 10.0 3.0 16.6 9.0 8.6 5.7 23.8 18.3 25.9 13.1 10.3 3.4 40.3 21.9 14.3 5.4 2.5 7.3 30.4 26.2 10.1 9.0 2.8 4.9 9.5 4.2 32.4 5.3 12.2 49.7 5.7 8.3 11.1 32.0 0.9 11.1 3.2 4.6 15.5 9.0 0.1 3.7 2.1 1.5 20.0 2.3 0.7 2.9 20.5 18.8 0.1 23.4 15.0 8.6 12.5 15.1 11.1 13.7 0.0 3.2 0.1 4.0 13.4 3.0 10.4 12.8 14.7 0.1 9.6 17.6 18.1 1.2 23.7 2.2 3.8 16.1 32.4 5.9 17.1 7.4 1.4 0.0 20.7 0.5 0.1 0.1 5.4 7.4 8.2 7.2 8.8 33.1 9.9 13.8 9.5 13.4 0.2 10.6 2.5 0.4 13.1 24.8 17.5 5.7 4.7 0.1 0.0 0.1 6.5 1.3 11.0 2.1 0.7 0.7 0.1 0.7 0.0 0.0 0.3 0.2 3.7 0.1 2.3 0.9 0.3 20.0 1.5 0.3 0.2 0.7 17.2 26.2 14.4 25.5 23.8 18.3 40.3 21.9 26.2 32.0 GNAI3 87U6 ENSG00000065135 "G protein subunit alpha i3" P08754 1 109548611-109618321 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022099, HPA042141" Approved Approved Nucleoplasm,Nucleoli,Centrosome 8400000 Centrosome "Nucleoplasm, Nucleoli" "CAB022099: , HPA042141: " "unprognostic (2.19e-1)" "unprognostic (1.64e-1)" "prognostic favourable (1.62e-4)" "unprognostic (1.44e-2)" "unprognostic (2.59e-1)" "unprognostic (9.45e-3)" "prognostic unfavourable (5.30e-6)" "unprognostic (2.56e-3)" "unprognostic (2.18e-2)" "prognostic favourable (4.59e-4)" "unprognostic (1.83e-3)" "unprognostic (6.91e-2)" "prognostic unfavourable (4.34e-4)" "unprognostic (7.27e-2)" "unprognostic (1.39e-1)" "unprognostic (1.25e-2)" "unprognostic (1.66e-2)" 25.2 13.0 12.3 15.5 11.3 26.4 15.8 12.8 10.7 19.0 14.7 10.3 14.3 12.1 19.7 15.7 34.8 12.5 13.2 9.3 12.3 9.4 18.1 25.8 13.2 23.8 13.1 8.3 18.4 13.7 10.7 11.0 22.4 11.5 17.2 13.8 8.0 16.2 14.4 8.6 27.9 17.0 15.9 12.9 21.6 12.1 14.0 12.0 22.2 12.9 25.2 20.6 20.0 20.4 6.1 9.6 16.8 13.1 5.8 7.2 9.3 13.9 4.9 9.5 5.6 9.1 10.9 7.8 10.6 8.5 10.8 10.8 7.5 4.9 7.5 7.1 11.3 7.4 8.9 10.8 15.1 8.4 5.5 6.5 8.5 6.4 7.8 10.2 6.0 8.1 9.2 12.4 8.6 12.9 8.5 7.4 10.7 9.5 7.8 8.3 9.5 5.8 5.6 22.4 4.8 12.0 10.7 6.1 10.7 7.4 8.4 11.6 6.5 9.0 11.7 9.1 12.5 13.6 12.0 7.9 8.9 8.7 15.1 10.1 14.1 8.5 9.1 16.6 6.8 13.1 7.2 6.1 6.7 6.5 9.6 5.0 5.6 6.4 16.8 5.8 12.3 4.3 6.9 9.3 12.3 11.3 12.8 10.7 12.3 9.4 13.1 8.3 11.5 12.0 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530211-54561071 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 12.7 12.9 10.3 16.1 12.3 19.2 12.5 8.6 13.1 10.8 10.2 14.8 10.5 8.5 15.2 10.2 16.3 11.0 10.1 15.3 8.1 8.0 12.0 12.5 13.0 15.5 13.0 10.8 13.2 17.5 15.9 16.9 12.0 10.2 10.6 13.3 12.3 13.3 12.4 24.0 13.2 13.5 15.0 11.5 17.6 11.7 5.9 13.9 20.5 18.0 12.0 18.6 13.7 13.1 17.2 11.4 20.2 15.2 21.8 17.7 11.5 11.1 27.7 5.7 11.8 5.9 4.0 10.6 6.7 4.9 7.5 6.0 23.4 9.2 15.7 12.9 9.6 10.9 19.2 8.4 10.4 10.8 9.9 15.7 22.2 11.0 4.5 24.4 15.5 5.8 4.0 17.6 10.6 8.1 10.3 15.8 7.5 21.7 13.8 5.1 16.6 15.6 14.9 13.1 15.2 5.7 17.7 9.4 5.6 21.8 13.5 6.3 17.8 6.2 11.5 13.7 13.7 13.2 11.3 11.9 15.2 20.2 7.1 20.2 15.2 18.9 14.2 15.1 17.7 12.6 16.1 15.0 16.2 15.4 11.4 17.2 12.4 13.0 20.2 21.8 15.2 9.6 8.6 11.5 10.3 12.3 8.6 13.1 8.1 8.0 13.0 10.8 10.2 13.9 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: " "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavourable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favourable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 8.9 20.0 6.9 20.0 13.5 7.2 29.3 10.7 9.0 10.7 6.9 14.7 12.6 9.2 18.6 6.7 18.0 9.6 5.9 3.1 29.1 12.1 8.7 20.5 9.4 7.7 5.8 17.0 9.0 9.4 9.3 7.1 5.7 7.8 22.5 6.4 22.7 6.5 15.6 9.4 20.0 13.0 7.4 14.9 7.4 12.2 11.0 13.4 13.0 17.7 11.5 19.4 2.4 9.2 29.6 20.5 22.3 7.7 18.0 33.1 7.7 21.2 4.9 18.0 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 GPR157 FLJ12132 ENSG00000180758 "G protein-coupled receptor 157" Q5UAW9 1 9100305-9129170 "G-protein coupled receptors, Predicted membrane proteins" Differentiation "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 32.2" "Cell line enhanced" "Detected in many" "Karpas-707: 16.9;SK-BR-3: 33.2;U-266/70: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028697 Uncertain Uncertain "Nucleoli,Plasma membrane,Cell Junctions" Nucleoli "Plasma membrane, Cell Junctions" "HPA028697: AB_10601810" "unprognostic (2.83e-3)" "unprognostic (1.13e-2)" "unprognostic (5.91e-2)" "unprognostic (5.42e-2)" "unprognostic (2.13e-4)" "unprognostic (7.11e-2)" "unprognostic (7.52e-3)" "unprognostic (3.60e-2)" "unprognostic (9.20e-2)" "unprognostic (1.26e-1)" "unprognostic (9.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.02e-2)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-3)" 3.5 3.1 0.3 3.7 0.6 0.5 3.5 0.5 0.4 6.2 2.8 0.9 3.9 2.2 2.1 2.1 23.4 2.1 6.9 10.7 0.8 0.4 2.9 6.9 5.5 3.1 0.3 0.1 4.5 4.3 9.8 1.2 19.0 1.4 2.9 1.2 5.2 14.7 7.1 32.2 14.2 3.3 4.0 0.4 2.4 2.2 2.1 0.8 3.6 4.8 25.2 16.2 4.4 8.3 2.4 1.1 4.6 1.5 1.2 2.6 0.7 4.6 2.6 0.8 2.1 0.7 0.7 4.3 1.4 0.9 1.2 1.6 2.1 1.8 0.6 1.8 1.5 9.9 2.4 0.9 1.8 12.8 3.9 0.0 7.7 3.1 2.6 0.0 1.0 0.7 2.0 2.1 1.3 0.9 0.7 16.9 0.5 3.4 1.9 0.9 0.9 3.3 0.3 0.7 2.2 0.8 3.1 1.2 3.2 5.7 33.2 2.8 4.7 0.5 7.0 4.2 1.1 10.9 0.6 16.3 2.6 0.0 3.1 6.6 1.7 1.9 1.5 0.4 2.6 1.2 2.0 1.5 1.9 2.3 0.8 2.4 1.9 2.2 4.6 1.2 0.6 1.1 0.8 0.7 0.3 0.6 0.5 0.4 0.8 0.4 0.3 0.1 1.4 0.8 GPR65 "hTDAG8, TDAG8" ENSG00000140030 "G protein-coupled receptor 65" Q8IYL9 14 88005124-88014811 "G-protein coupled receptors, Predicted membrane proteins" Apoptosis "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.4;lymphoid tissue: 40.8" "Cell line enhanced" "Detected in some" "Daudi: 6.1;HEL: 6.6;HL-60: 7.9;HMC-1: 10.2;RH-30: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA072624, HPA077397" Enhanced Approved Nucleoli,Vesicles,Cytosol Vesicles "Nucleoli, Cytosol" "HPA072624: , HPA077397: " "unprognostic (8.56e-2)" "unprognostic (8.65e-3)" "unprognostic (1.98e-3)" "unprognostic (3.59e-3)" "unprognostic (3.10e-1)" "unprognostic (3.55e-3)" "unprognostic (1.15e-1)" "unprognostic (3.01e-2)" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (4.99e-4)" "unprognostic (3.79e-1)" "unprognostic (4.46e-3)" "unprognostic (9.03e-2)" "unprognostic (3.80e-1)" 9.8 3.1 1.8 12.1 6.4 15.2 2.3 0.7 3.0 1.9 2.4 0.9 0.9 2.3 2.2 2.2 2.3 2.2 4.1 2.3 6.0 2.1 4.0 6.9 10.6 13.1 8.2 0.0 1.7 1.8 0.8 6.2 3.6 6.3 2.9 2.3 1.2 2.6 0.9 0.9 1.2 7.7 3.3 15.7 40.8 2.5 1.5 6.2 12.5 1.8 2.3 8.9 4.8 2.3 4.3 5.9 19.1 13.7 21.3 30.4 9.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 6.6 0.0 0.0 0.3 7.9 10.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.2 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.1 14.6 9.1 19.1 16.5 12.8 30.4 4.3 8.4 12.6 5.9 4.0 4.4 9.7 6.9 21.3 13.7 2.7 4.0 9.4 1.8 6.4 0.7 3.0 6.0 2.1 8.2 0.0 6.3 6.2 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 108.0" "Cell line enhanced" "Detected in many" "EFO-21: 38.4;HHSteC: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "naive CD4 T-cell: 6.5" "Lineage enriched" "Detected in many" 4 "T-cells: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavourable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favourable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 12.6 4.4 45.2 3.2 55.9 1.0 7.3 22.8 108.0 5.4 2.9 95.1 4.9 4.0 7.1 9.3 5.5 12.7 9.2 22.3 47.8 28.7 12.1 2.7 3.9 4.6 63.1 34.9 13.7 12.7 9.5 3.8 9.3 38.6 6.3 2.3 3.8 20.8 11.5 35.1 2.5 3.3 5.1 61.6 2.2 22.7 19.6 63.1 0.0 7.2 2.6 2.7 6.2 3.0 0.0 0.0 0.0 1.5 0.0 6.5 1.3 0.4 12.3 12.3 2.2 12.7 0.8 2.2 0.1 3.1 1.2 0.8 11.3 0.4 0.0 38.4 0.4 0.6 9.0 0.0 0.7 0.0 3.3 0.0 0.0 0.0 26.2 0.0 0.0 1.1 0.0 2.1 0.0 6.0 2.5 0.2 2.8 0.6 0.0 0.0 13.4 5.8 3.5 0.0 0.0 0.4 5.7 9.5 0.8 1.4 0.8 11.0 0.0 0.2 1.1 0.0 1.4 6.0 0.3 0.1 0.0 0.0 0.6 0.1 0.7 0.0 0.1 0.0 0.0 1.5 0.0 0.0 1.6 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.3 0.0 0.0 1.3 45.2 55.9 22.8 40.5 47.8 28.7 63.1 34.9 38.6 63.1 GRAMD1B "KIAA1201, LINC01059" ENSG00000023171 "GRAM domain containing 1B" Q3KR37 11 123358428-123627774 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.7;brain: 55.2;intestine: 21.7" "Group enriched" "Detected in many" 4 "A549: 21.8;HDLM-2: 57.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008557 Approved Approved "Nucleoplasm,Nucleoli,Intermediate filaments" Nucleoli "Nucleoplasm, Intermediate filaments" "HPA008557: AB_1079197" "unprognostic (1.86e-1)" "unprognostic (7.18e-3)" "unprognostic (2.43e-2)" "unprognostic (2.74e-3)" "unprognostic (8.15e-2)" "unprognostic (4.28e-2)" "unprognostic (2.69e-3)" "unprognostic (4.12e-3)" "unprognostic (1.40e-1)" "unprognostic (2.90e-2)" "unprognostic (9.60e-2)" "unprognostic (8.06e-2)" "prognostic unfavourable (4.30e-7)" "unprognostic (1.39e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (1.69e-1)" 1.4 67.7 15.5 3.1 16.0 11.8 1.1 55.2 25.0 1.2 3.1 5.1 5.9 21.7 1.2 6.6 0.9 2.9 8.1 4.3 13.6 7.5 10.4 1.3 1.9 3.6 6.8 15.1 7.6 2.0 0.6 6.7 5.0 14.4 1.1 1.2 11.9 1.3 2.5 1.8 0.8 15.6 1.3 4.1 2.7 7.8 10.6 5.1 3.4 3.7 0.0 2.7 1.5 0.8 0.1 11.5 0.6 2.0 2.6 2.7 0.7 0.0 21.8 1.2 0.0 0.1 0.2 3.6 7.2 5.2 1.6 0.6 0.9 0.1 1.3 3.8 3.6 0.0 2.3 0.0 1.7 57.6 2.0 0.0 9.8 0.2 0.0 7.5 0.0 0.4 0.0 2.8 0.0 0.6 0.0 0.0 1.3 0.1 1.2 2.5 2.8 8.2 3.9 3.5 2.3 0.1 0.0 7.2 5.9 1.7 0.1 0.0 0.2 4.2 4.3 8.7 1.4 1.5 0.3 0.0 0.0 0.0 1.8 7.9 0.4 0.0 2.0 0.6 0.7 1.0 0.4 0.0 2.7 2.1 3.0 0.1 0.3 0.3 0.2 2.6 1.0 11.5 1.1 0.7 15.5 16.0 55.2 25.0 13.6 7.5 6.8 15.1 14.4 5.1 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159807-72197785 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 24.6;placenta: 49.2" "Group enriched" "Detected in some" 12 "BEWO: 58.1;SK-BR-3: 26.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "myeloid DC: 2.3" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.3" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavourable (7.01e-4)" "unprognostic (7.29e-2)" 0.1 0.0 2.0 0.2 4.5 0.0 6.8 1.1 1.0 3.1 0.7 1.2 9.8 0.6 0.4 24.6 1.0 8.2 0.8 0.1 2.9 6.5 1.9 0.1 9.7 0.2 1.1 0.1 1.1 1.0 0.2 0.9 49.2 3.9 1.2 0.5 1.0 1.8 4.0 0.3 1.5 3.6 0.1 1.0 0.1 0.4 0.7 0.9 0.2 7.7 1.3 1.1 0.3 0.6 0.0 2.3 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 58.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 26.5 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.5 1.1 1.0 2.9 6.5 1.1 0.1 3.9 0.9 GSKIP C14orf129 ENSG00000100744 "GSK3B interacting protein" Q9P0R6 14 96363452-96387288 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 63.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043054, HPA046782" Approved Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoli "HPA043054: , HPA046782: " "unprognostic (3.48e-1)" "unprognostic (1.16e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (6.23e-3)" "unprognostic (1.11e-1)" "unprognostic (9.35e-2)" "unprognostic (1.16e-3)" "unprognostic (6.82e-2)" "unprognostic (2.84e-1)" "unprognostic (8.74e-3)" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.48e-2)" "unprognostic (2.30e-1)" 6.6 7.1 11.2 8.0 21.9 7.1 6.7 5.1 14.6 6.6 29.5 5.4 6.7 23.5 5.5 6.4 20.8 5.5 7.0 5.2 12.0 9.6 12.8 36.4 5.3 8.7 9.2 9.7 3.6 6.1 4.0 10.8 11.1 10.7 7.1 28.3 8.7 7.8 5.2 5.5 8.5 63.0 8.0 10.4 6.6 11.3 26.4 7.2 9.0 5.8 10.7 10.7 8.2 9.0 20.1 11.2 27.5 16.6 17.8 34.1 14.8 9.4 13.6 15.2 10.3 11.5 13.4 25.8 17.7 13.5 11.7 13.0 10.0 16.1 9.1 10.8 13.4 10.5 9.9 10.6 17.1 21.6 9.4 3.8 7.8 7.6 10.7 9.7 6.6 10.8 16.9 15.0 15.1 15.2 8.2 8.3 14.8 23.5 7.1 7.9 16.9 17.2 7.2 14.2 8.2 27.5 35.5 5.4 17.4 20.0 18.9 15.4 14.2 6.3 16.7 5.4 7.0 11.5 5.5 9.8 27.9 7.7 13.9 7.0 8.6 27.5 10.8 24.3 15.5 12.6 24.0 20.1 21.7 18.3 11.2 16.6 21.4 19.8 21.7 17.8 16.6 9.6 34.1 14.8 11.2 21.9 5.1 14.6 12.0 9.6 9.2 9.7 10.7 7.2 GYG2 GN-2 ENSG00000056998 "Glycogenin 2" O15488 X 2828788-2882820 "Enzymes, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 76.7;brain: 21.2;breast: 30.4" "Cell line enhanced" "Detected in many" "AF22: 17.7;BEWO: 12.8;CACO-2: 13.1;Hep G2: 14.2;NTERA-2: 17.4;SK-MEL-30: 37.7" "Cancer enhanced" "Detected in all" "melanoma: 42.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005495, HPA064686" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA005495: AB_1079035, HPA064686: " "unprognostic (4.45e-2)" "unprognostic (4.21e-2)" "unprognostic (6.41e-3)" "unprognostic (8.50e-2)" "unprognostic (2.07e-3)" "unprognostic (5.16e-1)" "unprognostic (1.74e-2)" "unprognostic (1.18e-1)" "unprognostic (7.43e-3)" "unprognostic (6.74e-2)" "prognostic favourable (3.01e-5)" "unprognostic (9.76e-2)" "unprognostic (6.10e-5)" "unprognostic (1.78e-1)" "unprognostic (5.05e-3)" "unprognostic (5.41e-2)" "unprognostic (6.60e-2)" 76.7 1.4 4.6 1.3 4.6 0.5 30.4 2.1 3.7 2.1 3.5 8.2 0.7 1.2 4.2 0.9 1.0 3.6 1.7 1.7 3.9 2.9 1.4 9.9 0.7 0.7 5.5 2.9 1.9 3.2 0.4 0.5 1.6 12.9 2.7 2.0 4.2 2.8 4.4 0.5 1.2 1.3 2.8 21.2 0.5 2.2 0.8 5.1 0.0 1.3 0.5 0.6 2.9 1.4 1.0 0.6 0.6 0.4 1.2 0.7 0.0 0.0 5.4 17.7 0.0 10.6 0.0 12.8 0.5 3.1 3.1 3.9 13.1 0.3 0.0 1.4 2.2 0.0 10.0 0.2 3.0 0.1 2.8 0.0 0.2 14.2 3.1 0.0 4.3 3.8 0.1 0.3 0.0 0.0 0.1 0.0 3.2 0.8 0.0 0.4 17.4 0.1 2.9 5.9 0.0 0.0 0.0 0.0 0.3 0.0 0.1 37.7 1.7 10.7 0.0 0.0 3.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.2 0.7 0.5 0.4 0.3 0.1 1.0 0.3 0.2 0.6 1.2 0.4 0.6 0.4 0.0 4.6 4.6 2.1 3.7 3.9 2.9 5.5 2.9 12.9 5.1 HEATR5B "DKFZp686P15184, KIAA1414" ENSG00000008869 "HEAT repeat containing 5B" Q9P2D3 2 36968383-37084342 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042025, HPA055639" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA042025: AB_10959880, HPA055639: " "unprognostic (3.11e-2)" "unprognostic (1.65e-2)" "unprognostic (4.07e-1)" "unprognostic (6.05e-2)" "unprognostic (3.70e-2)" "unprognostic (7.75e-2)" "unprognostic (5.95e-2)" "unprognostic (3.33e-3)" "unprognostic (8.26e-2)" "unprognostic (3.08e-2)" "unprognostic (1.66e-1)" "unprognostic (8.07e-2)" "unprognostic (5.80e-3)" "unprognostic (8.69e-2)" "unprognostic (4.18e-1)" "unprognostic (2.72e-1)" "unprognostic (3.95e-1)" 14.7 13.6 13.5 14.1 23.8 21.8 15.0 23.3 22.8 11.1 10.2 15.4 10.1 10.9 16.5 18.0 14.9 9.7 10.9 10.7 11.4 12.1 9.9 12.9 12.5 29.6 13.0 16.6 12.3 23.8 17.9 16.6 10.3 21.6 12.2 14.0 12.4 18.0 9.6 7.1 18.0 14.9 9.4 16.1 18.0 12.8 9.6 14.5 16.0 13.6 8.4 30.0 11.3 12.9 15.2 10.7 15.8 4.9 7.0 9.1 5.0 10.2 5.2 7.7 11.7 8.0 8.0 9.8 6.5 4.8 5.9 6.1 5.9 7.1 22.0 4.7 5.5 8.7 7.6 5.3 7.8 10.7 8.2 14.3 6.9 8.3 5.0 15.3 18.9 7.3 7.4 8.6 8.2 9.9 13.5 19.5 7.1 6.1 13.3 11.0 5.0 3.7 12.9 7.9 16.4 7.0 8.9 9.5 8.4 6.7 10.9 5.1 7.8 5.0 11.1 9.1 5.2 6.5 5.0 12.2 10.0 24.2 7.4 9.2 5.9 15.8 4.9 11.3 7.9 2.6 7.2 9.9 8.8 8.8 8.6 15.2 9.1 7.9 5.1 7.0 3.8 10.7 8.9 5.0 13.5 23.8 23.3 22.8 11.4 12.1 13.0 16.6 21.6 14.5 HELZ "DHRC, HUMORF5, KIAA0054" ENSG00000198265 "Helicase with zinc finger" P42694 17 67070438-67245989 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028276 Approved Approved "Nucleoli,Plasma membrane,Actin filaments" Nucleoli "Plasma membrane, Actin filaments" "HPA028276: AB_10601814" "unprognostic (3.16e-1)" "unprognostic (2.10e-2)" "unprognostic (7.56e-3)" "unprognostic (1.29e-1)" "unprognostic (4.83e-2)" "unprognostic (4.71e-2)" "unprognostic (5.85e-2)" "unprognostic (5.31e-2)" "unprognostic (3.60e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-3)" "unprognostic (1.42e-1)" "unprognostic (1.24e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" 17.9 12.9 11.2 14.3 14.3 17.7 12.6 24.3 17.7 14.4 14.0 11.6 12.9 7.9 17.0 13.0 9.1 11.1 11.5 11.1 12.0 9.7 11.8 17.3 14.8 14.6 10.7 6.2 20.5 13.9 34.1 33.5 19.2 16.5 11.9 10.9 12.2 12.4 10.9 18.9 9.0 15.6 12.2 13.5 17.3 11.7 16.4 12.7 34.1 15.3 8.8 13.9 15.3 11.9 4.8 4.4 4.3 4.9 4.0 11.0 3.2 7.5 7.6 9.2 9.5 11.7 6.5 14.2 6.7 6.7 8.8 9.7 11.0 6.0 15.6 5.6 9.0 8.0 17.6 8.5 14.2 6.0 5.5 19.9 8.3 9.0 5.6 16.4 12.2 7.7 8.2 8.7 11.1 13.6 13.8 10.0 7.4 9.6 21.1 5.7 5.6 7.3 14.3 16.8 6.8 7.1 10.7 9.3 8.5 10.6 8.9 11.6 10.5 10.2 12.2 11.4 13.1 6.2 6.0 8.2 9.6 11.8 5.6 10.2 11.8 3.6 4.9 4.3 8.8 4.5 11.0 2.9 5.4 5.3 4.4 4.8 3.3 4.5 3.7 4.0 2.9 3.6 4.8 3.2 11.2 14.3 24.3 17.7 12.0 9.7 10.7 6.2 16.5 12.7 HINT3 FLJ33126 ENSG00000111911 "Histidine triad nucleotide binding protein 3" Q9NQE9 6 125956781-125980244 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 65.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027914 Approved Approved Nucleoli,Mitochondria,Cytosol "Nucleoli, Mitochondria" Cytosol "HPA027914: AB_10602424" "prognostic unfavourable (4.99e-4)" "unprognostic (4.75e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (1.74e-1)" "unprognostic (4.88e-3)" "unprognostic (3.82e-1)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (1.05e-1)" "prognostic favourable (1.05e-6)" "unprognostic (4.09e-2)" "unprognostic (4.76e-2)" "unprognostic (9.56e-2)" "unprognostic (1.64e-1)" 11.4 16.3 27.4 8.0 23.3 7.2 15.6 19.4 24.3 13.1 13.1 24.8 10.6 10.4 11.5 12.6 15.2 11.4 10.9 19.0 28.1 23.0 15.1 18.5 13.9 7.0 28.7 17.0 10.4 12.8 16.3 13.4 12.1 20.7 20.5 12.1 10.3 16.0 16.2 65.8 11.6 10.5 15.2 40.8 6.8 16.0 21.9 17.0 7.7 15.9 16.8 7.4 16.1 8.8 11.0 11.1 15.0 13.2 7.9 9.9 7.0 6.9 5.5 7.7 15.9 3.0 8.3 9.5 7.5 10.9 5.8 6.0 13.5 3.8 15.1 14.0 5.0 10.4 9.8 6.3 6.8 14.2 12.6 6.3 8.3 11.3 14.2 9.9 10.7 6.5 14.1 5.8 14.8 8.7 19.6 10.2 5.7 10.5 7.9 7.2 2.6 5.3 6.7 5.3 5.0 12.0 12.7 15.4 9.5 6.8 9.8 35.1 9.9 15.3 6.1 4.0 5.6 18.9 10.6 14.8 16.9 9.6 11.2 9.5 5.1 14.4 13.2 11.4 7.2 8.4 7.8 11.0 9.2 7.5 11.1 10.4 9.9 8.7 15.0 7.9 10.8 6.9 9.1 7.0 27.4 23.3 19.4 24.3 28.1 23.0 28.7 17.0 20.7 17.0 HJURP "DKFZp762E1312, FAKTS, hFLEG1, URLC9" ENSG00000123485 "Holliday junction recognition protein" Q8NCD3 2 233833416-233854566 "Predicted intracellular proteins" "Cell cycle" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 4.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2" "Not detected" "Not detected" "HPA008436, HPA027261" Uncertain Enhanced Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli" Mitochondria "HPA008436: AB_1850757, HPA027261: " "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.87e-1)" "unprognostic (1.44e-3)" "unprognostic (3.62e-1)" "unprognostic (1.75e-1)" "prognostic unfavourable (3.37e-5)" "prognostic unfavourable (2.46e-4)" "prognostic unfavourable (6.49e-4)" "unprognostic (9.48e-2)" "prognostic unfavourable (7.72e-5)" "unprognostic (7.60e-2)" "unprognostic (0.00e+0)" "unprognostic (7.42e-2)" "unprognostic (5.58e-2)" "unprognostic (1.89e-2)" "unprognostic (5.74e-2)" 1.4 0.9 0.1 12.2 0.4 27.4 2.2 0.1 0.7 1.1 3.7 0.3 0.1 2.6 0.6 1.8 8.0 0.3 0.7 1.1 0.1 0.2 1.0 1.2 2.0 8.1 0.2 0.1 0.6 0.4 0.0 0.2 3.1 0.2 0.7 3.6 0.3 1.5 1.0 0.2 2.6 4.8 1.1 0.4 5.8 2.4 20.9 0.1 51.1 0.4 3.0 11.6 1.0 2.8 0.5 0.3 1.2 1.3 0.5 4.2 1.7 17.0 23.0 22.6 10.6 0.8 1.8 14.1 25.6 12.3 18.3 20.0 16.2 18.6 5.3 2.9 10.1 19.9 18.0 13.2 24.4 12.5 6.7 20.5 18.5 15.7 0.1 16.9 14.2 0.6 0.5 14.9 10.3 11.4 17.4 13.3 33.6 17.2 23.7 18.6 19.2 16.0 18.3 33.8 9.4 9.4 10.3 13.0 8.1 14.7 11.2 10.5 8.4 13.1 8.3 19.8 21.5 14.5 27.6 12.7 10.0 21.4 11.8 12.5 49.2 0.6 0.2 0.2 0.3 0.2 0.2 0.4 0.7 0.6 0.3 0.5 0.3 0.5 1.2 0.5 1.3 0.2 4.2 1.7 0.1 0.4 0.1 0.7 0.1 0.2 0.2 0.1 0.2 0.1 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 231.4" "Cell line enriched" "Detected in some" 9 "CACO-2: 37.0" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: , HPA043264: , HPA044028: " "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favourable (4.59e-5)" 0.1 0.6 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 231.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 11.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.1 0.4 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 223.2" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;TIME: 1.2;WM-115: 3.2" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enriched" "Detected in single" 198 "basal ganglia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: , HPA043264: , HPA044028: " "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.0 223.2 0.0 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.5 43.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.4 0.0 0.0 5.1 0.0 0.0 1.2 0.2 0.1 0.1 0.7 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSPB6 "FLJ32389, Hsp20, PPP1R91" ENSG00000004776 "Heat shock protein family B (small) member 6" O14558 19 35754569-35758079 "Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 356.8" "Cell line enhanced" "Detected in some" "ASC diff: 184.7;ASC TERT1: 77.9;HHSteC: 62.6;HSkMC: 72.9" "Cancer enhanced" "Detected in all" "stomach cancer: 93.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB001974, HPA044153, HPA054811" Enhanced Supported "Nucleoli,Golgi apparatus,Cytosol" "Intracellular and membrane" 86000 Cytosol "Nucleoli, Golgi apparatus" "CAB001974: , HPA044153: , HPA054811: " "unprognostic (3.19e-2)" "unprognostic (8.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.01e-1)" "unprognostic (5.21e-3)" "unprognostic (7.02e-2)" "unprognostic (9.67e-2)" "unprognostic (7.57e-2)" "unprognostic (1.18e-1)" "unprognostic (7.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.02e-2)" "prognostic unfavourable (1.93e-5)" "unprognostic (3.32e-2)" "unprognostic (6.65e-2)" "unprognostic (5.61e-2)" "prognostic unfavourable (1.43e-6)" 95.3 39.5 3.9 18.3 8.1 1.1 40.5 1.1 6.1 49.7 48.4 3.8 18.6 5.7 42.6 57.4 24.6 33.3 80.6 132.0 4.4 2.4 6.2 3.5 8.7 7.2 5.4 2.8 53.4 5.8 1.7 1.2 12.7 8.1 42.1 8.7 18.2 8.6 35.8 356.8 2.5 14.3 128.2 10.2 1.9 32.4 22.6 4.9 0.0 11.0 153.5 16.4 121.6 23.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.2 184.7 77.9 0.1 8.2 0.1 0.5 0.9 0.1 0.0 0.0 0.0 24.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 62.6 0.0 0.0 72.9 0.0 1.9 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 0.0 1.7 0.0 0.1 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 8.1 1.1 6.1 4.4 2.4 5.4 2.8 8.1 4.9 IFI16 "IFNGIP1, PYHIN2" ENSG00000163565 "Interferon gamma inducible protein 16" Q16666 1 158999968-159055155 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA002134, CAB016293" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB016293: AB_627775, HPA002134: AB_1079099" "unprognostic (7.23e-3)" "unprognostic (2.20e-2)" "unprognostic (5.15e-2)" "unprognostic (7.70e-3)" "unprognostic (1.87e-1)" "unprognostic (6.08e-2)" "unprognostic (1.80e-1)" "unprognostic (5.83e-2)" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (5.92e-3)" "unprognostic (7.62e-2)" "prognostic unfavourable (1.11e-16)" "unprognostic (5.07e-2)" "unprognostic (4.08e-1)" "unprognostic (7.97e-2)" "unprognostic (1.14e-1)" 64.2 21.0 10.9 42.5 18.0 10.2 34.8 6.7 11.4 28.5 18.6 9.6 7.8 7.5 32.5 21.8 32.8 25.0 33.4 24.8 16.5 7.5 13.3 10.2 32.1 51.0 19.5 6.3 32.6 5.5 3.2 7.0 21.4 18.0 23.0 15.2 10.9 33.6 11.2 14.6 23.7 21.6 29.1 32.2 63.2 11.8 14.2 16.0 81.8 19.1 24.2 41.8 30.9 27.6 28.9 20.8 51.2 21.0 27.9 24.6 16.9 6.9 0.5 2.4 0.1 16.8 55.6 0.0 14.8 39.7 41.7 55.5 0.0 8.9 40.9 12.8 9.0 20.3 0.3 15.0 16.7 12.6 0.1 10.5 3.1 0.0 31.4 3.6 0.7 52.3 26.9 21.3 30.4 43.8 0.2 30.0 23.1 0.0 48.0 3.3 6.4 5.4 22.7 15.4 47.2 5.8 2.6 1.1 0.0 19.4 0.1 42.1 0.0 4.2 24.7 10.7 5.1 30.2 6.2 28.0 13.1 38.4 30.8 11.8 25.8 2.5 21.0 0.1 18.9 20.5 16.9 27.6 18.1 19.3 20.8 28.9 11.5 14.6 51.2 27.9 18.5 15.6 24.6 16.9 10.9 18.0 6.7 11.4 16.5 7.5 19.5 6.3 18.0 16.0 ILF3 "DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Supported Nucleoplasm,Nucleoli,Mitochondria 1100000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavourable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavourable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 31.0 39.0 29.6 45.5 26.8 88.2 34.5 48.3 35.2 34.2 30.2 30.8 35.2 30.3 45.4 31.7 40.5 41.9 32.5 34.0 25.5 20.0 28.1 25.6 34.1 44.9 24.7 27.8 52.8 36.8 34.9 34.9 31.8 32.3 34.9 27.3 35.5 35.1 46.2 50.1 37.7 37.2 33.2 33.3 44.5 32.6 54.3 28.0 58.6 43.4 32.4 41.1 38.5 32.1 18.7 18.7 11.5 14.3 15.4 19.4 8.0 45.4 37.0 60.0 54.9 13.0 17.9 34.9 29.1 24.7 48.9 38.3 42.4 26.4 56.8 29.0 26.1 40.8 64.8 39.3 44.1 36.3 57.7 73.7 32.7 39.5 18.7 53.0 36.8 16.9 17.6 38.8 43.5 41.7 62.9 44.7 28.4 37.4 87.9 85.3 72.0 40.7 64.8 57.2 39.3 19.4 48.3 66.3 48.2 37.5 29.8 21.6 25.2 34.1 33.4 40.1 38.2 41.5 57.4 38.4 52.4 69.0 22.4 56.7 43.2 11.5 13.4 7.1 19.4 10.4 16.1 14.7 15.9 17.3 16.8 18.7 15.7 16.0 2.1 15.4 14.3 18.7 15.0 8.0 29.6 26.8 48.3 35.2 25.5 20.0 24.7 27.8 32.3 28.0 IRAK4 NY-REN-64 ENSG00000198001 "Interleukin 1 receptor associated kinase 4" Q9NWZ3 12 43758944-43789543 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016685, CAB022077" Uncertain Approved Nucleoli,Microtubules,Cytosol Microtubules "Nucleoli, Cytosol" "CAB016685: AB_1618505, CAB022077: " "unprognostic (2.76e-2)" "unprognostic (5.63e-2)" "unprognostic (1.47e-2)" "prognostic favourable (3.46e-5)" "unprognostic (6.15e-2)" "unprognostic (3.50e-3)" "unprognostic (1.44e-2)" "unprognostic (8.49e-2)" "unprognostic (6.44e-3)" "unprognostic (7.50e-2)" "unprognostic (4.00e-3)" "unprognostic (6.29e-2)" "unprognostic (4.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "prognostic favourable (4.42e-5)" 18.0 9.4 5.1 15.0 10.4 10.3 11.3 3.7 6.0 10.3 12.2 9.1 12.5 10.2 13.0 14.1 15.0 9.4 10.8 7.6 6.7 5.2 13.3 11.8 12.0 24.0 13.2 3.9 9.3 20.1 9.1 16.1 14.0 9.8 10.5 10.0 11.9 11.9 15.1 4.1 15.2 15.0 11.8 13.0 25.0 12.3 7.1 11.7 30.3 17.0 7.7 18.9 11.1 10.7 5.1 5.8 16.9 6.0 8.8 7.7 4.7 5.3 3.9 2.8 3.7 10.1 17.0 4.0 7.5 5.3 6.0 5.5 3.3 5.1 9.1 7.4 6.2 4.4 3.1 4.8 8.6 13.0 2.9 8.7 3.0 2.1 5.8 12.0 10.7 9.0 7.8 7.6 4.4 8.8 8.0 6.8 16.4 2.9 10.4 6.8 1.0 4.6 6.9 3.4 4.8 4.6 5.1 2.0 1.9 3.6 4.7 3.6 5.9 10.7 7.8 7.4 1.4 9.0 5.1 8.4 10.8 7.9 7.6 32.4 4.0 16.9 4.6 9.4 7.4 5.4 7.7 4.0 6.1 6.3 4.5 5.1 5.5 5.9 9.3 8.8 6.0 5.8 7.5 4.7 5.1 10.4 3.7 6.0 6.7 5.2 13.2 3.9 9.8 11.7 JPT1 "ARM2, HN1, HN1A" ENSG00000189159 "Jupiter microtubule associated homolog 1" Q9UK76 17 75135248-75168281 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 109.4;testis: 101.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 109.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059729 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA059729: AB_2684114" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-3)" "unprognostic (3.57e-3)" "unprognostic (6.71e-2)" "unprognostic (2.51e-3)" "prognostic unfavourable (1.58e-7)" "unprognostic (3.58e-2)" "unprognostic (1.37e-1)" "prognostic favourable (4.91e-4)" "unprognostic (1.25e-3)" "unprognostic (8.24e-2)" "prognostic unfavourable (1.77e-7)" "unprognostic (1.83e-1)" "unprognostic (8.99e-2)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" 8.0 18.5 15.6 25.9 22.2 23.0 8.1 30.7 25.4 9.4 43.3 4.6 7.7 37.5 6.1 5.4 52.8 4.3 23.7 6.1 17.9 19.6 15.5 12.8 13.9 26.3 11.1 15.0 5.6 6.5 1.2 6.6 29.2 13.7 7.0 23.7 3.3 15.9 17.6 23.7 9.3 51.3 7.3 8.3 26.2 42.5 101.3 4.9 32.6 5.8 28.9 28.7 17.9 17.0 15.4 14.5 109.4 28.4 10.2 28.7 14.6 91.6 91.4 48.1 47.7 10.2 10.5 38.4 48.3 14.4 47.5 36.6 74.8 55.0 25.8 31.0 38.6 54.8 44.9 60.1 35.8 25.8 56.4 41.5 36.3 74.0 24.0 31.1 40.1 16.0 28.8 38.6 39.8 86.2 23.4 53.2 43.4 66.4 99.7 30.4 28.0 120.5 63.7 57.5 40.0 50.7 57.6 59.8 48.6 69.1 36.6 25.7 98.1 19.1 49.6 27.2 76.9 38.1 56.0 20.8 33.5 38.6 23.7 29.2 31.0 27.5 18.5 51.6 12.4 26.6 8.9 15.4 17.2 14.9 14.5 8.0 8.2 12.0 109.4 10.2 28.4 9.6 28.7 14.6 15.6 22.2 30.7 25.4 17.9 19.6 11.1 15.0 13.7 4.9 JRK "jerky, JH8" ENSG00000234616 "Jrk helix-turn-helix protein" 8 142657460-142681968 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052675 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA052675: " "unprognostic (3.65e-2)" "unprognostic (5.30e-2)" "unprognostic (9.67e-2)" "unprognostic (3.90e-3)" "unprognostic (1.27e-1)" "unprognostic (1.84e-2)" "unprognostic (6.58e-6)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.90e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (7.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.53e-1)" "unprognostic (1.22e-2)" "unprognostic (1.69e-2)" 2.6 3.3 6.4 4.0 6.5 1.6 3.7 11.1 7.1 2.8 2.8 6.1 6.8 2.9 5.4 3.6 3.1 4.7 2.6 3.7 4.4 2.9 0.7 2.6 5.3 5.2 5.2 9.6 4.6 5.6 4.4 3.0 4.3 4.5 2.8 5.4 4.1 4.5 6.2 6.5 3.2 4.9 3.5 4.8 4.3 6.1 5.3 4.3 4.2 2.6 6.1 2.6 7.9 4.5 2.3 3.3 2.3 2.0 4.4 1.2 5.4 5.9 6.9 5.6 6.7 9.9 4.3 8.5 3.6 10.5 6.0 5.3 11.4 9.4 3.7 7.0 7.4 6.1 5.3 5.3 7.2 10.4 9.4 18.8 6.1 2.8 7.2 6.6 6.3 4.7 6.7 3.8 5.9 10.0 4.2 8.8 9.4 8.3 4.0 5.9 8.4 11.0 4.4 5.2 3.6 9.4 12.8 8.5 15.7 6.4 3.7 6.3 4.5 6.9 8.2 17.6 8.0 4.7 5.5 6.1 5.6 6.2 9.1 7.9 3.3 2.3 2.9 3.1 1.6 1.8 1.4 3.5 3.1 2.3 4.5 4.4 3.5 2.5 2.0 0.8 2.2 2.0 1.2 KAT6A "MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220" ENSG00000083168 "Lysine acetyltransferase 6A" Q92794 8 41929479-42051990 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017023, HPA063266, HPA065052" Supported Approved "Nucleoli,Nuclear speckles,Cytosol" "Nuclear speckles" "Nucleoli, Cytosol" "CAB017023: , HPA063266: , HPA065052: " "unprognostic (3.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-1)" "unprognostic (3.23e-2)" "unprognostic (2.28e-1)" "unprognostic (9.27e-3)" "unprognostic (3.61e-1)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.50e-1)" "unprognostic (4.45e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-1)" "unprognostic (2.24e-1)" "unprognostic (8.58e-2)" "unprognostic (2.95e-2)" 20.8 10.9 15.3 19.8 20.3 36.8 22.6 29.9 18.7 19.7 14.6 19.4 14.4 10.7 20.6 12.1 16.9 16.5 14.3 13.0 15.5 11.5 12.3 13.6 26.9 28.2 23.2 10.3 27.2 13.1 26.8 22.3 20.9 15.7 14.1 12.0 12.8 15.1 17.0 21.0 25.5 18.0 25.0 22.9 20.4 14.0 14.1 21.7 30.4 17.9 14.3 20.1 16.9 24.2 4.7 1.8 10.9 1.6 3.1 3.9 1.4 12.9 10.6 17.5 11.1 9.8 11.2 5.9 8.7 11.3 10.8 8.4 6.7 6.2 19.2 8.7 8.5 8.3 13.6 8.2 12.7 9.9 7.9 27.6 6.6 5.0 7.4 14.5 12.7 9.3 9.4 10.0 12.4 10.3 23.1 12.2 9.8 5.7 29.5 4.6 6.7 4.2 23.6 19.6 6.1 5.3 14.9 10.9 9.4 10.1 6.8 7.0 15.6 6.4 12.0 13.3 9.4 11.8 9.3 10.0 16.1 20.8 7.1 6.6 11.5 3.5 1.6 2.8 3.5 1.2 3.9 2.4 2.6 3.3 1.0 4.7 3.6 2.9 10.9 3.1 1.2 1.8 3.5 1.4 15.3 20.3 29.9 18.7 15.5 11.5 23.2 10.3 15.7 21.7 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.0;HEK 293: 7.4;SCLC-21H: 6.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" "Plasma membrane" "Nucleoli, Midbody" "HPA065970: " "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 KIAA1551 "C12orf35, FLJ10652, FLJ20696, GET, UTA2-1" ENSG00000174718 KIAA1551 Q9HCM1 12 31959370-31993107 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.8;lymphoid tissue: 56.3" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "testis cancer: 65.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 58.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 58.8" "Low region specificity" "Detected in all" "HPA013816, HPA015622" Approved Supported "Nucleoli,Intermediate filaments,Cytosol" Nucleoli "Intermediate filaments, Cytosol" "HPA013816: AB_1848661, HPA015622: AB_1848663" "unprognostic (7.97e-3)" "unprognostic (1.69e-1)" "unprognostic (1.76e-1)" "unprognostic (8.49e-2)" "unprognostic (3.21e-1)" "unprognostic (3.09e-3)" "unprognostic (2.24e-1)" "unprognostic (2.19e-1)" "unprognostic (8.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.90e-2)" "prognostic unfavourable (5.04e-9)" "unprognostic (3.83e-1)" "unprognostic (1.09e-1)" "unprognostic (2.61e-1)" "unprognostic (7.26e-3)" 12.4 5.8 4.7 28.8 6.1 9.0 10.3 8.7 7.0 15.7 17.5 2.7 7.1 10.7 11.2 10.3 12.3 19.0 8.9 6.2 4.8 3.5 8.1 14.2 17.0 56.3 7.5 4.1 38.3 7.0 3.6 8.0 17.5 5.4 11.6 6.5 3.5 8.6 5.5 5.4 6.7 30.0 8.5 8.1 39.1 8.8 8.7 5.9 48.5 10.0 7.6 27.6 17.3 13.9 9.6 3.3 58.8 4.5 8.0 13.2 5.0 2.9 5.3 9.2 3.5 4.2 5.0 13.7 3.6 3.6 2.6 2.8 20.0 19.6 14.3 9.0 3.0 4.0 12.6 2.4 3.7 10.5 1.7 20.0 2.6 2.6 8.2 14.4 32.4 2.7 3.7 2.9 4.8 20.2 11.4 22.8 2.7 1.4 20.2 6.0 19.6 2.2 9.4 8.8 6.2 2.6 5.5 3.7 3.3 4.7 2.4 2.5 8.4 16.0 12.7 2.7 4.4 4.7 3.8 13.9 14.7 17.6 1.5 8.1 3.0 12.5 3.9 3.9 12.5 4.4 11.8 9.6 11.2 11.6 3.3 7.5 13.2 12.6 58.8 8.0 4.5 2.0 10.2 5.0 4.7 6.1 8.7 7.0 4.8 3.5 7.5 4.1 5.4 5.9 KIAA1755 RP5-1054A22.3 ENSG00000149633 KIAA1755 Q5JYT7 20 38210488-38260772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell line enhanced" "Detected in some" "AF22: 39.9;ASC diff: 6.1;ASC TERT1: 9.2;WM-115: 10.1" "Cancer enhanced" "Detected in many" "melanoma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051064 Approved Approved "Nucleoli,Golgi apparatus,Vesicles" Nucleoli "Golgi apparatus, Vesicles" "HPA051064: " "unprognostic (3.98e-3)" "unprognostic (2.20e-2)" "unprognostic (3.79e-1)" "unprognostic (3.01e-3)" "unprognostic (1.77e-1)" "unprognostic (7.01e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (4.50e-2)" "unprognostic (2.70e-1)" "unprognostic (3.88e-2)" "unprognostic (1.69e-1)" "unprognostic (2.42e-8)" "unprognostic (1.41e-2)" "unprognostic (2.78e-2)" "unprognostic (1.25e-2)" "unprognostic (5.53e-3)" 6.1 2.5 13.6 5.8 27.3 0.7 3.8 4.8 22.1 13.2 8.1 47.2 3.1 2.7 15.5 7.2 5.6 10.0 16.9 11.5 13.9 8.4 4.6 1.7 2.7 4.9 22.7 13.7 14.7 1.5 0.3 3.1 0.4 24.5 7.3 4.7 8.8 6.1 8.2 1.3 1.6 4.5 15.8 20.4 2.8 4.1 2.9 29.2 0.0 2.6 1.6 4.9 6.8 5.4 0.3 0.5 0.9 0.4 0.4 0.7 0.0 1.5 0.1 39.9 0.0 6.1 9.2 0.0 3.9 2.2 0.0 0.0 0.2 1.1 0.0 0.2 1.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.6 0.2 0.7 0.0 0.0 0.0 0.1 0.0 10.1 0.9 0.4 0.1 0.7 0.2 0.5 0.1 0.5 0.6 0.1 0.3 0.4 0.4 0.7 0.4 0.1 0.5 0.0 0.0 13.6 27.3 4.8 15.7 13.9 8.4 22.7 13.7 24.5 29.2 KIF2A "HK2, KIF2" ENSG00000068796 "Kinesin family member 2A" O00139 5 62306162-62537249 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis" "Developmental protein, Motor protein" "Cancer-related genes, Disease mutation, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004715, HPA004716" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome 2100000 "Nucleoplasm, Nucleoli, Centrosome" "HPA004715: , HPA004716: AB_1079211" "unprognostic (2.40e-2)" "unprognostic (3.43e-1)" "prognostic favourable (1.70e-4)" "unprognostic (2.74e-2)" "unprognostic (1.43e-1)" "prognostic favourable (5.45e-4)" "prognostic unfavourable (3.17e-6)" "unprognostic (8.77e-3)" "unprognostic (4.69e-2)" "unprognostic (9.10e-2)" "unprognostic (1.85e-1)" "unprognostic (1.34e-1)" "prognostic unfavourable (3.81e-5)" "unprognostic (3.53e-2)" "unprognostic (2.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.58e-1)" 11.3 9.3 25.4 21.9 26.4 12.4 15.5 15.4 40.1 19.7 13.5 19.4 8.0 10.3 12.9 7.6 14.3 17.5 13.7 7.2 26.2 24.1 8.2 5.8 10.6 29.4 24.9 24.6 13.0 12.3 15.2 14.3 27.8 37.0 10.2 14.5 6.8 10.7 11.9 7.4 7.9 15.8 13.5 34.3 17.4 9.6 39.2 26.4 28.7 13.0 5.6 26.7 17.4 14.8 9.0 8.4 7.1 3.0 15.8 25.4 9.7 17.2 17.3 28.9 25.6 10.9 15.4 23.6 18.5 15.3 20.2 25.6 18.6 18.9 42.8 20.4 16.3 11.0 21.9 14.9 27.0 42.9 15.3 43.0 16.2 10.1 12.9 23.4 16.4 12.7 9.8 19.6 17.8 18.4 30.4 26.1 16.8 13.0 39.1 11.6 16.8 10.9 28.9 22.9 23.6 9.0 21.0 25.9 21.5 25.1 10.6 13.0 13.8 13.2 15.9 12.0 19.9 13.9 18.4 24.7 35.6 45.2 13.9 28.2 14.7 7.1 3.0 3.4 20.2 2.6 22.8 9.0 20.3 20.6 4.0 7.8 17.9 18.4 5.3 15.8 1.8 8.4 25.4 9.7 25.4 26.4 15.4 31.2 26.2 24.1 24.9 24.6 37.0 26.4 KIF3B "FLA8, KIAA0359, KLP-11" ENSG00000101350 "Kinesin family member 3B" O15066 20 32277664-32335011 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007119 Approved Uncertain "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA007119: AB_1852498" "unprognostic (1.74e-2)" "unprognostic (2.25e-1)" "unprognostic (5.14e-2)" "unprognostic (1.84e-1)" "unprognostic (2.73e-1)" "unprognostic (2.89e-1)" "unprognostic (1.49e-2)" "unprognostic (2.14e-1)" "unprognostic (9.01e-3)" "unprognostic (9.30e-2)" "unprognostic (1.41e-1)" "unprognostic (1.18e-1)" "prognostic favourable (1.44e-12)" "unprognostic (2.41e-2)" "unprognostic (2.68e-1)" "unprognostic (5.11e-2)" "unprognostic (4.42e-2)" 8.4 11.0 22.9 7.7 30.2 5.5 9.1 17.6 24.6 11.6 13.4 13.3 7.7 14.3 8.8 13.5 5.8 15.4 11.0 6.2 19.9 15.1 26.4 17.8 9.3 7.7 15.1 18.7 10.5 16.9 38.5 18.1 6.4 13.2 9.0 14.2 11.8 8.4 8.6 5.3 5.8 17.1 9.0 16.0 6.8 12.7 15.3 13.7 4.3 14.3 4.1 8.4 8.5 6.5 6.5 3.1 3.7 5.9 2.6 6.6 1.8 22.6 15.5 10.7 13.8 14.3 22.8 11.0 11.3 15.9 13.7 10.8 26.3 12.5 12.2 13.6 21.2 14.7 13.8 16.7 17.5 5.8 6.3 10.6 12.3 12.9 9.1 8.9 8.1 14.0 12.0 23.6 9.4 11.1 6.5 4.9 11.0 10.4 4.1 4.1 5.8 13.6 3.8 17.7 4.4 14.1 16.8 17.7 14.9 29.5 7.9 11.3 17.4 6.9 13.5 25.8 17.6 15.0 13.9 8.3 11.8 6.4 25.7 15.6 10.4 1.3 3.1 3.7 6.6 4.2 5.5 6.1 5.0 6.1 1.7 6.5 3.1 4.6 3.2 2.6 5.9 3.1 3.9 1.8 22.9 30.2 17.6 24.6 19.9 15.1 15.1 18.7 13.2 13.7 LDB2 "CLIM1, LDB1" ENSG00000169744 "LIM domain binding 2" O43679 4 16501541-16898809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 9.5;fHDF/TERT166: 9.6;HAP1: 17.6;HUVEC TERT2: 33.3;U-138 MG: 13.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7" "Cell type enriched" "Detected in single" 13 "NK-cell: 5.1" "Lineage enriched" "Detected in single" 13 "NK-cells: 5.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017544, HPA068634" Supported Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "CAB017544: AB_2137013, HPA068634: " "unprognostic (3.43e-1)" "unprognostic (2.77e-1)" "unprognostic (9.10e-2)" "unprognostic (4.37e-1)" "unprognostic (7.25e-2)" "unprognostic (4.62e-3)" "unprognostic (2.10e-3)" "unprognostic (1.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.96e-2)" "unprognostic (2.05e-3)" "unprognostic (1.26e-3)" "unprognostic (1.60e-1)" "unprognostic (9.63e-2)" "unprognostic (7.10e-3)" 27.9 9.5 14.5 4.6 30.3 0.4 26.8 1.1 45.3 27.1 6.8 2.7 8.0 4.0 54.9 14.4 9.5 15.6 18.3 18.5 16.6 4.8 14.9 15.0 31.3 6.9 5.5 21.7 11.9 4.6 15.2 5.6 33.7 3.4 10.4 5.4 15.4 6.1 8.6 7.5 5.4 6.8 32.8 4.2 32.9 6.7 6.4 3.4 0.7 17.8 7.5 3.0 14.7 13.3 0.2 0.0 0.3 0.0 5.1 0.0 0.6 0.0 0.0 9.5 0.0 5.5 9.1 0.0 5.2 4.0 0.6 1.4 0.0 0.0 0.0 0.0 9.6 0.0 17.6 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 5.1 0.0 6.5 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 4.4 0.0 0.0 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.7 13.4 0.0 0.6 0.0 4.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.1 0.0 0.0 0.0 0.6 14.5 30.3 1.1 45.3 16.6 4.8 5.5 21.7 3.4 3.4 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: " "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favourable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favourable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.5 5.1 7.7 12.8 8.2 9.2 16.2 15.4 19.7 9.6 8.3 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 8.2 14.7 14.3 11.1 11.6 8.9 12.3 3.4 18.3 7.6 6.1 10.7 10.2 11.4 15.1 6.9 5.8 13.1 17.6 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 LHX8 Lhx7 ENSG00000162624 "LIM homeobox 8" Q68G74 1 75128434-75161533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9" "Group enriched" "Detected in some" 6 "SCLC-21H: 23.3;U-266/70: 7.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "basal ganglia: 9.5;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "basal ganglia: 9.9" "Group enriched" "Detected in some" 32 "basal ganglia: 15.3;hypothalamus: 4.4" HPA071806 Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA071806: " "unprognostic (2.28e-2)" "unprognostic (6.23e-2)" "unprognostic (3.85e-3)" "unprognostic (1.52e-9)" "unprognostic (1.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.06e-2)" 0.0 0.0 0.1 0.0 9.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.8 0.0 2.1 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.3 0.0 3.9 0.0 0.2 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.3 0.0 0.5 4.9 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.2 0.0 0.0 7.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.5 0.0 1.1 0.0 0.6 0.0 3.3 LIN28A "CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1" ENSG00000131914 "Lin-28 homolog A" Q9H9Z2 1 26410778-26429722 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 9.8" "Cell line enriched" "Detected in some" 10 "NTERA-2: 137.5" "Cancer enriched" "Detected in single" 261 "testis cancer: 101.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "CAB020785, HPA063074, HPA068814" Enhanced Supported "Nucleoli,Cytosol,Rods & Rings" Cytosol "Nucleoli, Rods & Rings" "CAB020785: , HPA063074: , HPA068814: " "unprognostic (9.64e-3)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.40e-1)" "unprognostic (1.55e-1)" "unprognostic (1.17e-2)" "unprognostic (1.85e-1)" "unprognostic (2.21e-1)" "unprognostic (2.49e-2)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" 0.1 0.0 0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.5 0.5 0.1 0.1 0.1 0.2 0.3 9.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.6 2.3 0.5 1.0 0.8 0.1 0.0 0.0 13.5 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 137.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.5 0.7 0.7 0.3 0.4 1.0 0.5 0.6 0.2 1.3 0.8 0.7 2.2 1.0 0.3 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 51.9" "Cell line enhanced" "Detected in some" "AF22: 13.9;BEWO: 71.7;K-562: 23.2;NTERA-2: 12.6" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 1.2 0.0 0.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.1 0.1 0.1 0.5 0.8 0.0 0.0 0.0 1.0 51.9 1.2 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 5.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.7 2.1 0.4 0.2 0.5 0.3 0.0 0.9 13.9 2.8 0.0 0.0 71.7 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 6.7 9.9 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.3 0.0 0.0 1.4 1.6 12.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 1.1 0.0 2.9 0.3 0.0 1.5 0.0 0.0 4.2 5.9 0.0 0.0 0.0 0.0 1.6 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.1 0.2 2.1 0.2 0.4 0.7 0.2 0.3 1.2 0.8 0.1 1.3 0.9 1.3 0.5 0.8 1.2 0.4 LRCH1 "CHDC1, KIAA1016" ENSG00000136141 "Leucine rich repeats and calponin homology domain containing 1" Q9Y2L9 13 46553168-46753040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 46.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021536 Approved Approved "Nucleoli,Actin filaments,Cytosol" "Actin filaments, Cytosol" Nucleoli "HPA021536: AB_1853258" "unprognostic (7.13e-3)" "prognostic unfavourable (6.24e-4)" "unprognostic (3.59e-2)" "unprognostic (8.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.37e-1)" "unprognostic (5.16e-2)" "prognostic unfavourable (6.67e-4)" "unprognostic (2.16e-1)" "prognostic unfavourable (5.75e-4)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "prognostic favourable (1.04e-4)" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-1)" "unprognostic (1.98e-2)" 17.9 5.0 6.5 20.3 5.9 7.2 15.2 46.4 7.2 17.5 14.6 4.6 11.5 7.0 24.6 9.8 10.6 11.9 14.1 8.0 6.3 5.9 13.8 10.9 14.3 13.5 6.6 4.9 9.5 5.1 5.2 13.1 24.1 8.0 12.8 9.3 8.4 11.3 14.5 5.3 18.1 12.0 20.9 8.5 13.7 14.6 5.0 6.0 31.7 7.8 6.4 13.7 16.6 18.3 6.2 2.3 1.8 2.0 5.1 3.6 1.8 4.6 6.7 6.1 6.3 4.5 8.6 15.7 8.0 10.5 10.0 9.5 15.1 8.0 15.0 2.2 7.5 6.8 4.6 8.1 14.5 15.4 4.3 13.4 2.7 7.0 5.6 8.7 23.0 5.4 6.4 9.2 11.3 8.6 2.6 4.5 7.3 9.0 9.3 10.9 3.4 3.6 5.1 6.6 4.0 18.6 4.9 9.7 9.7 4.5 4.5 12.0 3.4 11.7 8.1 5.9 4.0 7.3 7.6 0.8 2.3 6.7 6.9 7.6 7.1 1.5 2.0 1.8 3.6 1.6 2.1 5.3 2.7 2.6 1.9 6.2 2.1 2.1 0.7 5.1 1.2 2.3 1.9 1.8 6.5 5.9 46.4 7.2 6.3 5.9 6.6 4.9 8.0 6.0 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell line enhanced" "Detected in many" "AF22: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.6 17.3 5.2 10.8 2.9 4.0 0.7 1.5 2.3 2.6 2.2 0.0 0.0 1.1 8.9 3.1 9.6 5.9 1.8 0.0 8.1 0.8 3.0 5.3 2.3 0.1 1.5 3.7 3.4 3.6 0.9 2.0 0.7 0.0 1.3 0.6 0.1 0.2 9.4 0.7 1.2 5.9 0.0 0.2 2.2 0.0 11.4 0.9 0.0 2.8 0.2 0.4 0.1 4.7 2.9 5.3 1.6 0.0 0.0 0.3 3.5 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 LRRC75A "C17orf76, FAM211A, FLJ35696" ENSG00000181350 "Leucine rich repeat containing 75A" Q8NAA5 17 16441577-16492153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 42.3" "Cell line enhanced" "Detected in some" "HEL: 11.8;HUVEC TERT2: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028528, HPA065840" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA028528: AB_10600755, HPA065840: " "unprognostic (1.09e-1)" "unprognostic (5.60e-2)" "unprognostic (5.79e-2)" "unprognostic (3.85e-5)" "unprognostic (3.93e-2)" "unprognostic (3.23e-2)" "unprognostic (3.44e-1)" "unprognostic (7.66e-3)" "unprognostic (7.74e-2)" "unprognostic (2.84e-1)" "prognostic favourable (7.46e-5)" "unprognostic (8.36e-2)" "unprognostic (4.28e-3)" "unprognostic (8.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-3)" "unprognostic (2.06e-1)" 1.0 8.9 5.2 2.8 3.7 1.7 0.6 0.7 6.3 2.2 26.3 1.5 1.4 15.0 1.9 0.5 0.4 0.9 0.5 0.4 4.1 2.4 0.8 0.2 1.6 1.9 1.6 3.2 1.8 1.6 3.7 4.1 1.5 2.1 1.1 10.4 1.9 0.3 1.7 0.4 0.4 42.3 3.0 0.8 6.4 1.3 8.5 0.4 0.5 1.2 0.0 1.9 1.3 0.7 0.8 0.0 0.3 0.6 0.3 0.6 0.2 1.1 1.0 1.2 0.8 0.3 0.5 0.1 0.3 0.8 2.7 2.2 1.1 0.3 0.0 0.8 0.1 0.4 0.3 0.2 0.1 0.4 0.9 11.8 0.6 0.0 0.4 0.2 0.9 0.0 0.0 0.6 0.0 3.8 0.5 0.2 0.0 1.9 1.9 0.8 0.2 0.1 0.6 0.7 0.1 0.5 0.2 2.3 0.6 0.0 0.2 2.8 0.2 0.1 0.0 0.3 1.4 0.9 1.5 1.5 0.3 0.2 0.1 0.7 1.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.6 0.3 0.3 0.6 0.0 0.0 0.2 5.2 3.7 0.7 6.3 4.1 2.4 1.6 3.2 2.1 0.4 LRWD1 "CENP-33, DKFZp434K1815, ORCA" ENSG00000161036 "Leucine rich repeats and WD repeat domain containing 1" Q9UFC0 7 102464929-102473168 "Predicted intracellular proteins" "DNA replication" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "testis: 129.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021320 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA021320: AB_1853372" "unprognostic (1.50e-1)" "unprognostic (1.25e-1)" "unprognostic (1.31e-2)" "unprognostic (7.66e-3)" "unprognostic (1.60e-2)" "unprognostic (2.08e-3)" "unprognostic (1.72e-3)" "unprognostic (4.97e-2)" "unprognostic (3.34e-1)" "unprognostic (3.04e-2)" "prognostic favourable (8.71e-5)" "unprognostic (1.00e-1)" "prognostic unfavourable (1.25e-4)" "unprognostic (1.46e-2)" "unprognostic (4.14e-2)" "unprognostic (7.82e-2)" "unprognostic (9.20e-2)" 2.7 4.6 3.6 3.8 5.0 7.6 1.9 7.9 5.8 2.5 2.5 3.4 3.4 2.9 2.8 2.8 2.1 7.1 2.5 2.6 4.3 4.0 4.0 5.1 2.6 4.4 3.4 3.7 3.1 3.4 3.4 4.9 2.0 4.2 2.2 1.6 1.7 3.3 4.0 3.6 2.2 4.3 2.7 2.4 6.6 3.3 129.9 3.8 3.9 2.7 1.6 4.2 2.3 1.8 12.6 9.8 9.2 4.0 9.9 10.4 5.8 7.3 10.2 5.5 15.5 4.2 3.2 8.6 7.8 5.1 13.3 9.2 9.7 4.3 18.1 11.2 5.9 7.8 8.1 7.0 4.0 6.3 15.7 3.7 4.6 6.0 5.6 6.9 7.3 3.0 4.3 15.4 3.3 7.0 17.5 5.6 7.2 22.1 21.0 16.7 11.7 14.7 11.1 5.1 19.5 4.0 4.6 7.3 20.7 8.6 8.2 7.6 4.7 5.8 4.1 7.4 15.8 22.8 12.4 20.6 35.5 17.3 8.2 6.5 12.8 9.1 2.5 9.2 10.4 4.0 9.9 11.1 9.1 9.1 2.8 12.6 5.8 7.4 5.9 9.9 3.5 9.8 9.0 5.8 3.6 5.0 7.9 5.8 4.3 4.0 3.4 3.7 4.2 3.8 MAD2L1BP "CMT2, dJ261G23.1, KIAA0110" ENSG00000124688 "MAD2L1 binding protein" Q15013 6 43629540-43640952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028729 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA028729: " "unprognostic (2.60e-1)" "unprognostic (2.06e-1)" "unprognostic (3.92e-2)" "unprognostic (6.97e-2)" "unprognostic (6.91e-2)" "unprognostic (6.92e-2)" "unprognostic (5.74e-3)" "unprognostic (2.67e-3)" "unprognostic (3.60e-1)" "unprognostic (7.18e-2)" "unprognostic (1.71e-1)" "unprognostic (6.64e-2)" "unprognostic (4.61e-2)" "unprognostic (1.18e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-1)" "unprognostic (3.25e-3)" 12.1 16.6 11.0 13.3 14.4 35.7 13.8 16.5 24.4 12.2 21.3 10.1 6.3 18.1 12.9 14.1 17.0 13.4 13.2 19.2 11.9 12.1 18.3 18.9 11.4 18.2 11.0 12.6 11.3 18.5 11.5 12.8 12.6 14.0 12.6 22.0 13.6 24.2 11.3 25.1 11.9 22.0 12.4 9.8 17.5 16.8 17.6 7.9 29.0 18.9 13.9 19.9 14.3 13.2 27.9 27.6 39.7 22.2 26.8 39.8 21.4 19.1 8.9 14.0 15.5 12.2 13.3 8.5 11.5 18.7 25.6 24.0 18.1 7.8 14.9 6.6 13.5 12.6 21.7 16.0 19.8 13.7 16.9 18.4 9.8 15.5 13.2 10.8 11.2 13.4 19.7 19.0 11.7 19.1 23.6 8.1 17.7 18.0 9.6 20.1 8.6 11.5 11.2 10.9 14.1 18.2 15.4 16.7 16.9 8.3 12.8 54.2 15.0 28.9 10.4 13.7 11.5 9.0 18.3 10.4 8.8 35.0 12.5 18.3 15.0 39.7 22.2 25.0 25.7 22.1 25.8 27.9 30.8 28.4 27.6 25.6 32.3 29.0 18.6 26.8 19.9 18.3 39.8 21.4 11.0 14.4 16.5 24.4 11.9 12.1 11.0 12.6 14.0 7.9 MAF1 DKFZp586G1123 ENSG00000179632 "MAF1 homolog, negative regulator of RNA polymerase III" Q9H063 8 144104499-144107611 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024821, HPA058548" Uncertain Supported Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA024821: , HPA058548: " "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.71e-2)" "unprognostic (2.21e-1)" "unprognostic (8.51e-2)" "unprognostic (9.67e-2)" "prognostic unfavourable (7.09e-4)" "unprognostic (6.12e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-3)" "unprognostic (9.42e-2)" "unprognostic (6.48e-2)" "unprognostic (9.40e-3)" "unprognostic (9.02e-2)" "unprognostic (2.59e-1)" "unprognostic (2.38e-1)" "unprognostic (3.99e-2)" 26.8 23.2 17.5 18.4 17.5 43.6 35.7 20.5 26.3 27.3 47.2 23.7 22.8 19.5 33.0 22.5 34.4 26.1 33.6 72.5 17.3 15.5 24.1 21.4 21.2 28.2 19.7 18.6 36.3 39.8 25.2 20.8 23.8 14.9 36.8 18.9 23.8 28.7 32.3 114.3 18.7 29.8 50.9 17.2 27.7 28.9 30.2 16.2 35.5 40.4 38.7 22.8 35.2 46.7 48.0 39.9 45.1 34.5 33.2 46.2 32.6 23.9 38.6 17.9 17.9 49.1 24.5 14.6 18.9 31.3 29.6 30.2 14.1 26.7 26.7 32.2 31.6 14.8 24.3 26.7 21.8 23.5 29.4 29.1 26.6 22.1 33.1 12.3 20.0 21.6 31.4 23.7 44.7 31.8 22.5 18.2 17.6 57.2 46.0 22.8 13.4 103.8 18.4 25.1 28.4 18.5 18.1 26.2 21.8 25.1 32.7 30.5 22.2 19.0 19.1 13.8 31.6 24.3 23.7 22.0 16.7 12.5 22.9 23.1 9.1 15.8 34.5 45.1 28.5 26.8 32.3 40.1 41.0 46.2 39.9 48.0 44.2 41.4 19.9 33.2 27.0 29.8 29.2 32.6 17.5 17.5 20.5 26.3 17.3 15.5 19.7 18.6 14.9 16.2 MAGED2 "11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386" ENSG00000102316 "MAGE family member D2" Q9UNF1 X 54807599-54816012 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Tumor antigen" "Bartter syndrome, Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031572, HPA031573" Supported Enhanced Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA031572: AB_10599819, HPA031573: AB_10602181" "unprognostic (1.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.32e-1)" "unprognostic (1.69e-3)" "unprognostic (4.79e-2)" "unprognostic (3.52e-1)" "unprognostic (2.41e-3)" "unprognostic (1.39e-1)" "unprognostic (2.97e-1)" "prognostic favourable (2.88e-4)" "prognostic favourable (2.82e-4)" "unprognostic (6.34e-2)" "unprognostic (3.55e-3)" "prognostic unfavourable (9.43e-4)" "unprognostic (1.58e-1)" "unprognostic (9.77e-2)" "unprognostic (3.58e-1)" 22.1 38.4 26.9 14.8 26.5 8.2 50.2 24.4 43.0 55.7 27.3 27.8 21.4 16.2 41.1 31.8 21.9 45.9 28.5 40.7 23.8 38.2 42.7 17.3 24.0 13.5 30.3 36.0 79.7 23.5 34.5 57.6 58.6 57.1 63.9 16.4 43.1 32.0 53.7 25.6 16.5 17.6 41.6 24.7 17.5 22.5 21.8 18.3 23.4 45.1 17.3 22.0 31.9 29.2 17.1 11.7 43.1 37.0 28.5 35.5 32.5 5.5 10.3 61.7 18.8 29.4 40.0 11.4 23.1 41.2 18.3 32.6 10.2 14.2 7.7 60.6 46.4 7.6 17.5 17.4 13.2 13.8 14.5 16.1 12.2 20.0 25.2 4.1 12.4 52.4 7.3 18.6 9.4 34.8 3.9 9.5 35.0 15.4 9.1 6.9 22.8 12.3 6.1 22.1 11.0 25.1 4.2 9.7 25.1 9.2 10.7 53.4 44.0 7.0 29.9 15.6 24.4 23.3 6.5 6.1 5.1 5.6 22.8 10.8 79.7 43.1 9.1 35.5 35.5 22.4 27.3 16.3 29.4 33.1 11.7 17.1 29.7 34.1 3.4 28.5 37.0 7.2 29.2 32.5 26.9 26.5 24.4 43.0 23.8 38.2 30.3 36.0 57.1 18.3 MAPK13 "p38delta, PRKM13, SAPK4" ENSG00000156711 "Mitogen-activated protein kinase 13" O15264 6 36127809-36144524 "Enzymes, Predicted intracellular proteins" "Cell cycle, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 45.7;RPMI-8226: 27.6;RT4: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 16.5;T-cells: 27.8" "Region enhanced" "Detected in some" "cerebellum: 6.5" "Region enriched" "Detected in some" 15 "cerebellum: 59.9" "HPA007667, CAB025854" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "CAB025854: , HPA007667: AB_1079867" "unprognostic (6.36e-2)" "unprognostic (6.88e-2)" "unprognostic (2.93e-1)" "unprognostic (6.64e-3)" "unprognostic (1.13e-2)" "unprognostic (4.80e-2)" "unprognostic (4.30e-3)" "unprognostic (5.28e-2)" "unprognostic (1.77e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-1)" "unprognostic (7.21e-2)" "prognostic favourable (9.00e-4)" "unprognostic (3.12e-2)" "unprognostic (1.70e-1)" "unprognostic (2.21e-2)" "unprognostic (1.41e-1)" 6.5 22.0 2.2 5.4 4.0 2.9 6.8 2.8 7.3 6.8 18.9 0.5 36.8 18.8 1.9 10.3 41.1 2.4 12.0 1.2 1.7 1.8 6.5 2.8 9.6 11.2 0.8 3.8 3.9 24.6 18.8 12.4 10.5 2.5 6.8 16.0 2.4 20.7 26.3 0.9 28.6 37.7 2.1 0.8 5.9 12.2 23.7 1.1 5.0 13.8 16.0 18.5 7.3 13.9 16.5 0.1 5.2 0.3 2.8 27.8 6.7 19.3 0.1 0.3 0.2 1.1 5.6 2.7 1.5 0.2 0.2 0.5 16.2 19.1 4.6 1.2 1.5 15.1 0.0 45.7 0.4 11.8 5.1 0.1 0.5 16.0 1.9 0.1 1.2 4.8 16.2 2.9 0.6 3.0 0.3 5.2 0.5 10.2 0.1 1.2 0.1 0.3 11.4 0.2 27.6 8.8 28.6 19.3 0.3 1.7 0.3 0.1 21.7 2.5 4.0 1.4 0.2 0.5 0.3 0.3 6.9 1.4 0.0 0.5 0.1 5.2 0.3 4.5 16.2 0.0 10.5 10.8 11.6 13.0 0.1 16.5 10.6 11.9 3.9 2.8 0.0 0.0 27.8 6.7 2.2 4.0 2.8 7.3 1.7 1.8 0.8 3.8 2.5 1.1 MBIP ENSG00000151332 "MAP3K12 binding inhibitory protein 1" Q9NS73 14 36298558-36320676 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003388 Supported Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA003388: AB_1079322" "unprognostic (8.79e-2)" "unprognostic (9.92e-2)" "unprognostic (5.07e-2)" "unprognostic (8.66e-2)" "unprognostic (9.85e-2)" "unprognostic (4.71e-2)" "unprognostic (2.71e-1)" "prognostic favourable (1.52e-4)" "unprognostic (5.24e-2)" "prognostic favourable (1.14e-4)" "unprognostic (4.65e-1)" "unprognostic (9.27e-2)" "prognostic favourable (1.25e-4)" "unprognostic (2.95e-1)" "unprognostic (1.12e-1)" "unprognostic (1.74e-3)" "unprognostic (1.09e-1)" 10.4 11.7 11.4 5.7 17.0 15.4 12.9 16.4 14.9 15.4 12.2 11.5 3.6 8.6 14.0 11.3 14.0 9.1 8.6 7.2 10.7 13.0 19.5 15.0 46.2 8.1 9.9 8.9 20.0 9.0 10.4 25.1 9.8 13.3 13.8 11.7 10.1 7.7 8.9 6.0 14.3 13.2 11.0 13.6 9.8 19.0 8.8 11.8 14.4 61.2 4.0 7.9 12.4 9.3 12.0 10.4 5.1 9.3 8.3 17.9 9.6 16.5 8.7 18.5 18.6 18.6 18.0 14.0 14.2 17.7 18.8 19.8 17.7 16.6 15.7 21.7 18.2 12.6 19.4 13.1 23.2 22.6 14.6 9.2 8.6 30.0 20.3 18.7 10.2 18.4 20.2 12.2 15.9 11.7 15.6 19.6 13.8 15.9 17.9 15.2 15.6 25.8 8.6 16.2 10.9 21.2 12.8 27.7 11.0 11.6 11.3 18.7 18.4 12.2 9.1 21.0 13.7 15.3 14.6 16.3 18.7 24.5 8.0 9.6 14.5 1.4 9.3 2.0 11.2 6.8 14.1 12.0 13.7 13.8 9.2 8.7 17.9 14.5 5.1 8.3 5.3 10.4 16.1 9.6 11.4 17.0 16.4 14.9 10.7 13.0 9.9 8.9 13.3 11.8 MED21 "SRB7, SURB7" ENSG00000152944 "Mediator complex subunit 21" Q13503 12 27022546-27066343 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017177 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA017177: AB_1857665" "unprognostic (3.02e-1)" "unprognostic (7.33e-2)" "unprognostic (2.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.39e-1)" "unprognostic (2.10e-1)" "unprognostic (7.18e-3)" "unprognostic (1.01e-1)" "unprognostic (4.78e-3)" "unprognostic (7.32e-2)" "unprognostic (1.03e-2)" "unprognostic (1.54e-1)" "prognostic favourable (3.74e-8)" "unprognostic (3.18e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-2)" "unprognostic (1.42e-2)" 20.7 31.5 20.7 13.3 32.4 31.9 23.9 25.9 31.9 24.8 21.9 18.0 18.8 14.9 25.9 21.7 30.4 20.8 19.6 31.3 19.5 21.9 34.1 18.8 20.8 15.7 21.1 26.2 30.8 17.1 30.3 26.0 19.8 23.6 27.6 20.6 18.3 25.3 24.5 30.7 19.3 17.4 27.3 20.2 16.0 19.6 28.9 22.1 22.1 28.2 28.7 19.9 31.6 27.2 20.1 15.8 35.5 18.6 12.8 28.0 19.1 16.8 17.7 9.4 14.9 20.9 21.2 15.6 19.2 14.4 16.2 21.2 18.6 19.1 11.1 12.2 14.7 13.9 20.0 17.8 28.0 9.7 17.8 16.0 18.4 11.4 11.7 19.5 11.5 14.9 26.0 20.1 24.1 23.5 12.9 14.9 18.3 12.6 17.0 35.9 28.8 23.4 14.7 60.2 12.5 16.9 19.3 7.1 10.5 23.4 10.1 15.1 17.8 13.0 17.0 18.1 14.1 22.5 19.3 4.6 9.4 18.2 17.3 21.7 12.2 35.5 17.5 23.9 20.4 18.6 20.8 20.1 24.6 23.9 15.8 16.6 28.0 25.3 14.0 12.8 16.5 12.9 23.8 19.1 20.7 32.4 25.9 31.9 19.5 21.9 21.1 26.2 23.6 22.1 MED27 "CRSP34, CRSP8, MED3, TRAP37" ENSG00000160563 "Mediator complex subunit 27" Q6P2C8 9 131860107-132079908 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007002 Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA007002: AB_1078574" "unprognostic (8.81e-2)" "prognostic favourable (1.59e-4)" "unprognostic (2.42e-2)" "unprognostic (2.21e-2)" "unprognostic (9.57e-2)" "unprognostic (1.32e-2)" "unprognostic (1.55e-2)" "unprognostic (6.07e-2)" "unprognostic (6.63e-3)" "unprognostic (1.63e-1)" "unprognostic (8.59e-3)" "unprognostic (5.93e-2)" "unprognostic (7.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.19e-1)" "unprognostic (1.32e-1)" "unprognostic (4.60e-2)" 11.1 12.1 18.0 9.5 18.1 15.5 11.5 14.0 21.4 10.9 11.7 19.5 10.1 7.8 18.6 23.5 15.5 13.9 9.5 17.5 17.5 11.2 10.4 7.5 10.9 13.5 18.6 19.1 12.7 7.9 10.6 17.8 12.7 17.4 12.7 10.7 16.0 17.7 14.4 15.2 15.7 8.6 16.3 16.1 11.7 10.2 14.7 14.0 17.9 13.2 9.6 15.8 12.3 10.5 12.9 19.8 13.4 18.6 18.0 19.7 11.8 16.0 15.8 18.2 14.4 13.1 12.1 15.4 16.7 22.2 33.4 26.2 23.5 13.0 15.9 11.3 17.3 29.1 25.2 23.7 21.9 17.0 14.9 11.9 16.6 14.0 19.6 21.3 15.0 13.3 16.3 26.4 27.0 17.4 17.3 13.2 24.3 25.5 22.8 12.4 18.6 26.8 20.2 25.7 19.4 13.4 8.9 34.1 13.8 21.5 11.1 11.1 17.6 10.0 14.6 34.1 15.0 25.2 25.0 5.4 16.5 28.1 18.9 14.9 23.1 3.5 12.2 13.4 18.9 18.6 15.3 11.6 14.8 18.5 19.2 12.9 12.7 15.5 4.8 18.0 16.0 19.8 19.7 11.8 18.0 18.1 14.0 21.4 17.5 11.2 18.6 19.1 17.4 14.0 MIF4GD "AD023, MGC45027, MIFD, SLIP1" ENSG00000125457 "MIF4G domain containing" A9UHW6 17 75266228-75271227 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 67.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051222 Approved Supported "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "HPA051222: " "unprognostic (1.05e-1)" "unprognostic (9.17e-2)" "unprognostic (1.94e-2)" "unprognostic (3.82e-3)" "unprognostic (2.92e-1)" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-1)" "unprognostic (8.15e-2)" "prognostic favourable (2.70e-4)" "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (9.88e-2)" "unprognostic (2.29e-1)" "unprognostic (7.12e-2)" "unprognostic (7.31e-2)" 19.0 13.9 10.4 14.5 11.1 30.5 13.3 7.4 14.6 11.9 12.9 20.8 14.2 10.3 16.8 12.8 18.3 13.9 20.4 20.4 10.2 8.2 16.0 15.1 15.1 30.4 12.0 9.9 12.2 16.2 18.2 7.4 15.9 12.0 12.0 11.7 15.5 15.4 11.5 34.4 18.6 14.1 20.4 15.4 22.0 11.7 12.6 10.9 21.8 15.0 20.7 20.9 16.6 12.2 14.1 67.0 11.3 21.5 14.5 17.5 14.4 11.8 21.0 4.7 10.9 7.6 2.2 6.7 3.0 8.6 6.1 4.2 7.4 13.4 18.5 5.5 4.8 9.5 5.7 10.6 4.6 9.1 14.4 9.1 9.1 6.5 8.4 8.0 10.7 2.1 16.7 4.2 17.4 12.6 12.0 22.6 1.6 23.1 25.5 19.1 2.1 10.3 16.6 6.0 25.2 12.3 6.5 7.0 10.3 6.2 16.4 15.2 30.3 18.7 4.8 3.1 7.6 3.9 6.1 33.1 8.5 15.6 5.8 14.2 4.1 5.7 21.5 11.3 15.4 11.0 16.2 14.1 12.5 13.7 25.4 13.0 11.4 12.0 3.8 14.5 13.1 67.0 17.5 14.4 10.4 11.1 7.4 14.6 10.2 8.2 12.0 9.9 12.0 10.9 MNX1 "HB9, HLXB9, HOXHB9, SCRA1" ENSG00000130675 "Motor neuron and pancreas homeobox 1" P50219 7 156994051-157010651 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "pancreas: 43.3" "Cell line enhanced" "Detected in many" "AN3-CA: 11.5;EFO-21: 11.1;HEK 293: 8.8;RPMI-8226: 24.2;SCLC-21H: 13.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA071717 Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA071717: " "unprognostic (2.01e-1)" "unprognostic (1.21e-1)" "unprognostic (1.87e-2)" "unprognostic (3.72e-3)" "unprognostic (8.85e-2)" "unprognostic (1.08e-2)" "unprognostic (2.07e-1)" "unprognostic (4.07e-2)" "unprognostic (5.06e-2)" "unprognostic (8.62e-4)" "unprognostic (1.00e-2)" "unprognostic (3.35e-2)" "unprognostic (2.23e-5)" "unprognostic (1.67e-3)" "unprognostic (5.80e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" 0.1 0.0 0.1 0.4 0.2 0.0 0.1 0.2 0.1 0.1 6.0 0.2 0.1 9.0 0.1 0.1 0.3 0.0 7.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 43.3 0.0 3.2 0.1 0.2 0.8 3.7 0.1 1.9 0.1 0.1 0.1 7.3 0.1 0.2 0.1 2.7 1.0 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 3.8 0.0 11.5 0.0 0.0 8.6 0.0 0.0 0.1 0.0 5.0 1.6 0.9 11.1 0.0 0.2 2.0 1.5 0.9 1.4 8.8 0.0 0.7 2.3 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 3.6 1.9 0.0 6.4 0.6 0.1 0.0 0.7 0.0 1.7 24.2 4.3 0.4 13.0 0.0 1.6 1.4 0.2 3.6 2.9 0.0 0.0 0.0 0.0 0.0 3.6 1.8 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 MOB1A "C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B" ENSG00000114978 "MOB kinase activator 1A" Q9H8S9 2 74152528-74178898 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA047088: , HPA071690: " "unprognostic (5.32e-2)" "unprognostic (2.45e-1)" "unprognostic (5.38e-2)" "unprognostic (2.62e-1)" "unprognostic (2.19e-1)" "unprognostic (8.19e-2)" "prognostic unfavourable (3.34e-4)" "unprognostic (9.36e-2)" "unprognostic (3.91e-2)" "unprognostic (1.13e-1)" "unprognostic (2.05e-3)" "unprognostic (1.04e-1)" "unprognostic (2.20e-3)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (1.10e-1)" "unprognostic (5.11e-3)" 32.2 18.0 12.2 41.5 16.3 36.6 36.2 10.8 11.3 24.5 21.5 12.6 16.1 19.7 27.1 19.8 28.9 22.0 19.9 20.9 11.0 10.4 34.7 21.4 28.4 65.1 14.7 6.9 28.4 12.6 13.8 11.5 20.9 15.9 21.0 20.7 14.3 18.1 18.8 12.8 22.9 30.2 31.6 21.8 51.1 18.7 17.9 12.8 57.0 25.4 16.9 42.4 29.2 24.6 22.3 22.2 32.3 42.8 20.6 15.9 25.2 20.7 11.9 15.0 16.1 24.7 27.0 17.7 16.7 22.5 21.8 21.6 16.2 15.1 42.6 14.3 20.9 17.4 19.1 19.1 33.2 29.9 11.4 38.4 8.2 17.1 19.7 33.2 62.1 22.8 18.7 17.4 14.8 22.8 16.4 15.8 21.1 11.2 41.6 28.3 13.9 9.8 28.7 51.5 22.6 18.7 26.0 7.6 9.9 23.7 17.6 15.2 14.0 15.8 21.6 28.4 15.0 19.8 26.4 11.8 10.4 32.7 19.1 28.4 15.1 30.8 24.0 32.3 14.8 39.0 15.9 22.3 13.3 15.7 22.2 17.2 12.3 14.6 24.0 20.6 42.8 15.5 13.4 25.2 12.2 16.3 10.8 11.3 11.0 10.4 14.7 6.9 15.9 12.8 MOB1B "MOB4A, MOBKL1A" ENSG00000173542 "MOB kinase activator 1B" Q7L9L4 4 70902326-71022449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047088, HPA071690" Supported Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA047088: , HPA071690: " "unprognostic (1.05e-1)" "unprognostic (1.48e-2)" "unprognostic (1.84e-1)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavourable (4.92e-4)" "unprognostic (2.94e-1)" "unprognostic (1.36e-1)" "unprognostic (3.45e-1)" "unprognostic (1.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.09e-3)" "unprognostic (2.70e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-3)" 9.8 10.1 15.7 17.8 13.0 30.9 11.1 10.4 20.0 10.5 9.7 17.3 4.8 6.1 13.9 8.6 9.9 11.8 9.1 11.1 19.8 10.6 29.3 8.3 20.6 13.4 15.5 18.6 13.8 11.0 18.0 10.9 11.2 12.8 12.7 8.5 8.0 11.1 8.6 10.8 11.2 8.4 14.1 17.4 10.6 10.1 7.6 15.4 52.3 14.4 8.2 12.8 10.8 9.8 0.6 5.3 2.5 3.1 0.7 1.4 1.2 3.8 3.1 11.9 9.7 6.5 8.3 9.8 11.7 6.4 6.6 5.8 4.1 7.4 21.6 5.6 10.4 2.7 7.4 9.8 16.0 11.4 2.6 33.8 3.6 3.2 6.5 7.3 6.8 6.8 5.4 7.3 6.0 7.7 20.7 7.1 10.4 4.1 22.8 4.6 3.9 4.2 7.3 11.6 2.9 10.9 6.8 4.2 8.0 5.0 2.2 15.7 5.3 4.8 9.2 18.3 9.4 8.2 4.7 4.6 1.5 9.2 6.4 5.4 8.4 0.8 3.1 2.5 1.3 1.6 1.1 0.5 0.6 0.6 4.0 0.6 0.8 0.7 0.4 0.7 0.9 5.3 1.4 1.2 15.7 13.0 10.4 20.0 19.8 10.6 15.5 18.6 12.8 15.4 MOB2 HCCA2 ENSG00000182208 "MOB kinase activator 2" Q70IA6 11 1469457-1501247 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "smooth muscle: 57.3;urinary bladder: 51.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046313 Uncertain Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA046313: AB_10959882" "unprognostic (5.02e-1)" "unprognostic (5.71e-2)" "unprognostic (6.24e-3)" "unprognostic (4.42e-3)" "prognostic unfavourable (4.64e-4)" "unprognostic (8.30e-2)" "unprognostic (1.06e-3)" "unprognostic (3.06e-2)" "unprognostic (1.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.30e-2)" "unprognostic (2.87e-1)" "prognostic favourable (2.02e-4)" "unprognostic (2.67e-1)" "unprognostic (8.56e-2)" "unprognostic (9.78e-2)" "unprognostic (1.15e-1)" 9.2 4.2 2.4 17.0 2.5 3.0 12.1 2.5 3.2 14.9 30.9 1.8 6.7 2.5 12.5 8.7 17.3 13.8 26.8 8.1 2.8 1.9 3.2 3.0 4.1 8.2 2.1 2.1 8.6 5.8 6.8 1.8 4.2 2.9 21.2 6.7 4.3 12.9 20.1 7.1 9.4 10.6 57.3 2.5 3.7 9.9 4.2 2.0 2.0 4.3 3.2 4.4 51.8 21.2 10.6 10.8 11.2 12.5 11.6 17.3 9.0 13.9 15.2 9.4 7.6 23.6 16.6 8.7 11.0 16.1 21.3 16.8 9.7 19.2 10.3 8.5 25.9 17.1 14.6 24.8 13.0 13.8 21.8 7.8 5.5 12.3 15.9 10.2 12.3 13.4 29.8 11.3 13.4 22.5 12.6 10.7 10.8 9.9 13.2 17.4 11.6 14.2 9.6 9.7 10.7 17.7 13.4 17.6 18.8 13.7 17.2 13.3 7.9 10.3 18.5 13.0 6.6 4.2 7.0 10.6 10.3 10.7 9.0 9.9 9.9 8.2 8.6 11.2 17.3 8.7 14.6 8.2 14.9 13.8 10.8 10.6 12.5 10.5 7.1 11.6 12.5 6.9 12.8 9.0 2.4 2.5 2.5 2.5 2.8 1.9 2.1 2.1 2.9 2.0 MPPED2 "239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638" ENSG00000066382 "Metallophosphoesterase domain containing 2" Q15777 11 30384493-30586872 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 31.0;thyroid gland: 30.0" "Cell line enhanced" "Detected in some" "HaCaT: 19.4;HAP1: 11.5;RT4: 8.1;SH-SY5Y: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062575 Approved Nucleoli,Vesicles,Mitochondria Nucleoli "Vesicles, Mitochondria" "HPA062575: " "unprognostic (9.60e-3)" "unprognostic (6.12e-3)" "unprognostic (3.70e-3)" "unprognostic (4.56e-2)" "unprognostic (5.46e-2)" "unprognostic (5.04e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-2)" "unprognostic (1.13e-1)" "unprognostic (7.98e-4)" "unprognostic (6.82e-2)" "unprognostic (2.47e-7)" "unprognostic (3.64e-3)" "unprognostic (2.50e-1)" "unprognostic (2.22e-2)" "unprognostic (2.57e-2)" 2.9 7.0 6.3 1.7 19.3 1.1 5.5 4.6 8.9 31.0 4.2 1.8 4.4 1.5 8.3 7.9 1.6 11.1 1.9 4.6 8.5 9.7 12.2 1.2 1.1 0.9 7.0 6.7 1.2 2.5 5.0 10.7 2.5 11.2 15.6 1.4 7.1 12.1 10.1 5.7 1.0 1.4 5.1 4.6 3.1 1.9 3.8 3.4 9.1 30.0 1.2 1.0 4.7 4.9 1.3 0.7 0.3 0.2 2.0 4.8 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 11.5 0.0 0.0 0.0 2.1 0.0 0.2 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 3.2 0.0 0.0 3.1 0.2 0.0 8.1 0.1 6.1 0.0 0.0 3.1 1.8 0.0 0.1 0.0 1.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.9 0.0 4.8 0.0 0.0 0.6 0.4 1.3 1.3 0.2 0.2 2.0 0.0 0.7 0.1 0.2 6.3 19.3 4.6 8.8 8.5 9.7 7.0 6.7 11.2 3.4 MRTO4 "C1orf33, dJ657E11.4, MRT4" ENSG00000053372 "MRT4 homolog, ribosome maturation factor" Q9UKD2 1 19251539-19260128 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026446 Approved Approved "Nucleoplasm,Nuclear membrane,Nucleoli" "Nucleoplasm, Nuclear membrane" Nucleoli "HPA026446: AB_10601441" "unprognostic (3.99e-1)" "unprognostic (1.75e-1)" "unprognostic (2.18e-2)" "unprognostic (2.94e-1)" "unprognostic (4.12e-1)" "unprognostic (4.22e-2)" "prognostic unfavourable (1.56e-8)" "unprognostic (7.46e-2)" "unprognostic (5.58e-2)" "unprognostic (2.61e-2)" "unprognostic (2.69e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (4.11e-8)" "unprognostic (5.87e-2)" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (3.23e-2)" 17.2 16.5 20.4 16.9 18.5 12.0 21.6 10.7 21.7 12.1 13.8 12.4 10.2 17.5 15.6 15.2 21.6 18.8 11.8 11.7 19.1 15.9 13.6 23.7 10.5 23.0 16.1 19.1 18.7 41.2 10.2 8.8 12.5 15.1 12.2 17.6 10.6 13.2 11.9 22.8 15.3 19.3 17.3 10.0 14.5 13.7 21.6 11.6 14.5 12.9 29.3 22.7 11.4 12.4 14.7 12.8 1.0 8.2 10.6 15.7 7.2 24.1 17.2 14.2 18.6 6.9 11.1 12.6 18.9 10.7 32.5 21.4 24.8 25.1 35.7 15.9 15.6 19.2 39.4 28.5 32.8 12.7 30.1 26.4 15.4 21.2 8.8 34.8 11.1 9.7 18.9 36.6 19.0 18.2 39.9 11.6 19.2 17.7 28.3 25.2 18.2 26.2 26.6 17.4 27.6 17.6 8.3 23.0 16.8 14.5 20.0 20.0 14.2 20.5 11.9 17.8 22.0 27.2 32.2 9.4 16.4 47.1 17.3 44.8 28.3 0.7 7.5 0.7 7.9 8.2 15.7 14.7 9.6 10.8 11.4 13.1 13.0 11.6 1.0 10.6 6.2 12.8 6.7 7.2 20.4 18.5 10.7 21.7 19.1 15.9 16.1 19.1 15.1 11.6 MXI1 "bHLHc11, MAD2, MXD2, MXI" ENSG00000119950 "MAX interactor 1, dimerization protein" P50539 10 110207605-110287365 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 29.5;SK-MEL-30: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035319, HPA035320, HPA056762" Approved Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA035319: AB_10670588, HPA035320: , HPA056762: " "unprognostic (1.77e-2)" "unprognostic (2.02e-1)" "unprognostic (3.34e-1)" "unprognostic (3.03e-2)" "unprognostic (1.11e-1)" "unprognostic (1.71e-2)" "unprognostic (1.08e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.26e-3)" "prognostic unfavourable (9.17e-4)" "prognostic unfavourable (1.02e-5)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (2.29e-1)" "unprognostic (2.96e-1)" 16.9 19.4 37.2 7.5 34.9 32.7 26.5 56.4 36.9 20.3 26.4 33.9 20.1 12.0 26.0 23.8 39.5 19.1 17.4 36.0 35.1 26.6 23.9 30.5 16.5 7.1 37.0 25.9 46.4 23.1 25.6 12.1 14.4 26.2 24.5 22.1 15.8 41.2 32.7 22.8 25.4 22.5 18.2 44.7 7.8 14.7 13.5 38.1 7.0 29.2 13.4 9.8 32.8 33.9 4.5 2.2 11.0 4.7 1.4 8.6 2.3 5.5 2.2 5.7 11.4 9.0 6.8 2.5 3.2 11.0 2.1 6.8 1.0 10.0 7.3 5.2 5.6 7.2 6.8 7.7 5.7 3.7 9.2 1.9 4.5 4.1 5.9 3.9 4.4 7.2 29.5 3.7 15.0 2.1 7.3 15.9 3.5 3.6 2.6 7.9 2.4 6.8 1.6 7.5 11.6 7.5 0.5 9.7 15.9 3.2 2.4 53.2 2.7 12.7 2.1 3.8 6.5 4.0 1.7 13.2 6.9 2.6 10.1 14.5 4.0 2.2 3.1 11.0 3.1 2.5 5.8 3.9 6.7 3.6 1.7 4.5 8.6 2.2 7.8 1.4 4.7 2.2 5.0 2.3 37.2 34.9 56.4 36.9 35.1 26.6 37.0 25.9 26.2 38.1 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175813 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 53.8" "Group enriched" "Detected in some" 5 "CACO-2: 17.2;HSkMC: 33.7;THP-1: 8.4" "Group enriched" "Detected in many" 7 "glioma: 4.9;head and neck cancer: 20.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: " "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.8 0.1 1.1 0.8 0.8 0.3 0.4 0.4 0.6 0.1 0.1 0.0 0.0 0.1 0.4 4.4 3.9 0.2 0.1 0.2 0.4 0.3 1.1 1.5 0.2 0.3 1.3 0.0 0.1 0.2 0.1 0.6 0.3 1.0 4.2 0.1 0.0 8.8 0.1 53.8 0.2 0.1 0.1 0.4 0.4 0.1 0.2 2.1 0.9 3.9 12.7 2.0 0.3 0.8 0.0 6.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.3 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.5 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 6.1 0.0 0.1 1.1 0.8 0.4 0.6 0.4 0.3 1.3 0.0 1.0 2.1 MYLK4 SgK085 ENSG00000145949 "Myosin light chain kinase family member 4" Q86YV6 6 2663629-2750966 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "skeletal muscle: 23.6;tongue: 63.6" "Cell line enriched" "Detected in some" 6 "HEL: 12.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA015860 Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoli, Vesicles" "HPA015860: AB_2147922" "unprognostic (1.75e-1)" "unprognostic (2.04e-1)" "unprognostic (1.87e-1)" "unprognostic (5.22e-3)" "unprognostic (1.85e-1)" "unprognostic (2.99e-2)" "unprognostic (7.48e-2)" "unprognostic (2.80e-1)" "unprognostic (5.32e-2)" "unprognostic (2.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.91e-1)" "unprognostic (2.74e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-1)" "unprognostic (1.19e-2)" "unprognostic (4.63e-2)" 0.5 0.3 0.3 0.3 0.4 0.4 0.8 1.4 0.7 0.3 0.3 0.3 0.3 0.1 0.3 0.5 1.0 0.2 0.3 1.0 0.5 0.5 2.6 0.3 0.5 0.3 0.4 0.3 0.3 1.1 0.7 0.7 0.4 0.4 0.4 0.1 0.4 2.4 0.4 23.6 0.8 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 1.0 63.6 1.5 0.5 0.3 0.1 0.8 0.3 0.3 0.9 1.4 0.1 0.3 0.1 0.6 1.1 1.0 1.2 0.6 0.7 1.5 0.5 0.4 0.5 1.0 1.0 1.6 0.8 1.9 0.2 0.4 0.7 0.2 0.6 12.4 0.6 0.1 0.3 0.3 0.6 1.5 0.5 0.1 1.2 0.5 0.1 0.1 0.3 0.5 0.1 1.3 0.2 0.0 0.9 0.0 0.0 0.8 0.3 1.0 0.6 0.3 0.2 0.5 0.4 0.8 0.7 0.5 0.1 0.2 0.4 0.4 0.2 0.1 0.2 0.3 1.2 0.1 0.1 0.1 0.5 0.0 0.3 0.1 0.2 1.4 0.2 0.1 0.6 0.1 0.3 0.9 0.3 0.8 0.1 0.1 0.3 0.4 1.4 0.7 0.5 0.5 0.4 0.3 0.4 0.3 MYO10 KIAA0799 ENSG00000145555 "Myosin X" Q9HD67 5 16661914-16936276 "Plasma proteins, Predicted intracellular proteins" Transport "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 38.8;SK-MEL-30: 45.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "non-classical monocyte: 6.0" "Lineage enriched" "Detected in many" 5 "monocytes: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015224, HPA024223" Enhanced Supported "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoli "CAB015224: , HPA024223: AB_1854248" "unprognostic (1.13e-2)" "prognostic unfavourable (4.35e-4)" "unprognostic (7.63e-2)" "unprognostic (1.04e-1)" "unprognostic (4.43e-2)" "unprognostic (2.96e-2)" "unprognostic (4.40e-2)" "unprognostic (8.34e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-2)" "unprognostic (8.42e-2)" "unprognostic (1.85e-1)" "prognostic favourable (2.75e-4)" "unprognostic (8.93e-2)" "unprognostic (9.86e-2)" "unprognostic (4.56e-2)" "unprognostic (1.84e-1)" 10.5 3.4 28.1 5.1 30.1 3.0 8.0 8.9 39.7 6.3 15.3 17.3 6.6 19.5 5.7 4.3 7.7 3.8 7.7 3.7 26.2 10.9 13.3 7.1 14.5 1.6 14.6 15.3 12.1 22.0 10.4 16.2 22.0 10.6 5.4 15.8 19.7 9.8 7.4 6.6 13.4 14.6 4.3 11.1 10.9 24.2 12.4 18.5 0.5 28.6 3.3 2.3 6.6 7.1 0.9 0.5 1.1 6.0 0.5 0.6 0.3 13.1 20.9 8.7 4.1 6.4 3.5 8.0 23.6 16.7 6.6 5.4 13.2 2.2 0.4 16.2 10.7 7.0 38.8 15.5 12.3 0.0 3.9 0.0 34.9 3.7 23.6 0.1 0.4 7.1 6.8 15.9 19.0 22.0 0.0 1.3 6.4 2.6 0.0 0.1 22.5 7.6 5.3 2.2 13.9 6.6 10.2 1.1 0.6 5.1 2.6 45.3 1.7 2.1 26.6 16.0 5.9 0.2 12.9 0.2 0.1 0.1 7.9 2.5 15.9 1.0 0.6 0.5 0.3 1.5 0.4 0.3 0.4 0.3 0.5 0.9 0.6 0.6 1.1 0.5 6.0 0.4 0.3 0.3 28.1 30.1 8.9 20.7 26.2 10.9 14.6 15.3 10.6 18.5 NBAS NAG ENSG00000151779 "Neuroblastoma amplified sequence" A2RRP1 2 15166909-15561330 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036817 Approved Approved "Nuclear membrane,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nuclear membrane, Nucleoli" "HPA036817: AB_10670925" "unprognostic (1.72e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (2.45e-1)" "prognostic unfavourable (1.10e-4)" "unprognostic (3.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.33e-1)" "unprognostic (1.55e-1)" "unprognostic (1.53e-2)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-1)" "prognostic unfavourable (5.84e-5)" 16.8 18.1 23.2 16.3 30.9 21.9 22.5 21.5 28.3 21.9 17.1 20.6 17.4 13.3 27.1 23.4 14.1 18.7 13.5 21.6 20.9 21.5 19.1 16.9 15.4 16.3 19.3 20.8 24.1 28.6 34.1 35.5 16.2 24.9 16.9 17.7 16.8 22.9 19.0 26.5 23.4 20.5 21.0 18.1 18.1 19.0 31.4 16.7 23.8 20.1 14.6 20.0 14.4 15.2 5.3 6.0 3.2 8.7 9.4 9.9 3.6 5.4 7.2 8.0 5.5 20.9 23.0 8.2 10.1 11.1 7.9 8.0 7.2 7.9 7.0 2.3 15.3 6.6 8.6 12.7 9.4 6.9 5.5 26.6 6.4 20.1 21.5 6.9 13.6 15.1 10.1 10.4 17.5 16.2 20.6 8.0 12.0 6.7 5.7 15.5 6.9 6.9 6.0 14.0 8.3 16.3 7.4 4.7 7.7 8.6 7.1 12.7 5.0 6.3 14.0 10.0 6.2 7.1 7.3 12.0 10.2 9.9 17.8 8.1 8.9 1.4 5.7 3.2 7.6 3.9 9.5 5.3 5.9 9.9 5.2 5.1 5.9 6.1 1.0 9.4 8.7 6.0 6.9 3.6 23.2 30.9 21.5 28.3 20.9 21.5 19.3 20.8 24.9 16.7 NCAPD2 "CAP-D2, CNAP1, hCAP-D2, KIAA0159" ENSG00000010292 "Non-SMC condensin I complex subunit D2" Q15021 12 6493356-6531955 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "lymphoid tissue: 84.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012423, HPA036947, HPA037363" Approved Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-2)" "unprognostic (1.03e-2)" "unprognostic (7.84e-2)" "prognostic unfavourable (1.79e-8)" "unprognostic (2.73e-3)" "unprognostic (1.45e-2)" "unprognostic (5.00e-2)" "unprognostic (5.41e-3)" "unprognostic (4.53e-1)" "prognostic unfavourable (1.13e-7)" "unprognostic (4.80e-3)" "unprognostic (1.18e-1)" "unprognostic (4.53e-1)" "unprognostic (8.75e-2)" 6.8 8.8 6.5 24.6 12.7 16.7 7.7 7.7 9.0 8.0 11.3 16.2 7.0 10.6 11.5 8.8 17.7 8.1 6.5 6.2 7.5 5.4 7.0 5.1 7.7 20.4 16.5 6.2 7.7 7.2 9.6 6.3 13.9 8.7 8.2 12.4 8.1 10.5 8.3 7.0 14.8 13.0 8.2 12.7 16.4 9.9 17.2 11.4 84.1 11.4 12.4 24.3 10.9 9.5 5.0 4.8 7.2 2.8 7.8 7.4 3.2 21.9 20.4 21.9 15.8 5.7 6.0 25.6 15.1 12.2 24.6 19.9 18.3 23.3 23.1 4.5 9.9 19.4 36.0 17.7 47.0 41.8 20.2 21.1 23.3 10.4 2.4 26.2 15.3 3.8 6.6 19.2 19.6 16.2 13.4 9.4 21.7 10.9 29.6 17.2 34.2 15.9 25.3 49.8 12.2 8.2 12.3 9.0 9.5 22.6 10.7 8.1 4.7 16.5 10.1 16.2 26.6 10.9 29.4 7.4 9.9 32.9 9.5 15.2 20.0 7.2 2.0 3.6 6.3 2.8 5.6 5.0 6.2 7.3 3.0 3.8 7.4 7.2 1.9 7.8 1.9 4.8 7.2 3.2 6.5 12.7 7.7 9.0 7.5 5.4 16.5 6.2 8.7 11.4 NCOA4 "ARA70, DKFZp762E1112, ELE1, PTC3, RFG" ENSG00000266412 "Nuclear receptor coactivator 4" Q13772 10 46005088-46030714 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 30.2;granulocytes: 100.1;monocytes: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051260, HPA065208" Uncertain Approved "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "HPA051260: , HPA065208: " "unprognostic (4.23e-2)" "unprognostic (1.50e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "prognostic favourable (3.26e-4)" "unprognostic (1.34e-1)" "unprognostic (1.80e-1)" "unprognostic (9.34e-2)" "unprognostic (4.67e-2)" "unprognostic (5.22e-2)" "unprognostic (9.16e-2)" "unprognostic (2.04e-2)" "prognostic favourable (8.04e-6)" "unprognostic (1.35e-1)" "unprognostic (4.71e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" 18.5 6.9 5.5 9.5 10.0 17.4 10.0 5.5 11.3 10.8 22.5 13.6 5.9 27.0 9.9 9.4 17.0 6.3 9.0 16.6 5.7 20.8 40.9 11.6 11.6 8.7 7.1 11.0 9.1 9.3 9.6 28.4 13.5 14.7 12.4 9.9 12.6 8.5 15.5 6.8 36.4 11.2 9.7 23.8 8.9 6.4 8.1 26.8 13.2 13.9 16.3 13.0 6.4 7.3 30.2 100.1 40.4 13.4 10.9 53.9 31.3 13.3 15.6 16.0 41.4 37.6 39.1 28.8 46.7 28.5 27.9 20.4 23.2 35.4 34.7 47.1 32.0 16.3 31.7 31.7 25.0 16.8 23.9 18.3 58.5 29.1 60.8 53.4 36.5 31.8 24.2 40.7 41.8 26.0 21.4 38.7 14.0 29.5 22.8 9.4 7.8 17.5 22.7 21.2 34.1 26.7 15.7 10.6 29.1 33.3 28.8 24.0 29.9 38.5 17.6 21.2 18.6 19.4 15.9 17.0 35.2 22.0 51.2 9.3 69.1 40.4 70.7 10.0 26.8 10.9 7.3 9.4 9.5 30.2 6.6 10.2 8.6 100.1 13.4 30.4 9.3 10.8 53.9 NDP "EVR2, norrin" ENSG00000124479 "NDP, norrin cystine knot growth factor" Q00604 X 43948776-43973504 "Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision, Wnt signaling pathway" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 40.4" "Cell line enriched" "Detected in some" 17 "U-87 MG: 40.3" "Cancer enhanced" "Detected in many" "glioma: 25.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 14 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003095 Supported Nucleoplasm,Nucleoli,Vesicles "Secreted to extracellular matrix" Vesicles "Nucleoplasm, Nucleoli" "HPA003095: AB_1079457" "unprognostic (1.12e-1)" "unprognostic (7.12e-2)" "unprognostic (2.27e-2)" "unprognostic (2.55e-3)" "unprognostic (6.84e-3)" "unprognostic (1.51e-1)" "unprognostic (9.09e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (2.87e-3)" 0.9 0.6 17.3 0.6 18.6 0.5 3.6 14.6 15.0 19.1 0.7 12.6 0.2 0.6 13.6 19.9 0.6 18.0 0.9 1.4 14.0 7.8 0.7 0.5 0.6 0.7 11.0 10.9 40.4 0.6 0.8 0.2 5.3 13.1 6.8 0.7 1.4 0.6 12.4 1.5 1.1 0.6 10.7 7.5 0.6 0.7 1.4 12.2 0.0 1.2 0.0 0.7 1.0 1.7 0.1 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.9 0.0 0.1 1.0 0.7 0.0 0.0 1.1 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 40.3 0.4 2.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.3 18.6 14.6 15.0 14.0 7.8 11.0 10.9 13.1 12.2 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469688-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 20.1 17.6 17.2 19.3 23.6 35.7 26.9 28.9 25.8 17.8 17.8 21.2 18.7 15.0 29.1 22.3 17.4 21.7 12.1 14.8 17.6 15.7 20.6 21.0 15.5 20.4 23.5 17.4 27.2 16.6 20.9 20.7 19.7 19.1 19.7 19.4 17.4 24.0 19.9 32.8 22.7 17.9 21.0 21.6 19.7 17.5 19.0 25.2 19.6 23.7 17.2 22.8 17.3 19.7 42.0 26.7 18.9 23.4 35.2 44.6 28.2 10.7 21.5 16.4 15.4 16.0 11.6 21.7 14.4 15.0 30.7 24.9 21.1 19.9 26.9 10.6 13.1 18.8 32.5 17.8 36.2 17.8 17.2 24.1 13.1 65.4 21.8 31.8 17.2 14.5 22.6 24.2 28.8 15.5 26.6 19.2 15.0 25.7 23.6 24.0 20.8 29.0 19.4 19.7 13.7 19.6 20.6 16.8 19.1 17.0 20.4 23.5 12.6 20.4 11.7 14.5 17.2 13.6 20.8 24.1 41.7 39.0 6.2 16.3 15.5 17.5 21.5 18.9 31.6 23.4 33.5 42.0 34.3 32.1 25.3 36.6 44.6 35.1 6.6 35.2 22.4 26.7 37.4 28.2 17.2 23.6 28.9 25.8 17.6 15.7 23.5 17.4 19.1 25.2 NIN ENSG00000100503 Ninein Q8N4C6 14 50719763-50831121 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005939, HPA070691" Approved Enhanced Nucleoplasm,Nucleoli,Centrosome Centrosome "Nucleoplasm, Nucleoli" "HPA005939: , HPA070691: " "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (3.54e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (1.43e-2)" "unprognostic (3.41e-2)" "unprognostic (3.31e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-2)" "unprognostic (2.07e-1)" "unprognostic (4.06e-1)" "unprognostic (2.46e-2)" "unprognostic (2.67e-1)" "unprognostic (1.28e-1)" "unprognostic (2.58e-2)" "unprognostic (7.66e-3)" 13.0 6.1 15.1 24.9 10.3 34.8 9.7 12.6 14.0 8.0 9.2 7.6 4.5 5.0 11.8 6.1 11.8 8.2 7.6 16.4 11.7 4.9 6.7 5.2 10.7 30.2 7.6 10.0 11.0 5.4 9.1 12.3 20.2 7.1 6.5 7.7 6.2 8.2 5.1 16.9 10.9 8.3 12.0 7.1 18.2 9.3 4.6 9.0 16.4 7.8 5.1 25.8 11.7 10.3 6.8 6.3 18.4 2.3 1.5 6.0 1.3 12.2 8.7 18.1 15.4 7.0 11.2 7.6 10.5 9.1 8.9 7.5 5.6 6.5 28.8 7.2 14.1 12.9 14.5 6.6 18.7 13.9 4.5 10.6 5.3 5.3 4.1 18.4 30.6 7.7 5.3 15.5 6.4 14.1 2.6 11.8 13.4 13.4 13.9 7.4 2.5 9.6 15.8 33.5 2.0 8.0 13.9 8.4 9.5 13.2 4.0 11.3 7.5 16.4 20.5 22.6 31.4 8.6 11.6 9.5 4.8 19.9 5.9 15.0 12.2 12.6 2.3 18.4 3.3 1.7 3.5 6.8 2.2 6.0 1.5 5.5 4.4 3.8 8.3 1.5 1.5 6.3 1.9 1.3 15.1 10.3 12.6 14.0 11.7 4.9 7.6 10.0 7.1 9.0 NLK ENSG00000087095 "Nemo like kinase" Q9UBE8 17 28041737-28196381 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 32 "basophil: 17.6" "Lineage enriched" "Detected in single" 32 "granulocytes: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018192, HPA056511" Approved Supported "Nucleoplasm,Nucleoli,Cell Junctions" Nucleoplasm "Nucleoli, Cell Junctions" "HPA018192: AB_1854525, HPA056511: " "unprognostic (7.19e-2)" "unprognostic (1.98e-1)" "unprognostic (5.54e-2)" "unprognostic (5.64e-3)" "unprognostic (2.11e-1)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (2.59e-3)" "unprognostic (2.72e-2)" "unprognostic (4.23e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-2)" "unprognostic (5.29e-2)" "unprognostic (1.66e-1)" "unprognostic (3.92e-1)" "unprognostic (5.27e-2)" "unprognostic (6.57e-2)" 6.4 30.5 19.4 10.9 14.1 7.4 7.5 7.5 38.2 6.2 6.7 8.3 14.4 8.3 5.7 8.8 4.5 5.1 8.2 8.5 18.2 12.0 13.0 8.2 7.1 11.7 15.2 23.6 4.6 11.5 20.8 9.4 9.1 7.0 6.7 7.1 12.7 5.8 17.4 4.9 4.5 8.3 4.6 15.3 10.1 7.0 17.4 7.5 10.9 13.2 3.7 11.0 7.2 4.4 0.5 0.3 17.6 0.3 0.1 0.5 0.2 4.6 5.4 13.0 4.5 2.8 3.6 5.7 4.6 4.7 7.8 6.0 27.0 4.2 6.3 7.1 3.8 4.4 9.1 8.5 9.0 14.5 5.8 24.7 5.0 4.6 4.7 5.2 25.5 4.7 5.2 5.1 6.1 9.1 9.5 7.6 7.1 5.4 13.3 6.0 5.0 2.7 11.2 8.4 4.6 14.1 5.7 9.5 3.5 7.1 6.8 29.0 10.6 8.3 9.3 5.6 7.5 4.6 9.3 9.0 8.6 6.1 5.4 5.6 6.1 17.6 0.2 0.2 0.3 0.3 0.1 0.5 0.4 0.4 0.2 0.3 0.2 0.5 0.1 0.1 0.3 0.3 0.4 0.2 19.4 14.1 7.5 38.2 18.2 12.0 15.2 23.6 7.0 7.5 NOL12 "MGC3731, Nop25, RRP17" ENSG00000273899 "Nucleolar protein 12" Q9UGY1 22 37681673-37693478 "Predicted intracellular proteins" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 31.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003547 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA003547: AB_10602012" "unprognostic (3.37e-2)" "prognostic favourable (6.80e-5)" "unprognostic (2.65e-1)" "unprognostic (9.62e-2)" "unprognostic (2.13e-1)" "unprognostic (7.89e-2)" "unprognostic (3.23e-3)" "prognostic favourable (9.41e-4)" "unprognostic (9.96e-2)" "unprognostic (4.62e-2)" "unprognostic (2.18e-3)" "unprognostic (4.60e-2)" "prognostic unfavourable (2.56e-6)" "unprognostic (1.34e-2)" "unprognostic (8.40e-2)" "unprognostic (4.65e-2)" "prognostic favourable (3.24e-4)" 3.8 11.8 9.3 9.5 10.1 14.6 5.0 13.1 10.6 3.6 6.5 7.9 5.4 8.4 4.1 4.6 7.8 6.2 5.6 7.2 7.7 5.2 4.1 4.8 11.0 8.7 6.4 5.4 5.4 5.4 3.9 6.8 7.2 4.5 6.2 4.4 8.9 4.8 7.9 11.4 7.1 4.5 3.7 8.6 5.8 4.8 9.5 7.2 7.4 7.1 8.0 5.8 5.6 8.1 9.6 31.1 17.1 8.5 11.6 6.4 17.0 15.7 11.8 13.4 3.8 4.1 14.8 8.5 3.9 3.9 4.1 8.9 7.1 14.5 5.1 3.8 18.6 6.7 22.5 1.4 15.2 24.5 12.3 12.7 20.2 10.3 29.1 18.1 5.9 7.3 15.3 5.9 7.3 9.1 13.2 3.3 14.8 15.9 21.8 13.5 21.2 21.8 7.6 10.9 8.5 6.0 9.6 18.7 9.9 9.1 13.5 13.0 13.8 10.2 16.2 16.4 11.8 15.7 11.0 13.4 18.7 15.4 21.7 19.0 21.3 14.0 14.2 9.1 14.1 6.5 8.0 8.9 7.9 9.6 8.1 9.1 7.9 31.1 8.5 17.1 7.5 11.6 6.4 NOP9 C14orf21 ENSG00000196943 "NOP9 nucleolar protein" Q86U38 14 24299862-24309124 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000850 Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA000850: AB_1078287" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (4.57e-3)" "unprognostic (1.85e-1)" "unprognostic (8.28e-2)" "unprognostic (3.54e-1)" "unprognostic (1.69e-2)" "unprognostic (9.37e-2)" "unprognostic (7.22e-2)" "unprognostic (1.40e-1)" "unprognostic (1.09e-1)" "unprognostic (6.77e-2)" "prognostic favourable (9.39e-6)" "unprognostic (7.03e-3)" "unprognostic (3.80e-1)" "unprognostic (1.95e-1)" "unprognostic (1.59e-2)" 12.0 12.9 11.3 11.4 11.4 14.4 10.0 13.3 17.5 11.3 14.4 16.8 9.6 16.5 11.1 10.1 16.6 10.3 13.8 19.4 10.9 10.6 9.7 14.2 9.5 15.1 13.7 10.0 13.3 13.3 20.1 8.9 11.6 10.9 10.8 12.3 13.0 12.5 11.5 29.7 13.5 12.4 12.3 12.3 18.8 10.9 13.0 10.7 11.8 11.2 18.3 14.9 12.1 9.4 1.6 2.1 1.8 5.2 0.4 1.6 1.4 5.1 10.2 8.3 10.4 7.2 6.2 8.3 9.1 6.8 10.8 8.5 7.6 9.0 13.1 5.2 8.3 13.3 16.4 11.3 11.3 8.3 6.2 9.6 14.1 17.5 5.8 22.0 11.0 6.2 8.9 7.9 7.4 10.0 8.1 6.5 7.5 8.8 10.1 8.3 3.7 13.1 12.8 5.0 8.4 6.6 11.7 8.4 6.4 12.8 15.0 2.8 6.3 5.8 10.2 7.3 6.0 6.0 8.6 9.2 8.1 9.9 4.0 10.1 5.7 1.4 2.3 1.8 1.5 2.4 1.6 1.2 1.4 0.7 2.1 1.6 1.0 1.0 0.5 0.4 5.2 1.1 1.2 1.4 11.3 11.4 13.3 17.5 10.9 10.6 13.7 10.0 10.9 10.7 NPM3 ENSG00000107833 "Nucleophosmin/nucleoplasmin 3" O75607 10 101781325-101783413 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036295, HPA036296" Approved Approved "Nucleoli,Actin filaments,Cytosol" "Nucleoli, Actin filaments, Cytosol" "HPA036295: AB_10671244, HPA036296: AB_10672083" "unprognostic (3.41e-2)" "unprognostic (3.70e-2)" "unprognostic (4.33e-2)" "unprognostic (1.75e-1)" "unprognostic (8.06e-2)" "prognostic unfavourable (1.42e-4)" "unprognostic (1.00e-2)" "unprognostic (1.98e-1)" "unprognostic (5.17e-2)" "unprognostic (1.75e-1)" "unprognostic (2.45e-2)" "unprognostic (1.35e-2)" "unprognostic (2.86e-2)" "unprognostic (3.55e-2)" "unprognostic (1.81e-1)" "unprognostic (5.69e-2)" "unprognostic (9.58e-2)" 9.8 17.0 14.3 20.9 8.5 17.2 14.3 1.5 16.8 13.3 12.3 2.4 6.2 6.0 15.7 15.0 22.7 11.7 12.4 8.9 9.9 7.3 13.6 13.7 8.8 26.3 7.3 11.4 17.7 39.0 11.3 11.1 12.0 9.1 11.5 15.1 3.7 13.2 7.1 11.7 14.0 8.7 15.0 4.8 14.7 11.0 16.4 7.7 18.5 9.8 23.7 18.8 13.0 13.9 4.5 8.3 0.1 3.7 7.0 10.4 5.7 17.1 21.8 6.5 42.7 14.9 15.7 6.9 9.3 14.2 14.5 12.4 23.4 22.0 28.5 17.4 10.3 18.5 36.2 39.5 11.4 12.0 37.6 22.8 10.2 37.4 16.8 51.9 16.7 13.6 19.2 20.0 80.4 18.9 28.1 15.8 11.9 31.7 21.6 67.6 11.5 16.8 17.0 34.2 28.9 14.1 8.5 13.4 8.6 5.8 13.7 25.9 17.8 10.8 7.4 5.7 18.4 8.5 17.2 6.8 7.1 32.7 8.0 48.3 5.9 0.0 2.7 0.0 3.8 3.7 7.0 4.3 6.3 7.2 6.3 4.5 10.4 10.4 0.1 7.0 0.8 8.3 2.6 5.7 14.3 8.5 1.5 16.8 9.9 7.3 7.3 11.4 9.1 7.7 NPR1 "ANPa, ANPRA, GUCY2A, NPRA" ENSG00000169418 "Natriuretic peptide receptor 1" P16066 1 153678637-153693992 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "cGMP biosynthesis" "Lyase, Receptor, Vasoactive" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 98.4" "Cell line enriched" "Detected in some" 6 "ASC diff: 59.1" "Cancer enhanced" "Detected in all" "ovarian cancer: 39.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 5 "olfactory region: 23.0" "Region enhanced" "Detected in many" "olfactory region: 11.1" HPA031087 Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA031087: AB_10601975" "unprognostic (2.54e-1)" "unprognostic (3.03e-3)" "unprognostic (6.31e-2)" "prognostic unfavourable (3.97e-4)" "unprognostic (1.55e-1)" "unprognostic (6.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.03e-1)" "unprognostic (2.46e-1)" "unprognostic (3.27e-2)" "prognostic favourable (2.49e-4)" "unprognostic (1.27e-1)" "unprognostic (6.69e-2)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" "unprognostic (4.06e-1)" "unprognostic (1.74e-2)" 41.1 4.3 0.5 5.9 0.9 0.1 98.4 0.5 0.8 8.1 8.2 0.3 7.3 1.2 16.8 11.1 8.7 25.0 9.3 19.6 0.9 0.5 28.7 3.7 34.8 8.6 0.7 0.0 19.5 4.2 7.8 4.5 11.8 2.5 4.9 1.5 2.0 2.0 9.0 6.9 3.4 4.6 15.6 2.2 1.2 5.0 6.4 0.2 0.8 7.6 5.1 1.1 11.6 26.5 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 59.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.8 0.0 7.1 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.5 0.8 0.9 0.5 0.7 0.0 2.5 0.2 NRIP1 RIP140 ENSG00000180530 "Nuclear receptor interacting protein 1" P48552 21 14961235-15065936 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029785, HPA046571, HPA060036" Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA029785: , HPA046571: , HPA060036: " "unprognostic (5.60e-2)" "unprognostic (1.87e-1)" "unprognostic (5.20e-3)" "unprognostic (4.64e-3)" "unprognostic (7.98e-2)" "unprognostic (2.59e-2)" "unprognostic (2.74e-1)" "unprognostic (2.75e-3)" "unprognostic (8.94e-3)" "unprognostic (1.55e-1)" "unprognostic (2.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.80e-2)" "unprognostic (6.53e-2)" "unprognostic (1.07e-1)" "unprognostic (2.72e-1)" "unprognostic (2.80e-1)" 29.0 15.0 10.8 12.6 7.5 19.6 18.4 20.8 10.5 23.1 21.2 6.7 8.5 14.5 16.6 13.4 13.1 18.8 9.0 11.8 9.3 5.8 16.0 22.7 9.3 8.9 5.9 7.3 14.4 15.8 8.3 11.2 16.8 7.2 13.9 15.8 12.7 10.3 7.7 36.5 7.6 30.3 17.3 12.9 17.0 8.4 6.8 7.7 22.1 7.3 12.4 5.9 13.0 14.9 2.6 1.7 0.5 1.4 1.2 5.6 0.7 9.6 20.4 16.1 0.0 8.1 5.2 5.7 11.5 5.1 7.6 5.8 3.8 7.6 0.0 6.5 10.9 5.0 1.0 6.8 15.4 0.0 4.4 14.5 7.1 11.7 4.8 7.2 3.2 6.4 9.5 7.9 9.3 5.6 10.3 8.0 5.0 5.4 3.3 0.0 6.5 6.1 40.9 12.6 0.3 4.4 16.6 1.4 0.0 9.5 5.0 3.8 12.2 5.5 9.7 6.2 4.2 9.6 4.6 3.8 0.0 0.0 13.6 0.0 3.1 0.0 1.4 0.5 1.0 0.8 5.6 0.9 1.0 1.1 1.7 2.6 1.7 0.6 0.3 1.2 1.4 1.7 0.5 0.7 10.8 7.5 20.8 10.5 9.3 5.8 5.9 7.3 7.2 7.7 NUDT19 RP2 ENSG00000213965 "Nudix hydrolase 19" A8MXV4 19 32691961-32713796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042761 Uncertain Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA042761: " "unprognostic (1.20e-1)" "unprognostic (2.90e-1)" "unprognostic (2.35e-3)" "unprognostic (6.61e-3)" "unprognostic (2.62e-2)" "unprognostic (2.44e-1)" "unprognostic (6.18e-3)" "unprognostic (1.97e-1)" "unprognostic (3.14e-2)" "unprognostic (2.19e-1)" "unprognostic (2.99e-1)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (2.64e-2)" "unprognostic (2.81e-1)" "unprognostic (1.23e-1)" "prognostic favourable (1.35e-4)" 9.9 18.7 7.2 11.1 7.0 10.8 10.7 7.4 7.6 5.6 12.8 6.1 8.4 10.2 6.6 8.8 16.9 6.3 7.6 19.3 6.1 6.5 10.5 16.4 15.9 9.2 6.2 5.5 8.5 18.9 9.5 9.3 6.6 6.1 11.2 10.7 9.4 14.7 11.8 29.5 13.2 12.9 6.9 5.6 8.9 11.3 6.8 6.6 6.8 5.9 13.1 13.0 9.9 8.4 8.4 11.9 9.0 23.6 18.7 14.8 6.5 13.6 16.0 1.8 15.9 5.5 7.2 0.3 7.8 2.9 5.8 5.5 9.0 7.6 0.2 9.4 8.9 8.9 10.9 9.0 7.7 15.8 6.6 17.7 6.4 3.3 7.6 13.3 5.5 5.8 12.0 4.9 12.0 8.5 13.6 10.2 10.4 9.1 0.1 12.2 1.9 7.6 0.1 3.5 7.7 9.5 10.2 7.2 10.3 13.8 11.8 9.8 6.5 16.3 6.8 8.1 5.2 8.0 13.8 11.9 10.1 4.5 9.7 12.8 7.3 6.6 17.3 9.0 11.9 21.7 12.8 8.4 12.5 14.8 11.9 5.9 10.0 13.8 3.3 18.7 23.6 9.5 13.8 6.5 7.2 7.0 7.4 7.6 6.1 6.5 6.2 5.5 6.1 6.6 NUP188 KIAA0169 ENSG00000095319 "Nucleoporin 188" Q5SRE5 9 128947699-129007096 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061750, HPA063942" Approved Uncertain Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA061750: , HPA063942: " "unprognostic (4.64e-1)" "unprognostic (6.91e-3)" "unprognostic (2.36e-1)" "prognostic favourable (5.20e-5)" "unprognostic (9.50e-2)" "unprognostic (4.41e-2)" "unprognostic (1.85e-3)" "unprognostic (1.91e-1)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (7.78e-2)" "unprognostic (4.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.68e-2)" "unprognostic (2.87e-1)" "unprognostic (2.81e-3)" "unprognostic (3.53e-3)" 10.2 11.1 7.6 12.6 9.2 14.3 14.0 13.3 8.7 9.2 9.3 10.1 9.6 5.8 9.8 6.7 16.6 8.3 7.6 9.2 5.6 6.3 8.1 9.6 13.1 16.6 6.5 6.7 10.8 13.3 12.6 13.6 9.1 7.3 9.5 9.3 11.2 9.9 8.3 10.9 16.4 9.0 11.0 7.7 12.2 9.5 60.3 7.3 26.5 9.2 11.3 17.3 8.5 10.5 6.1 7.9 6.3 10.7 6.0 12.0 7.0 10.8 20.7 17.2 23.4 13.0 13.0 15.4 15.2 12.0 27.9 18.6 24.9 8.7 19.0 5.7 16.7 32.1 38.5 18.8 20.9 15.2 18.5 16.9 38.7 19.7 8.3 28.8 17.1 9.0 8.9 29.3 15.0 16.0 37.0 13.5 19.7 27.4 24.6 11.8 23.0 19.9 22.6 37.2 19.3 8.6 12.3 24.2 11.7 39.4 15.0 5.8 16.5 10.6 12.9 23.2 16.5 23.3 27.2 11.6 21.3 25.7 13.5 18.5 17.1 6.3 5.3 1.9 9.3 10.7 12.0 6.1 7.9 9.0 7.9 5.9 8.1 8.6 0.8 6.0 5.9 3.3 9.5 7.0 7.6 9.2 13.3 8.7 5.6 6.3 6.5 6.7 7.3 7.3 OLFM1 "AMY, NOE1, NOELIN, OlfA" ENSG00000130558 "Olfactomedin 1" Q99784 9 135075422-135121179 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 159.5" "Cell line enhanced" "Detected in some" "HeLa: 25.2;MCF7: 21.2;NTERA-2: 28.3;SCLC-21H: 40.8;SiHa: 33.8;T-47d: 52.4;U-2197: 22.8" "Cancer enhanced" "Detected in all" "glioma: 18.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 38 "classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 51 "dendritic cells: 5.1;monocytes: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057444 Approved Nucleoplasm,Nucleoli,Cytosol "Secreted in brain" 130000000 Nucleoli "Nucleoplasm, Cytosol" "HPA057444: " "unprognostic (6.77e-2)" "prognostic favourable (7.14e-4)" "unprognostic (1.01e-1)" "unprognostic (3.76e-2)" "prognostic unfavourable (6.58e-4)" "unprognostic (3.08e-1)" "unprognostic (1.30e-1)" "unprognostic (3.69e-3)" "unprognostic (2.67e-1)" "unprognostic (6.04e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (9.46e-3)" "unprognostic (4.60e-2)" "unprognostic (1.51e-1)" "unprognostic (6.20e-2)" "unprognostic (7.53e-4)" 7.7 10.0 80.5 5.0 41.5 0.9 4.7 30.9 159.5 7.4 5.4 4.6 0.7 2.5 6.9 26.4 5.0 4.4 3.8 3.9 77.2 19.1 3.4 2.4 4.7 5.2 18.8 36.5 6.2 5.1 3.6 9.9 1.1 13.5 4.8 5.7 0.9 2.6 7.5 6.1 4.5 3.5 6.9 6.1 5.8 3.9 2.8 2.8 0.3 2.7 0.8 7.1 4.1 6.2 0.0 5.1 0.0 5.0 0.0 0.0 0.6 0.0 1.5 3.1 0.0 0.4 0.3 0.1 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.3 0.6 0.6 0.0 0.0 3.6 0.2 0.0 25.2 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 21.2 0.1 0.0 28.3 0.0 0.0 0.0 11.9 0.0 0.0 40.8 5.4 33.8 0.1 2.1 52.4 0.0 0.0 2.0 4.5 22.8 0.0 0.0 0.0 0.1 0.1 0.0 1.1 0.0 3.4 0.0 0.0 5.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 80.5 41.5 30.9 119.7 77.2 19.1 18.8 36.5 13.5 2.8 OSCP1 "C1orf102, NOR1" ENSG00000116885 "Organic solute carrier partner 1" Q8WVF1 1 36415827-36450451 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 35.8;testis: 49.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028436, HPA052655" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA028436: AB_10600885, HPA052655: " "unprognostic (3.46e-3)" "unprognostic (7.57e-2)" "unprognostic (4.67e-2)" "prognostic favourable (6.88e-4)" "unprognostic (1.28e-2)" "unprognostic (4.81e-2)" "unprognostic (3.38e-2)" "unprognostic (4.52e-2)" "unprognostic (5.52e-2)" "unprognostic (8.80e-2)" "unprognostic (2.21e-2)" "unprognostic (3.87e-2)" "prognostic favourable (2.18e-6)" "unprognostic (1.20e-1)" "unprognostic (2.04e-2)" "unprognostic (1.02e-2)" "unprognostic (4.20e-2)" 3.9 5.3 6.2 1.5 14.0 1.2 6.0 3.6 12.7 6.2 3.6 6.5 7.5 1.8 6.3 14.1 3.2 35.8 5.5 4.7 6.5 8.9 11.9 1.8 6.7 1.3 4.9 5.3 5.9 6.2 15.7 15.7 8.9 7.8 6.4 2.5 6.7 5.3 6.8 2.4 3.4 1.3 5.0 3.2 0.9 3.5 49.9 3.2 1.3 11.1 3.5 2.4 3.2 2.6 0.8 3.8 0.3 1.7 0.3 3.1 0.8 5.1 4.9 6.1 7.1 7.3 7.2 1.1 3.1 7.7 7.8 5.4 0.1 4.6 1.1 5.9 5.7 4.1 0.2 5.9 5.1 0.9 4.7 0.0 3.3 0.5 9.1 0.6 0.9 8.1 9.7 11.0 4.8 5.3 0.1 1.3 6.1 3.7 2.7 1.9 6.2 2.1 2.9 2.5 0.9 12.8 1.8 16.5 7.3 5.9 2.8 4.1 6.0 0.8 4.6 5.7 2.1 10.2 5.3 2.3 2.3 0.5 10.9 0.1 3.8 0.0 0.7 0.0 0.9 1.7 0.0 0.4 0.9 0.7 1.8 0.8 2.2 3.1 0.3 0.3 0.2 3.8 2.2 0.8 6.2 14.0 3.6 12.7 6.5 8.9 4.9 5.3 7.8 3.2 P3H3 "GRCB, HSU47926, LEPREL2" ENSG00000110811 "Prolyl 3-hydroxylase 3" Q8IVL6 12 6828410-6839851 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 22.2;NTERA-2: 15.8;U-251 MG: 15.3" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.1;naive CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 21 "T-cells: 2.1" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 17.6" HPA043695 Approved Approved "Nucleoli,Plasma membrane,Cytosol" "Intracellular and membrane" "Plasma membrane, Cytosol" Nucleoli "HPA043695: AB_10797146" "unprognostic (2.54e-1)" "unprognostic (6.66e-2)" "unprognostic (1.14e-1)" "unprognostic (3.34e-2)" "unprognostic (5.76e-2)" "unprognostic (6.55e-2)" "unprognostic (2.66e-1)" "unprognostic (2.92e-1)" "unprognostic (6.90e-2)" "unprognostic (1.44e-1)" "prognostic favourable (4.91e-4)" "unprognostic (1.29e-1)" "prognostic unfavourable (1.64e-4)" "unprognostic (2.58e-2)" "unprognostic (9.67e-2)" "unprognostic (2.27e-1)" "unprognostic (7.77e-3)" 3.7 3.1 1.2 2.2 2.6 0.3 3.0 10.7 2.5 12.1 2.7 0.0 7.6 1.1 11.0 8.5 2.5 2.1 5.6 4.4 1.2 1.1 0.4 1.6 1.9 0.0 2.2 9.3 3.6 12.1 7.4 2.5 0.8 5.6 0.5 8.1 5.9 6.5 0.5 1.8 1.7 8.8 0.5 1.0 2.8 2.1 0.1 0.0 3.5 1.2 1.4 5.9 4.7 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.9 4.2 8.0 4.9 6.0 0.1 22.2 12.8 7.1 7.8 0.3 0.0 0.0 0.3 8.3 0.0 2.5 0.2 1.6 0.0 10.6 0.5 2.3 1.0 3.5 0.5 0.0 6.5 0.2 3.4 1.9 7.4 2.0 0.0 3.3 0.0 0.0 0.2 15.8 0.6 0.0 3.9 0.1 0.3 0.0 1.6 6.0 0.0 0.0 2.5 0.1 0.1 13.0 6.9 10.3 10.6 15.3 0.0 0.1 0.2 5.9 0.0 2.7 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.9 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.1 0.0 PAFAH1B2 ENSG00000168092 "Platelet activating factor acetylhydrolase 1b catalytic subunit 2" P68402 11 117144267-117176894 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051836 Approved Supported "Nucleoli,Plasma membrane,Cytosol" 1600000 Cytosol "Nucleoli, Plasma membrane" "HPA051836: " "unprognostic (1.08e-2)" "unprognostic (3.14e-2)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (9.94e-2)" "unprognostic (1.21e-3)" "prognostic unfavourable (9.44e-4)" "prognostic unfavourable (3.07e-4)" "unprognostic (1.01e-1)" "prognostic favourable (4.25e-4)" "prognostic unfavourable (7.79e-5)" "unprognostic (8.18e-2)" "unprognostic (1.11e-2)" "unprognostic (9.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.46e-1)" "unprognostic (1.34e-1)" 21.5 34.1 30.6 19.2 29.7 33.5 32.3 43.5 41.3 21.6 20.2 33.3 12.7 21.1 23.4 22.8 23.3 20.8 19.3 26.2 31.9 36.8 24.6 22.5 20.5 17.7 39.3 31.6 23.6 23.0 23.1 24.2 26.9 39.6 22.2 19.6 17.3 19.3 17.4 14.1 20.8 18.0 19.9 51.6 18.3 21.4 29.9 26.3 15.1 30.9 10.8 20.4 25.9 20.3 26.8 21.6 36.8 35.7 18.9 31.4 26.9 14.8 17.0 19.7 28.3 22.0 15.4 15.3 25.0 21.9 13.9 12.7 31.0 32.8 16.1 35.9 29.9 23.9 28.5 32.3 18.4 14.3 11.0 41.3 15.6 19.9 19.7 14.2 15.8 17.0 25.6 27.8 35.1 22.8 21.9 12.3 21.3 9.5 13.7 21.0 18.0 13.4 15.4 22.3 17.6 21.3 23.3 21.9 29.1 28.8 21.8 9.5 24.3 12.3 36.4 25.5 16.9 12.4 17.7 3.9 5.9 21.6 10.3 27.4 21.4 32.1 30.8 26.7 24.2 33.3 28.2 26.8 28.0 25.3 21.6 25.4 29.3 31.4 36.8 18.9 35.7 15.8 19.5 26.9 30.6 29.7 43.5 37.8 31.9 36.8 39.3 31.6 39.6 26.3 PARP10 FLJ14464 ENSG00000178685 "Poly(ADP-ribose) polymerase family member 10" Q53GL7 8 143977153-144012772 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 16.4" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "HPA028122, HPA052427" Approved Supported "Nucleoli,Golgi apparatus,Cytosol" Nucleoli "Golgi apparatus, Cytosol" "HPA028122: AB_10601979, HPA052427: " "unprognostic (9.80e-3)" "unprognostic (5.89e-2)" "unprognostic (2.63e-3)" "unprognostic (9.10e-2)" "unprognostic (1.74e-2)" "unprognostic (1.46e-2)" "unprognostic (7.37e-2)" "unprognostic (3.61e-1)" "unprognostic (9.05e-2)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (1.05e-1)" "unprognostic (4.69e-3)" "unprognostic (1.09e-3)" "unprognostic (4.17e-2)" "unprognostic (8.69e-2)" "unprognostic (5.30e-3)" 14.2 18.8 8.8 27.4 9.5 15.7 18.6 5.3 8.7 14.4 16.5 9.3 20.7 20.5 20.3 18.3 15.8 18.0 21.8 6.4 8.9 4.1 20.5 19.1 21.4 23.6 10.4 6.8 22.4 15.3 9.3 14.2 10.4 9.2 17.7 3.8 12.7 27.7 14.9 12.5 14.3 21.8 9.6 8.9 31.1 13.1 15.8 9.8 27.8 15.4 10.4 21.6 8.8 12.9 2.4 16.4 3.2 2.8 1.9 4.6 2.4 8.4 0.8 0.6 1.5 4.2 3.8 4.6 1.4 1.8 9.5 10.7 0.4 14.8 10.5 20.2 4.5 3.2 0.2 5.0 0.4 23.7 0.0 11.6 4.9 5.3 4.1 4.5 14.0 2.4 5.0 4.7 1.9 1.4 0.2 8.4 1.8 10.3 15.7 7.9 0.5 6.8 14.8 1.7 14.1 3.9 10.7 0.5 0.5 9.8 1.0 18.6 11.0 6.8 6.5 4.9 7.4 8.2 5.2 14.3 8.4 2.4 7.1 15.4 2.6 0.0 1.9 3.2 4.6 2.8 3.0 1.2 2.2 3.7 2.3 2.4 1.6 2.3 1.1 1.9 2.7 16.4 1.6 2.4 8.8 9.5 5.3 8.7 8.9 4.1 10.4 6.8 9.2 9.8 PBDC1 "CXorf26, MGC874" ENSG00000102390 "Polysaccharide biosynthesis domain containing 1" Q9BVG4 X 76172936-76178204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003155 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol 88000 Nucleoplasm "Nucleoli, Cytosol" "HPA003155: AB_1078592" "unprognostic (6.95e-2)" "unprognostic (9.85e-2)" "unprognostic (1.02e-2)" "unprognostic (3.78e-2)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (2.47e-3)" "unprognostic (7.23e-2)" "unprognostic (1.78e-1)" "unprognostic (1.56e-3)" "unprognostic (8.82e-3)" "unprognostic (3.64e-1)" "unprognostic (1.39e-2)" "unprognostic (1.05e-1)" "unprognostic (4.98e-2)" "prognostic favourable (8.57e-4)" "unprognostic (1.62e-1)" 24.9 25.4 12.7 15.1 14.3 28.9 17.1 15.3 14.9 21.3 31.5 10.0 14.8 28.5 21.3 18.4 26.9 15.1 14.2 14.7 12.5 12.5 36.3 39.1 16.6 17.0 17.6 8.8 23.1 16.1 15.2 22.8 21.9 15.0 22.3 20.9 10.3 18.0 14.3 19.2 19.5 48.9 22.3 22.7 23.8 17.8 8.4 14.6 21.1 22.5 21.2 18.2 20.8 17.6 28.1 24.0 17.0 27.8 27.1 30.6 17.1 12.1 17.8 15.2 10.4 19.5 19.5 13.1 21.6 18.6 20.0 17.2 17.0 16.9 16.7 14.6 21.8 17.6 25.4 24.2 26.1 12.3 16.1 12.3 10.0 25.4 30.7 36.2 18.1 15.5 20.0 27.3 23.3 25.3 17.4 8.3 24.3 14.3 17.0 26.5 42.3 27.9 14.6 16.0 2.1 29.1 22.6 8.9 11.5 9.6 15.9 0.1 9.7 13.7 21.8 14.9 15.0 17.7 19.8 14.7 25.8 9.9 16.6 12.7 11.7 6.7 17.6 17.0 30.6 25.6 22.2 28.1 27.5 29.7 22.5 23.7 28.2 26.9 3.3 27.1 27.8 24.0 22.5 17.1 12.7 14.3 15.3 14.9 12.5 12.5 17.6 8.8 15.0 14.6 PCDH1 pc42 ENSG00000156453 "Protocadherin 1" Q08174 5 141853111-141879246 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.7;HaCaT: 37.1;HUVEC TERT2: 19.5;RT4: 25.4;TIME: 25.3;WM-115: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.2;naive CD8 T-cell: 1.6" "Lineage enriched" "Detected in single" 6 "T-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047720, HPA050538" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" 270000 "Nucleoplasm, Cell Junctions" Nucleoli "HPA047720: AB_2680130, HPA050538: " "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (5.30e-2)" "unprognostic (4.61e-3)" "unprognostic (5.03e-2)" "unprognostic (4.16e-2)" "prognostic unfavourable (4.96e-5)" "unprognostic (1.98e-2)" "unprognostic (4.87e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (3.61e-4)" "unprognostic (2.43e-1)" "prognostic favourable (7.55e-5)" "unprognostic (2.05e-1)" "unprognostic (4.16e-2)" "unprognostic (3.13e-2)" "unprognostic (1.91e-1)" 22.4 4.5 14.8 7.4 17.6 1.4 19.0 16.1 25.6 8.3 22.2 7.3 11.4 20.6 7.0 7.0 26.9 9.7 6.8 8.9 11.6 7.4 14.9 13.0 18.9 3.4 8.8 16.9 2.5 11.0 1.3 5.2 32.5 9.2 11.1 14.4 6.0 23.7 12.3 7.4 17.3 15.8 7.5 7.5 1.6 22.8 1.5 9.8 0.0 9.1 3.9 8.8 8.6 11.7 0.0 0.0 0.3 0.0 0.0 2.2 0.5 6.3 0.3 2.7 2.9 0.1 0.0 1.9 0.0 0.0 0.0 0.0 1.5 29.7 0.0 15.3 0.2 37.1 3.4 2.7 0.0 0.0 0.1 0.0 0.1 0.0 2.5 0.0 0.1 0.0 6.2 0.0 0.4 19.5 0.0 3.2 0.0 5.1 0.1 0.0 11.3 5.1 0.1 0.0 4.3 2.2 25.4 0.3 0.6 0.1 8.1 6.5 6.5 0.1 25.3 0.0 0.2 0.0 2.3 0.0 0.0 0.0 0.2 0.0 18.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 0.5 14.8 17.6 16.1 25.6 11.6 7.4 8.8 16.9 9.2 9.8 PCDHAC1 ENSG00000248383 "Protocadherin alpha subfamily C, 1" Q9H158 5 140926369-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 12 "parathyroid gland: 33.3" "Cell line enhanced" "Detected in some" "A549: 8.5;EFO-21: 3.6;hTCEpi: 11.0;PC-3: 6.2;SCLC-21H: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA052775 Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA052775: " "unprognostic (2.52e-1)" "unprognostic (1.06e-1)" "unprognostic (3.32e-3)" "unprognostic (9.52e-3)" "unprognostic (1.36e-1)" "unprognostic (9.63e-2)" "unprognostic (4.27e-2)" "unprognostic (2.51e-2)" "unprognostic (1.17e-1)" "unprognostic (6.24e-2)" "unprognostic (2.09e-1)" "unprognostic (3.64e-3)" "unprognostic (1.04e-3)" "unprognostic (3.25e-3)" "unprognostic (1.35e-1)" "unprognostic (2.96e-1)" "unprognostic (3.29e-2)" 0.3 0.4 0.9 0.3 1.0 0.0 0.0 2.0 2.8 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.9 0.0 1.0 1.6 0.2 0.1 0.8 1.0 1.1 0.0 1.5 33.3 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.8 0.8 0.4 0.0 0.0 0.2 0.1 0.5 0.2 0.2 0.1 0.0 0.0 8.5 1.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.6 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 11.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 6.2 0.0 0.0 0.0 0.5 0.4 4.9 2.3 0.0 0.6 0.0 0.5 0.0 0.0 0.6 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.2 0.1 0.0 0.0 PDGFRL PRLTS ENSG00000104213 "Platelet derived growth factor receptor like" Q15198 8 17576433-17644071 "Disease related genes, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 14.3" "Group enriched" "Detected in some" 5 "AN3-CA: 48.4;BJ hTERT+: 39.2;HSkMC: 21.4" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052801 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted - unknown location" "Nucleoli, Golgi apparatus" Nucleoplasm "HPA052801: " "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (5.10e-2)" "unprognostic (1.59e-2)" "unprognostic (7.39e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (6.54e-2)" "unprognostic (3.86e-1)" "unprognostic (7.46e-2)" "unprognostic (1.63e-1)" "unprognostic (6.72e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (1.58e-3)" "unprognostic (1.26e-1)" "unprognostic (4.47e-3)" "unprognostic (6.00e-3)" 7.7 0.4 0.5 0.1 0.9 0.0 14.3 0.6 0.5 8.0 1.3 0.0 3.6 2.0 0.3 5.8 2.6 1.2 0.3 0.4 0.4 0.3 0.7 0.0 0.4 11.6 1.6 2.3 2.0 1.5 0.9 0.0 1.4 1.1 3.3 1.8 0.6 6.3 0.5 0.2 1.0 0.9 8.3 0.0 0.9 2.0 0.0 0.9 1.4 1.4 0.0 0.0 0.1 0.0 4.4 0.2 48.4 1.5 0.6 3.1 0.9 39.2 1.8 7.8 0.2 0.0 0.0 0.2 0.6 0.0 2.6 0.2 0.9 0.0 2.9 0.0 1.4 1.0 3.7 0.0 0.0 21.4 0.0 2.2 0.0 3.2 0.0 0.6 0.2 3.1 0.0 0.1 2.4 0.6 0.0 0.0 0.1 0.2 2.8 0.1 0.3 0.3 0.3 0.8 0.1 0.0 0.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 PELI1 ENSG00000197329 "Pellino E3 ubiquitin protein ligase 1" Q96FA3 2 64092652-64144454 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.7" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;U-698: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 33.9" "Group enriched" "Detected in all" 4 "granulocytes: 33.9;monocytes: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: " "unprognostic (3.33e-2)" "unprognostic (3.43e-2)" "unprognostic (1.79e-2)" "prognostic unfavourable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (3.12e-3)" "unprognostic (6.73e-3)" "unprognostic (8.01e-3)" "unprognostic (4.16e-2)" "unprognostic (3.52e-3)" "unprognostic (5.99e-3)" "unprognostic (3.33e-1)" "prognostic unfavourable (5.67e-6)" "unprognostic (6.72e-2)" "unprognostic (6.22e-2)" "unprognostic (8.88e-2)" "unprognostic (1.03e-1)" 15.7 5.1 10.0 15.1 20.5 105.7 22.3 15.1 8.9 9.9 14.5 11.0 3.3 9.9 14.5 7.1 26.4 8.0 14.9 11.6 11.3 6.8 6.7 8.6 20.1 16.8 15.6 5.2 4.8 6.2 11.0 14.8 13.7 10.8 7.6 11.8 6.0 12.3 8.5 4.5 17.5 17.3 8.4 15.0 17.8 10.2 7.8 12.8 19.9 6.3 10.2 19.3 14.1 14.8 3.9 2.3 33.9 9.2 1.3 5.0 2.5 1.2 1.0 13.7 9.1 1.6 1.2 3.1 1.7 2.0 1.6 2.6 21.3 1.5 17.5 4.3 0.6 2.1 4.1 3.8 3.2 4.3 3.3 1.6 0.6 3.4 4.8 1.7 3.1 1.6 3.0 2.4 8.2 9.0 0.9 4.4 1.3 0.1 3.7 2.5 8.9 0.6 4.7 4.7 9.9 6.6 3.9 6.3 8.8 1.3 2.0 4.7 1.1 1.2 6.4 1.5 2.2 1.5 2.5 10.1 0.9 53.0 0.8 1.5 4.0 5.1 6.5 6.3 0.4 6.1 0.7 3.9 2.2 0.9 2.3 2.4 2.7 1.1 33.9 1.3 9.2 0.2 5.0 2.5 10.0 20.5 15.1 8.8 11.3 6.8 15.6 5.2 10.8 12.8 PELI2 ENSG00000139946 "Pellino E3 ubiquitin protein ligase family member 2" Q9HAT8 14 56117814-56301526 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 20.7;MOLT-4: 23.2;REH: 11.4;SCLC-21H: 10.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 21.4" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053182 Uncertain Approved "Nucleoplasm,Nucleoli,Intermediate filaments" "Nucleoplasm, Nucleoli, Intermediate filaments" "HPA053182: " "unprognostic (3.26e-1)" "unprognostic (2.25e-1)" "unprognostic (9.21e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (1.68e-1)" "unprognostic (2.53e-2)" "unprognostic (3.36e-3)" "unprognostic (1.81e-1)" "unprognostic (2.68e-2)" "unprognostic (1.18e-1)" "unprognostic (2.14e-1)" "prognostic favourable (1.53e-6)" "unprognostic (3.64e-1)" "unprognostic (2.15e-1)" "unprognostic (5.43e-2)" "unprognostic (2.22e-1)" 12.3 3.3 5.2 5.6 4.6 16.5 8.7 21.4 6.5 7.5 9.4 5.4 9.7 11.1 9.3 7.1 4.7 5.9 11.5 3.4 4.6 4.5 9.7 3.1 7.3 4.8 5.2 3.9 16.0 38.9 1.7 5.5 3.3 4.4 8.2 4.2 9.2 7.6 12.4 3.8 6.5 12.6 17.7 5.8 6.6 14.1 10.0 4.2 38.2 4.9 3.4 2.6 13.3 14.9 0.9 2.0 9.0 3.0 0.5 0.8 1.1 0.0 1.9 5.5 0.0 3.1 4.6 0.1 0.7 2.5 0.5 0.0 0.1 0.4 0.1 2.6 1.5 0.5 4.2 0.0 0.2 1.3 1.5 4.7 8.5 0.0 2.6 0.7 20.7 2.9 0.2 0.0 0.0 1.0 3.5 0.1 0.6 0.0 23.2 0.2 9.0 0.7 11.4 0.3 1.0 2.2 9.3 10.9 0.0 0.5 0.0 6.1 0.0 3.8 0.3 1.6 2.8 0.5 2.6 0.4 0.0 0.6 2.9 3.2 1.6 1.4 3.0 3.5 0.5 1.6 0.8 0.2 0.6 0.3 2.0 0.9 0.4 0.3 9.0 0.5 1.2 0.5 0.0 1.1 5.2 4.6 21.4 4.4 4.6 4.5 5.2 3.9 4.4 4.2 PELI3 MGC35521 ENSG00000174516 "Pellino E3 ubiquitin protein ligase family member 3" Q8N2H9 11 66466327-66477337 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033750, HPA038875, HPA062281" Uncertain Approved Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Vesicles" Nucleoli "CAB033750: AB_2161361, HPA038875: , HPA062281: " "unprognostic (1.15e-1)" "unprognostic (1.58e-1)" "unprognostic (3.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.02e-2)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (1.94e-1)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (2.19e-3)" "unprognostic (7.91e-3)" "prognostic favourable (8.19e-4)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.01e-2)" 6.7 9.5 14.5 3.8 17.0 1.8 7.4 19.6 33.1 7.4 8.3 6.7 6.4 4.8 10.3 9.1 10.6 8.2 10.1 7.7 17.4 13.5 4.6 3.2 7.1 4.3 13.0 12.5 15.3 9.9 21.5 8.3 3.8 15.8 11.5 2.9 6.4 10.4 22.3 10.8 11.2 4.7 11.3 6.2 5.0 5.8 6.2 7.8 0.3 8.5 2.7 3.4 9.0 11.8 3.3 3.3 1.3 6.8 1.2 3.1 1.4 15.3 6.5 5.3 4.1 8.5 3.3 4.2 4.9 6.4 4.7 4.0 9.5 3.5 3.8 4.9 5.4 8.2 3.5 6.2 1.9 7.5 3.0 1.0 5.4 2.8 5.4 0.8 7.5 3.1 7.0 4.8 1.7 0.9 1.8 6.1 2.0 9.4 3.1 2.4 3.3 6.7 10.7 3.9 4.0 2.6 4.9 6.4 3.5 2.5 7.1 16.7 8.3 4.2 2.7 4.2 6.4 18.1 4.1 5.6 3.2 2.0 8.7 2.5 3.4 1.3 2.5 0.4 2.5 1.8 2.0 2.8 2.1 3.1 3.3 3.3 2.2 1.8 0.1 1.2 6.8 1.0 2.4 1.4 14.5 17.0 19.6 33.1 17.4 13.5 13.0 12.5 15.8 7.8 PFDN1 PFD1 ENSG00000113068 "Prefoldin subunit 1" O60925 5 140245039-140303121 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006499 Approved Approved "Nucleoli,Plasma membrane,Cytosol" 10000 "Plasma membrane, Cytosol" Nucleoli "HPA006499: AB_1079596" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.11e-2)" "unprognostic (5.66e-3)" "prognostic unfavourable (8.81e-5)" "unprognostic (2.12e-2)" "unprognostic (2.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (4.10e-1)" "unprognostic (8.60e-3)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.00e-1)" 36.1 24.8 39.5 18.8 38.8 26.4 25.8 28.5 48.7 23.1 27.0 29.3 15.8 20.9 28.2 29.6 26.8 22.5 18.6 46.7 38.2 34.7 32.7 20.2 24.2 21.6 38.8 35.3 20.6 18.1 26.5 19.9 26.9 45.6 24.3 23.0 19.8 23.1 24.4 69.5 20.9 22.0 32.1 37.1 23.1 19.2 19.6 24.1 23.7 24.4 28.7 25.5 23.0 19.2 38.9 36.3 45.6 46.4 39.5 45.1 37.2 38.5 18.1 32.4 18.6 21.2 21.8 31.3 52.8 26.3 40.7 45.3 38.6 24.7 26.0 53.4 28.1 14.4 23.4 51.9 47.9 27.5 23.6 23.1 18.6 24.9 24.9 47.5 18.1 23.2 27.6 34.5 36.4 44.6 20.7 17.1 34.1 17.2 32.3 32.6 21.4 27.2 22.8 46.1 19.1 45.4 17.7 18.3 19.4 39.6 34.8 30.2 23.7 28.1 57.3 28.7 28.5 16.9 47.2 16.6 42.7 67.5 29.0 31.4 33.3 43.2 31.1 45.6 33.4 46.4 35.3 38.9 38.4 38.4 36.3 35.9 38.5 34.6 5.1 39.5 44.1 33.9 45.1 37.2 39.5 38.8 28.5 48.7 38.2 34.7 38.8 35.3 45.6 24.1 PGAM2 PGAM-M ENSG00000164708 "Phosphoglycerate mutase 2" P15259 7 44062727-44065587 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043801, HPA050314, HPA060173" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol 60000000 Nucleoplasm "Nucleoli, Cytosol" "HPA043801: , HPA050314: , HPA060173: " 1.4 0.8 2.0 0.4 2.2 0.4 0.5 6.9 2.1 0.5 0.5 3.6 0.0 0.6 0.5 9.1 6.1 0.6 0.7 111.6 2.1 3.2 0.8 0.4 0.4 0.4 4.2 1.6 0.5 0.6 0.6 1.3 0.4 2.0 1.9 0.4 2.3 7.6 0.5 379.1 0.4 0.4 0.4 3.2 0.5 0.5 16.7 1.1 4.8 1.5 119.0 4.8 0.4 0.0 0.3 1.3 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 38.1 4.2 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 1.3 1.7 0.2 2.0 2.2 6.9 2.1 2.1 3.2 4.2 1.6 2.0 1.1 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 4.4" "Lineage enriched" "Detected in single" 5 "T-cells: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: " "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavourable (8.33e-4)" "prognostic unfavourable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 0.9 0.7 0.7 9.4 0.6 19.5 1.3 2.6 0.8 1.3 2.9 0.3 0.5 1.9 0.8 1.5 7.2 0.2 1.5 1.4 0.7 0.7 0.8 1.0 1.3 6.2 0.8 0.2 0.3 1.3 0.0 0.7 4.3 0.4 0.6 0.8 0.3 1.3 0.2 1.6 3.4 3.2 0.6 1.0 4.4 2.7 61.4 0.2 42.8 0.3 9.2 12.7 0.7 2.0 0.8 0.4 0.3 0.5 0.4 4.4 1.0 24.6 17.3 6.8 9.7 0.1 0.3 18.3 19.2 4.6 12.2 11.7 13.4 14.7 15.4 8.6 2.1 31.7 4.7 6.1 2.2 19.8 15.6 7.8 15.6 11.7 0.0 8.7 22.3 0.2 0.5 7.2 1.9 2.5 22.4 27.4 3.9 37.0 24.4 24.2 11.1 9.2 26.6 15.1 29.8 2.3 5.4 12.9 13.6 9.3 24.2 7.2 13.8 17.4 2.3 16.4 20.8 23.9 20.0 20.8 15.4 26.5 6.2 11.7 19.0 0.0 0.4 0.3 0.3 0.3 0.0 0.8 0.5 0.5 0.4 0.0 0.0 0.0 0.1 0.4 0.5 0.1 4.4 1.0 0.7 0.6 2.6 0.8 0.7 0.7 0.8 0.2 0.4 0.2 PNPLA3 "adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon" ENSG00000100344 "Patatin like phospholipase domain containing 3" Q9NST1 22 43923739-43964488 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 31.1;retina: 39.3" "Cell line enhanced" "Detected in many" "AF22: 13.3;LHCN-M2: 15.0" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA058058 Approved Approved Nucleoli,Mitochondria,Cytosol Nucleoli "Mitochondria, Cytosol" "HPA058058: " "unprognostic (4.74e-3)" "unprognostic (4.52e-2)" "unprognostic (1.76e-1)" "unprognostic (2.31e-1)" "unprognostic (1.36e-2)" "unprognostic (1.89e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.63e-1)" "unprognostic (2.93e-1)" "unprognostic (2.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-3)" "unprognostic (2.52e-3)" "unprognostic (5.91e-2)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" 2.8 0.4 0.5 0.7 1.0 0.3 4.0 0.3 2.4 0.8 1.3 0.4 0.0 1.0 0.5 1.9 0.4 1.1 0.5 0.9 0.8 0.6 4.6 31.1 1.4 0.4 0.3 1.8 0.5 0.2 0.6 0.2 0.4 2.2 0.2 0.2 39.3 0.9 0.2 2.2 5.3 0.6 0.2 0.5 0.6 0.3 0.5 0.3 0.0 0.2 0.0 0.3 0.2 0.4 1.2 0.7 1.8 0.6 0.9 0.8 0.0 3.9 1.2 13.3 5.4 3.8 4.2 0.4 2.4 1.4 3.3 7.1 3.8 7.0 0.0 2.0 4.0 3.3 8.3 3.9 2.7 0.0 0.7 0.2 3.1 7.1 6.1 0.0 0.2 4.8 3.0 10.4 0.5 0.4 0.0 0.0 15.0 0.6 0.2 0.0 9.1 0.0 0.0 7.2 0.1 1.4 0.2 1.2 0.1 2.7 1.0 3.7 4.2 4.5 0.4 1.3 4.0 0.1 0.1 0.0 0.0 0.0 11.4 0.0 4.7 1.5 0.6 0.4 0.5 0.4 0.3 0.7 0.4 0.3 0.2 1.2 0.6 0.8 1.8 0.9 0.3 0.7 0.2 0.0 0.5 1.0 0.3 2.4 0.8 0.6 0.3 1.8 2.2 0.3 PPDPF "C20orf149, dJ697K14.9, exdpf" ENSG00000125534 "Pancreatic progenitor cell differentiation and proliferation factor" Q9H3Y8 20 63520724-63522206 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 18.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040929 Approved Nucleoplasm,Nucleoli,Microtubules "Nucleoplasm, Microtubules" Nucleoli "HPA040929: AB_10794155" "unprognostic (3.75e-2)" "unprognostic (5.39e-2)" "unprognostic (4.37e-2)" "unprognostic (9.03e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-2)" "unprognostic (1.91e-1)" "unprognostic (2.00e-1)" "unprognostic (4.20e-1)" "prognostic favourable (3.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.03e-1)" "unprognostic (4.20e-1)" "unprognostic (2.09e-2)" 63.9 19.9 42.2 46.0 43.0 36.5 38.8 22.3 55.1 54.3 78.6 61.5 43.5 41.3 39.9 46.0 112.6 44.7 67.3 53.2 32.9 31.0 72.1 28.4 56.5 42.8 44.5 34.9 45.6 69.5 15.4 35.0 22.2 48.7 75.3 32.2 58.8 143.7 54.1 116.1 86.2 48.5 61.8 72.0 40.0 120.2 49.0 21.6 28.7 48.0 73.3 87.9 68.6 65.2 5.8 3.4 18.9 4.5 2.4 5.2 3.4 44.0 13.7 9.4 19.0 10.7 18.0 30.3 27.2 8.8 35.5 14.0 25.1 26.6 9.5 36.6 18.1 46.7 4.7 31.0 5.7 16.9 9.3 3.9 12.8 4.7 29.3 0.0 20.4 17.7 62.6 9.0 12.5 13.9 15.9 22.4 12.9 60.0 45.1 0.4 10.1 79.8 20.6 21.2 19.2 25.4 18.2 32.2 24.5 27.0 43.5 18.6 62.2 25.8 22.9 30.1 34.1 39.7 22.4 17.8 14.0 6.4 21.2 11.2 19.5 1.9 2.4 18.9 5.2 3.1 4.3 4.6 4.6 4.8 2.9 5.8 4.1 4.5 1.1 2.4 4.5 3.4 5.0 3.4 42.2 43.0 22.3 55.1 32.9 31.0 44.5 34.9 48.7 21.6 PPID CYP-40 ENSG00000171497 "Peptidylprolyl isomerase D" Q08752 4 158709134-158723396 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Protein transport, Transport" "Chaperone, Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019520, HPA019692" Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA019520: AB_1847400, HPA019692: AB_1847401" "unprognostic (4.26e-2)" "unprognostic (2.03e-2)" "unprognostic (8.91e-3)" "unprognostic (8.17e-3)" "unprognostic (1.50e-1)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.62e-2)" "unprognostic (4.72e-2)" "unprognostic (5.92e-2)" "unprognostic (4.54e-2)" "unprognostic (1.46e-2)" "unprognostic (2.66e-3)" "unprognostic (8.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.64e-1)" "unprognostic (1.09e-1)" 16.8 25.8 20.1 15.5 21.4 14.9 22.3 26.7 26.8 12.6 16.8 14.4 18.2 33.4 14.6 13.6 16.5 15.4 13.0 28.8 19.4 22.1 21.5 45.3 11.0 17.4 22.6 18.9 14.6 17.5 11.3 30.3 14.5 26.0 16.1 14.2 9.1 15.4 13.7 53.3 24.0 29.2 13.1 22.7 16.5 15.5 16.9 23.4 22.7 21.7 16.0 16.8 15.4 55.0 15.6 17.2 33.4 22.2 23.9 24.4 17.1 15.3 14.3 14.4 19.7 21.4 16.1 21.8 15.2 8.3 14.0 10.6 18.5 10.5 16.2 6.8 14.1 11.8 43.6 17.4 17.1 53.7 15.2 29.0 12.9 25.5 16.6 18.2 21.8 10.1 14.2 12.0 17.9 15.2 36.2 29.0 15.5 14.7 26.0 16.5 19.8 19.1 11.8 7.1 13.9 15.4 7.7 24.4 16.3 11.4 23.7 21.6 10.9 17.4 14.7 14.0 15.8 15.4 20.0 16.7 34.6 20.7 17.8 19.7 14.0 33.4 15.3 33.2 21.2 22.2 24.4 14.6 20.7 19.6 16.7 15.6 21.5 22.0 20.9 23.9 22.0 17.2 22.4 17.1 20.1 21.4 26.7 26.8 19.4 22.1 22.6 18.9 26.0 23.4 PPP1R1C Inhibitor-1-like ENSG00000150722 "Protein phosphatase 1 regulatory inhibitor subunit 1C" Q8WVI7 2 181954241-182131398 "Predicted intracellular proteins" "Cell cycle, Cell division" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.5;heart muscle: 27.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.0;HAP1: 1.2;MOLT-4: 2.1;SiHa: 1.3;U-266/70: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA055043 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoplasm "Nucleoli, Golgi apparatus" "HPA055043: " "unprognostic (1.70e-1)" "unprognostic (3.15e-1)" "unprognostic (4.54e-3)" "unprognostic (1.08e-2)" "unprognostic (1.36e-1)" "unprognostic (1.01e-1)" "unprognostic (2.44e-2)" "unprognostic (3.77e-2)" "unprognostic (6.57e-2)" "unprognostic (6.59e-3)" "unprognostic (1.13e-1)" "unprognostic (7.98e-2)" "unprognostic (3.70e-2)" "unprognostic (1.00e-3)" "unprognostic (7.68e-2)" "unprognostic (3.07e-2)" "unprognostic (9.75e-3)" 0.2 0.1 0.7 0.1 3.5 0.1 0.2 3.5 1.8 0.1 0.2 3.0 0.0 0.2 0.2 0.1 0.3 0.2 0.5 27.8 1.5 1.1 0.2 1.2 0.3 0.2 0.8 0.6 0.1 0.6 0.1 0.4 0.2 7.5 1.4 0.2 0.5 0.5 0.2 4.3 0.2 0.7 0.1 2.5 0.2 0.4 0.6 1.3 0.0 0.2 3.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 1.3 0.2 0.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.2 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.5 3.5 1.8 1.5 1.1 0.8 0.6 7.5 1.3 PPP1R3D PPP1R6 ENSG00000132825 "Protein phosphatase 1 regulatory subunit 3D" O95685 20 59936668-59940297 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 20.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041146 Approved Approved Nucleoli,Vesicles,Mitochondria "Vesicles, Mitochondria" Nucleoli "HPA041146: AB_10793870" "unprognostic (2.50e-3)" "unprognostic (3.55e-3)" "unprognostic (6.90e-2)" "unprognostic (1.23e-1)" "unprognostic (7.23e-2)" "unprognostic (5.87e-2)" "unprognostic (5.73e-2)" "unprognostic (2.39e-3)" "unprognostic (5.54e-2)" "unprognostic (3.27e-1)" "unprognostic (3.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.48e-2)" "prognostic favourable (9.14e-4)" "unprognostic (4.71e-2)" "unprognostic (1.47e-2)" "unprognostic (5.71e-2)" 8.2 6.1 9.3 8.2 9.5 9.9 17.2 8.6 9.5 9.1 8.2 6.4 7.1 9.5 9.0 6.5 13.3 7.4 6.5 11.3 8.4 7.8 7.8 2.0 10.0 16.8 9.5 5.4 8.8 17.5 13.3 12.1 9.8 9.3 12.0 5.6 7.6 9.1 11.2 12.9 9.1 10.1 7.1 8.9 11.2 9.6 4.7 6.6 4.0 8.0 8.8 8.9 9.1 8.8 0.7 1.2 6.0 3.5 0.8 1.0 0.4 4.0 2.4 1.7 3.5 3.8 4.0 14.2 5.3 5.8 6.5 3.1 3.8 5.5 1.7 6.6 4.4 11.8 3.5 3.8 4.2 3.9 2.7 4.4 3.3 2.0 3.5 1.8 12.5 2.8 10.4 2.3 2.0 3.5 0.8 0.4 4.1 6.1 1.5 5.8 1.2 5.9 1.9 0.8 2.5 4.3 6.4 3.2 2.0 6.6 20.0 5.7 7.3 6.5 3.8 3.8 1.6 4.0 0.8 1.4 3.4 0.4 2.8 6.4 2.3 0.6 1.6 6.0 1.0 0.7 0.9 0.7 0.7 0.8 1.2 0.6 0.9 0.6 4.2 0.8 3.5 0.5 1.0 0.4 9.3 9.5 8.6 9.5 8.4 7.8 9.5 5.4 9.3 6.6 PRDM5 PFM2 ENSG00000138738 "PR/SET domain 5" Q9NQX1 4 120684919-120922870 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 15.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "eosinophil: 9.1;neutrophil: 6.7" "Lineage enriched" "Detected in single" 29 "granulocytes: 9.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051406 Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nuclear bodies" Nucleoli "HPA051406: " "unprognostic (7.74e-2)" "unprognostic (8.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.09e-1)" "unprognostic (7.20e-2)" "unprognostic (9.30e-2)" "unprognostic (3.28e-2)" "unprognostic (4.52e-2)" "unprognostic (5.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.13e-1)" "unprognostic (3.00e-2)" "unprognostic (4.91e-4)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (5.56e-3)" 5.0 5.9 3.5 3.6 3.9 4.6 5.4 1.9 5.4 9.3 5.2 2.7 6.3 1.9 8.6 7.0 3.3 7.7 6.1 5.0 3.2 3.1 3.1 0.8 7.4 2.7 3.4 4.2 15.2 10.3 19.3 12.5 5.0 6.1 7.7 4.4 9.4 3.3 6.8 2.2 2.7 3.2 9.5 6.2 3.3 4.1 5.0 3.3 0.5 8.4 5.1 2.3 5.8 14.1 0.0 0.0 9.1 0.0 0.0 0.3 0.0 1.7 2.8 6.5 0.1 3.9 8.1 7.7 3.8 8.4 3.9 3.5 3.6 1.0 0.4 1.0 5.1 0.0 0.0 0.8 5.2 0.0 1.1 2.3 2.5 0.2 4.2 7.9 0.1 5.7 2.5 2.8 3.5 2.9 0.0 11.9 4.8 0.3 1.2 0.0 4.8 2.2 0.0 7.5 4.9 1.4 0.0 1.2 5.2 0.0 0.1 0.7 5.4 3.4 1.1 0.2 2.3 4.0 3.8 11.0 15.3 0.0 3.0 0.0 2.9 0.1 0.0 9.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 6.7 0.0 0.0 0.0 0.0 0.0 3.5 3.9 1.9 5.4 3.2 3.1 3.4 4.2 6.1 3.3 PRIMA1 PRIMA ENSG00000175785 "Proline rich membrane anchor 1" Q86XR5 14 93718298-93788481 "Predicted membrane proteins" "Neurotransmitter degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 26.2" "Cell line enhanced" "Detected in some" "HAP1: 7.3;Hep G2: 4.7;NTERA-2: 3.0;SCLC-21H: 12.9;SH-SY5Y: 7.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "Low region specificity" "Detected in all" "HPA046671, HPA060047" Approved Approved "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoli, Cytosol" "HPA046671: , HPA060047: " "unprognostic (3.60e-2)" "unprognostic (1.97e-1)" "unprognostic (7.54e-2)" "prognostic unfavourable (6.99e-5)" "unprognostic (1.03e-2)" "unprognostic (3.73e-2)" "unprognostic (1.07e-1)" "unprognostic (5.81e-2)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (8.94e-2)" "unprognostic (6.61e-3)" "prognostic unfavourable (2.62e-7)" "unprognostic (2.33e-2)" "unprognostic (2.67e-1)" "unprognostic (7.94e-4)" "unprognostic (4.57e-3)" 4.6 6.0 4.2 5.9 16.7 0.4 2.4 4.5 8.2 7.7 26.2 21.7 4.2 4.6 7.9 7.9 13.7 10.7 3.3 4.8 5.8 3.3 1.2 0.7 1.0 0.7 20.2 4.0 6.9 1.2 0.6 0.3 2.2 15.5 8.6 7.6 9.9 4.6 10.2 0.7 2.1 11.6 14.9 24.3 0.7 12.1 1.8 14.7 0.0 1.3 0.9 4.4 4.7 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.3 0.0 0.0 0.2 0.4 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.0 0.0 0.0 0.0 0.3 0.0 0.0 12.9 7.3 0.4 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 16.7 4.5 8.2 5.8 3.3 20.2 4.0 15.5 14.7 PRRG2 PRGP2 ENSG00000126460 "Proline rich and Gla domain 2" O14669 19 49580646-49591015 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.6;CAPAN-2: 12.0;RT4: 9.2;SK-BR-3: 10.8;T-47d: 11.6;U-266/84: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010702 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA010702: AB_1079693" "unprognostic (2.25e-2)" "unprognostic (1.04e-1)" "unprognostic (3.46e-2)" "unprognostic (1.04e-2)" "unprognostic (1.04e-1)" "unprognostic (7.55e-2)" "unprognostic (5.60e-1)" "unprognostic (1.55e-1)" "unprognostic (1.14e-1)" "unprognostic (1.77e-1)" "unprognostic (1.51e-1)" "unprognostic (1.67e-1)" "prognostic favourable (3.82e-9)" "unprognostic (4.89e-2)" "unprognostic (1.46e-1)" "unprognostic (6.58e-3)" "unprognostic (3.68e-2)" 0.9 0.4 0.5 1.1 0.6 0.0 4.8 1.1 1.3 4.0 14.3 0.4 17.5 8.3 1.9 9.6 13.7 3.3 9.8 0.7 0.5 0.4 15.0 12.1 5.2 0.4 0.7 0.4 1.9 13.4 13.8 16.1 8.6 0.7 5.4 5.3 0.7 24.9 14.6 1.2 10.1 23.2 1.4 0.5 1.0 7.1 1.7 0.4 2.1 21.9 9.8 7.8 4.2 4.2 1.2 4.2 2.1 0.9 0.0 1.4 0.4 8.6 0.3 0.2 0.7 1.1 0.0 3.7 0.2 0.0 0.3 0.3 1.7 12.0 0.5 1.3 0.1 7.0 0.2 6.8 0.3 0.8 0.9 0.4 0.5 0.6 0.7 0.3 0.9 0.7 6.0 0.2 0.2 2.7 0.2 0.6 0.0 1.9 0.1 0.7 0.5 1.1 0.2 0.3 6.7 5.3 9.2 1.9 0.2 1.0 10.8 0.1 11.6 0.1 0.4 0.7 0.5 0.3 0.1 4.2 14.0 0.4 0.1 0.3 0.3 0.0 0.9 0.4 1.4 0.1 0.7 1.2 0.6 0.6 0.1 0.7 0.8 0.7 2.1 0.0 0.7 4.2 0.6 0.4 0.5 0.6 1.1 1.3 0.5 0.4 0.7 0.4 0.7 0.4 PSTK "C10orf89, MGC35392" ENSG00000179988 "Phosphoseryl-tRNA kinase" Q8IV42 10 122954381-122997513 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037780, HPA037781" Approved Approved "Nucleoli,Nuclear bodies,Actin filaments" "Actin filaments" "Nucleoli, Nuclear bodies" "HPA037780: , HPA037781: AB_10670530" "unprognostic (8.95e-3)" "unprognostic (5.51e-3)" "unprognostic (1.37e-1)" "unprognostic (7.39e-4)" "unprognostic (5.21e-2)" "unprognostic (4.08e-3)" "unprognostic (1.60e-2)" "unprognostic (5.92e-4)" "unprognostic (3.55e-2)" "unprognostic (1.16e-1)" "unprognostic (6.22e-3)" "unprognostic (7.10e-3)" "unprognostic (2.39e-1)" "unprognostic (4.50e-2)" "unprognostic (4.92e-2)" "unprognostic (3.02e-2)" "unprognostic (5.55e-4)" 2.8 5.6 7.0 2.5 8.8 12.5 8.8 4.3 10.4 5.8 4.3 10.5 4.7 4.6 5.4 11.4 3.7 5.6 3.5 4.7 7.5 7.3 5.5 10.6 2.8 4.0 8.8 8.7 3.8 5.4 4.2 7.2 3.7 9.3 5.6 4.3 3.8 4.3 3.6 6.8 3.8 3.8 5.4 8.7 2.9 3.0 11.1 8.6 2.9 6.8 1.4 3.6 4.8 3.2 6.5 7.4 6.3 5.5 6.6 10.0 6.0 5.4 3.8 2.0 1.0 2.5 4.7 2.6 2.0 5.2 4.6 5.5 5.6 4.8 5.5 5.0 3.7 2.9 1.0 4.6 5.3 2.9 10.2 3.7 0.9 4.4 6.0 7.6 4.6 5.2 8.0 4.1 7.9 3.2 5.1 8.5 6.7 8.1 2.6 4.7 4.7 5.5 5.5 3.6 5.0 6.9 3.3 2.2 2.4 4.6 5.2 7.6 2.4 0.6 3.8 3.6 3.4 1.4 5.2 3.1 1.7 7.5 3.3 5.2 1.4 0.0 5.5 6.3 8.9 3.3 10.0 6.5 6.9 8.4 7.4 5.8 9.2 9.4 0.6 6.6 3.9 7.0 4.2 6.0 7.0 8.8 4.3 10.4 7.5 7.3 8.8 8.7 9.3 8.6 PURG "PURG-A, PURG-B" ENSG00000172733 "Purine rich element binding protein G" Q9UJV8 8 30995802-31033715 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7" "Cell line enhanced" "Detected in some" "AF22: 8.8;HEK 293: 4.4;HUVEC TERT2: 4.3;NTERA-2: 6.9;SH-SY5Y: 8.3" "Cancer enhanced" "Detected in some" "glioma: 1.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047746 Enhanced Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Plasma membrane" Nucleoli "HPA047746: " "unprognostic (3.37e-1)" "unprognostic (2.15e-1)" "unprognostic (6.69e-2)" "unprognostic (7.33e-3)" "unprognostic (3.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.51e-3)" "unprognostic (1.10e-2)" "unprognostic (1.49e-1)" "unprognostic (1.62e-1)" "unprognostic (4.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.27e-1)" "unprognostic (1.83e-2)" "unprognostic (5.30e-2)" 1.3 1.9 11.0 1.2 10.3 0.6 0.9 14.7 13.5 2.4 1.0 2.4 0.5 1.0 5.6 2.6 1.5 1.6 3.0 1.6 9.4 6.2 1.7 0.7 1.4 1.3 4.9 7.3 1.6 0.7 0.6 3.9 1.5 6.2 1.9 1.1 1.7 1.6 2.6 1.0 0.9 1.0 5.0 4.5 2.5 1.3 8.1 6.4 0.0 0.8 0.0 1.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.2 0.1 0.0 0.0 0.2 0.4 0.7 1.8 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 1.1 0.0 4.4 1.6 0.0 0.2 0.0 0.0 0.2 1.3 0.0 1.3 0.0 4.3 0.4 0.5 0.2 0.0 0.9 0.0 6.9 0.3 2.2 1.2 0.0 0.0 0.0 1.2 8.3 0.0 0.0 0.0 0.0 0.0 2.7 3.0 3.7 0.0 0.4 0.3 0.0 0.2 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 10.3 14.7 8.9 9.4 6.2 4.9 7.3 6.2 6.4 PVALB D22S749 ENSG00000100362 Parvalbumin P20472 22 36800684-36819479 "Predicted intracellular proteins" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 125.0;parathyroid gland: 137.5" "Cell line enriched" "Detected in single" 198 "RPMI-8226: 130.9" "Group enriched" "Detected in many" 10 "breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3" "Region enhanced" "Detected in all" "cerebellum: 125.0" "Cell type enriched" "Detected in single" 6 "neutrophil: 3.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.4" "Region enriched" "Detected in many" 5 "cerebellum: 2377.5" "Low region specificity" "Detected in many" "CAB002515, HPA048536" Enhanced Approved "Nucleoplasm,Nucleoli,Cell Junctions" Nucleoplasm "Nucleoli, Cell Junctions" "CAB002515: AB_563948, HPA048536: " "unprognostic (4.41e-2)" "unprognostic (1.60e-1)" "unprognostic (9.75e-2)" "unprognostic (1.79e-3)" "unprognostic (7.80e-2)" "unprognostic (2.49e-2)" "unprognostic (2.52e-2)" "unprognostic (6.53e-2)" "unprognostic (2.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.61e-1)" "unprognostic (2.13e-1)" "unprognostic (5.21e-2)" "unprognostic (6.92e-2)" "unprognostic (1.91e-1)" "unprognostic (1.65e-2)" "unprognostic (8.99e-3)" 0.9 0.8 1.2 0.9 3.9 0.8 4.3 125.0 47.2 0.8 0.8 6.6 0.0 0.8 1.1 0.9 0.8 0.8 0.9 0.8 4.5 9.4 16.7 1.8 1.2 1.2 28.6 2.5 0.8 0.8 137.5 0.2 1.2 22.9 0.9 0.9 27.3 1.2 1.0 5.0 0.8 0.8 0.9 12.6 1.2 0.9 1.1 1.2 0.0 0.9 0.0 1.4 1.2 1.0 0.0 0.5 3.4 0.4 0.0 0.3 12.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 130.9 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.3 12.2 1.2 3.9 125.0 47.2 4.5 9.4 28.6 2.5 22.9 1.2 PYCARD "ASC, CARD5, TMS-1" ENSG00000103490 "PYD and CARD domain containing" Q9ULZ3 16 31201485-31203450 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 130.8" "Cell line enhanced" "Detected in many" "MCF7: 33.9;NB-4: 53.4;THP-1: 39.4;U-937: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0" "Group enriched" "Detected in all" 6 "dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4" "CAB006853, CAB015948, HPA049074, HPA054496" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol 1100000 Nucleoplasm "Nucleoli, Cytosol" "CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506" "unprognostic (1.00e-3)" "unprognostic (2.62e-2)" "unprognostic (2.40e-1)" "unprognostic (4.67e-3)" "unprognostic (3.34e-1)" "unprognostic (1.87e-1)" "unprognostic (5.29e-2)" "unprognostic (2.88e-2)" "unprognostic (3.12e-1)" "unprognostic (2.33e-1)" "unprognostic (6.52e-3)" "unprognostic (3.88e-2)" "prognostic unfavourable (6.09e-7)" "unprognostic (4.45e-3)" "unprognostic (2.51e-1)" "unprognostic (3.61e-2)" "unprognostic (6.97e-2)" 11.6 4.4 3.6 16.7 4.6 22.4 8.6 3.6 3.3 8.2 26.8 6.8 4.1 38.7 5.4 7.9 20.7 6.8 8.5 6.6 2.4 2.6 5.6 6.8 15.0 32.8 6.4 1.8 6.6 6.1 1.3 3.2 6.6 4.0 9.7 4.4 4.7 9.6 5.6 3.5 31.2 29.9 3.5 6.4 34.1 13.3 3.7 3.3 20.6 5.5 22.3 26.3 7.9 11.8 17.1 66.8 130.8 90.4 16.0 16.0 53.1 5.6 13.3 0.1 0.0 1.3 3.0 0.1 2.8 3.9 1.8 1.2 0.0 7.1 2.3 0.0 2.7 15.7 0.6 10.5 0.0 17.0 0.0 2.2 1.6 4.3 4.6 19.8 15.7 3.9 5.5 0.8 0.1 3.8 9.7 3.6 0.5 33.9 0.0 53.4 3.6 0.0 17.2 0.0 7.4 0.1 5.5 0.1 0.0 2.4 0.0 2.7 3.3 39.4 2.5 0.1 0.2 2.3 0.0 0.1 0.0 0.0 1.3 24.4 0.0 37.8 90.4 71.4 15.1 87.5 9.5 17.1 12.7 15.5 66.8 15.2 8.9 12.3 130.8 16.0 85.0 61.0 16.0 53.1 3.6 4.6 3.6 3.3 2.4 2.6 6.4 1.8 4.0 3.3 RAC1 "p21-Rac1, Rac-1, TC-25" ENSG00000136238 "Rac family small GTPase 1" P63000 7 6374523-6403977 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035994, HPA047820" Approved Approved Nucleoplasm,Nucleoli,Cytosol 44000000 "Nucleoplasm, Cytosol" Nucleoli "CAB035994: , HPA047820: " "unprognostic (8.66e-3)" "unprognostic (2.47e-1)" "unprognostic (4.00e-1)" "unprognostic (2.40e-2)" "unprognostic (1.88e-3)" "unprognostic (4.06e-2)" "prognostic unfavourable (1.74e-5)" "prognostic unfavourable (4.59e-4)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "prognostic unfavourable (4.57e-5)" "unprognostic (3.63e-1)" "prognostic unfavourable (2.11e-4)" "unprognostic (1.95e-1)" "unprognostic (2.11e-2)" "unprognostic (4.13e-2)" "unprognostic (8.72e-3)" 45.2 35.0 71.0 28.4 64.0 24.4 46.5 42.1 93.0 48.7 58.9 75.5 22.5 51.6 48.7 49.5 93.4 47.2 40.0 48.4 73.8 59.8 47.8 42.9 45.6 38.3 76.7 60.9 45.1 29.2 51.0 25.2 55.8 54.9 40.5 64.0 37.2 43.3 48.9 57.4 58.6 49.8 57.3 88.2 35.0 49.7 28.1 47.1 41.3 40.9 42.8 50.7 52.2 54.0 11.0 32.0 49.1 31.9 7.3 11.8 10.7 73.9 33.6 34.7 37.7 41.2 52.7 20.7 41.7 51.3 55.7 56.8 32.9 70.0 20.9 27.1 58.2 52.8 37.0 50.6 71.4 9.7 30.7 21.0 27.2 23.8 49.6 18.9 17.2 35.1 45.3 40.1 45.0 49.0 37.4 16.5 60.0 53.9 10.4 44.4 62.2 40.3 18.4 35.3 30.6 71.6 46.9 26.3 44.3 29.4 107.9 33.5 60.8 56.9 51.4 36.6 55.1 44.8 48.1 12.6 13.8 19.6 33.7 36.1 69.3 7.6 31.9 16.4 7.2 22.2 4.5 11.0 8.1 9.2 32.0 11.0 9.8 6.5 49.1 7.3 22.1 18.2 11.8 10.7 71.0 64.0 42.1 93.0 73.8 59.8 76.7 60.9 54.9 47.1 RASSF4 "AD037, MGC44914" ENSG00000107551 "Ras association domain family member 4" Q9H2L5 10 44959407-44995891 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 21.0;RH-30: 53.4;RPMI-8226: 17.4;U-937: 27.3;WM-115: 17.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5" "Group enriched" "Detected in many" 9 "dendritic cells: 28.5;monocytes: 28.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA038834 Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA038834: AB_10795576" "unprognostic (1.83e-1)" "unprognostic (8.21e-3)" "unprognostic (1.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (5.14e-2)" "unprognostic (3.15e-2)" "unprognostic (2.18e-2)" "unprognostic (8.81e-2)" "unprognostic (4.83e-2)" "unprognostic (8.75e-3)" "unprognostic (4.20e-1)" "unprognostic (4.11e-3)" "unprognostic (4.02e-2)" "unprognostic (2.22e-2)" "unprognostic (1.42e-1)" "unprognostic (6.20e-2)" 23.4 5.9 16.7 17.0 25.5 6.0 8.4 12.5 36.5 3.6 8.2 26.7 12.1 11.2 2.6 14.9 4.3 3.3 9.0 29.1 16.6 15.1 37.2 10.5 9.7 14.1 34.5 9.7 3.0 11.5 2.2 8.4 10.4 19.4 4.5 5.3 8.4 14.0 9.9 7.6 2.9 10.8 7.0 21.8 12.6 4.3 5.7 31.5 1.2 23.0 2.9 7.4 8.3 3.9 0.0 28.5 0.9 28.3 2.2 3.0 13.8 0.4 0.1 1.9 3.8 6.0 0.3 1.3 0.2 0.3 0.6 1.1 1.5 0.1 0.0 0.7 0.2 0.0 0.8 0.9 0.9 11.9 0.0 0.0 0.0 12.4 6.3 0.8 0.0 4.4 0.0 0.6 0.0 0.9 0.0 21.0 0.9 0.0 0.9 13.6 0.3 0.4 2.5 53.4 17.4 0.1 0.3 0.3 0.2 0.0 0.1 0.6 0.3 10.4 0.2 0.1 1.2 1.0 2.0 0.2 0.2 0.0 6.3 27.3 17.7 0.0 28.3 0.0 3.0 21.7 0.0 0.0 0.2 1.3 28.5 0.0 0.2 1.0 0.9 2.2 11.5 0.7 0.1 13.8 16.7 25.5 12.5 18.2 16.6 15.1 34.5 9.7 19.4 31.5 RBL2 "p130, Rb2" ENSG00000103479 "RB transcriptional corepressor like 2" Q08999 16 53433977-53491649 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016547, HPA019703" Supported Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "CAB016547: AB_785011, HPA019703: AB_1856106" "unprognostic (1.51e-1)" "unprognostic (4.38e-2)" "unprognostic (4.00e-2)" "unprognostic (1.26e-1)" "unprognostic (6.88e-2)" "unprognostic (6.43e-2)" "unprognostic (5.03e-2)" "unprognostic (2.46e-2)" "unprognostic (1.04e-1)" "unprognostic (2.11e-1)" "unprognostic (4.70e-1)" "unprognostic (8.12e-2)" "prognostic favourable (3.57e-5)" "unprognostic (9.57e-3)" "unprognostic (1.02e-1)" "unprognostic (8.70e-2)" "unprognostic (7.51e-2)" 27.8 20.6 15.7 22.2 20.0 11.1 25.5 24.1 18.7 26.3 23.7 24.7 25.6 15.4 30.0 20.2 21.5 25.1 19.5 19.9 15.5 11.7 23.8 34.2 24.0 31.6 25.8 13.7 29.3 30.7 55.3 22.6 12.4 15.8 28.2 18.9 20.2 26.2 30.5 28.3 20.8 24.6 26.1 17.9 27.2 24.9 28.6 22.8 54.4 31.0 10.3 31.6 36.5 26.8 9.1 8.0 20.2 9.8 26.2 35.1 24.5 12.6 8.6 11.5 10.6 30.2 29.2 5.4 9.3 13.3 11.6 4.0 5.6 15.9 18.5 14.1 15.7 15.9 8.6 14.4 18.5 6.6 11.9 8.3 8.7 10.4 13.0 11.5 26.1 18.5 17.7 7.9 11.3 17.9 6.7 11.6 12.9 3.7 22.9 15.5 4.7 7.8 16.7 21.0 21.2 11.4 12.9 9.4 7.8 21.1 9.3 9.1 12.0 15.2 14.8 14.4 7.7 11.9 6.9 17.9 10.5 21.7 18.0 14.4 9.9 16.4 8.2 20.2 21.2 5.9 23.7 8.7 23.8 24.3 8.0 9.1 35.1 29.6 15.7 26.2 9.8 4.9 17.5 24.5 15.7 20.0 24.1 18.7 15.5 11.7 25.8 13.7 15.8 22.8 REXO2 "CGI-114, DKFZP566E144, SFN" ENSG00000076043 "RNA exonuclease 2" Q9Y3B8 11 114439386-114450279 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038450, HPA038451" Enhanced Supported "Nucleoli,Focal adhesion sites,Mitochondria" 390000 Mitochondria "Nucleoli, Focal adhesion sites" "HPA038450: AB_10672516, HPA038451: AB_10697391" "unprognostic (3.26e-3)" "unprognostic (2.36e-2)" "prognostic favourable (6.51e-4)" "unprognostic (6.84e-3)" "unprognostic (5.80e-3)" "unprognostic (1.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.78e-1)" "unprognostic (8.18e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-3)" "unprognostic (1.02e-1)" "unprognostic (1.73e-2)" "unprognostic (6.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.69e-2)" "prognostic unfavourable (6.70e-4)" 21.8 31.1 13.5 15.8 14.2 16.2 30.0 14.9 12.6 31.4 36.0 11.2 24.0 8.4 38.4 24.8 33.5 17.7 23.9 64.3 13.3 10.5 35.7 28.6 20.1 13.9 17.0 13.1 28.5 27.7 61.2 24.9 45.0 15.3 32.0 17.7 11.6 61.6 22.8 27.8 22.7 15.8 44.6 15.7 18.6 31.5 29.6 14.5 9.9 20.0 25.2 15.2 34.9 40.6 15.5 28.6 19.0 7.9 18.1 30.5 12.2 27.4 16.0 6.2 16.6 49.9 53.0 14.8 46.5 36.4 23.5 30.0 41.9 47.0 15.1 46.9 41.1 17.5 13.9 41.2 38.9 14.6 10.8 16.6 22.1 26.0 65.6 12.1 5.3 36.6 39.5 29.7 31.6 42.0 30.7 9.3 52.6 6.5 8.8 15.2 19.1 28.3 7.8 20.2 54.9 33.7 22.3 11.0 6.9 21.4 16.5 19.6 33.6 6.3 39.7 30.3 36.3 23.3 28.5 7.3 8.7 25.5 20.9 28.6 16.1 19.0 6.0 8.8 14.3 7.9 16.5 15.5 21.6 17.9 7.8 11.7 19.9 16.1 1.5 18.1 7.9 28.6 30.5 12.2 13.5 14.2 14.9 12.6 13.3 10.5 17.0 13.1 15.3 14.5 REXO5 NEF-sp ENSG00000005189 "RNA exonuclease 5" Q96IC2 16 20806429-20849668 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "blood: 33.9;testis: 119.4" "Cell line enhanced" "Detected in many" "K-562: 24.1;U-266/70: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 15 "basophil: 33.9" "Lineage enriched" "Detected in single" 39 "granulocytes: 33.9" "Low region specificity" "Detected in all" "HPA040755, HPA040868" Enhanced Approved "Nuclear membrane,Nucleoli,Endoplasmic reticulum" "Nuclear membrane" "Nucleoli, Endoplasmic reticulum" "HPA040755: AB_10965790, HPA040868: AB_10963549" "unprognostic (2.39e-1)" "unprognostic (2.09e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (5.63e-2)" "unprognostic (9.15e-2)" "unprognostic (6.24e-2)" "unprognostic (2.26e-1)" "unprognostic (1.80e-2)" "unprognostic (8.24e-2)" "unprognostic (4.72e-2)" "unprognostic (2.42e-4)" "unprognostic (1.01e-2)" "unprognostic (8.23e-2)" "unprognostic (2.00e-1)" "unprognostic (6.93e-2)" 0.8 0.7 0.7 1.4 1.9 2.6 1.0 1.0 1.0 0.4 0.6 0.6 0.2 0.7 0.9 0.8 0.6 1.1 0.7 1.1 0.6 0.5 0.5 0.5 0.6 0.7 0.4 1.2 0.8 0.6 3.3 0.4 0.4 0.6 1.4 0.8 0.7 0.8 0.7 0.4 0.6 0.6 0.7 0.3 0.3 1.6 119.4 0.4 4.1 0.3 0.5 0.9 0.8 0.6 0.0 0.3 33.9 0.2 0.8 0.7 0.1 6.3 3.5 5.7 2.5 2.3 4.8 1.9 4.2 4.7 4.7 5.3 2.6 5.5 3.9 6.8 3.6 3.2 4.3 1.9 5.0 4.0 3.1 6.4 5.4 3.6 0.5 9.5 9.4 2.2 0.8 5.5 7.2 1.6 24.1 17.3 11.5 8.2 1.5 7.2 3.1 3.7 7.7 10.6 6.9 1.4 2.1 5.1 5.7 4.0 5.4 1.3 9.2 8.1 0.8 3.5 3.1 4.6 5.1 24.9 16.8 1.5 7.3 12.3 3.3 33.9 0.2 2.2 0.1 0.0 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.1 0.1 0.8 0.1 0.1 0.7 0.1 0.7 1.9 1.0 1.0 0.6 0.5 0.4 1.2 0.6 0.4 RGS12 ENSG00000159788 "Regulator of G protein signaling 12" O14924 4 3293028-3439913 "Plasma proteins, Predicted intracellular proteins" Transcription "GTPase activation, Repressor, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054646, HPA067421" Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA054646: , HPA067421: " "unprognostic (2.08e-1)" "unprognostic (1.71e-3)" "unprognostic (7.50e-2)" "unprognostic (4.18e-2)" "unprognostic (1.65e-1)" "prognostic favourable (7.03e-4)" "unprognostic (3.43e-2)" "unprognostic (1.93e-1)" "unprognostic (1.76e-1)" "unprognostic (9.02e-2)" "unprognostic (1.70e-2)" "unprognostic (2.13e-1)" "prognostic favourable (8.43e-4)" "unprognostic (2.54e-1)" "unprognostic (2.60e-1)" "unprognostic (5.92e-2)" "unprognostic (1.11e-2)" 4.7 4.4 20.7 4.1 22.0 2.3 4.4 10.2 37.2 5.4 2.9 10.2 1.5 5.3 6.4 5.6 13.5 7.5 4.4 4.7 13.4 5.6 4.4 6.7 6.5 3.4 12.3 16.3 8.9 3.1 3.1 6.1 4.1 9.4 6.8 2.2 3.1 6.5 5.7 6.8 20.6 4.6 3.0 18.9 4.1 3.2 5.5 9.9 4.3 3.8 3.4 3.6 5.5 7.9 1.0 1.5 1.6 3.9 0.4 1.3 0.7 3.9 5.0 10.1 7.3 3.4 2.7 4.2 4.3 3.4 4.4 3.3 4.0 2.4 0.9 2.7 3.7 3.9 2.0 13.6 1.4 0.1 1.6 0.4 2.8 9.8 3.1 0.3 5.6 2.3 9.3 2.3 3.1 9.7 4.6 0.2 4.0 3.4 0.7 10.6 4.8 4.8 10.0 3.9 3.2 2.3 11.8 11.4 11.8 2.7 1.9 9.0 4.6 6.7 7.3 8.6 5.6 1.7 4.5 5.0 3.9 2.2 5.1 5.9 6.1 1.0 1.2 0.3 0.9 3.9 0.3 0.2 0.8 0.5 1.5 1.0 1.3 0.5 1.6 0.4 3.7 0.8 0.6 0.7 20.7 22.0 10.2 37.2 13.4 5.6 12.3 16.3 9.4 9.9 RGS6 ENSG00000182732 "Regulator of G protein signaling 6" P49758 14 71932439-72566529 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8" "Group enriched" "Detected in some" 7 "HEL: 8.1;Karpas-707: 29.3" "Group enriched" "Detected in some" 7 "glioma: 3.1;thyroid cancer: 1.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.6;T-reg: 1.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003067 Uncertain Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA003067: AB_1079807" "unprognostic (7.18e-2)" "unprognostic (7.78e-2)" "unprognostic (1.00e-1)" "unprognostic (6.85e-2)" "unprognostic (5.61e-2)" "unprognostic (3.80e-2)" "unprognostic (1.24e-4)" "unprognostic (7.83e-2)" "unprognostic (2.03e-1)" "unprognostic (8.17e-2)" "unprognostic (1.30e-1)" "unprognostic (2.06e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-2)" "unprognostic (8.06e-3)" "unprognostic (2.10e-1)" "unprognostic (3.68e-2)" 6.9 0.8 8.6 1.1 11.1 2.0 4.9 4.0 18.0 7.9 1.8 2.8 0.3 0.8 2.7 4.2 1.0 3.6 1.9 15.7 3.7 7.5 3.3 0.6 1.7 0.5 15.4 9.3 2.3 0.6 10.9 2.6 4.6 20.8 0.7 1.8 1.3 1.3 2.5 1.7 1.4 1.4 2.2 5.2 1.5 0.8 13.9 2.4 0.0 8.5 0.3 1.0 1.1 1.3 0.5 0.4 1.6 0.2 0.6 1.2 4.1 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 29.3 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.6 0.6 0.0 0.4 1.2 4.1 8.6 11.1 4.0 18.0 3.7 7.5 15.4 9.3 20.8 2.4 RHOJ "ARHJ, FLJ14445, RASL7B, TCL" ENSG00000126785 "Ras homolog family member J" Q9H4E5 14 63204114-63293219 "Predicted intracellular proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 15.2;HUVEC TERT2: 88.4;TIME: 23.5;WM-115: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003050 Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003050: AB_1079812" "unprognostic (7.24e-2)" "unprognostic (1.72e-1)" "unprognostic (4.37e-2)" "unprognostic (2.42e-1)" "unprognostic (6.71e-2)" "unprognostic (1.77e-2)" "unprognostic (2.89e-1)" "unprognostic (2.33e-2)" "unprognostic (2.19e-1)" "unprognostic (3.04e-3)" "unprognostic (1.42e-2)" "unprognostic (7.07e-2)" "prognostic unfavourable (1.31e-4)" "unprognostic (3.50e-3)" "unprognostic (4.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.06e-3)" 17.0 2.9 11.4 6.4 12.0 0.2 14.3 7.3 15.8 15.1 12.0 3.4 7.9 5.8 22.8 14.7 12.4 15.6 20.0 13.0 11.3 4.6 7.3 4.0 18.6 7.0 8.0 9.8 11.9 3.6 3.3 6.5 7.3 6.8 15.9 8.8 14.8 7.2 11.8 5.8 6.0 8.4 25.3 5.4 9.4 9.4 4.7 8.5 0.0 13.1 13.9 3.9 16.9 9.2 1.2 0.9 2.6 0.8 1.4 0.6 0.1 0.0 0.0 15.2 0.0 0.0 0.0 0.0 2.5 10.2 0.9 1.5 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 88.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 23.5 0.0 0.2 0.1 1.4 0.0 0.0 0.0 0.0 0.0 25.4 1.0 0.8 0.6 0.5 0.4 0.3 0.7 0.4 0.4 0.2 1.2 0.6 0.6 2.6 1.4 0.2 0.9 0.2 0.1 11.4 12.0 7.3 15.8 11.3 4.6 8.0 9.8 6.8 8.5 RIN2 RASSF4 ENSG00000132669 "Ras and Rab interactor 2" Q8WYP3 20 19886521-20002457 "Disease related genes, Predicted intracellular proteins" Endocytosis "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "PC-3: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 6 "dendritic cells: 1.2;granulocytes: 2.2;monocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034641 Approved Approved "Nucleoli,Golgi apparatus,Cytosol" Cytosol "Nucleoli, Golgi apparatus" "HPA034641: AB_10671230" "unprognostic (8.23e-3)" "unprognostic (8.09e-3)" "unprognostic (3.71e-2)" "unprognostic (1.97e-1)" "unprognostic (3.12e-2)" "unprognostic (3.86e-2)" "unprognostic (1.61e-2)" "unprognostic (3.69e-2)" "unprognostic (2.69e-2)" "unprognostic (1.78e-3)" "unprognostic (2.49e-1)" "unprognostic (6.27e-2)" "prognostic favourable (8.34e-6)" "unprognostic (3.10e-1)" "unprognostic (2.08e-2)" "unprognostic (8.02e-3)" "unprognostic (3.63e-2)" 19.2 6.7 9.9 6.1 8.7 4.0 24.4 4.3 10.2 11.7 21.6 9.5 7.6 10.5 12.7 6.6 11.1 9.7 14.7 13.7 10.0 6.2 12.2 4.6 26.8 4.3 8.3 4.4 12.7 5.1 4.2 4.9 16.7 9.3 8.0 10.4 16.5 12.0 11.3 10.9 6.6 23.4 13.2 7.7 17.5 6.5 3.5 9.9 0.3 13.1 5.5 3.7 9.9 15.6 0.3 1.2 2.2 3.3 0.1 0.3 0.4 3.4 11.2 2.1 6.7 12.3 7.5 6.9 2.7 11.5 2.9 1.7 5.3 3.1 0.0 12.2 7.0 12.4 0.1 17.8 3.3 1.4 0.0 0.0 1.9 0.4 2.7 0.0 0.0 11.0 3.0 5.6 6.2 15.9 0.0 0.2 8.8 2.5 0.0 0.2 0.3 24.8 0.0 7.4 1.8 3.8 4.8 1.8 0.4 2.7 11.0 0.0 1.0 0.9 17.2 6.2 1.4 3.7 4.6 0.0 0.0 0.0 4.0 0.0 0.9 0.6 3.3 0.2 0.2 2.7 0.2 0.2 0.2 0.2 1.2 0.3 0.3 0.3 2.2 0.1 2.8 0.6 0.1 0.4 9.9 8.7 4.3 10.2 10.0 6.2 8.3 4.4 9.3 9.9 RIOK1 "AD034, bA288G3.1, FLJ30006, RRP10" ENSG00000124784 "RIO kinase 1" Q9BRS2 6 7389496-7418037 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017866, HPA051446" Enhanced Approved "Nucleoli,Nuclear speckles,Cytosol" "Nucleoli, Nuclear speckles" Cytosol "HPA017866: , HPA051446: " "unprognostic (2.33e-2)" "unprognostic (1.24e-1)" "unprognostic (2.38e-1)" "unprognostic (1.03e-2)" "unprognostic (1.16e-1)" "unprognostic (1.51e-1)" "prognostic unfavourable (3.41e-5)" "unprognostic (2.23e-1)" "prognostic unfavourable (4.43e-4)" "unprognostic (3.45e-2)" "unprognostic (1.47e-1)" "unprognostic (1.87e-1)" "prognostic unfavourable (5.85e-5)" "unprognostic (2.33e-1)" "unprognostic (2.09e-1)" "unprognostic (6.12e-3)" "unprognostic (2.59e-2)" 13.8 10.6 7.7 13.2 13.0 17.5 13.1 12.2 13.5 12.7 11.6 7.3 4.0 7.3 15.4 6.0 15.6 12.3 8.5 11.8 8.0 8.1 8.7 11.7 10.1 14.2 11.6 9.4 13.8 15.3 7.7 17.8 13.9 13.3 10.7 9.6 7.2 10.2 10.3 18.8 12.5 9.9 15.5 9.4 14.4 10.3 21.3 9.2 19.2 10.1 14.7 16.8 10.9 12.6 15.4 14.9 7.7 11.1 18.6 15.0 8.2 7.5 4.4 7.1 16.7 11.1 9.1 10.9 9.5 6.4 8.9 7.4 12.8 3.9 19.7 16.9 7.7 7.7 17.9 7.6 11.4 13.0 19.3 10.5 7.1 13.7 9.4 30.2 13.8 6.7 10.6 9.6 19.8 7.8 26.8 4.6 8.3 9.9 20.5 14.3 15.3 10.4 15.8 9.3 21.4 5.0 7.4 23.7 11.7 8.0 4.8 13.8 7.3 10.0 7.8 9.8 7.4 6.4 14.3 6.4 12.1 29.3 3.0 15.6 14.9 7.7 8.5 5.9 11.5 11.1 13.8 15.2 11.9 12.1 14.9 15.4 13.7 15.0 1.7 18.6 9.7 12.4 11.3 8.2 7.7 13.0 12.2 13.5 8.0 8.1 11.6 9.4 13.3 9.2 RPL10A "Csa-19, L10A, NEDD6" ENSG00000198755 "Ribosomal protein L10a" P62906 6 35468408-35470785 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053803 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" 360000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA053803: " "unprognostic (5.47e-2)" "unprognostic (8.02e-2)" "unprognostic (1.45e-1)" "unprognostic (3.37e-1)" "unprognostic (3.40e-2)" "unprognostic (1.36e-1)" "unprognostic (3.34e-2)" "unprognostic (4.74e-2)" "unprognostic (1.52e-2)" "unprognostic (1.18e-1)" "unprognostic (1.37e-2)" "unprognostic (9.66e-2)" "prognostic unfavourable (3.77e-4)" "unprognostic (2.21e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" "unprognostic (9.72e-2)" 55.0 41.7 35.5 80.8 28.0 79.0 96.9 25.3 37.6 71.5 76.4 22.8 62.3 35.0 91.2 62.5 88.7 91.0 72.6 45.2 28.1 23.1 45.4 71.1 44.8 94.0 28.5 38.0 155.3 141.2 18.6 35.6 56.6 25.6 86.5 55.2 34.7 104.5 66.1 98.5 92.9 47.2 56.8 27.3 51.4 55.5 33.2 20.1 70.6 62.0 121.6 76.5 77.4 86.4 165.3 104.4 8.5 62.8 101.1 186.5 235.1 65.8 68.0 77.4 72.7 116.0 211.6 87.7 68.3 140.6 96.3 76.8 98.4 63.8 197.7 63.0 92.5 58.5 104.2 155.8 80.1 68.5 91.8 75.9 63.0 137.4 171.8 110.6 63.3 245.9 182.7 70.6 237.0 141.0 89.4 97.8 109.2 116.4 116.7 134.5 81.2 60.1 92.4 74.6 153.0 121.7 109.0 54.6 80.0 42.0 96.6 192.8 104.5 201.8 81.3 31.5 56.9 41.8 85.9 61.8 100.6 130.6 39.5 129.1 56.3 8.5 62.8 5.9 82.7 61.2 146.9 165.3 137.8 106.1 104.4 146.8 186.5 145.8 6.1 101.1 52.4 98.5 104.4 235.1 35.5 28.0 25.3 37.6 28.1 23.1 28.5 38.0 25.6 20.1 RPL13 "BBC1, D16S444E, L13" ENSG00000167526 "Ribosomal protein L13" P26373 16 89560657-89566828 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051702 Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" 53000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA051702: " "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.14e-2)" "prognostic favourable (6.26e-4)" "unprognostic (1.57e-2)" "unprognostic (3.68e-2)" "unprognostic (7.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.57e-2)" "prognostic unfavourable (6.64e-4)" "unprognostic (4.34e-2)" "unprognostic (7.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" 82.5 56.0 46.7 105.0 38.4 112.7 150.9 37.7 44.0 114.5 114.9 31.3 76.9 65.5 118.4 85.4 144.0 98.4 101.6 85.2 38.6 32.1 60.8 118.3 90.4 385.1 38.8 37.4 231.3 255.8 36.5 57.5 66.0 27.0 136.2 44.4 43.0 267.3 87.6 197.4 137.7 66.7 90.2 44.8 104.7 71.1 106.5 24.6 135.0 102.4 129.6 98.6 109.3 156.8 277.8 163.1 26.9 96.9 120.7 299.0 355.4 66.8 74.4 52.9 85.7 95.2 158.6 110.8 42.3 91.7 88.4 35.9 112.3 103.8 94.1 87.4 71.7 93.1 62.8 111.2 44.1 26.3 174.3 32.0 41.5 148.9 203.8 38.9 39.1 192.1 237.1 56.6 142.9 92.1 97.8 53.7 67.9 209.5 106.4 305.2 108.1 79.1 158.7 56.0 132.2 107.3 56.2 74.6 109.1 58.6 76.5 126.9 150.5 231.1 53.7 57.1 61.7 50.3 57.9 81.4 76.5 96.0 74.6 137.3 60.0 26.9 96.9 15.3 129.1 74.9 239.2 252.5 234.3 176.5 116.8 277.8 299.0 230.2 10.7 120.7 56.7 163.1 163.7 355.4 46.7 38.4 37.7 44.0 38.6 32.1 38.8 37.4 27.0 24.6 RPL18 L18 ENSG00000063177 "Ribosomal protein L18" Q07020 19 48615328-48619536 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "NB-4: 548.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046572 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" 100000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA046572: " "unprognostic (2.12e-2)" "unprognostic (1.86e-2)" "unprognostic (7.30e-2)" "unprognostic (2.57e-2)" "unprognostic (3.48e-3)" "unprognostic (4.76e-2)" "unprognostic (3.21e-3)" "unprognostic (2.80e-1)" "unprognostic (2.39e-1)" "unprognostic (9.15e-2)" "unprognostic (6.15e-2)" "unprognostic (1.80e-1)" "prognostic unfavourable (1.21e-4)" "unprognostic (2.40e-1)" "unprognostic (3.04e-2)" "unprognostic (6.36e-2)" "unprognostic (1.27e-2)" 56.2 57.3 50.3 79.1 40.8 122.4 84.9 35.2 51.1 89.8 76.6 44.8 60.8 66.1 100.6 56.1 129.6 78.2 99.2 43.4 38.3 33.1 56.4 101.9 62.1 194.1 40.3 27.0 206.5 260.5 19.8 57.1 74.8 26.8 100.5 39.6 54.6 136.7 62.3 78.8 108.6 60.5 69.1 39.7 88.7 64.0 45.8 28.6 114.9 115.8 116.5 122.2 91.2 90.5 137.1 84.5 19.0 57.5 71.1 144.1 148.6 57.1 89.2 32.9 57.0 33.5 66.1 48.0 26.3 43.8 54.5 45.9 80.4 53.2 83.7 27.6 25.1 47.4 29.8 59.7 20.8 35.6 103.8 30.3 41.7 76.8 67.8 42.1 47.3 77.9 87.7 29.2 39.4 53.6 42.7 73.7 34.2 72.6 66.2 548.2 52.3 44.5 69.4 26.4 75.8 44.1 70.7 46.7 60.9 23.7 83.6 79.3 47.1 82.1 30.5 40.5 45.0 25.0 60.2 61.3 71.4 49.9 25.4 65.1 47.6 19.0 57.5 12.2 65.7 47.6 115.3 130.3 116.4 88.1 79.2 137.1 144.1 113.9 8.6 71.1 37.3 84.5 89.6 148.6 50.3 40.8 35.2 51.1 38.3 33.1 40.3 27.0 26.8 28.6 RPL26 L26 ENSG00000161970 "Ribosomal protein L26" P61254 17 8377516-8383250 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 586.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030449, CAB037301" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "CAB037301: AB_796168, HPA030449: AB_10602125" "unprognostic (2.02e-2)" "unprognostic (3.73e-1)" "unprognostic (2.12e-1)" "unprognostic (2.76e-1)" "unprognostic (6.82e-2)" "unprognostic (1.39e-1)" "unprognostic (1.10e-1)" "unprognostic (3.95e-1)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (1.12e-1)" "unprognostic (7.15e-2)" "unprognostic (1.96e-3)" "unprognostic (2.73e-1)" "unprognostic (1.08e-1)" "unprognostic (5.44e-2)" "unprognostic (2.38e-1)" 122.5 64.5 70.2 102.5 49.8 132.2 170.4 44.4 52.4 127.6 131.6 34.8 68.1 53.1 76.4 97.0 161.2 87.6 98.6 68.1 54.8 42.5 100.6 138.3 97.5 117.5 61.6 32.6 183.0 586.0 32.2 41.1 82.2 47.7 129.0 84.0 41.5 95.3 87.4 170.8 106.3 98.6 103.6 62.9 129.0 75.9 53.0 45.1 104.9 131.6 145.8 107.9 154.7 127.6 154.9 120.8 25.1 92.1 93.0 158.2 165.0 101.9 93.8 92.3 109.2 174.4 287.2 90.3 88.6 131.8 120.3 90.9 99.1 52.5 178.2 101.9 104.9 113.3 117.4 181.5 141.7 66.5 211.4 69.5 103.6 114.3 203.9 103.2 90.2 244.7 363.4 99.6 299.5 148.1 78.7 53.7 126.3 70.1 113.8 141.3 86.8 62.3 113.7 93.8 110.8 161.7 76.6 38.4 82.0 47.7 89.2 204.8 91.2 138.3 92.8 48.7 60.8 67.1 155.0 43.2 50.4 77.9 79.7 146.9 72.1 25.1 92.1 18.2 89.9 78.3 130.5 154.9 134.3 116.8 120.8 140.1 158.2 136.0 10.9 93.0 69.5 104.5 111.3 165.0 70.2 49.8 44.4 52.4 54.8 42.5 61.6 32.6 47.7 45.1 RPL26L1 RPL26P1 ENSG00000037241 "Ribosomal protein L26 like 1" Q9UNX3 5 172958729-172969771 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 73.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030449 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA030449: AB_10602125" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (3.39e-2)" "unprognostic (4.12e-2)" "unprognostic (1.31e-1)" "prognostic unfavourable (2.49e-4)" "unprognostic (2.04e-3)" "unprognostic (2.45e-1)" "unprognostic (7.51e-2)" "unprognostic (5.86e-3)" "unprognostic (3.18e-1)" "unprognostic (1.06e-1)" "unprognostic (7.17e-2)" "unprognostic (2.55e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-3)" 11.2 23.0 17.9 14.7 17.9 18.0 15.2 10.5 21.1 13.1 12.8 8.2 14.4 13.5 14.5 21.6 18.1 14.7 11.9 19.5 20.7 16.8 20.0 25.9 10.5 16.7 16.2 18.0 14.1 25.5 9.1 15.4 14.2 16.3 12.1 14.6 11.5 18.4 16.7 19.0 9.7 10.8 14.0 12.8 13.3 12.2 73.6 11.8 20.0 16.2 18.2 14.9 13.1 11.9 19.7 40.0 17.5 36.2 14.6 21.7 20.9 29.6 26.9 24.4 33.5 16.9 17.9 31.7 28.4 16.7 41.1 36.7 32.8 32.0 22.4 73.0 38.9 19.3 40.2 56.4 38.0 28.5 52.3 16.5 31.6 40.1 33.3 24.0 14.7 22.3 23.9 42.3 29.7 23.5 22.6 18.9 29.2 65.9 29.3 38.0 15.5 42.9 21.4 37.8 29.7 23.9 18.7 24.6 15.1 26.0 23.9 37.7 29.3 25.9 24.7 47.0 26.1 27.4 21.3 16.9 26.3 41.8 37.0 30.2 27.8 7.8 36.2 15.5 14.3 31.4 18.3 19.7 17.4 19.6 40.0 15.1 14.5 18.4 17.5 14.6 26.8 27.5 21.7 20.9 17.9 17.9 10.5 21.1 20.7 16.8 16.2 18.0 16.3 11.8 RPL29 "HIP, HUMRPL29, L29, RPL29P10" ENSG00000162244 "Ribosomal protein L29" P47914 3 51993600-51995942 "Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 434.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA069064 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA069064: " "unprognostic (3.77e-3)" "unprognostic (2.72e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (2.89e-3)" "unprognostic (5.46e-2)" "unprognostic (6.79e-3)" "unprognostic (1.79e-1)" "unprognostic (2.16e-1)" "unprognostic (5.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (9.99e-2)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" 91.6 61.7 42.5 64.6 33.0 110.2 111.0 30.1 39.7 102.4 98.1 30.3 57.1 53.6 59.6 72.8 124.7 76.0 68.7 72.1 33.8 26.0 55.7 122.9 64.8 219.4 36.0 26.0 150.1 434.1 16.3 34.3 50.7 26.3 91.1 41.2 38.9 103.7 54.8 160.8 102.5 73.8 80.2 38.1 83.9 59.7 58.7 25.2 85.9 83.3 123.3 92.4 88.5 87.1 137.9 98.1 32.8 80.0 74.8 132.2 202.9 69.2 90.1 69.5 105.9 123.9 194.9 98.1 77.5 95.8 106.5 88.7 107.2 106.5 193.8 33.8 78.7 63.1 100.2 164.9 51.0 78.8 136.3 100.3 116.5 178.9 147.0 145.5 96.8 238.2 234.6 78.5 139.9 119.2 78.2 148.9 78.5 158.2 126.2 189.2 115.4 153.0 58.7 76.6 187.9 136.2 144.9 56.2 109.7 58.0 133.9 132.4 100.2 248.9 103.3 59.8 80.4 92.2 115.5 97.1 137.7 137.8 79.1 174.5 79.0 32.8 80.0 22.6 68.8 61.7 115.0 137.9 112.2 87.6 98.1 128.2 132.2 109.9 10.8 74.8 48.4 82.8 100.8 202.9 42.5 33.0 30.1 39.7 33.8 26.0 36.0 26.0 26.3 25.2 RPL34 L34 ENSG00000109475 "Ribosomal protein L34" P49207 4 108620566-108630412 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 400.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035139 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA035139: AB_10602925" "unprognostic (1.49e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-2)" "prognostic favourable (2.76e-5)" "unprognostic (2.45e-1)" "unprognostic (1.10e-1)" "unprognostic (2.78e-1)" "unprognostic (8.22e-2)" "unprognostic (7.14e-2)" "unprognostic (2.12e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (3.72e-3)" "unprognostic (6.17e-2)" "unprognostic (8.96e-3)" "unprognostic (2.71e-1)" "unprognostic (1.19e-2)" 68.5 52.6 65.9 77.6 63.7 118.0 165.2 43.7 52.9 82.0 70.1 25.5 57.5 47.3 106.0 111.1 76.4 75.2 61.9 59.2 53.7 41.4 60.2 98.4 56.1 110.1 54.6 49.7 157.4 305.1 17.8 68.3 63.8 59.0 74.3 61.0 35.2 129.9 60.2 87.1 77.6 57.6 87.5 57.5 70.8 60.3 43.2 32.2 63.3 82.2 109.5 95.4 67.6 102.3 300.5 153.8 56.2 116.4 134.2 331.0 400.6 58.6 42.9 77.9 110.7 169.1 267.7 76.7 90.7 115.2 74.8 62.7 108.6 104.4 178.5 54.6 88.1 41.9 83.7 141.4 98.3 65.8 134.1 74.5 90.1 166.2 142.4 186.8 83.5 238.0 202.1 61.1 139.0 134.5 130.5 102.5 123.2 114.0 114.4 228.2 89.3 86.8 105.2 83.7 108.1 156.2 99.0 83.6 107.1 37.0 216.2 127.0 71.9 170.9 99.3 51.3 69.6 53.6 80.1 76.6 99.9 143.9 69.9 116.8 62.7 56.2 116.4 35.6 122.0 86.8 207.8 300.5 247.8 165.5 121.2 257.1 331.0 244.9 24.9 134.2 74.9 153.8 176.2 400.6 65.9 63.7 43.7 52.9 53.7 41.4 54.6 49.7 59.0 32.2 RPL5 "L5, PPP1R135" ENSG00000122406 "Ribosomal protein L5" P46777 1 92831983-92841924 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Cancer-related genes, Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA043717, HPA054444" Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" 130000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA043717: AB_10964719, HPA054444: " "unprognostic (5.81e-3)" "unprognostic (3.96e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (9.44e-3)" "unprognostic (1.96e-1)" "unprognostic (1.03e-3)" "unprognostic (9.95e-2)" "unprognostic (8.68e-2)" "unprognostic (1.23e-1)" "unprognostic (3.98e-2)" "unprognostic (3.48e-1)" "prognostic unfavourable (6.81e-5)" "unprognostic (2.26e-2)" "unprognostic (3.12e-2)" "unprognostic (1.09e-1)" "unprognostic (3.97e-1)" 119.4 80.3 50.0 70.0 50.1 113.8 140.5 46.9 46.8 158.6 111.4 45.0 75.1 61.7 135.2 114.6 159.4 100.5 73.1 73.0 43.5 43.1 99.7 114.9 89.9 148.2 54.5 36.2 296.8 306.5 40.8 90.3 90.2 44.3 175.4 78.8 64.3 121.5 73.2 109.1 97.8 95.3 153.4 61.9 130.1 90.0 68.8 45.7 156.6 210.0 97.7 118.9 191.2 146.6 104.5 85.2 12.8 45.9 72.4 143.0 142.1 116.8 50.2 89.5 75.5 116.4 235.3 143.6 69.9 93.6 87.1 62.4 133.0 51.1 220.5 112.3 78.5 74.7 102.6 131.0 111.3 69.8 140.4 114.4 83.6 122.4 139.7 175.1 48.2 192.4 206.7 77.3 170.2 120.2 141.6 116.3 99.7 66.3 139.4 198.6 138.2 94.9 128.1 173.4 142.4 105.6 97.3 76.3 91.3 45.5 127.1 203.3 70.0 240.9 73.0 44.0 80.4 83.1 126.0 72.0 68.3 149.2 29.8 151.0 29.8 12.8 45.9 7.2 60.9 44.8 122.1 104.5 111.5 91.6 85.2 88.4 143.0 123.9 4.4 72.4 38.3 71.1 83.2 142.1 50.0 50.1 46.9 46.8 43.5 43.1 54.5 36.2 44.3 45.7 RPL7 "humL7-1, L7" ENSG00000147604 "Ribosomal protein L7" P18124 8 73290267-73295789 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 536.3" "Cell line enhanced" "Detected in all" "SK-BR-3: 627.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA058373 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" 170000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA058373: " "unprognostic (3.75e-1)" "unprognostic (3.60e-2)" "unprognostic (6.99e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (7.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.41e-2)" "unprognostic (8.31e-2)" "unprognostic (4.78e-2)" "unprognostic (1.76e-1)" "unprognostic (3.09e-1)" "unprognostic (1.63e-2)" "unprognostic (9.89e-2)" "unprognostic (5.52e-2)" "unprognostic (3.14e-1)" "unprognostic (2.31e-1)" 54.7 36.5 54.6 37.9 49.3 67.6 86.9 55.9 54.1 57.5 46.2 36.4 41.0 33.6 54.9 50.6 59.5 50.6 26.5 36.7 32.1 22.0 46.4 67.6 40.3 53.3 55.9 20.5 125.8 87.5 22.9 67.7 33.4 55.0 43.6 44.9 44.1 51.8 36.6 61.9 72.7 37.0 49.5 46.9 46.5 51.2 135.1 54.9 33.7 42.6 69.0 66.6 50.8 58.5 338.1 231.5 66.1 171.7 205.0 464.0 536.3 98.1 71.3 76.7 92.3 156.6 200.7 75.5 107.9 86.8 73.7 58.3 85.7 102.8 292.0 88.3 87.0 94.2 101.2 137.7 115.1 78.5 84.0 159.8 93.3 88.2 94.1 112.6 82.0 187.8 162.8 68.2 213.6 119.5 142.4 110.8 104.6 83.3 178.7 172.3 89.4 76.7 120.9 87.9 113.8 114.9 98.5 106.2 77.4 50.7 627.9 151.0 158.7 148.1 112.1 56.7 86.8 72.1 99.6 64.1 90.8 188.4 59.3 139.9 93.1 66.1 171.7 41.1 179.1 138.9 322.3 338.1 314.4 232.5 231.5 282.6 464.0 327.0 22.3 205.0 118.6 192.4 237.0 536.3 54.6 49.3 55.9 54.1 32.1 22.0 55.9 20.5 55.0 54.9 RPL8 L8 ENSG00000161016 "Ribosomal protein L8" P62917 8 144789765-144792587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 322.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045095, HPA050165" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Cytosol" 240000000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA045095: AB_2679213, HPA050165: AB_2681038" "unprognostic (2.52e-2)" "unprognostic (2.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (9.84e-2)" "prognostic unfavourable (7.22e-4)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.54e-1)" "unprognostic (9.28e-2)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (2.31e-1)" "unprognostic (4.13e-2)" 65.9 45.5 32.1 53.7 34.7 120.1 115.2 31.0 61.9 63.9 78.4 26.4 51.1 95.2 106.4 57.1 76.0 51.2 68.9 78.7 27.2 23.6 48.2 62.6 54.5 169.4 29.0 28.8 125.7 349.6 11.8 45.2 38.4 28.8 61.3 15.7 45.6 174.7 57.3 202.1 89.0 82.8 84.9 29.2 79.7 96.4 48.9 17.0 61.2 73.2 103.2 72.8 64.7 100.0 174.8 117.5 31.1 82.7 77.9 136.8 251.3 120.4 142.3 10.2 44.2 11.4 26.0 97.8 87.3 16.5 26.7 19.0 124.2 65.2 162.1 126.4 10.3 73.0 13.3 30.4 4.9 70.4 161.9 96.2 109.6 87.5 28.6 63.0 52.5 28.0 34.7 12.0 20.6 19.6 129.5 37.6 11.3 322.1 89.9 85.4 95.0 161.3 88.2 58.9 152.4 14.2 91.4 62.3 104.0 83.8 45.7 119.9 105.8 61.0 78.4 35.5 135.2 74.1 104.9 68.8 58.7 140.2 70.7 104.8 48.6 24.1 80.3 31.1 70.5 82.7 117.9 166.8 119.3 86.9 117.5 174.8 136.8 105.0 9.8 77.9 78.5 64.5 113.8 251.3 32.1 34.7 31.0 61.9 27.2 23.6 29.0 28.8 28.8 17.0 RPL9 L9 ENSG00000163682 "Ribosomal protein L9" P32969 4 39452521-39458949 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA003372 Approved Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" 24000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA003372: AB_1079843" "unprognostic (1.08e-3)" "unprognostic (2.14e-1)" "unprognostic (1.24e-1)" "unprognostic (8.06e-3)" "unprognostic (5.59e-2)" "unprognostic (1.27e-2)" "unprognostic (3.16e-2)" "unprognostic (2.14e-1)" "unprognostic (8.58e-2)" "unprognostic (6.68e-2)" "unprognostic (2.50e-2)" "unprognostic (7.85e-2)" "prognostic unfavourable (7.34e-4)" "unprognostic (1.34e-1)" "unprognostic (2.10e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-2)" 52.6 35.2 42.2 73.9 44.4 179.1 202.3 35.7 51.6 63.0 59.8 34.5 42.2 69.8 50.4 226.8 49.9 48.1 69.7 58.2 42.3 27.6 47.4 73.2 35.8 48.7 34.7 51.7 158.5 126.2 37.4 44.7 38.7 42.5 47.8 59.1 31.7 93.7 71.4 66.3 62.9 38.8 49.5 34.0 45.2 46.5 56.9 25.9 36.0 63.2 70.1 59.0 46.0 56.6 118.3 72.5 26.2 41.4 63.0 145.0 148.9 3.2 2.8 122.4 2.8 6.6 9.0 4.7 57.6 87.0 71.9 54.6 8.0 65.4 142.9 6.6 57.9 65.1 5.4 6.2 78.7 52.0 115.0 4.5 24.1 7.8 8.5 9.3 37.8 11.9 180.9 4.4 82.7 5.4 109.2 66.7 5.0 4.3 77.5 9.8 109.2 3.8 71.6 122.7 4.9 89.4 3.7 4.6 48.8 1.9 47.3 7.3 104.4 6.7 4.1 3.0 4.6 83.7 7.9 102.5 143.9 124.1 83.1 86.9 3.3 26.2 41.4 12.3 52.1 40.1 101.2 118.3 102.2 71.4 57.2 103.8 145.0 111.7 6.9 63.0 31.2 72.5 77.0 148.9 42.2 44.4 35.7 51.6 42.3 27.6 34.7 51.7 42.5 25.9 RPS11 S11 ENSG00000142534 "Ribosomal protein S11" P62280 19 49496365-49499689 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049719 Uncertain Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA049719: " "unprognostic (1.49e-3)" "unprognostic (3.71e-2)" "unprognostic (1.22e-1)" "unprognostic (1.50e-2)" "unprognostic (5.89e-3)" "unprognostic (3.57e-1)" "unprognostic (1.04e-2)" "unprognostic (4.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.47e-1)" "unprognostic (5.68e-2)" "unprognostic (1.49e-1)" "prognostic unfavourable (3.50e-7)" "unprognostic (5.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "unprognostic (1.71e-3)" 103.0 76.8 80.6 187.8 68.7 161.8 165.7 50.4 75.3 138.6 134.1 43.2 105.8 67.0 149.4 132.4 142.8 132.3 133.0 135.9 63.2 53.5 84.3 105.7 101.9 354.2 71.5 64.2 242.4 490.0 41.7 89.7 72.2 63.4 116.6 103.4 72.7 193.2 104.0 223.4 140.8 88.1 198.4 69.9 132.6 96.3 67.2 48.3 137.3 119.0 190.7 169.5 145.6 230.6 232.4 173.3 45.1 96.7 91.3 161.6 231.8 110.2 171.9 130.6 201.7 188.9 286.0 87.5 93.8 185.4 133.7 128.2 119.0 92.1 270.6 58.6 127.7 74.3 154.0 185.9 131.9 115.3 267.3 163.6 113.1 171.0 176.5 289.0 121.6 283.7 303.3 89.3 230.0 192.9 161.5 144.3 144.2 123.2 134.8 217.7 120.6 177.3 130.1 165.4 143.9 191.9 260.5 139.6 186.3 63.9 215.3 139.5 70.0 300.6 110.4 106.2 95.5 51.5 123.4 144.4 219.6 192.4 44.2 199.1 90.6 45.1 96.7 29.9 95.6 82.8 127.6 232.4 137.5 110.9 144.1 221.1 161.6 135.7 25.9 91.3 70.6 173.3 109.8 231.8 80.6 68.7 50.4 75.3 63.2 53.5 71.5 64.2 63.4 48.3 RPS17 "MGC72007, RPS17L, RPS17L1, RPS17L2, S17" ENSG00000182774 "Ribosomal protein S17" P08708 15 82536750-82540564 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 146.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055060 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" 39000 "Endoplasmic reticulum, Cytosol" Nucleoli "HPA055060: " "unprognostic (3.37e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-2)" "unprognostic (6.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-2)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (4.49e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (1.78e-4)" "unprognostic (2.83e-1)" "unprognostic (5.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.31e-1)" 40.1 37.3 23.9 41.5 28.0 78.5 93.7 20.5 39.7 41.3 35.4 18.0 32.7 12.0 34.4 69.6 58.2 48.5 36.3 36.2 24.9 16.0 33.0 56.8 30.4 75.5 22.2 22.4 100.0 160.7 8.0 28.1 28.7 29.1 32.2 54.1 21.2 64.2 38.1 47.5 60.8 33.0 54.2 26.6 40.9 38.1 29.3 19.2 36.1 38.5 85.2 82.2 34.1 55.8 42.1 34.6 12.5 19.7 26.5 48.5 63.4 10.2 74.1 23.9 15.5 40.5 56.4 18.6 5.6 10.4 17.7 16.3 105.6 33.8 14.7 10.5 22.6 32.5 57.7 57.2 32.0 8.9 146.2 2.6 76.6 70.9 55.3 12.9 14.1 72.5 105.7 21.9 75.0 37.5 10.0 39.1 27.3 82.5 16.6 45.7 36.0 59.2 11.1 6.1 26.3 52.9 93.5 17.4 11.2 2.2 31.4 30.9 38.2 39.9 9.7 27.7 20.2 17.1 12.3 11.8 18.2 12.8 22.6 33.5 15.1 12.5 19.7 4.5 16.6 17.2 43.6 39.9 41.3 26.8 27.2 42.1 48.5 42.4 2.5 26.5 14.8 34.6 23.7 63.4 23.9 28.0 20.5 39.7 24.9 16.0 22.2 22.4 29.1 19.2 RPS19BP1 "FLJ21770, MGC52010" ENSG00000187051 "Ribosomal protein S19 binding protein 1" Q86WX3 22 39529093-39532855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042874 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA042874: AB_10793988" "unprognostic (2.44e-1)" "unprognostic (1.67e-1)" "unprognostic (7.79e-2)" "unprognostic (5.07e-3)" "unprognostic (1.65e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (3.71e-4)" "unprognostic (1.65e-1)" "unprognostic (5.68e-2)" "unprognostic (8.31e-2)" "unprognostic (7.00e-2)" "unprognostic (6.73e-2)" "unprognostic (1.04e-1)" "unprognostic (6.11e-2)" "unprognostic (1.65e-1)" "unprognostic (2.34e-1)" "unprognostic (4.32e-2)" 32.8 38.8 38.9 29.5 30.6 36.9 47.5 24.2 34.7 26.4 28.0 19.2 40.6 31.4 18.8 25.2 24.1 18.0 25.0 30.5 38.9 28.4 30.8 40.7 22.5 29.4 40.3 27.0 23.4 45.0 15.4 18.8 21.9 31.9 31.6 14.4 19.2 65.2 35.4 55.0 19.8 30.9 28.5 31.1 27.1 32.6 28.8 24.6 16.3 40.8 28.0 23.7 24.3 54.5 64.2 73.5 67.3 57.7 42.8 60.3 50.5 21.2 26.3 12.6 17.8 14.2 9.3 26.6 24.4 19.9 21.4 17.0 29.0 14.0 26.6 25.5 14.4 17.2 19.9 25.0 7.4 38.2 63.5 25.5 22.3 25.6 20.9 37.3 33.3 13.9 18.9 18.3 22.5 14.5 28.5 19.2 13.5 23.5 17.8 37.2 22.0 50.3 28.4 16.5 39.9 22.3 21.0 28.2 15.8 19.8 31.5 43.8 22.7 30.2 17.2 17.8 40.7 19.9 31.8 33.5 30.7 41.2 24.2 25.9 41.6 42.1 57.7 67.3 53.4 52.1 49.2 62.0 54.4 55.2 46.3 64.2 53.2 54.1 63.4 42.8 42.0 73.5 60.3 50.5 38.9 30.6 24.2 34.7 38.9 28.4 40.3 27.0 31.9 24.6 RPS26 S26 ENSG00000197728 "Ribosomal protein S26" P62854 12 56041351-56044676 "Disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043961, HPA055803" Uncertain Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA043961: AB_10963579, HPA055803: " "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (3.36e-1)" "unprognostic (9.58e-2)" "unprognostic (3.74e-1)" "unprognostic (7.84e-3)" "unprognostic (1.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.25e-1)" "unprognostic (3.76e-2)" "unprognostic (2.49e-1)" "unprognostic (3.03e-1)" "unprognostic (2.06e-2)" "unprognostic (1.41e-1)" "unprognostic (4.40e-2)" "unprognostic (2.18e-1)" "unprognostic (7.99e-2)" 36.5 66.6 33.3 29.0 48.8 39.2 49.7 23.8 73.7 44.5 45.6 34.9 20.5 20.0 35.9 50.4 49.9 43.5 28.4 39.8 25.8 24.8 61.8 154.3 29.5 56.0 31.4 26.2 75.8 80.4 25.6 29.7 28.7 45.1 35.4 49.1 28.5 38.0 41.1 62.2 50.9 57.5 36.9 30.0 51.6 40.3 47.0 32.5 47.3 58.4 60.0 78.4 46.7 41.2 93.0 69.8 29.8 42.8 63.6 107.4 108.8 52.8 65.1 74.2 27.5 102.8 152.5 74.4 53.9 80.1 89.9 52.6 99.9 24.0 118.0 34.1 56.9 24.9 83.3 46.4 61.6 46.6 133.6 62.3 43.4 59.6 94.9 40.4 34.2 92.3 148.7 47.4 54.0 68.2 42.4 39.4 72.7 82.0 30.3 73.5 72.8 147.4 41.3 22.3 72.6 75.1 53.6 27.9 48.2 21.1 46.6 30.6 41.2 45.3 22.1 22.4 45.8 28.5 43.2 33.9 64.9 63.7 24.8 80.8 28.6 29.8 41.4 27.1 74.6 42.8 83.8 93.0 97.8 81.8 55.3 79.8 107.4 99.3 17.0 63.6 38.2 69.8 101.7 108.8 33.3 48.8 23.8 73.7 25.8 24.8 31.4 26.2 45.1 32.5 RPS27 "MPS-1, MPS1, S27" ENSG00000177954 "Ribosomal protein S27" P42677 1 153990755-153992155 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 778.4;lymphoid tissue: 769.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066851 Approved "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: " "prognostic favourable (9.69e-4)" "unprognostic (1.40e-1)" "unprognostic (2.34e-1)" "unprognostic (1.35e-1)" "unprognostic (1.01e-2)" "unprognostic (1.28e-1)" "unprognostic (8.62e-2)" "unprognostic (5.88e-3)" "unprognostic (2.05e-2)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "unprognostic (6.81e-2)" "prognostic unfavourable (4.86e-7)" "unprognostic (1.53e-1)" "unprognostic (1.71e-1)" "unprognostic (2.44e-1)" "unprognostic (8.81e-2)" 120.7 72.5 74.9 188.7 118.6 186.7 268.2 51.3 91.4 172.5 114.2 35.9 136.4 58.1 169.0 135.6 107.5 129.0 144.1 176.5 59.6 50.1 98.6 102.5 167.8 769.0 92.1 76.0 317.8 227.2 44.6 91.5 67.5 71.2 117.6 113.6 63.5 248.2 116.1 243.8 160.1 115.9 254.3 65.6 159.3 111.5 119.0 81.9 118.2 113.0 224.0 270.9 162.9 286.0 720.2 296.5 132.9 139.9 324.1 750.5 778.4 104.0 122.0 161.3 87.8 379.9 374.5 100.0 126.2 302.5 170.0 153.7 244.4 115.1 236.9 106.0 182.0 104.8 142.1 208.9 143.7 115.1 183.2 93.3 161.8 158.5 251.8 207.4 123.1 363.6 410.9 135.2 249.1 139.3 113.9 128.9 161.3 261.5 223.2 131.3 195.4 178.0 143.0 118.2 184.3 157.0 210.8 85.8 191.2 72.3 254.7 219.3 141.9 416.9 82.3 58.8 97.3 93.6 126.1 258.9 263.9 287.2 102.0 116.5 80.6 132.9 139.9 68.1 393.0 138.9 473.7 720.2 594.4 502.0 179.5 637.3 750.5 579.6 32.4 324.1 127.0 296.5 397.8 778.4 74.9 118.6 51.3 91.4 59.6 50.1 92.1 76.0 71.2 81.9 RPS27A "S27A, Uba80, UBCEP80" ENSG00000143947 "Ribosomal protein S27a" P62979 2 55231903-55235853 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033319, HPA041344, HPA049132, HPA054087" Supported Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Nucleoli, Endoplasmic reticulum, Cytosol" "CAB033319: AB_793618, HPA041344: , HPA049132: , HPA054087: " "unprognostic (7.32e-2)" "unprognostic (1.41e-2)" "unprognostic (1.11e-1)" "unprognostic (3.20e-3)" "unprognostic (2.16e-1)" "unprognostic (9.75e-2)" "prognostic unfavourable (2.26e-4)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (2.46e-1)" "unprognostic (6.89e-2)" "unprognostic (1.70e-1)" "prognostic unfavourable (2.60e-6)" "unprognostic (1.09e-1)" "unprognostic (8.82e-2)" "unprognostic (1.47e-1)" "unprognostic (3.60e-1)" 54.1 45.0 46.8 66.0 85.5 111.5 120.1 33.3 77.9 74.5 60.0 21.4 43.0 37.3 66.0 57.8 68.3 61.4 51.2 47.1 57.0 32.7 71.1 172.7 43.9 84.3 42.4 68.3 167.1 88.9 20.7 53.7 57.1 52.1 57.7 52.5 25.3 70.5 46.9 101.9 69.1 52.5 46.3 40.4 77.1 58.9 48.6 36.4 62.8 64.0 144.0 82.1 52.1 71.1 194.8 130.9 42.2 62.9 122.8 253.3 267.6 104.8 61.0 66.9 111.2 93.4 178.5 127.9 82.7 95.2 90.9 57.6 113.8 119.1 146.9 139.9 78.9 99.7 96.6 113.1 106.3 124.5 111.8 135.3 65.6 152.2 135.9 201.7 92.7 160.5 225.1 61.0 166.4 123.2 120.6 134.9 103.8 82.1 117.9 243.0 160.7 78.2 112.5 170.5 173.6 102.8 100.4 88.5 70.2 56.8 247.2 184.4 109.9 172.3 117.3 83.4 126.9 74.3 140.0 121.5 84.2 95.5 119.3 171.7 83.0 42.2 62.9 24.1 129.3 59.1 183.5 194.8 197.3 154.8 91.1 179.3 253.3 206.8 14.4 122.8 52.5 130.9 120.7 267.6 46.8 85.5 33.3 77.9 57.0 32.7 42.4 68.3 52.1 36.4 RPS27L ENSG00000185088 "Ribosomal protein S27 like" Q71UM5 15 63125872-63158021 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066851 Supported "Nucleoli,Endoplasmic reticulum,Cytosol" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: " "unprognostic (4.62e-2)" "unprognostic (5.81e-2)" "unprognostic (1.38e-1)" "prognostic favourable (9.08e-6)" "unprognostic (1.75e-1)" "unprognostic (7.24e-2)" "unprognostic (1.42e-3)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (1.80e-1)" "unprognostic (2.19e-3)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (5.31e-2)" "unprognostic (1.36e-1)" "unprognostic (1.97e-3)" "unprognostic (5.10e-3)" 46.8 64.2 21.3 19.8 29.7 18.2 53.6 16.3 23.4 29.4 58.5 15.5 30.4 46.0 30.2 49.3 40.4 27.0 38.3 47.1 22.8 22.2 61.0 75.2 31.7 23.4 32.6 19.2 26.5 65.9 19.2 38.8 35.6 43.9 56.2 55.3 18.3 99.8 46.0 47.1 18.1 80.4 54.8 39.9 28.2 41.9 15.7 27.3 19.4 53.9 25.7 19.8 55.0 36.3 34.5 30.9 51.5 47.6 27.2 75.4 38.3 17.1 48.0 43.5 11.7 63.7 75.5 43.6 54.2 38.7 11.9 29.2 8.8 23.9 16.1 19.4 51.8 6.6 14.7 26.7 20.1 11.9 19.9 13.3 40.5 62.7 73.4 10.5 36.9 59.0 35.9 26.9 20.5 67.5 12.2 16.2 99.3 23.7 13.5 16.5 12.8 14.0 10.6 20.9 18.2 33.5 34.7 6.3 9.6 19.7 8.3 38.3 18.4 24.5 71.4 63.3 59.6 13.6 24.0 18.3 15.6 14.3 67.1 29.2 57.0 51.5 34.3 40.0 27.5 35.9 33.9 34.5 41.6 32.0 30.9 26.9 32.9 33.1 11.4 27.2 47.6 30.8 75.4 38.3 21.3 29.7 16.3 23.4 22.8 22.2 32.6 19.2 43.9 27.3 RPS3A "MFTL, S3A" ENSG00000145425 "Ribosomal protein S3A" P61247 4 151099573-151104652 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" Differentiation "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 440.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047100, HPA053454" Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" 63000 "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA047100: AB_2679931, HPA053454: AB_2682156" "unprognostic (6.24e-3)" "unprognostic (3.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-2)" "unprognostic (5.46e-2)" "prognostic unfavourable (6.56e-4)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.27e-1)" "unprognostic (6.81e-3)" "unprognostic (2.36e-1)" "unprognostic (1.96e-1)" "unprognostic (2.00e-1)" "unprognostic (3.39e-1)" 71.7 46.9 48.4 69.2 47.7 124.7 160.3 40.4 43.5 114.1 98.4 30.4 61.9 45.0 75.3 84.4 142.8 73.3 53.9 51.1 36.8 33.3 72.8 94.2 79.4 102.5 42.6 43.5 179.5 143.8 18.1 49.3 70.5 38.0 113.3 62.4 39.0 113.8 48.5 116.8 97.1 73.5 62.0 43.1 94.2 64.2 61.9 30.7 120.4 126.8 111.6 90.6 111.4 86.3 211.6 187.7 44.3 92.8 142.9 282.7 440.7 79.4 58.5 111.6 109.6 143.6 281.1 113.9 84.8 130.9 120.2 74.4 113.0 116.2 360.7 42.4 92.4 52.8 113.1 141.5 114.2 79.4 109.4 77.9 72.3 130.5 166.3 184.8 80.8 208.5 292.1 73.9 196.6 142.5 125.2 188.9 142.6 118.7 199.5 219.6 104.7 45.3 146.2 108.9 120.6 139.1 96.6 107.3 106.2 38.1 139.5 186.6 93.3 224.7 86.5 58.8 77.8 64.8 93.2 146.9 236.3 220.8 75.5 135.0 69.6 44.3 92.8 27.2 120.6 74.5 203.9 211.6 203.1 157.9 156.5 185.7 282.7 226.9 15.1 142.9 62.1 187.7 145.5 440.7 48.4 47.7 40.4 43.5 36.8 33.3 42.6 43.5 38.0 30.7 RPS6KA3 "CLS, HU-3, MRX19, RSK, RSK2" ENSG00000177189 "Ribosomal protein S6 kinase A3" P51812 X 20149911-20267519 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003221, CAB003853, CAB013520" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553" "unprognostic (1.87e-2)" "unprognostic (1.03e-1)" "unprognostic (1.80e-2)" "unprognostic (4.26e-2)" "unprognostic (3.53e-1)" "unprognostic (1.11e-1)" "unprognostic (1.15e-2)" "unprognostic (1.61e-3)" "unprognostic (1.02e-1)" "unprognostic (1.57e-1)" "unprognostic (5.04e-1)" "unprognostic (1.07e-1)" "unprognostic (1.04e-1)" "unprognostic (4.49e-3)" "unprognostic (3.91e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-1)" 19.7 12.5 9.9 23.0 12.5 8.2 16.5 15.2 12.1 11.4 23.2 4.4 22.1 13.7 12.4 10.1 13.6 12.7 15.7 21.3 9.7 8.8 14.1 25.8 21.6 34.0 9.9 10.0 12.7 14.0 36.6 9.8 11.0 10.2 14.5 18.8 7.7 14.3 11.3 45.2 11.7 23.7 16.1 11.7 25.8 11.8 4.8 9.7 29.4 13.5 15.0 18.2 20.3 19.0 4.2 8.6 12.5 6.9 8.3 11.3 2.7 12.6 22.2 8.4 4.3 8.2 14.5 2.5 11.0 16.8 8.2 11.3 25.1 16.4 8.3 3.8 11.5 9.0 9.6 9.3 15.3 7.0 7.6 9.8 14.0 67.5 8.4 19.0 10.2 9.2 7.5 12.9 16.3 29.8 6.4 23.9 8.6 6.0 12.3 5.8 6.0 13.4 6.6 17.8 9.6 7.1 10.6 3.9 3.8 14.8 4.5 16.0 0.0 5.7 16.6 9.0 6.3 28.5 6.2 19.1 11.6 9.3 17.0 9.5 21.2 12.5 4.7 9.5 6.3 6.9 11.3 2.9 7.3 6.9 7.0 4.2 5.0 6.0 7.5 8.3 6.9 8.6 3.5 2.7 9.9 12.5 15.2 12.1 9.7 8.8 9.9 10.0 10.2 9.7 RPS6KA6 RSK4 ENSG00000072133 "Ribosomal protein S6 kinase A6" Q9UK32 X 84058346-84187907 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.7" "Cell line enhanced" "Detected in many" "NTERA-2: 10.8;PC-3: 11.7;RH-30: 14.4;SH-SY5Y: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002852, HPA003904" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria "Nucleoplasm, Mitochondria" Nucleoli "HPA002852: AB_1079854, HPA003904: AB_1079853" "unprognostic (1.17e-1)" "unprognostic (1.02e-2)" "unprognostic (3.44e-1)" "unprognostic (4.93e-4)" "unprognostic (1.71e-1)" "unprognostic (3.04e-3)" "unprognostic (2.09e-2)" "unprognostic (2.50e-1)" "unprognostic (2.86e-1)" "unprognostic (4.88e-2)" "unprognostic (3.38e-3)" "unprognostic (2.88e-1)" "unprognostic (2.12e-9)" "unprognostic (4.44e-3)" "unprognostic (1.30e-2)" "unprognostic (2.34e-2)" "unprognostic (8.49e-3)" 0.7 2.9 5.9 1.0 12.2 0.0 2.3 4.7 5.1 3.1 4.5 1.1 20.7 1.7 2.7 4.0 1.5 4.0 1.9 1.2 5.1 2.9 9.2 0.9 0.8 0.2 1.5 3.3 4.9 3.4 13.5 9.1 0.5 4.4 4.3 3.7 1.5 3.0 15.0 1.4 2.3 2.0 1.7 1.0 0.6 2.4 2.6 2.7 0.8 14.5 0.9 0.6 3.3 2.3 1.2 0.8 2.4 0.5 0.7 2.8 0.1 0.0 3.6 3.5 0.0 3.4 3.4 0.0 7.5 4.0 3.4 2.8 2.7 3.0 0.0 0.0 4.1 0.1 9.0 6.0 7.9 0.0 4.5 0.0 0.1 0.0 3.0 0.0 0.0 1.9 0.0 0.0 3.7 0.8 0.0 0.1 2.7 0.0 1.3 0.1 10.8 11.7 0.0 14.4 0.0 0.5 8.3 0.0 11.5 0.0 4.2 0.0 1.9 0.0 0.0 0.1 4.3 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 2.4 0.4 0.5 0.5 0.3 0.4 1.2 0.4 0.7 0.8 0.6 0.4 0.4 1.1 0.7 0.5 0.4 2.8 0.1 5.9 12.2 4.7 5.1 5.1 2.9 1.5 3.3 4.4 2.7 RRP15 "CGI-115, KIAA0507" ENSG00000067533 "Ribosomal RNA processing 15 homolog" Q9Y3B9 1 218285287-218337983 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024639 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Nucleoli "Nucleoplasm, Mitochondria" "HPA024639: AB_1844368" "unprognostic (2.68e-2)" "unprognostic (4.94e-2)" "unprognostic (2.04e-1)" "unprognostic (1.22e-1)" "unprognostic (5.19e-2)" "unprognostic (1.33e-2)" "prognostic unfavourable (4.26e-5)" "unprognostic (7.87e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (3.65e-3)" "unprognostic (2.54e-1)" "unprognostic (2.76e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-1)" "unprognostic (1.11e-2)" "unprognostic (3.23e-2)" 10.3 7.2 8.9 8.0 9.9 8.5 11.6 11.6 10.4 8.4 8.0 5.5 5.4 5.3 10.1 7.1 8.7 8.9 5.0 11.4 8.6 6.3 9.3 10.7 7.5 8.3 8.0 5.0 9.8 8.4 12.1 10.0 8.7 8.6 7.8 7.2 5.8 7.9 6.4 33.5 8.5 6.8 11.8 9.4 10.3 7.6 6.3 9.0 6.5 8.9 10.5 8.3 8.5 9.4 5.1 3.3 0.6 2.4 3.1 5.7 1.6 8.0 6.1 6.8 4.9 5.0 6.9 5.9 8.3 6.3 8.7 6.3 11.8 7.5 11.7 11.4 6.4 7.4 11.6 11.0 14.6 4.7 8.7 9.1 5.7 6.5 10.3 14.0 4.9 4.7 6.8 11.3 15.2 5.6 18.5 3.8 9.7 7.4 9.2 6.8 13.5 12.7 6.5 4.2 11.5 7.0 7.5 7.9 11.5 7.1 13.2 12.2 9.5 10.1 7.8 7.1 6.5 12.4 15.3 4.7 7.2 12.2 8.0 6.9 11.1 0.6 1.6 0.2 3.5 2.4 4.8 4.7 4.2 2.9 2.4 5.1 5.7 5.5 0.5 3.1 2.1 3.3 2.5 1.6 8.9 9.9 11.6 10.4 8.6 6.3 8.0 5.0 8.6 9.0 RRP7A "CGI-96, Rrp7" ENSG00000189306 "Ribosomal RNA processing 7 homolog A" Q9Y3A4 22 42509968-42519802 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001586, HPA046768" Approved Approved "Nucleoplasm,Nucleoli,Cell Junctions" "Nucleoplasm, Nucleoli" "Cell Junctions" "HPA001586: AB_1078506, HPA046768: " "unprognostic (8.46e-2)" "unprognostic (3.30e-3)" "unprognostic (5.96e-2)" "unprognostic (3.21e-3)" "unprognostic (9.71e-3)" "unprognostic (2.92e-1)" "prognostic unfavourable (1.21e-5)" "unprognostic (6.73e-2)" "unprognostic (3.00e-1)" "unprognostic (2.28e-1)" "unprognostic (2.41e-1)" "unprognostic (3.22e-2)" "unprognostic (9.53e-3)" "unprognostic (8.02e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-2)" "unprognostic (1.71e-2)" 10.4 12.9 19.9 15.4 26.6 16.5 13.5 18.5 20.9 12.8 12.2 15.1 9.4 10.2 12.0 47.3 15.1 18.9 12.0 11.1 17.5 14.8 14.0 18.1 11.3 21.5 14.8 9.3 21.2 12.0 16.6 10.3 17.7 17.4 17.8 10.8 12.6 15.2 14.6 13.5 14.9 13.3 11.9 11.7 15.6 12.0 11.2 18.6 17.4 11.6 8.7 16.4 10.7 11.0 26.2 30.5 17.4 27.5 15.2 18.4 20.3 12.8 18.1 10.0 11.7 6.4 4.3 20.2 11.0 6.6 14.2 12.1 23.1 7.4 21.4 5.6 7.8 14.3 11.4 15.2 6.1 5.4 23.4 11.7 12.7 12.4 6.1 27.9 10.1 5.4 7.7 19.2 9.8 8.6 16.4 6.2 8.4 26.1 26.8 11.4 8.3 13.2 46.7 10.2 9.5 7.4 15.8 5.4 3.9 8.0 23.2 10.6 9.5 12.6 6.4 10.9 14.0 8.3 11.1 9.5 7.1 25.3 9.0 10.7 15.5 10.0 23.5 17.4 18.4 26.4 17.7 20.5 16.1 16.8 18.1 26.2 17.7 16.5 4.7 15.2 27.5 30.5 13.5 20.3 19.9 26.6 18.5 20.9 17.5 14.8 14.8 9.3 17.4 18.6 RRP8 "KIAA0409, NML" ENSG00000132275 "Ribosomal RNA processing 8" O43159 11 6595075-6603620 "Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038487, HPA057562" Supported Supported Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA038487: AB_10672518, HPA057562: " "unprognostic (9.01e-2)" "unprognostic (5.84e-2)" "unprognostic (2.53e-1)" "unprognostic (1.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.72e-1)" "prognostic unfavourable (3.10e-7)" "unprognostic (4.64e-2)" "unprognostic (2.48e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.23e-2)" "unprognostic (3.81e-3)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.87e-2)" 13.8 11.9 13.9 15.8 14.8 32.1 17.9 18.1 15.3 15.9 24.9 16.1 10.5 14.0 15.5 21.3 13.8 11.9 15.4 16.2 16.0 10.3 13.3 24.7 14.3 16.0 18.4 13.6 12.4 12.7 12.0 12.3 12.8 14.2 19.8 14.4 11.8 10.9 19.7 18.6 15.5 12.8 19.5 11.0 17.7 15.1 12.3 18.6 11.8 14.2 9.7 16.6 20.2 13.9 13.3 14.4 20.3 12.0 14.4 13.8 10.2 10.2 10.2 4.1 5.3 8.6 7.5 5.8 5.3 6.6 12.3 11.6 10.5 12.0 14.4 5.2 5.0 10.4 11.7 9.3 13.1 6.9 16.8 6.8 12.3 11.8 9.8 12.3 9.5 6.4 12.2 5.8 10.7 12.6 13.4 8.4 9.7 12.7 11.9 18.4 10.1 9.3 10.7 3.3 3.2 11.5 8.2 6.3 7.4 7.6 15.5 8.6 8.4 10.8 6.5 11.7 5.4 11.3 10.2 9.4 8.5 13.7 9.9 12.4 7.5 20.3 11.0 10.7 13.7 11.8 13.2 10.9 13.5 12.6 14.4 13.3 13.3 13.8 4.4 14.4 12.0 11.0 12.6 10.2 13.9 14.8 18.1 15.3 16.0 10.3 18.4 13.6 14.2 18.6 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 29.1;testis: 22.1" "Cell line enhanced" "Detected in many" "MCF7: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.8 1.3 5.3 0.5 6.7 0.9 1.5 0.8 3.3 1.2 0.7 2.2 3.1 0.6 1.5 7.5 0.7 6.2 1.5 0.6 3.7 2.9 6.0 0.6 1.8 1.9 1.4 3.1 3.2 2.7 5.2 29.1 0.5 7.9 1.3 0.5 4.4 0.8 1.1 0.5 0.8 0.6 0.6 1.5 0.7 0.7 22.1 2.3 0.1 6.9 0.0 1.8 1.9 0.7 0.6 0.2 2.3 0.5 0.6 0.4 0.1 3.5 4.8 1.9 4.0 0.5 2.1 1.8 1.4 1.3 3.9 3.5 3.5 3.2 3.9 1.6 1.4 3.4 1.4 2.0 5.4 0.3 0.7 0.6 1.4 0.9 0.2 0.7 4.2 1.9 1.3 3.3 0.4 2.6 0.4 1.2 1.6 10.6 0.9 0.4 0.8 1.5 1.7 1.8 0.2 6.8 1.9 4.2 2.6 5.0 0.8 0.7 6.3 1.2 1.0 3.7 2.2 3.8 1.9 0.6 3.2 2.6 4.6 0.2 1.8 0.7 0.5 1.2 0.2 0.1 0.1 0.2 0.2 0.1 0.2 0.6 0.3 0.4 2.3 0.6 0.5 0.1 0.4 0.1 5.3 6.7 0.8 3.3 3.7 2.9 1.4 3.1 7.9 2.3 SAPCD2 "C9orf140, p42.3" ENSG00000186193 "Suppressor APC domain containing 2" Q86UD0 9 137062124-137070588 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Cell line enhanced" "Detected in many" "MCF7: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA044154 Approved Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA044154: AB_10959464" "unprognostic (3.68e-2)" "unprognostic (9.85e-2)" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.80e-2)" "unprognostic (1.27e-1)" "unprognostic (5.42e-8)" "prognostic unfavourable (5.88e-4)" "unprognostic (8.33e-2)" "unprognostic (7.47e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-1)" "unprognostic (9.83e-7)" "unprognostic (4.37e-3)" "unprognostic (4.62e-1)" "unprognostic (3.82e-2)" "unprognostic (1.35e-2)" 1.0 0.4 11.5 10.5 7.0 3.3 2.6 1.4 14.4 2.5 6.2 10.1 0.0 7.6 1.0 0.4 7.8 0.8 5.4 0.4 9.6 7.5 1.2 0.4 2.7 4.7 8.0 3.8 0.3 0.8 0.3 0.4 1.8 5.4 5.4 3.5 0.0 7.3 0.4 0.4 5.4 7.7 1.0 7.0 2.7 4.6 1.5 2.7 9.2 0.6 3.5 10.0 1.0 1.9 0.5 0.8 0.5 1.7 0.0 0.4 0.4 16.4 8.9 3.5 10.5 0.1 0.2 19.0 2.7 1.8 2.9 1.3 16.9 7.6 17.2 8.9 1.3 23.5 11.1 3.1 0.6 11.9 12.8 7.5 9.9 18.9 0.0 8.5 13.1 0.0 0.5 1.0 1.9 4.7 10.4 7.8 0.8 38.9 2.4 23.1 6.6 20.4 26.4 13.5 19.2 3.6 4.8 18.5 10.9 10.5 29.4 4.0 23.7 16.3 3.0 2.6 9.1 8.0 13.4 2.7 7.8 8.3 6.2 10.2 8.4 0.2 1.7 0.0 0.0 0.5 0.4 0.5 0.3 0.0 0.8 0.2 0.1 0.0 0.5 0.0 0.8 0.2 0.3 0.4 11.5 7.0 1.4 6.1 9.6 7.5 8.0 3.8 5.4 2.7 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649673 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "heart muscle: 67.3" "Group enriched" "Detected in some" 4 "LHCN-M2: 21.5;RH-30: 17.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0" "Low region specificity" "Detected in many" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.3 0.2 1.3 0.2 0.3 0.4 0.6 0.1 2.3 2.0 0.4 0.0 0.4 0.3 0.9 0.8 0.2 0.4 0.3 67.3 0.5 0.7 0.1 0.1 0.2 0.1 0.1 0.3 0.6 0.2 0.1 0.8 0.3 0.0 1.3 0.2 1.2 0.3 1.6 5.5 0.2 0.3 0.4 0.1 0.2 0.2 0.5 0.0 0.0 0.3 0.1 0.1 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.8 0.3 0.0 0.1 0.3 2.7 0.0 0.0 0.0 0.8 2.7 0.0 0.3 0.0 1.1 0.7 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.5 0.0 3.5 0.0 0.0 21.5 1.0 0.0 0.0 2.0 0.0 0.0 17.9 0.0 0.0 2.4 0.3 2.3 0.0 0.0 0.0 0.0 0.0 4.3 0.0 4.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.1 2.3 0.5 0.7 0.1 0.3 0.0 0.0 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61447529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 23.7 33.0 22.2 22.4 27.2 34.1 24.8 19.9 33.8 20.5 22.1 23.4 21.0 22.3 23.3 33.5 25.3 25.8 21.1 32.5 20.8 26.9 26.8 39.1 19.9 36.7 24.3 25.0 25.7 22.7 23.3 38.4 26.7 25.2 26.1 24.9 32.0 28.1 21.5 31.4 22.9 27.9 26.6 20.8 32.2 24.3 19.2 21.1 36.1 27.0 20.2 30.9 24.0 19.2 31.3 23.2 44.6 25.4 32.7 43.7 26.7 15.3 22.0 13.1 9.1 19.0 15.5 10.2 11.9 17.2 16.1 12.4 20.6 16.5 15.4 21.8 17.1 16.6 17.0 16.9 17.3 22.8 16.1 13.3 18.1 29.6 19.8 15.6 18.5 19.2 20.7 17.5 17.1 25.9 15.2 19.9 19.4 33.8 15.9 35.5 20.2 32.4 17.2 16.9 28.5 22.9 22.7 14.0 17.5 16.3 19.1 33.0 29.7 18.7 16.1 16.4 13.3 19.4 14.1 12.3 19.0 19.6 15.9 13.9 17.1 41.9 25.4 44.6 32.4 22.8 38.4 31.3 35.9 34.7 20.3 29.9 39.5 38.4 37.0 32.7 17.9 23.2 43.7 26.7 22.2 27.2 19.9 33.8 20.8 26.9 24.3 25.0 25.2 21.1 SH3TC1 FLJ20356 ENSG00000125089 "SH3 domain and tetratricopeptide repeats 1" Q8TE82 4 8182072-8241803 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 15.0;MOLT-4: 26.0;SK-MEL-30: 14.9;U-2197: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 14.5" "Group enriched" "Detected in many" 5 "B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6" "Low region specificity" "Detected in many" "HPA038132, HPA056807" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA038132: AB_10673041, HPA056807: " "unprognostic (2.46e-1)" "unprognostic (2.43e-1)" "unprognostic (1.61e-3)" "unprognostic (5.46e-2)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (1.04e-1)" "unprognostic (8.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.25e-1)" "unprognostic (1.46e-2)" "unprognostic (2.59e-2)" "unprognostic (4.24e-2)" "unprognostic (2.46e-1)" "unprognostic (3.77e-3)" "unprognostic (1.15e-2)" "unprognostic (4.29e-2)" 16.8 4.2 3.7 12.7 7.6 7.5 8.5 0.9 4.0 5.7 3.2 8.6 3.3 1.9 3.2 7.9 9.7 3.9 10.0 4.5 6.6 3.5 19.9 11.2 10.1 14.2 7.4 1.0 2.8 8.6 1.1 3.3 5.8 7.2 5.9 2.4 6.4 5.9 6.0 2.0 3.3 5.6 4.1 9.6 17.0 9.6 1.7 5.8 24.4 5.6 3.8 14.5 9.9 6.3 6.5 14.5 1.0 8.6 0.4 2.0 2.6 2.1 3.4 0.1 0.0 0.0 0.3 2.5 0.2 0.2 0.3 0.4 1.7 1.3 3.0 3.0 0.0 1.3 0.0 6.4 0.0 7.9 0.1 0.0 2.7 2.8 2.6 0.0 0.4 0.1 8.0 0.1 6.5 15.0 0.4 4.2 0.3 2.4 26.0 2.1 0.1 2.8 1.7 0.8 0.8 0.3 0.4 0.2 1.4 0.9 0.3 14.9 0.0 0.5 6.1 0.0 1.7 11.3 0.2 0.1 0.6 2.6 0.1 1.2 2.0 0.0 7.5 1.0 0.7 6.9 0.7 4.2 1.5 0.9 6.2 6.5 0.7 0.6 0.2 0.4 8.6 14.5 2.0 2.6 3.7 7.6 0.9 4.0 6.6 3.5 7.4 1.0 7.2 5.8 SIRT2 SIR2L ENSG00000068903 "Sirtuin 2" Q8IXJ6 19 38878555-38899862 "Cancer-related genes, Predicted intracellular proteins" "Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation" Transferase "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 86.6;skeletal muscle: 108.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004573, HPA011165" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "CAB004573: AB_2188600, HPA011165: AB_1856900" "unprognostic (2.15e-2)" "unprognostic (2.24e-2)" "unprognostic (2.88e-1)" "prognostic unfavourable (7.20e-7)" "unprognostic (3.75e-3)" "unprognostic (1.28e-2)" "unprognostic (2.85e-2)" "unprognostic (2.44e-3)" "unprognostic (2.73e-1)" "unprognostic (4.83e-2)" "unprognostic (2.97e-3)" "unprognostic (1.02e-1)" "unprognostic (1.90e-1)" "unprognostic (3.60e-2)" "unprognostic (1.19e-1)" "unprognostic (8.73e-2)" "unprognostic (1.70e-1)" 14.1 11.0 30.2 8.1 36.0 10.7 9.1 14.3 38.8 11.0 8.4 78.1 4.0 9.3 9.7 7.8 17.1 12.9 10.7 20.3 36.9 23.5 9.0 12.0 10.8 8.8 52.3 20.5 17.3 9.5 10.1 6.2 7.7 40.8 9.8 7.6 5.8 14.9 11.2 108.7 13.7 9.3 12.8 86.6 9.9 9.0 7.9 46.3 3.2 10.1 23.4 8.9 10.6 7.1 13.2 21.5 28.0 33.0 16.6 23.5 22.1 8.1 5.1 4.4 11.0 25.3 17.4 3.0 6.0 10.7 9.4 12.2 9.2 5.2 2.8 13.1 11.2 4.4 8.0 12.9 5.7 13.0 8.3 5.5 5.8 5.5 17.8 3.8 12.2 18.1 15.6 7.7 9.2 16.4 5.2 22.6 14.3 4.6 7.7 3.0 0.7 7.2 10.2 12.4 7.8 7.5 7.3 11.1 5.0 7.0 9.4 6.6 4.2 9.9 15.6 12.7 2.8 19.6 8.9 9.3 4.5 6.5 10.2 9.6 11.7 19.5 27.3 28.0 23.5 33.0 14.6 12.2 11.4 16.1 21.1 13.2 7.5 12.5 20.7 16.6 25.8 21.5 15.5 22.1 30.2 36.0 14.3 38.8 36.9 23.5 52.3 20.5 40.8 46.3 SLBP HBP ENSG00000163950 "Stem-loop binding protein" Q14493 4 1692800-1712555 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019254, HPA061670" Supported Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA019254: AB_1856951, HPA061670: AB_2684581" "unprognostic (1.81e-2)" "unprognostic (6.80e-3)" "unprognostic (2.05e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (7.09e-3)" "prognostic unfavourable (2.29e-5)" "unprognostic (5.53e-2)" "unprognostic (1.94e-2)" "unprognostic (1.13e-2)" "unprognostic (9.81e-3)" "unprognostic (9.55e-3)" "unprognostic (4.58e-2)" "unprognostic (7.31e-2)" "unprognostic (1.95e-1)" "unprognostic (1.44e-1)" "unprognostic (7.07e-2)" 19.8 18.1 26.9 30.4 28.0 60.7 27.5 23.8 30.0 19.3 19.3 14.2 20.7 16.3 20.4 21.9 25.0 19.0 15.8 17.9 25.1 26.5 23.7 21.2 18.7 43.9 19.9 24.0 23.1 17.8 13.0 19.5 27.7 16.0 20.0 21.3 17.9 24.7 21.2 15.1 24.7 17.0 20.5 17.1 26.1 18.2 50.6 12.4 52.4 24.9 17.7 42.8 23.7 26.6 24.4 24.1 45.3 29.8 19.8 36.1 30.4 28.8 11.9 17.1 18.0 15.2 17.4 17.8 25.4 21.7 30.9 31.3 24.5 33.7 38.2 15.2 21.0 17.7 34.4 23.0 36.2 15.6 18.6 47.8 14.8 24.6 18.8 44.2 23.4 12.0 18.5 23.5 15.6 17.5 34.2 37.7 37.8 10.4 68.0 40.3 21.3 21.1 51.3 28.0 24.1 29.7 22.0 19.5 15.0 21.5 14.0 15.0 23.2 29.2 14.8 25.9 14.9 27.3 39.5 22.0 39.9 91.2 24.3 37.9 25.5 9.3 29.8 21.8 23.6 22.3 21.4 24.4 30.8 33.2 24.1 18.0 26.5 25.1 45.3 19.8 19.8 19.1 36.1 30.4 26.9 28.0 23.8 30.0 25.1 26.5 19.9 24.0 16.0 12.4 SLC6A17 ENSG00000197106 "Solute carrier family 6 member 17" Q9H1V8 1 110150486-110202202 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 53.5" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 27.6" "Cancer enriched" "Detected in some" 9 "melanoma: 17.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007663, HPA008044" Enhanced Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA007663: AB_1857194, HPA008044: AB_1857192" "unprognostic (1.13e-1)" "unprognostic (1.37e-3)" "unprognostic (5.52e-3)" "unprognostic (3.00e-2)" "unprognostic (1.17e-1)" "unprognostic (4.88e-2)" "unprognostic (6.11e-3)" "unprognostic (3.87e-3)" "unprognostic (1.70e-2)" "unprognostic (1.80e-1)" "unprognostic (1.68e-2)" "unprognostic (2.94e-1)" "unprognostic (1.89e-2)" "unprognostic (1.73e-2)" "unprognostic (9.76e-2)" "unprognostic (1.38e-3)" "unprognostic (1.68e-3)" 1.4 7.8 9.3 1.2 18.3 1.1 1.3 21.8 53.5 1.0 1.1 2.3 0.0 1.0 1.0 2.1 1.3 1.0 1.1 1.0 11.2 14.9 2.1 0.9 1.0 0.9 6.0 16.2 1.0 2.6 1.0 12.4 1.8 19.5 1.0 1.0 2.6 1.2 1.0 1.0 7.6 1.1 1.1 1.8 1.0 1.8 2.4 0.7 0.0 1.3 0.0 0.9 1.0 0.1 0.3 0.0 0.8 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.2 0.4 1.6 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.6 4.7 1.4 27.6 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 5.6 0.0 2.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 9.3 18.3 21.8 37.3 11.2 14.9 6.0 16.2 19.5 0.7 SMAD2 "JV18-1, MADH2, MADR2" ENSG00000175387 "SMAD family member 2" Q15796 18 47808957-47931146 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025507, HPA067203, CAB073546" Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "CAB025507: , CAB073546: , HPA067203: " "unprognostic (1.55e-1)" "unprognostic (2.49e-1)" "unprognostic (1.43e-2)" "unprognostic (9.82e-3)" "unprognostic (9.88e-2)" "unprognostic (1.06e-1)" "prognostic unfavourable (9.44e-5)" "unprognostic (1.91e-2)" "unprognostic (7.59e-2)" "unprognostic (1.41e-3)" "unprognostic (6.46e-2)" "unprognostic (4.91e-2)" "unprognostic (9.20e-3)" "unprognostic (2.68e-1)" "unprognostic (6.13e-2)" "unprognostic (3.20e-2)" "unprognostic (6.28e-2)" 38.5 39.2 29.0 26.2 25.9 19.6 31.4 19.5 28.9 28.8 34.2 29.4 28.9 21.5 26.6 26.3 33.5 28.8 25.7 31.1 26.1 27.1 26.4 20.9 28.3 23.8 30.9 24.3 36.6 28.1 25.7 24.4 34.8 28.6 27.8 29.8 31.7 29.7 28.7 33.9 28.0 26.4 34.6 35.4 34.1 26.3 29.2 26.2 60.7 46.1 23.6 31.5 35.1 35.7 12.0 21.8 28.9 24.7 24.5 25.9 19.7 22.4 32.2 19.7 19.0 31.5 38.5 22.5 24.5 29.4 25.6 29.9 12.3 21.5 34.9 17.6 31.0 24.8 22.1 27.3 34.3 37.9 11.3 29.6 48.7 19.9 36.7 41.1 30.3 28.4 35.3 21.9 50.7 28.2 13.7 29.3 31.4 14.6 28.2 19.8 9.6 7.7 20.6 28.7 23.8 57.4 38.7 18.2 21.4 29.5 20.2 24.0 15.3 27.4 31.5 38.0 21.9 10.3 17.8 28.7 27.5 30.4 26.3 28.1 27.7 28.9 22.6 25.0 16.9 24.7 21.2 12.0 23.1 20.9 21.8 9.4 25.8 19.8 22.7 24.5 20.8 15.5 25.9 19.7 29.0 25.9 19.5 28.9 26.1 27.1 30.9 24.3 28.6 26.2 SMIM20 "C4orf52, MITRAC7, PNX" ENSG00000250317 "Small integral membrane protein 20" Q8N5G0 4 25861830-25929874 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016552 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA016552: AB_1859536" "unprognostic (1.18e-1)" "unprognostic (3.73e-2)" "unprognostic (1.78e-1)" "unprognostic (6.52e-3)" "unprognostic (1.55e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-3)" "unprognostic (7.01e-2)" "unprognostic (2.46e-1)" "unprognostic (1.02e-1)" "unprognostic (5.42e-2)" "unprognostic (2.86e-1)" "prognostic favourable (8.97e-5)" "unprognostic (5.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.53e-1)" "unprognostic (5.12e-3)" 14.9 20.5 21.8 15.6 26.7 7.1 25.0 11.4 28.0 12.9 16.4 8.3 12.8 24.1 13.7 46.4 11.9 15.1 22.5 33.7 17.9 16.2 27.1 22.7 18.5 26.0 19.2 14.3 19.5 50.0 8.7 10.0 9.5 22.8 13.6 16.1 11.3 20.4 15.7 51.3 6.9 23.8 24.0 22.6 12.7 18.8 17.7 13.5 9.3 21.3 15.3 14.5 14.5 15.9 27.1 21.4 13.3 20.3 18.1 31.1 18.2 12.7 10.7 14.4 13.9 16.0 34.8 19.2 12.4 15.2 10.7 13.7 9.5 22.7 21.0 21.7 13.8 3.7 16.7 15.9 15.1 11.9 13.3 12.1 7.8 18.0 27.1 14.4 8.1 24.6 32.0 13.7 20.8 8.2 19.3 6.9 13.2 8.2 15.6 24.5 27.2 16.0 12.9 18.8 13.5 23.9 9.4 18.6 17.3 8.0 5.6 27.4 11.6 20.5 13.7 11.7 13.8 13.1 15.8 13.6 11.2 22.0 17.7 15.3 14.7 13.3 18.2 8.4 15.7 20.3 20.5 27.1 22.7 19.7 20.5 26.8 31.1 24.7 9.2 18.1 15.2 21.4 23.2 18.2 21.8 26.7 11.4 28.0 17.9 16.2 19.2 14.3 22.8 13.5 SMPDL3A "ASM3A, ASML3a, FLJ20177, yR36GH4.1" ENSG00000172594 "Sphingomyelin phosphodiesterase acid like 3A" Q92484 6 122789049-122809720 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 23.8;hTCEpi: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "basophil: 31.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 31.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030148 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted to blood" 22000000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA030148: AB_10601591" "unprognostic (2.60e-1)" "unprognostic (1.22e-1)" "prognostic favourable (6.11e-4)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (8.30e-3)" "unprognostic (3.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.27e-2)" "unprognostic (3.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.8 15.9 4.0 8.3 5.4 8.1 24.9 9.7 9.9 35.3 46.7 3.8 8.0 19.2 10.0 9.8 9.6 5.1 8.5 11.9 4.5 4.1 20.1 36.9 13.0 29.1 4.7 5.6 6.2 24.6 16.1 7.0 23.2 6.5 19.6 28.5 7.6 9.5 13.7 56.1 32.1 63.6 10.9 4.9 37.7 13.1 3.8 3.2 3.3 7.2 18.0 7.6 18.7 24.3 0.1 0.4 31.2 3.2 0.0 0.0 0.5 0.1 1.3 3.2 1.5 23.8 10.8 10.3 5.4 14.5 1.6 3.5 1.7 1.4 0.0 0.8 3.4 2.5 0.9 2.7 1.3 0.0 2.8 1.2 5.4 4.5 15.3 0.0 0.1 13.1 19.5 1.5 2.8 2.8 1.9 0.0 6.6 4.7 0.0 0.1 0.5 4.2 0.0 5.7 0.2 7.9 2.1 2.4 0.0 0.7 9.7 13.6 1.6 0.7 5.6 3.2 1.9 0.3 3.5 0.0 0.0 0.0 4.6 2.5 7.1 31.2 1.7 0.4 0.0 1.9 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.5 4.0 5.4 9.7 9.9 4.5 4.1 4.7 5.6 6.5 3.2 SNAPC3 "MGC132011, MGC33124, PTFbeta, SNAP50" ENSG00000164975 "Small nuclear RNA activating complex polypeptide 3" Q92966 9 15422704-15465953 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053145, HPA066031" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nuclear bodies" Nucleoli "HPA053145: , HPA066031: " "unprognostic (2.62e-1)" "unprognostic (4.26e-1)" "unprognostic (5.42e-3)" "unprognostic (2.09e-1)" "unprognostic (4.93e-3)" "unprognostic (6.08e-2)" "unprognostic (5.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.12e-2)" "unprognostic (2.64e-2)" "unprognostic (1.36e-3)" "unprognostic (3.07e-1)" "unprognostic (2.63e-1)" "unprognostic (4.38e-2)" "unprognostic (2.09e-2)" 9.8 18.5 18.7 10.3 21.1 4.6 10.4 26.3 21.2 17.9 13.2 10.4 10.3 11.6 16.5 15.5 12.6 10.8 10.8 17.5 18.0 14.0 12.3 8.6 10.0 11.2 15.2 16.3 17.4 11.1 12.8 18.4 16.7 21.8 13.3 14.6 9.6 10.5 11.3 19.3 13.7 14.2 12.8 15.2 12.8 10.5 14.7 15.9 11.9 11.3 6.8 10.8 12.9 15.1 12.2 7.7 5.0 21.2 5.0 8.2 5.5 4.1 5.3 11.2 4.2 9.0 9.4 6.5 6.5 2.8 3.8 4.5 2.5 1.8 2.9 2.5 4.0 2.5 5.9 3.0 4.7 13.5 6.9 10.4 11.1 3.4 4.5 2.3 8.1 6.1 6.1 2.7 3.1 7.0 2.9 4.8 8.7 1.3 2.8 7.4 3.6 13.9 5.7 1.3 1.6 6.6 2.5 11.9 8.5 2.2 2.0 1.5 4.8 4.8 5.8 6.4 2.5 2.7 8.1 6.3 7.5 3.6 4.1 3.1 2.9 3.4 10.1 5.0 5.7 16.7 5.5 9.9 5.7 5.1 7.7 12.2 8.2 7.9 1.2 5.0 21.2 6.3 7.9 5.5 18.7 21.1 26.3 21.2 18.0 14.0 15.2 16.3 21.8 15.9 SNX10 ENSG00000086300 "Sorting nexin 10" Q9Y5X0 7 26291895-26374329 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 67.6;brain: 39.0;liver: 37.4" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 26.6;U-937: 21.8;WM-115: 75.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 67.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015605, HPA064782" Approved Supported Nucleoplasm,Nucleoli,Microtubules "Nucleoplasm, Microtubules" Nucleoli "HPA015605: AB_1857342, HPA064782: " "unprognostic (6.42e-2)" "unprognostic (2.72e-3)" "unprognostic (2.45e-1)" "unprognostic (7.62e-2)" "prognostic unfavourable (1.16e-4)" "unprognostic (6.92e-2)" "unprognostic (2.48e-3)" "unprognostic (4.51e-2)" "unprognostic (4.87e-1)" "unprognostic (9.36e-2)" "unprognostic (1.59e-1)" "unprognostic (2.56e-1)" "prognostic unfavourable (8.06e-5)" "unprognostic (1.12e-2)" "unprognostic (3.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.50e-1)" 17.7 8.7 20.2 18.6 17.9 20.9 6.7 13.2 39.0 2.9 3.3 2.1 0.1 2.5 5.4 0.8 1.8 1.9 5.2 1.3 22.2 32.7 21.3 37.4 22.4 18.0 27.8 20.8 1.0 5.0 0.6 3.0 8.9 36.2 2.2 3.9 1.8 1.4 1.5 0.9 1.0 3.6 5.4 15.4 22.1 2.3 3.0 2.1 3.8 1.9 0.1 13.6 6.3 1.8 16.3 20.1 67.6 30.9 9.0 5.6 11.6 13.6 1.2 0.0 2.6 0.0 0.0 14.9 0.0 1.0 0.0 0.0 0.1 4.6 6.0 10.7 0.0 0.4 3.4 0.9 0.0 8.2 3.2 0.6 0.1 9.0 0.0 12.7 2.3 0.1 1.4 0.0 1.1 0.2 0.3 0.0 0.0 2.4 5.3 13.4 3.9 1.3 0.0 0.0 0.3 26.6 2.9 5.8 1.8 2.9 2.2 15.5 3.9 18.2 0.0 0.0 3.2 0.0 3.4 4.6 3.7 4.0 0.1 21.8 75.8 8.2 29.2 0.7 4.0 30.9 3.8 16.3 2.8 3.4 20.1 14.5 1.5 2.6 67.6 9.0 30.1 7.4 5.6 11.6 20.2 17.9 13.2 39.0 22.2 32.7 27.8 20.8 36.2 2.1 SNX30 ATG24A ENSG00000148158 "Sorting nexin family member 30" Q5VWJ9 9 112750838-112881671 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019346 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA019346: AB_2286395" "unprognostic (1.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.08e-1)" "unprognostic (3.61e-1)" "unprognostic (3.61e-1)" "unprognostic (3.69e-1)" "unprognostic (8.05e-3)" "unprognostic (2.04e-3)" "unprognostic (4.48e-2)" "unprognostic (3.59e-3)" "unprognostic (3.39e-2)" "unprognostic (1.48e-1)" "prognostic favourable (1.01e-7)" "unprognostic (4.48e-3)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-2)" 4.9 4.4 12.2 7.7 12.6 8.3 7.7 18.1 18.5 10.9 11.1 25.6 3.6 7.9 6.4 4.1 5.3 3.8 5.4 3.4 14.2 12.0 23.7 5.2 23.4 8.8 14.8 12.8 6.9 5.2 6.9 6.3 5.1 14.7 4.1 11.7 4.9 7.1 4.3 2.6 5.7 8.9 7.5 20.3 7.4 4.7 12.7 11.8 2.3 3.1 2.6 8.7 5.4 4.6 0.7 4.2 1.5 5.1 0.8 1.7 1.6 6.0 3.7 6.5 5.1 8.2 7.5 5.5 5.2 10.8 4.4 4.2 13.3 1.4 10.0 4.4 13.3 7.2 7.9 3.0 6.8 3.2 3.7 3.0 3.4 5.4 5.9 3.1 5.5 6.1 4.3 6.7 5.0 3.7 4.8 5.7 5.9 4.2 2.0 3.6 7.2 4.0 4.3 15.2 2.5 8.5 10.5 9.7 3.1 6.7 9.3 12.9 6.9 5.5 4.2 6.5 7.0 19.1 4.4 14.9 13.7 4.8 8.4 2.9 12.7 0.0 5.1 1.5 0.8 2.0 1.7 0.0 0.8 1.0 4.2 0.7 0.7 0.6 0.7 0.8 2.1 0.7 1.6 1.6 12.2 12.6 18.1 18.5 14.2 12.0 14.8 12.8 14.7 11.8 SPG11 "FLJ21439, KIAA1840" ENSG00000104133 "SPG11, spatacsin vesicle trafficking associated" Q96JI7 15 44562696-44663678 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040412, HPA040947" Approved Supported "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoli "HPA040412: AB_10795418, HPA040947: AB_10796232" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.98e-3)" "unprognostic (1.99e-1)" "unprognostic (9.31e-2)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (2.26e-3)" "unprognostic (2.58e-2)" "unprognostic (9.19e-2)" "prognostic favourable (6.28e-5)" "unprognostic (8.73e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.06e-2)" 23.8 24.6 16.6 26.4 22.2 25.8 23.4 21.2 21.2 20.8 26.0 31.7 25.8 17.9 18.6 28.1 22.9 19.0 20.2 19.3 16.1 15.2 22.0 25.1 22.6 26.9 26.3 15.6 20.5 25.5 33.4 25.9 15.7 22.1 22.3 21.6 18.7 22.7 26.6 19.0 31.8 26.2 21.5 22.1 39.2 22.8 22.1 23.1 35.8 30.9 12.6 26.0 23.0 19.4 12.8 7.1 13.6 13.0 6.7 8.3 3.8 8.1 5.5 14.2 13.8 22.2 21.9 10.2 8.6 11.1 8.4 10.8 6.7 7.9 6.0 10.8 11.4 18.7 9.8 13.2 8.3 18.0 6.0 13.8 13.1 10.1 15.7 13.7 12.7 16.7 15.1 6.9 19.9 11.9 17.5 15.5 11.9 7.1 6.1 12.7 7.5 7.6 8.1 11.9 6.5 17.9 21.4 9.3 10.9 9.4 15.0 8.0 14.2 18.8 12.9 11.2 5.6 13.9 10.3 15.5 13.7 12.0 11.5 18.2 11.4 6.0 8.8 12.3 7.8 10.2 8.3 10.9 6.5 5.8 6.9 12.8 5.4 6.4 13.6 6.7 13.0 7.1 6.6 3.8 16.6 22.2 21.2 21.2 16.1 15.2 26.3 15.6 22.1 23.1 SPOCD1 "FLJ25348, PPP1R146" ENSG00000134668 "SPOC domain containing 1" Q6ZMY3 1 31790422-31816051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.9;urinary bladder: 13.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 18.6;hTEC/SVTERT24-B: 19.3;RT4: 32.6;TIME: 16.9;U-87 MG: 32.1" "Group enriched" "Detected in many" 7 "glioma: 13.9;urothelial cancer: 5.6" "Region enhanced" "Detected in many" "pons and medulla: 8.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.9" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.9" "Low region specificity" "Detected in some" "HPA031713, HPA031714, HPA031715" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA031713: AB_10604099, HPA031714: , HPA031715: " "unprognostic (7.78e-2)" "unprognostic (2.58e-2)" "unprognostic (1.85e-3)" "unprognostic (2.70e-3)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (2.15e-3)" "unprognostic (2.60e-2)" "unprognostic (3.51e-1)" "unprognostic (2.18e-1)" "unprognostic (3.01e-2)" "unprognostic (3.00e-1)" "unprognostic (0.00e+0)" "unprognostic (1.97e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "prognostic favourable (4.05e-5)" 28.9 0.5 1.8 5.1 1.6 0.3 1.6 0.4 3.9 2.0 0.7 1.5 0.1 1.6 2.4 2.8 0.3 2.1 1.6 0.4 1.2 1.6 0.5 0.2 12.9 0.9 2.6 0.3 1.8 0.1 0.1 1.6 3.5 8.2 1.8 0.9 1.8 0.1 0.3 0.4 0.1 0.9 2.4 3.1 1.9 1.1 11.9 0.6 0.1 0.4 0.8 0.2 13.7 2.1 0.0 0.0 1.9 0.1 0.0 0.0 7.3 10.6 0.3 0.0 0.0 0.2 1.5 0.5 13.9 18.6 13.5 9.0 0.2 0.6 0.1 1.9 15.6 1.4 0.0 0.2 4.3 0.0 0.0 0.0 1.9 0.0 0.6 0.0 0.2 6.8 0.2 19.3 0.6 9.1 0.2 0.2 7.9 0.0 0.1 0.0 0.2 0.3 0.0 1.4 0.0 0.0 32.6 0.0 0.0 0.3 0.0 0.9 8.0 0.0 16.9 14.2 1.4 9.2 5.2 0.0 0.1 0.0 32.1 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 1.8 1.6 0.4 0.6 1.2 1.6 2.6 0.3 8.2 0.6 SRFBP1 "BUD22, FLJ25286, p49, Rlb1, STRAP" ENSG00000151304 "Serum response factor binding protein 1" Q8NEF9 5 121961961-122075570 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042737, HPA058150" Approved Supported Nucleoplasm,Nucleoli,Vesicles "Nucleoplasm, Nucleoli" Vesicles "HPA042737: AB_10796583, HPA058150: " "unprognostic (8.94e-2)" "unprognostic (1.80e-1)" "unprognostic (4.68e-2)" "unprognostic (1.61e-2)" "unprognostic (4.14e-1)" "unprognostic (1.18e-1)" "unprognostic (5.07e-3)" "unprognostic (2.03e-1)" "unprognostic (8.96e-3)" "unprognostic (6.31e-3)" "prognostic unfavourable (5.31e-4)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (1.78e-1)" "unprognostic (4.71e-1)" "unprognostic (1.43e-1)" "unprognostic (8.45e-2)" 21.8 9.4 11.6 11.1 15.2 10.1 17.2 15.0 14.8 12.7 10.2 6.1 8.5 9.1 13.0 12.1 14.2 11.1 9.6 10.7 11.8 8.0 14.3 12.6 11.2 12.5 13.1 11.9 17.1 10.6 15.5 20.2 11.5 14.2 12.8 10.9 5.1 13.0 9.5 19.7 10.7 9.5 11.3 16.0 15.4 10.1 9.3 14.9 12.5 15.6 13.8 11.6 14.4 17.5 10.3 9.6 2.6 12.8 7.4 11.5 4.3 10.8 8.0 7.4 11.6 8.5 7.9 12.3 10.4 7.6 11.5 13.5 6.5 10.8 13.7 12.2 6.5 8.0 12.0 14.2 21.5 19.4 6.8 13.1 5.8 6.6 9.1 15.1 11.0 9.5 11.0 14.4 14.3 12.4 12.0 11.2 12.0 4.9 10.4 4.8 10.8 5.3 10.8 17.4 14.3 12.6 11.2 7.6 7.1 9.6 9.5 17.9 9.7 9.1 9.0 17.8 10.9 12.6 15.1 6.0 11.2 15.8 10.2 12.3 15.6 0.6 7.3 2.6 6.6 12.8 8.4 10.3 7.3 7.2 9.6 8.9 8.6 11.5 1.2 7.4 10.1 9.1 6.7 4.3 11.6 15.2 15.0 14.8 11.8 8.0 13.1 11.9 14.2 14.9 SRSF5 "HRS, SFRS5, SRP40" ENSG00000100650 "Serine and arginine rich splicing factor 5" Q13243 14 69726900-69772005 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043484, HPA056523" Approved Supported Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA043484: AB_10797143, HPA056523: " "unprognostic (2.08e-3)" "prognostic favourable (7.91e-4)" "unprognostic (1.89e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.79e-2)" "unprognostic (1.86e-1)" "unprognostic (2.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.61e-1)" "unprognostic (9.30e-3)" "unprognostic (1.07e-3)" "unprognostic (2.37e-2)" "unprognostic (1.13e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (1.00e-2)" 66.6 60.1 67.1 60.9 74.4 131.5 70.3 111.7 88.8 54.3 63.3 67.8 77.1 42.6 71.3 74.6 66.3 79.3 50.1 48.5 66.2 43.0 40.5 60.8 69.4 63.3 86.4 62.1 76.6 41.0 56.4 124.8 59.2 74.0 59.0 54.7 69.2 68.5 75.6 76.0 78.1 74.1 59.7 68.6 66.5 62.0 35.3 75.6 47.8 70.8 52.3 69.1 69.6 55.8 41.2 37.4 60.8 45.1 30.8 38.2 24.4 69.2 20.2 49.6 22.3 30.7 26.5 27.5 33.4 36.0 27.3 29.0 25.4 44.5 71.8 17.7 45.3 33.1 37.5 47.7 32.3 61.3 20.6 54.1 54.3 27.8 35.7 50.4 41.0 55.1 30.4 31.5 33.8 37.8 37.5 42.8 16.9 56.2 57.9 34.2 29.1 18.7 49.7 23.6 27.6 34.7 85.3 25.9 37.0 56.7 34.4 43.1 37.4 42.5 46.6 16.0 42.9 17.4 31.2 41.7 27.2 116.1 37.7 43.0 22.0 39.0 24.1 37.2 37.3 43.4 38.2 41.2 33.2 33.4 26.2 40.6 33.2 31.5 60.8 30.8 45.1 37.4 27.4 24.4 67.1 74.4 111.7 88.8 66.2 43.0 86.4 62.1 74.0 75.6 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42595114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: " "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favourable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 12.7 11.6 24.5 17.8 26.4 29.9 20.8 25.2 23.8 14.0 14.8 14.4 9.1 19.4 9.1 20.6 16.6 10.6 11.8 10.8 23.5 20.6 15.8 26.2 11.9 34.8 20.5 15.9 13.5 29.0 10.9 16.1 10.7 17.4 22.2 15.5 11.3 18.6 10.8 10.1 14.9 19.3 8.4 24.0 19.7 15.6 6.4 14.9 20.4 18.7 14.7 32.0 16.0 11.1 48.0 30.0 32.8 25.9 31.0 53.5 32.9 15.8 7.3 14.6 13.2 18.8 15.3 9.1 10.3 11.8 15.4 17.4 13.9 14.5 21.7 9.5 7.0 8.9 17.5 14.4 17.0 10.8 20.4 23.5 14.2 23.3 13.6 30.7 18.6 12.0 9.3 12.4 11.6 16.8 21.2 32.7 12.4 15.0 21.5 38.1 23.1 17.9 11.4 10.7 30.1 17.0 20.0 8.2 11.8 8.7 13.7 13.9 18.0 28.7 9.8 9.1 14.8 21.7 18.7 23.8 37.6 36.8 13.3 33.7 8.6 19.0 23.5 32.8 38.4 25.9 51.6 48.0 50.5 45.3 24.9 40.8 43.9 44.1 31.1 31.0 19.2 30.0 53.5 32.9 24.5 26.4 25.2 23.8 23.5 20.6 20.5 15.9 17.4 14.9 STK33 ENSG00000130413 "Serine/threonine kinase 33" Q9BYT3 11 8391868-8594289 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 34.4" "Cell line enhanced" "Detected in many" "Daudi: 14.1;HEK 293: 12.0;Karpas-707: 13.2;SCLC-21H: 14.8;U-251 MG: 14.9;U-266/84: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 7.1;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 5 "B-cells: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015742, HPA056855" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA015742: AB_1857592, HPA056855: " "unprognostic (2.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.23e-3)" "unprognostic (2.76e-3)" "unprognostic (3.57e-1)" "unprognostic (1.40e-1)" "unprognostic (7.28e-2)" "unprognostic (3.85e-4)" "unprognostic (1.23e-1)" "unprognostic (8.06e-2)" "unprognostic (1.33e-3)" "unprognostic (9.46e-2)" "prognostic favourable (4.89e-6)" "unprognostic (2.39e-2)" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.90e-2)" 0.9 6.1 4.7 1.6 7.5 1.1 0.6 6.1 4.4 5.4 5.3 6.8 7.7 2.6 9.6 15.3 2.3 30.7 4.5 11.4 6.6 6.1 7.7 0.4 5.3 2.3 4.9 2.7 10.3 4.6 20.4 29.9 0.3 17.7 5.3 1.3 14.8 1.6 8.9 2.6 0.3 2.5 7.0 6.7 1.2 4.4 34.4 4.6 4.5 14.6 1.5 1.8 3.7 1.4 7.1 0.7 0.0 0.0 0.2 1.4 0.3 0.0 2.0 9.8 0.0 0.0 0.0 0.0 1.7 1.9 4.2 3.9 1.2 0.0 14.1 7.4 0.3 0.0 4.3 1.3 3.7 0.0 12.0 0.0 2.6 3.3 1.6 7.8 0.0 0.4 0.0 0.1 0.0 0.3 0.0 13.2 0.1 0.0 0.3 0.0 7.0 0.0 5.3 1.3 8.9 3.8 0.0 14.8 3.9 0.0 0.0 0.1 0.0 0.8 0.0 0.0 6.7 0.1 14.9 3.1 12.5 0.2 4.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 7.1 0.0 1.4 0.0 4.4 0.0 1.1 0.0 0.2 0.0 0.7 0.2 0.3 4.7 7.5 6.1 4.4 6.6 6.1 4.9 2.7 17.7 4.6 SUZ12 "CHET9, JJAZ1, KIAA0160" ENSG00000178691 "SUZ12 polycomb repressive complex 2 subunit" Q15022 17 31937018-32001045 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057436 Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli, Nuclear bodies" "HPA057436: " "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (3.65e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (7.31e-2)" "unprognostic (2.66e-3)" "unprognostic (8.05e-2)" "unprognostic (7.27e-2)" "unprognostic (3.06e-2)" "unprognostic (6.29e-2)" "unprognostic (8.70e-2)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (5.91e-2)" "unprognostic (1.31e-1)" 10.1 10.8 13.4 15.4 10.4 25.5 33.5 16.0 13.8 11.2 11.4 7.5 13.6 10.1 12.5 8.1 12.3 9.8 7.7 9.7 9.1 7.6 10.9 11.5 10.6 19.9 9.3 9.9 10.0 10.1 15.5 10.4 15.3 9.5 10.7 10.9 6.9 10.1 9.6 8.7 9.9 12.2 9.6 7.7 15.2 10.7 17.1 12.5 31.8 12.0 6.5 18.9 10.8 19.5 5.5 4.6 4.1 2.6 4.4 5.5 1.2 14.0 12.5 11.8 13.5 6.8 8.8 12.1 13.7 12.1 16.9 20.5 9.4 7.9 30.8 10.6 8.5 12.5 17.5 7.9 27.5 10.8 17.0 21.3 10.6 6.8 8.0 33.5 21.9 6.1 8.9 16.8 12.9 10.3 20.5 42.8 14.5 4.9 39.8 19.5 6.7 7.6 23.8 30.2 24.9 9.9 13.8 15.1 11.8 22.1 7.2 13.2 20.8 28.0 7.6 13.4 12.2 16.1 21.1 23.4 29.1 38.1 9.8 20.7 12.1 1.4 1.9 3.8 3.8 2.6 3.0 5.5 4.1 4.0 1.4 4.4 3.9 5.5 4.1 4.4 1.8 4.6 4.2 1.2 13.4 10.4 16.0 13.8 9.1 7.6 9.3 9.9 9.5 12.5 SYCE3 C22orf41 ENSG00000217442 "Synaptonemal complex central element protein 3" A1L190 22 50551112-50562905 "Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 61.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 8.7;Karpas-707: 7.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 8.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 8.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA047813 Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Nucleoplasm, Nucleoli, Golgi apparatus" "HPA047813: " "unprognostic (2.55e-1)" "unprognostic (2.52e-1)" "unprognostic (2.06e-2)" "unprognostic (2.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.63e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-1)" "unprognostic (2.98e-3)" "unprognostic (1.68e-2)" "unprognostic (4.05e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" "unprognostic (1.55e-2)" "unprognostic (5.20e-2)" 0.4 0.4 0.7 0.5 0.9 0.1 0.7 0.2 0.6 0.2 0.4 0.5 0.4 0.1 0.2 1.1 0.2 0.8 0.6 0.1 0.5 0.7 1.0 0.8 0.4 0.9 0.9 0.3 0.1 0.2 0.2 0.4 0.4 0.7 0.1 0.0 0.2 0.7 0.1 0.0 0.2 0.0 0.5 0.7 0.1 0.2 61.5 0.4 0.0 1.1 0.2 0.3 0.7 0.0 0.5 1.9 8.0 1.3 0.0 0.3 0.3 0.3 0.7 0.1 0.3 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 8.7 0.4 3.2 0.0 0.0 0.9 1.0 0.0 0.0 0.5 0.0 0.6 0.0 3.9 0.0 1.6 2.3 2.0 0.3 1.4 0.0 0.0 7.3 0.4 3.3 0.0 0.0 0.3 0.0 0.0 0.0 3.8 1.2 2.6 0.8 2.3 0.0 2.2 1.4 2.1 1.7 0.0 0.7 0.8 0.0 0.1 1.9 0.4 1.1 0.9 0.3 0.2 0.0 1.3 1.5 0.0 1.1 0.3 0.0 0.0 0.0 1.9 0.5 0.0 0.2 8.0 0.0 0.9 0.0 0.0 0.3 0.7 0.9 0.2 0.6 0.5 0.7 0.9 0.3 0.7 0.4 TACSTD2 "EGP-1, GA733-1, M1S1, TROP2" ENSG00000184292 "Tumor associated calcium signal transducer 2" P09758 1 58575423-58577773 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Tumor antigen" "Amyloidosis, Corneal dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;salivary gland: 56.4" "Cell line enhanced" "Detected in some" "A-431: 74.1;CAPAN-2: 100.5;HaCaT: 100.7;RT4: 34.8" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 12.4" "Group enriched" "Detected in many" 65 "dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043104, HPA055067, CAB072852" Enhanced Supported "Nucleoli,Vesicles,Plasma membrane" "Plasma membrane" "Nucleoli, Vesicles" "CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687" "unprognostic (1.80e-2)" "unprognostic (3.08e-1)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (5.70e-2)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (7.91e-2)" "prognostic favourable (3.99e-4)" "unprognostic (7.10e-2)" "unprognostic (2.55e-1)" "unprognostic (6.91e-3)" "unprognostic (2.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 17.1 0.0 0.0 23.1 0.0 0.0 1.7 2.6 103.9 2.7 0.9 0.0 0.0 0.0 10.4 0.0 8.0 0.0 0.0 0.0 9.0 0.0 0.0 1.5 15.7 0.0 56.4 12.6 0.0 42.1 0.0 0.0 0.0 0.0 7.3 0.0 0.1 20.6 17.7 36.1 0.0 3.7 12.4 3.2 0.0 0.0 1.8 74.1 0.0 0.0 0.1 0.0 0.0 28.4 0.0 0.0 0.0 0.0 0.0 100.5 0.0 9.7 6.3 100.7 0.0 18.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 27.6 0.0 1.1 4.2 0.0 0.1 0.0 15.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 13.5 34.8 0.0 0.0 3.2 26.8 0.1 17.5 0.1 4.5 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 12.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.8 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973641-29992261 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavourable (2.51e-4)" "prognostic favourable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favourable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favourable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 27.8 24.1 26.2 15.1 26.7 12.3 17.7 29.2 30.6 13.5 13.6 21.5 11.8 18.5 16.8 13.0 12.4 14.1 15.1 17.6 25.0 18.2 13.9 10.4 23.0 14.4 22.1 22.7 15.8 16.3 26.2 18.7 22.5 20.7 13.6 9.6 15.0 17.1 15.9 22.8 20.0 19.3 14.8 14.9 26.3 16.0 21.2 20.2 14.0 15.9 9.8 11.5 12.8 18.0 2.6 3.3 4.8 2.8 2.0 3.2 2.0 11.2 21.5 11.8 18.5 13.8 9.3 18.1 20.6 11.0 14.0 13.1 17.2 15.0 12.2 17.5 14.8 17.5 10.7 10.4 7.5 18.9 22.7 13.1 21.7 17.2 10.1 12.8 25.2 10.9 9.0 14.8 6.0 23.3 11.7 12.4 13.3 20.7 14.9 18.3 11.4 14.5 27.7 17.1 11.3 8.8 10.6 13.9 11.1 11.8 15.8 6.1 19.8 14.6 32.5 24.1 11.2 17.1 11.9 18.1 11.6 11.5 14.8 14.8 17.5 1.3 2.8 1.5 2.9 2.7 3.1 2.0 2.9 2.6 1.8 2.6 1.6 1.4 4.8 2.0 1.4 3.3 3.2 2.0 26.2 26.7 29.2 30.6 25.0 18.2 22.1 22.7 20.7 20.2 TAS2R5 T2R5 ENSG00000127366 "Taste 2 receptor member 5" Q9NYW4 7 141790217-141791367 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Taste" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 8.8" "Cell line enhanced" "Detected in many" "hTCEpi: 10.4" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA053742 Approved "Nucleoplasm,Nucleoli,Cytoplasmic bodies" "Nucleoplasm, Nucleoli" "Cytoplasmic bodies" "HPA053742: " "unprognostic (5.48e-3)" "unprognostic (3.90e-3)" "unprognostic (6.07e-2)" "unprognostic (8.00e-3)" "unprognostic (7.56e-2)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (1.71e-1)" "unprognostic (2.65e-2)" "unprognostic (1.67e-1)" "unprognostic (3.13e-5)" "unprognostic (1.13e-2)" "unprognostic (8.29e-7)" "unprognostic (1.29e-1)" "unprognostic (3.28e-1)" "unprognostic (6.92e-2)" "unprognostic (1.39e-2)" 1.0 1.0 0.4 1.4 1.1 0.2 3.2 4.9 0.7 2.5 0.9 0.8 2.8 6.1 1.1 3.0 0.8 0.8 0.6 0.7 1.0 0.5 1.1 1.2 0.4 4.6 1.5 0.1 2.9 1.0 1.7 1.2 1.6 1.0 2.6 8.8 1.7 1.2 1.2 1.9 0.7 1.4 1.7 1.2 1.3 2.4 1.0 0.6 0.5 0.2 0.4 1.4 0.1 0.5 0.2 1.4 0.6 0.9 2.7 1.7 0.6 0.6 0.5 0.9 2.0 0.4 1.1 0.9 0.2 0.3 1.5 0.8 0.3 0.6 1.7 0.3 1.2 2.7 0.9 1.7 1.3 2.3 10.4 1.2 2.8 1.0 2.6 0.3 0.1 1.7 0.6 3.9 1.3 0.3 0.2 0.1 2.8 0.4 0.7 2.0 1.2 0.3 0.4 0.2 0.1 0.4 0.3 0.9 0.6 0.6 1.2 1.9 0.4 1.4 0.8 0.8 0.5 0.5 0.2 0.0 1.0 0.0 0.0 0.9 0.3 0.4 0.0 1.0 0.9 1.4 0.0 0.4 0.0 0.6 1.3 0.1 TGDS "SDR2E1, TDPGD" ENSG00000088451 "TDP-glucose 4,6-dehydratase" O95455 13 94574051-94596257 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039927, HPA040857" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA039927: AB_10795238, HPA040857: AB_10794867" "unprognostic (4.07e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (2.87e-1)" "unprognostic (9.99e-2)" "unprognostic (1.96e-1)" "unprognostic (9.17e-2)" "prognostic unfavourable (2.48e-4)" "unprognostic (5.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-2)" "unprognostic (1.09e-1)" 11.1 12.2 7.9 11.4 11.8 5.8 13.4 8.0 7.8 11.9 9.0 9.0 13.4 11.1 13.7 13.2 10.3 10.5 8.7 7.7 7.0 7.0 11.8 31.9 7.8 12.5 11.8 6.8 13.9 14.1 6.2 24.3 10.8 10.1 10.5 10.6 15.4 12.5 12.7 7.6 7.9 11.1 10.3 12.6 11.9 9.8 7.2 12.6 27.1 15.8 8.9 12.5 10.9 9.2 9.9 8.0 10.5 7.0 10.4 17.4 6.7 7.2 3.0 5.1 4.6 7.6 6.1 6.4 6.6 6.4 6.3 6.1 8.4 7.1 11.2 6.7 4.6 4.6 9.0 5.2 6.5 8.9 3.6 9.0 3.6 7.8 9.6 30.8 6.2 7.1 4.2 3.5 10.1 5.8 8.8 3.9 5.6 4.4 8.4 15.9 6.7 3.9 7.2 5.2 6.6 7.9 3.2 7.3 4.0 5.0 10.5 18.6 4.7 16.7 5.3 2.5 6.6 3.9 5.5 8.9 4.8 41.2 6.9 11.4 6.8 10.5 5.3 9.6 9.6 6.2 14.5 9.9 11.3 10.5 8.0 7.3 17.4 12.4 1.5 10.4 7.0 7.1 12.5 6.7 7.9 11.8 8.0 7.8 7.0 7.0 11.8 6.8 10.1 12.6 THAP3 ENSG00000041988 "THAP domain containing 3" Q8WTV1 1 6624866-6635586 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067114 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Nucleoplasm "Nucleoli, Mitochondria" "HPA067114: " "unprognostic (1.82e-2)" "unprognostic (9.63e-2)" "prognostic unfavourable (1.33e-4)" "unprognostic (2.89e-2)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (2.14e-3)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (4.63e-2)" "unprognostic (3.50e-3)" "unprognostic (4.30e-2)" "unprognostic (1.11e-2)" "unprognostic (4.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.26e-3)" 14.2 17.2 16.4 11.4 16.8 12.9 31.4 21.5 20.3 16.5 16.6 13.8 11.8 12.0 15.2 13.6 11.8 16.3 11.9 19.0 16.0 14.5 17.2 17.3 10.8 15.5 18.1 14.1 23.7 28.8 12.1 14.2 11.4 17.6 17.0 7.2 11.5 24.8 16.7 20.9 14.2 11.4 12.7 13.0 15.3 12.0 11.9 16.3 11.6 22.6 9.0 12.9 17.2 21.6 22.2 18.0 10.6 14.7 17.0 22.0 15.0 9.8 9.3 8.5 12.3 14.1 12.7 8.2 8.9 11.7 23.8 14.9 12.5 6.2 8.7 12.0 9.8 7.8 13.5 7.9 8.3 15.0 22.1 10.0 12.5 11.1 17.7 7.1 10.4 11.9 10.2 14.9 13.2 10.2 10.1 11.2 8.7 6.8 12.2 16.0 7.3 15.8 11.8 10.3 12.5 10.6 2.3 11.2 12.7 10.9 15.0 20.6 9.6 12.8 9.2 12.6 7.6 8.6 13.8 12.7 13.5 11.4 10.7 15.2 7.1 10.2 14.7 10.6 20.1 11.7 20.2 17.1 19.7 20.8 18.0 22.2 22.0 18.5 9.0 17.0 9.1 16.4 19.3 15.0 16.4 16.8 21.5 20.3 16.0 14.5 18.1 14.1 17.6 16.3 TICAM1 "MGC35334, PRVTIRB, TICAM-1, TRIF" ENSG00000127666 "Toll like receptor adaptor molecule 1" Q8IUC6 19 4815932-4831704 "Disease related genes, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042460 Uncertain Uncertain "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA042460: AB_10806240" "unprognostic (2.09e-2)" "unprognostic (1.48e-1)" "unprognostic (1.86e-2)" "prognostic favourable (4.81e-4)" "unprognostic (3.52e-2)" "unprognostic (2.88e-2)" "unprognostic (7.60e-3)" "prognostic unfavourable (3.48e-4)" "unprognostic (9.86e-2)" "unprognostic (1.59e-1)" "unprognostic (6.16e-2)" "unprognostic (2.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.30e-2)" "unprognostic (5.02e-2)" "unprognostic (3.53e-2)" "unprognostic (6.48e-2)" 10.5 6.9 7.3 9.4 9.5 18.2 9.4 5.9 15.8 10.2 15.4 7.0 3.4 20.3 8.3 5.2 35.6 8.0 11.4 7.7 5.9 5.4 11.0 15.2 14.1 9.0 6.4 6.1 8.0 14.8 4.2 7.8 6.8 7.1 8.2 5.2 6.1 11.8 5.7 15.3 15.8 21.3 5.2 6.5 11.6 15.2 2.8 6.5 4.4 8.5 12.1 21.7 9.3 13.3 5.3 5.0 7.8 9.1 1.5 3.1 5.4 21.1 4.2 0.0 3.6 3.2 4.1 1.9 7.0 7.2 5.6 6.3 4.2 7.6 14.4 4.0 8.0 14.4 2.0 7.3 2.2 15.4 3.9 3.6 8.4 4.1 8.8 1.3 9.4 6.6 9.2 7.0 5.1 5.8 7.7 3.1 3.0 7.9 3.6 0.7 0.6 16.8 8.0 0.9 9.3 5.0 6.7 2.9 5.4 4.3 12.9 7.1 5.8 3.0 11.5 6.9 4.7 17.4 10.5 12.5 11.0 10.0 8.0 4.9 5.3 7.8 5.3 2.3 2.6 7.8 2.4 5.3 2.6 3.0 5.0 4.0 1.7 1.0 1.6 1.5 9.1 3.6 3.1 5.4 7.3 9.5 5.9 15.8 5.9 5.4 6.4 6.1 7.1 6.5 TIFA "MGC20791, T2BP, T6BP, TIFAA" ENSG00000145365 "TRAF interacting protein with forkhead associated domain" Q96CG3 4 112274542-112285903 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 45.1;U-698: 38.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA045889 Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA045889: AB_10963785" "unprognostic (2.41e-2)" "unprognostic (2.47e-2)" "unprognostic (4.13e-2)" "unprognostic (3.23e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-3)" "unprognostic (1.05e-1)" "unprognostic (2.25e-1)" "unprognostic (2.48e-2)" "unprognostic (2.14e-2)" "unprognostic (4.60e-3)" "unprognostic (5.26e-2)" "unprognostic (6.44e-3)" "unprognostic (1.52e-1)" "unprognostic (2.56e-1)" "unprognostic (2.99e-1)" "unprognostic (8.49e-3)" 5.7 6.4 3.3 16.7 3.8 19.2 7.4 6.1 4.5 7.0 3.9 2.0 8.4 3.4 3.6 2.3 14.3 4.0 4.2 7.9 4.7 2.1 4.1 14.6 6.7 22.9 5.4 1.6 9.2 32.2 4.1 3.3 7.4 3.9 6.6 3.7 5.4 21.3 4.5 4.0 9.0 8.7 4.7 4.0 20.3 7.1 3.0 4.8 12.5 14.8 7.8 23.2 7.2 7.3 23.2 7.0 11.3 3.8 9.1 17.7 6.1 6.8 1.7 2.6 4.3 3.2 2.6 5.2 5.5 10.4 3.5 6.0 0.9 6.2 21.1 4.5 2.1 2.0 3.5 4.2 7.4 17.1 2.1 2.1 4.2 1.9 2.1 6.6 2.9 3.5 2.3 3.7 4.1 5.5 2.1 45.1 4.6 3.4 11.6 3.6 0.5 2.2 20.1 6.5 14.0 7.7 4.7 6.0 6.2 4.4 9.3 2.1 4.0 9.5 4.1 5.5 6.6 4.6 4.3 28.2 25.9 38.9 5.2 4.4 4.1 2.9 3.8 2.0 6.3 2.7 10.3 21.2 11.7 11.0 7.0 23.2 5.4 6.6 11.3 9.1 3.2 6.5 17.7 6.1 3.3 3.8 6.1 4.5 4.7 2.1 5.4 1.6 3.9 4.8 TIGD1 EEYORE ENSG00000221944 "Tigger transposable element derived 1" Q96MW7 2 232547968-232550592 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA041717 Approved Approved "Nucleoplasm,Nucleoli,Nuclear bodies" Nucleoli "Nucleoplasm, Nuclear bodies" "HPA041717: " "unprognostic (2.48e-1)" "unprognostic (1.77e-2)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (2.58e-2)" "unprognostic (2.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-2)" "unprognostic (1.20e-2)" "unprognostic (4.40e-2)" "unprognostic (6.86e-2)" "prognostic unfavourable (4.41e-5)" "unprognostic (3.77e-2)" "unprognostic (1.85e-2)" "unprognostic (2.77e-1)" "unprognostic (3.21e-3)" 3.9 5.9 13.3 9.2 15.3 19.4 8.9 10.1 11.7 5.4 5.1 10.7 2.0 5.9 8.5 10.1 5.6 7.4 6.9 4.9 13.8 8.2 10.1 5.0 6.9 12.5 9.1 8.0 13.2 5.8 6.3 21.2 6.5 8.6 8.3 6.7 8.3 7.3 7.9 7.5 13.6 6.8 4.3 8.8 11.1 8.1 9.7 10.8 14.2 9.6 4.8 10.6 5.5 5.9 7.1 3.8 7.0 4.8 4.5 9.8 1.9 6.9 5.2 11.3 16.7 4.2 5.5 8.5 5.0 2.8 6.1 6.9 6.5 7.8 11.5 3.8 3.7 6.6 9.3 2.8 9.4 7.0 8.1 10.2 15.2 7.4 2.6 8.5 6.8 6.1 2.7 6.4 4.0 3.8 8.0 12.2 5.3 10.4 10.5 17.3 6.7 6.3 9.7 10.1 5.2 3.6 8.2 13.5 13.5 5.4 4.8 5.2 7.1 8.3 6.5 10.2 10.4 6.4 5.1 10.8 7.5 10.7 5.9 8.6 6.3 4.0 4.8 5.3 6.7 4.3 6.1 4.9 6.5 4.3 3.4 7.1 9.8 7.7 7.0 4.5 4.8 3.8 4.5 1.9 13.3 15.3 10.1 11.7 13.8 8.2 9.1 8.0 8.6 10.8 TLDC1 KIAA1609 ENSG00000140950 "TBC/LysM-associated domain containing 1" Q6P9B6 16 84476421-84554033 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041020 Approved Supported Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA041020: AB_10794184" "unprognostic (8.35e-3)" "unprognostic (4.27e-2)" "unprognostic (1.48e-1)" "unprognostic (5.45e-2)" "unprognostic (1.49e-2)" "unprognostic (3.39e-3)" "unprognostic (5.97e-4)" "prognostic unfavourable (1.03e-5)" "unprognostic (3.94e-1)" "unprognostic (2.85e-2)" "prognostic unfavourable (7.05e-5)" "unprognostic (2.92e-2)" "unprognostic (6.78e-3)" "unprognostic (9.87e-2)" "unprognostic (1.83e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-2)" 5.5 4.9 7.6 7.1 10.7 1.8 7.3 8.1 11.5 8.1 7.1 6.3 5.2 6.0 14.0 8.8 24.4 6.9 6.5 4.7 6.3 4.5 7.6 5.1 6.4 6.1 5.0 9.4 8.7 5.2 11.3 4.4 15.8 10.7 7.8 7.8 12.9 7.7 6.1 4.5 11.0 9.3 10.7 4.0 5.4 6.8 8.1 3.4 8.3 7.6 6.5 10.0 10.4 12.1 3.3 2.7 13.6 3.5 3.1 8.7 2.6 14.4 10.2 9.0 4.8 4.1 7.2 4.2 10.7 9.6 11.0 3.2 5.8 17.5 2.0 5.8 20.6 16.1 2.5 28.7 14.6 1.0 2.1 1.6 5.0 5.0 5.1 1.2 5.0 5.0 12.5 10.3 13.6 4.6 2.6 2.5 7.4 3.4 1.1 1.2 2.7 3.5 4.5 2.3 0.6 9.8 8.1 2.9 2.1 9.7 6.9 4.8 10.0 1.9 11.2 7.8 3.5 4.1 4.4 2.0 3.4 5.3 4.6 0.6 2.6 13.6 3.1 4.4 3.8 2.7 3.7 3.3 6.8 5.5 2.7 2.7 7.6 4.7 3.1 3.1 3.5 0.8 8.7 2.6 7.6 10.7 8.1 11.5 6.3 4.5 5.0 9.4 10.7 3.4 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 204.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" Nucleoli "Nucleoplasm, Nuclear bodies" "HPA047397: " "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favourable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 38.7 54.0 76.1 41.7 82.7 72.5 49.8 41.7 55.8 35.3 49.0 22.6 44.7 37.8 28.4 72.6 43.0 30.5 40.3 49.8 61.4 61.6 50.3 50.3 36.6 50.3 63.6 46.0 41.7 59.5 21.6 45.4 28.7 53.3 36.9 47.0 39.2 39.6 37.4 107.4 28.4 41.1 36.5 57.4 41.5 39.0 35.0 41.0 37.9 38.3 67.6 56.6 29.9 37.7 125.7 139.0 192.1 98.7 79.4 146.7 204.3 63.8 46.4 75.3 53.9 62.5 61.0 51.9 52.9 41.7 50.7 50.4 37.7 46.4 41.8 37.8 46.0 25.0 65.6 59.6 56.7 51.4 55.9 78.8 100.0 96.0 48.6 89.4 52.9 55.8 64.1 47.8 46.7 64.0 42.1 44.8 72.3 66.2 104.0 121.7 100.3 74.9 29.8 47.2 70.8 87.1 86.6 24.8 63.0 59.5 43.6 79.5 42.0 132.9 47.8 43.0 77.4 66.5 103.1 74.7 110.1 100.8 55.2 86.5 44.5 141.0 98.7 192.1 110.7 89.8 119.5 125.7 146.7 132.9 104.9 100.5 146.3 140.0 188.5 79.4 87.7 139.0 143.8 204.3 76.1 82.7 41.7 55.8 61.4 61.6 63.6 46.0 53.3 41.0 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377762 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 241 "heart muscle: 679.2" "Cell line enriched" "Detected in some" 26 "RH-30: 185.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 5.7" "CAB015371, HPA015774, HPA017888" Enhanced Uncertain "Nucleoplasm,Nucleoli,Focal adhesion sites" 50000 "Nucleoplasm, Nucleoli" "Focal adhesion sites" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 0.1 0.3 0.1 0.1 0.7 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.2 679.2 0.9 0.0 1.9 0.0 0.7 0.3 0.1 1.1 0.1 0.3 0.0 0.2 0.7 0.1 0.7 0.0 0.0 0.2 0.1 2.0 1.3 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.4 0.0 0.0 185.3 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.1 0.9 0.0 0.1 1.1 0.1 0.0 TOX4 "C14orf92, KIAA0737, LCP1" ENSG00000092203 "TOX high mobility group box family member 4" O94842 14 21476597-21499175 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017880, HPA027551" Approved Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA017880: AB_1845573, HPA027551: AB_10601701" "unprognostic (9.56e-2)" "unprognostic (2.54e-2)" "unprognostic (2.81e-1)" "unprognostic (7.46e-2)" "unprognostic (9.30e-2)" "unprognostic (1.23e-1)" "prognostic unfavourable (3.46e-4)" "unprognostic (8.05e-3)" "unprognostic (2.58e-1)" "unprognostic (5.00e-2)" "unprognostic (3.23e-2)" "unprognostic (2.94e-1)" "prognostic favourable (8.38e-5)" "unprognostic (1.84e-1)" "unprognostic (2.48e-1)" "unprognostic (9.03e-2)" "unprognostic (2.48e-3)" 16.5 15.1 18.0 13.4 24.7 18.8 16.9 19.9 29.8 19.8 17.3 21.0 10.9 12.7 18.9 16.2 21.8 15.6 14.7 19.2 17.0 18.4 14.3 15.8 15.8 13.7 19.3 15.9 17.0 17.0 23.2 15.5 21.3 25.3 15.6 15.9 16.0 19.7 19.2 46.0 20.2 20.0 20.5 17.3 14.7 16.9 18.0 13.3 19.5 17.7 16.6 21.6 18.2 14.4 18.4 23.7 34.1 19.9 19.1 21.4 17.6 12.9 13.8 11.5 10.9 16.7 16.1 15.4 12.6 24.9 26.9 26.0 13.3 15.8 7.9 8.9 20.7 15.8 18.8 19.4 34.5 13.9 7.6 8.8 9.4 18.4 21.7 16.2 14.5 20.9 20.1 21.0 20.3 19.0 10.8 13.6 19.1 11.1 16.0 9.0 6.5 21.8 14.4 11.9 9.1 12.5 16.5 10.7 10.9 12.4 13.3 10.9 12.6 6.2 12.4 13.6 12.9 12.2 11.0 17.9 19.4 17.7 6.6 7.9 14.4 25.2 19.6 27.0 17.3 19.9 18.6 17.0 15.3 16.2 17.7 18.4 16.4 17.9 34.1 19.1 17.7 23.7 21.4 17.6 18.0 24.7 19.9 29.8 17.0 18.4 19.3 15.9 25.3 13.3 TRA2A "AWMS1, htra-2-alpha, tra2a" ENSG00000164548 "Transformer 2 alpha homolog" Q13595 7 23504780-23532041 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054018 Uncertain Supported Nucleoplasm,Nucleoli,Vesicles Nucleoli "Nucleoplasm, Vesicles" "HPA054018: " "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.24e-1)" "unprognostic (6.77e-3)" "unprognostic (8.05e-2)" "unprognostic (3.41e-2)" "prognostic unfavourable (2.07e-5)" "unprognostic (1.28e-2)" "unprognostic (2.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.87e-3)" "unprognostic (6.04e-2)" "prognostic unfavourable (1.79e-6)" "unprognostic (1.46e-2)" "unprognostic (1.52e-2)" "unprognostic (8.74e-2)" "unprognostic (1.36e-3)" 23.4 29.4 27.8 29.5 34.1 70.6 27.4 38.1 27.5 30.3 22.9 29.0 31.6 19.8 32.7 34.5 29.4 25.9 17.6 18.7 28.6 29.3 21.3 21.8 28.6 32.2 35.8 18.5 36.8 27.4 14.9 46.6 24.4 28.2 26.4 30.1 23.7 21.9 26.7 15.7 31.6 22.6 35.2 30.4 33.8 21.1 25.9 37.3 35.6 24.7 20.5 38.0 25.0 31.8 15.5 23.9 20.4 23.0 14.7 21.7 8.2 19.0 21.1 32.7 51.2 17.6 11.1 21.2 24.2 11.5 24.3 20.1 17.3 26.2 35.9 14.0 17.9 31.6 39.2 22.6 30.7 21.6 22.9 22.0 23.3 27.3 18.4 25.6 20.7 13.1 15.7 18.4 23.1 27.7 42.7 17.6 27.6 18.6 31.0 43.1 29.3 21.8 35.4 25.8 21.5 28.2 27.5 28.4 23.1 22.7 26.3 16.2 20.6 28.9 24.9 19.5 27.9 17.8 28.1 19.8 24.7 29.5 16.7 35.0 25.9 11.5 14.9 18.5 21.7 23.0 18.7 15.5 20.3 19.8 16.8 14.4 17.7 20.9 20.4 14.7 20.4 23.9 20.0 8.2 27.8 34.1 38.1 27.5 28.6 29.3 35.8 18.5 28.2 37.3 TRDMT1 "DNMT2, RNMT1" ENSG00000107614 "TRNA aspartic acid methyltransferase 1" O14717 10 17142254-17202054 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009468, HPA036945, HPA036946" Approved Approved Nucleoplasm,Nucleoli,Centrosome Nucleoli "Nucleoplasm, Centrosome" "CAB009468: AB_2208432, HPA036945: , HPA036946: " "unprognostic (4.55e-1)" "unprognostic (3.22e-2)" "unprognostic (4.49e-6)" "unprognostic (7.07e-2)" "unprognostic (3.87e-3)" "unprognostic (1.33e-1)" "unprognostic (3.27e-4)" "unprognostic (3.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.55e-1)" "unprognostic (2.65e-2)" "unprognostic (3.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.40e-1)" "unprognostic (2.64e-2)" 6.1 4.4 4.4 8.5 7.7 4.0 6.3 14.0 6.2 5.3 3.8 4.2 4.7 4.1 7.5 14.4 3.9 6.8 5.1 5.0 4.9 4.5 6.7 2.7 5.3 5.3 4.3 2.9 9.6 5.0 12.8 12.6 5.1 6.2 5.0 3.6 8.0 5.6 3.8 4.3 4.4 5.0 5.4 5.1 5.9 4.2 4.2 6.1 19.9 11.5 3.3 5.7 4.0 5.2 6.1 10.5 5.2 4.4 3.5 8.0 3.6 5.1 2.5 10.0 2.6 3.8 2.2 0.0 4.4 3.2 4.7 5.5 4.2 4.3 3.5 0.6 5.0 2.6 6.7 4.2 5.4 7.4 4.3 5.2 3.8 2.5 3.4 3.4 3.9 3.0 2.6 3.2 2.3 6.1 6.5 3.9 7.7 1.6 17.0 0.8 6.3 2.9 3.7 7.8 2.2 2.5 2.8 2.7 3.4 0.0 1.9 3.4 4.8 3.1 3.6 3.4 7.2 6.3 5.1 5.0 4.7 8.9 4.3 4.8 3.4 5.2 4.4 2.4 3.9 2.5 7.2 5.4 6.6 4.9 5.5 6.1 8.0 5.8 2.8 3.5 1.4 10.5 2.2 3.6 4.4 7.7 14.0 6.2 4.9 4.5 4.3 2.9 6.2 6.1 TSG101 "TSG10, VPS23" ENSG00000074319 "Tumor susceptibility 101" Q99816 11 18468336-18527232 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004283, HPA006161" Approved Supported "Nucleoli,Plasma membrane,Cytosol" 14000 Cytosol "Nucleoli, Plasma membrane" "CAB004283: AB_671392, HPA006161: AB_1080408" "unprognostic (1.42e-1)" "unprognostic (7.91e-2)" "unprognostic (2.11e-1)" "unprognostic (6.77e-2)" "unprognostic (1.82e-1)" "unprognostic (2.72e-3)" "prognostic unfavourable (3.74e-6)" "unprognostic (5.67e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-2)" "unprognostic (4.15e-3)" "unprognostic (4.27e-2)" "prognostic favourable (5.52e-6)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" "unprognostic (4.02e-3)" "unprognostic (1.06e-1)" 24.7 30.5 18.4 14.2 25.5 23.5 27.6 22.7 25.9 22.5 23.1 23.7 21.6 20.5 25.8 27.7 34.3 23.9 18.4 31.8 17.7 20.6 33.4 29.0 20.1 23.4 21.6 21.4 23.2 39.5 33.2 23.5 38.5 24.6 21.9 28.4 19.4 25.4 22.4 44.5 27.3 25.7 23.1 21.7 20.5 23.0 33.7 20.2 27.5 32.3 37.1 25.5 24.2 25.5 20.5 18.2 42.3 29.2 14.3 22.0 22.2 14.3 23.7 21.0 14.6 24.9 26.0 19.5 22.3 30.1 27.3 27.0 16.2 7.6 19.4 13.7 24.8 22.0 20.9 20.2 30.4 27.2 25.5 12.0 12.5 23.8 32.0 18.0 20.8 22.4 41.1 14.2 38.8 22.4 19.5 16.5 33.0 25.9 11.4 19.6 12.9 24.0 10.3 21.2 16.1 18.3 20.5 15.0 26.9 21.4 18.0 28.5 17.9 18.1 12.0 18.3 11.2 38.2 16.5 10.6 20.4 15.4 18.9 10.0 23.4 42.3 19.5 40.7 14.9 21.7 15.0 20.5 14.4 15.9 18.2 18.0 15.4 16.4 34.5 14.3 29.2 15.4 22.0 22.2 18.4 25.5 22.7 25.9 17.7 20.6 21.6 21.4 24.6 20.2 TSPYL6 ENSG00000178021 "TSPY like 6" Q8N831 2 54253184-54256272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 54 "testis: 41.1" "Cell line enriched" "Detected in single" 131 "K-562: 13.1" "Cancer enriched" "Detected in single" 27 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034699, HPA034700" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA034699: , HPA034700: AB_10670159" "unprognostic (8.21e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (1.00e-1)" "unprognostic (5.54e-6)" "unprognostic (4.50e-2)" "unprognostic (1.77e-1)" "unprognostic (5.73e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 TSSK3 "SPOGA3, STK22C" ENSG00000162526 "Testis specific serine kinase 3" Q96PN8 1 32351521-32364312 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 68.1" "Cell line enhanced" "Detected in many" "HeLa: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA037516 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA037516: " "unprognostic (5.71e-2)" "unprognostic (1.42e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-1)" "unprognostic (7.69e-2)" "unprognostic (2.02e-4)" "unprognostic (2.06e-1)" "unprognostic (1.98e-3)" "unprognostic (2.05e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (9.20e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.68e-3)" 1.1 2.0 0.8 1.7 0.8 8.2 1.1 3.9 0.8 1.3 0.9 0.8 1.4 2.5 1.8 2.9 0.8 1.3 1.0 0.9 0.8 0.0 0.9 1.3 1.4 2.4 0.8 0.8 2.0 1.2 0.0 0.8 0.8 1.0 1.0 0.0 0.8 1.4 0.8 1.7 3.4 2.9 0.8 0.8 3.4 1.2 68.1 0.8 0.8 1.3 0.8 0.8 0.9 1.1 0.6 0.1 0.1 0.7 0.3 2.3 0.1 2.3 2.3 6.0 3.6 0.0 1.2 5.4 0.7 1.1 0.0 0.0 0.5 1.2 1.2 0.9 0.0 3.7 0.0 0.0 0.0 3.5 7.2 2.7 9.8 3.7 4.4 1.1 3.4 0.1 0.9 0.0 1.3 0.0 3.1 5.8 0.0 0.6 1.4 1.5 1.5 1.2 1.9 1.7 4.4 0.0 1.9 1.8 3.8 0.8 2.8 4.1 1.9 2.7 2.9 2.1 3.4 3.0 2.4 8.5 2.8 1.8 3.7 3.9 0.5 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.2 0.0 0.1 0.6 2.3 0.9 0.1 0.3 0.5 0.0 0.0 0.1 0.8 0.8 3.9 0.8 0.8 0.0 0.8 0.8 1.0 0.8 TTC3 "DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII" ENSG00000182670 "Tetratricopeptide repeat domain 3" P53804 21 37073226-37203112 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016810, HPA023964, HPA036304" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: " "unprognostic (3.90e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (1.53e-1)" "unprognostic (1.37e-2)" "unprognostic (8.52e-2)" "unprognostic (9.29e-2)" "unprognostic (8.71e-2)" "unprognostic (1.61e-1)" "unprognostic (2.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.10e-2)" "unprognostic (1.02e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (6.74e-2)" 22.9 22.1 34.0 18.7 36.5 12.0 23.4 39.2 40.0 34.9 20.6 15.9 26.7 13.0 21.6 33.3 15.3 19.5 19.0 21.5 29.1 16.5 21.4 17.0 15.4 14.3 17.7 27.5 34.5 25.8 27.4 50.4 15.2 34.7 28.9 19.9 16.1 24.5 25.4 21.6 16.1 16.8 21.6 21.7 13.6 21.3 19.5 19.9 19.7 35.4 11.1 15.1 23.3 18.9 10.6 12.8 4.8 5.7 9.1 18.6 3.8 21.4 7.6 35.7 6.7 34.5 50.2 12.4 23.6 29.4 10.7 14.5 10.1 10.8 18.5 8.2 39.5 7.0 10.7 14.5 15.1 19.6 7.7 37.4 11.5 13.1 12.6 20.8 12.1 25.9 9.0 10.8 9.7 15.8 22.5 21.8 20.0 16.6 20.2 5.4 10.1 13.0 27.1 17.1 9.7 12.4 16.6 27.3 20.8 29.3 16.8 15.2 19.0 8.2 20.5 15.3 6.1 18.7 8.8 21.9 15.7 18.5 25.2 20.9 11.5 2.9 4.4 4.8 9.1 4.8 13.6 9.5 10.6 12.3 7.9 10.6 18.6 11.3 0.7 9.1 5.7 12.8 7.2 3.8 34.0 36.5 39.2 40.0 29.1 16.5 17.7 27.5 34.7 19.9 TULP3 TUBL3 ENSG00000078246 "Tubby like protein 3" O75386 12 2877223-2941140 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015285, HPA018496" Uncertain Supported "Nucleoplasm,Nucleoli,Plasma membrane" "Secreted - unknown location" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA015285: AB_1858460, HPA018496: " "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (4.80e-2)" "prognostic favourable (2.99e-4)" "unprognostic (2.45e-1)" "unprognostic (1.78e-2)" "prognostic unfavourable (7.97e-5)" "unprognostic (2.44e-1)" "unprognostic (4.09e-2)" "unprognostic (1.73e-1)" "unprognostic (1.50e-1)" "unprognostic (3.37e-1)" "prognostic unfavourable (7.18e-4)" "unprognostic (7.52e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-2)" "unprognostic (3.19e-2)" 14.0 12.0 8.1 6.9 12.9 2.4 13.0 21.2 11.1 22.7 13.6 19.6 12.6 5.3 27.7 11.7 14.1 20.9 11.5 12.7 12.1 5.3 12.1 6.5 9.5 7.2 11.0 7.7 37.1 6.8 13.5 15.4 12.7 10.9 12.5 8.1 17.2 9.8 14.0 9.9 19.8 7.0 17.5 9.7 7.3 11.7 13.2 13.8 4.4 13.3 6.3 9.2 11.6 28.4 3.5 2.8 0.6 1.5 4.8 6.3 1.7 9.2 7.9 15.0 12.5 15.2 22.7 14.2 14.6 24.5 15.8 17.5 10.0 8.6 6.9 2.2 21.5 7.8 8.9 9.4 18.3 8.9 6.6 4.1 9.8 6.4 19.6 4.4 4.8 13.3 11.1 23.8 32.7 12.1 3.9 6.5 13.2 8.3 6.5 3.9 20.3 5.8 6.9 14.7 2.5 9.9 7.8 3.8 10.1 12.7 7.6 8.3 9.5 4.3 9.7 11.6 14.1 23.6 14.1 2.0 2.4 6.0 11.7 2.4 17.7 0.0 1.5 0.5 4.0 1.5 6.3 2.9 3.1 4.0 1.3 3.5 3.8 5.2 0.6 4.8 0.8 2.8 5.5 1.7 8.1 12.9 21.2 11.1 12.1 5.3 11.0 7.7 10.9 13.8 UBXN8 "D8S2298E, REP8, UBXD6" ENSG00000104691 "UBX domain protein 8" O00124 8 30732247-30767006 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 30.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017725, HPA077538" Enhanced Supported "Nucleoplasm,Nucleoli,Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "Nucleoplasm, Nucleoli" "HPA017725: AB_1847462, HPA077538: " "unprognostic (3.00e-2)" "unprognostic (2.30e-1)" "prognostic favourable (6.13e-4)" "unprognostic (7.71e-2)" "unprognostic (2.24e-1)" "unprognostic (1.03e-1)" "unprognostic (2.41e-1)" "unprognostic (1.84e-2)" "unprognostic (1.90e-1)" "unprognostic (5.13e-2)" "unprognostic (1.58e-1)" "unprognostic (1.06e-2)" "prognostic unfavourable (5.25e-5)" "unprognostic (2.49e-1)" "unprognostic (1.96e-1)" "unprognostic (1.51e-1)" "unprognostic (6.88e-2)" 5.0 5.3 3.9 1.4 4.8 1.4 4.3 1.5 9.2 3.0 3.5 4.0 6.7 3.1 3.8 14.3 4.1 3.6 3.8 2.8 5.7 8.2 21.5 2.1 3.9 7.6 4.0 30.6 10.3 6.2 3.5 6.2 6.2 4.8 4.7 1.6 1.8 6.1 1.7 4.1 2.9 2.9 7.1 5.7 3.3 11.5 6.1 0.9 9.1 2.8 2.3 2.9 3.7 6.0 8.2 1.0 6.1 3.3 8.4 3.4 7.6 7.7 5.6 5.8 9.1 12.2 6.2 13.7 8.0 7.5 9.2 12.2 2.7 12.2 11.3 11.1 6.8 1.1 7.6 11.6 6.4 12.5 34.3 6.3 14.9 13.6 7.8 19.4 9.5 7.9 12.0 5.9 6.5 33.4 9.2 16.5 7.2 7.9 6.0 10.8 5.8 9.5 5.4 8.5 12.8 10.0 3.2 8.1 3.8 11.3 24.7 8.4 13.6 8.3 8.5 3.7 3.8 12.7 4.0 12.5 9.2 7.6 12.6 12.1 0.0 6.0 0.7 8.4 6.1 7.3 6.0 4.5 8.0 6.7 2.9 4.4 7.4 1.0 3.3 3.0 8.2 4.3 3.4 UFD1 UFD1L ENSG00000070010 "Ubiquitin recognition factor in ER associated degradation 1" Q92890 22 19449910-19479215 "Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 130.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030286, HPA030287" Approved Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Cytosol" Nucleoli "HPA030286: , HPA030287: AB_10601830" "unprognostic (2.52e-1)" "unprognostic (5.41e-2)" "unprognostic (1.95e-3)" "unprognostic (7.61e-2)" "unprognostic (3.50e-2)" "unprognostic (2.70e-2)" "prognostic unfavourable (2.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-3)" "unprognostic (8.82e-2)" "unprognostic (1.73e-2)" "prognostic unfavourable (4.50e-8)" "unprognostic (1.45e-1)" "unprognostic (1.08e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" 27.8 28.0 22.7 24.3 38.0 38.7 23.9 25.3 30.4 21.1 28.9 23.3 24.7 21.7 32.8 40.3 31.6 21.3 21.7 35.6 21.9 22.9 28.0 46.6 24.6 34.8 44.3 15.9 22.4 34.7 22.5 22.6 31.6 33.0 21.7 27.7 21.9 26.7 24.4 57.9 27.3 24.7 28.3 39.7 26.7 26.2 31.8 29.9 37.8 27.8 26.9 31.7 23.9 23.7 27.7 35.3 53.5 42.8 31.1 67.6 37.5 31.4 22.9 19.6 29.6 16.1 11.3 15.1 26.0 26.0 36.0 33.4 25.4 13.7 22.0 20.3 21.8 27.3 22.9 22.8 31.5 40.5 24.2 23.2 16.2 20.0 15.3 36.8 31.7 10.4 23.5 30.7 15.1 28.9 130.1 42.5 21.9 45.7 23.6 22.5 14.0 19.5 28.7 46.3 8.5 22.1 29.7 16.1 18.1 20.4 22.2 20.4 13.3 17.7 31.3 30.5 41.4 25.3 27.9 18.2 36.1 28.7 25.6 18.8 27.7 39.8 29.0 47.8 36.1 42.8 34.7 27.7 41.6 37.3 25.5 23.9 35.9 35.1 53.5 31.1 41.1 35.3 67.6 37.5 22.7 38.0 25.3 30.4 21.9 22.9 44.3 15.9 33.0 29.9 UPF3B "HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X" ENSG00000125351 "UPF3B, regulator of nonsense mediated mRNA decay" Q9BZI7 X 119805311-119852998 "Disease related genes, Predicted intracellular proteins" "mRNA transport, Nonsense-mediated mRNA decay, Transport" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001592, HPA001800, HPA001882" Approved Enhanced Nucleoplasm,Nucleoli,Cytosol Cytosol "Nucleoplasm, Nucleoli" "HPA001592: , HPA001800: AB_1080476, HPA001882: AB_1080474" "unprognostic (1.79e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" "unprognostic (3.64e-3)" "unprognostic (8.58e-2)" "unprognostic (1.20e-1)" "prognostic unfavourable (1.52e-6)" "unprognostic (6.61e-2)" "prognostic unfavourable (5.39e-4)" "unprognostic (5.74e-2)" "unprognostic (4.51e-2)" "unprognostic (8.63e-3)" "prognostic unfavourable (1.44e-7)" "unprognostic (8.67e-2)" "unprognostic (1.04e-1)" "unprognostic (2.34e-1)" "unprognostic (8.95e-2)" 9.7 10.3 19.4 11.5 21.9 14.5 10.8 34.1 24.0 10.2 13.0 9.3 12.8 14.2 14.6 13.5 13.0 8.8 8.4 7.8 16.9 17.5 10.0 12.4 9.0 17.2 16.5 21.7 14.8 8.7 14.3 26.7 10.5 17.2 12.4 13.2 9.1 9.7 14.4 14.5 18.6 11.1 14.2 21.7 12.9 9.9 15.0 21.0 9.9 12.5 11.5 18.3 12.6 12.9 17.5 10.0 7.1 5.9 7.9 8.1 2.7 11.6 7.1 14.8 12.0 6.7 4.4 9.5 11.3 6.3 8.8 7.8 13.3 8.4 21.1 9.6 4.7 11.2 19.1 6.7 11.3 12.0 14.0 19.5 23.5 6.9 7.7 21.1 9.7 3.8 5.1 15.1 18.5 8.2 18.8 17.6 7.3 14.2 14.8 26.5 28.5 19.4 14.5 16.9 15.4 7.2 5.9 19.7 13.6 23.0 9.3 16.8 4.9 12.3 7.1 9.2 7.1 14.7 23.8 9.7 10.8 28.5 7.4 31.0 10.7 7.1 5.3 6.8 7.5 5.1 5.7 13.8 7.0 5.9 3.8 17.5 7.6 8.1 5.9 7.9 5.9 10.0 7.8 2.7 19.4 21.9 34.1 24.0 16.9 17.5 16.5 21.7 17.2 21.0 USF3 KIAA2018 ENSG00000176542 "Upstream transcription factor family member 3" Q68DE3 3 113648385-113696646 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029243, HPA029245" Uncertain Uncertain Nucleoplasm,Nucleoli,Centrosome "Nucleoplasm, Nucleoli" Centrosome "HPA029243: AB_10611114, HPA029245: AB_10600443" "unprognostic (2.80e-2)" "unprognostic (2.80e-1)" "unprognostic (4.21e-2)" "unprognostic (7.80e-2)" "unprognostic (2.25e-2)" "unprognostic (1.96e-2)" "unprognostic (3.53e-1)" "unprognostic (2.62e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (8.74e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (3.28e-1)" "unprognostic (5.55e-2)" 9.0 5.1 8.8 11.0 7.3 13.8 11.4 13.9 7.5 7.2 12.2 5.3 5.4 4.8 5.8 13.3 7.0 6.3 5.3 8.1 7.6 5.5 12.7 24.0 6.1 9.2 6.3 5.6 6.9 10.8 14.4 8.9 4.9 6.5 6.2 6.7 6.4 8.3 5.4 28.7 11.4 14.7 8.3 11.2 12.0 7.3 4.8 6.9 13.3 7.1 11.5 8.9 6.1 6.0 5.9 5.1 6.9 3.7 2.6 3.1 1.4 5.2 3.9 4.9 4.6 12.0 4.6 3.3 2.1 3.4 2.1 2.0 3.7 2.2 9.2 3.8 5.3 3.3 5.3 4.2 3.9 2.8 2.1 6.6 2.5 6.0 3.6 11.9 7.3 6.7 7.6 3.8 4.4 4.9 3.1 4.9 4.4 7.3 6.6 6.7 3.6 4.0 2.8 3.8 3.6 7.4 7.3 2.3 3.5 5.1 2.8 6.0 3.9 8.9 6.7 3.3 7.1 1.8 3.0 5.7 3.2 11.0 3.7 5.0 2.4 4.1 2.4 3.5 3.1 2.8 2.3 2.2 2.2 2.3 1.7 5.9 2.7 2.8 6.9 2.6 3.7 5.1 1.1 1.4 8.8 7.3 13.9 7.5 7.6 5.5 6.3 5.6 6.5 6.9 UTP18 "CGI-48, WDR50" ENSG00000011260 "UTP18, small subunit processome component" Q9Y5J1 17 51260528-51297936 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052378 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" Nucleoli "Nucleoplasm, Nuclear membrane" "HPA052378: " "unprognostic (1.36e-2)" "unprognostic (1.00e-1)" "prognostic favourable (3.33e-4)" "unprognostic (2.62e-2)" "unprognostic (2.55e-2)" "unprognostic (5.99e-2)" "prognostic unfavourable (1.99e-4)" "unprognostic (2.47e-2)" "unprognostic (8.37e-3)" "unprognostic (1.10e-2)" "unprognostic (8.82e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-3)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.72e-3)" "unprognostic (1.93e-2)" 15.6 16.1 14.4 18.0 20.5 26.9 20.2 23.3 20.9 15.0 13.6 14.5 12.4 13.6 13.0 13.4 17.7 14.0 11.1 8.9 14.2 13.9 17.1 16.9 14.0 22.9 17.0 20.5 19.4 18.1 17.3 19.4 28.3 16.1 13.1 15.0 12.8 14.9 11.9 19.1 25.7 13.0 10.2 14.4 22.0 13.5 42.5 16.9 21.6 19.1 15.6 25.3 15.2 17.9 26.1 26.4 12.4 22.9 17.4 28.1 24.9 26.3 26.2 16.7 15.3 11.0 16.6 43.7 14.6 12.1 25.6 24.7 16.4 14.8 33.5 20.9 10.9 14.4 27.1 15.6 38.2 21.8 35.3 35.1 15.9 28.5 15.1 37.1 17.3 10.6 12.1 21.7 17.7 15.3 28.5 15.4 19.2 16.3 33.3 25.3 23.9 27.8 30.3 38.1 26.2 18.7 17.6 18.6 23.7 17.0 20.3 33.1 25.0 19.0 13.3 26.5 22.2 21.7 30.3 29.9 55.1 38.8 16.4 25.9 18.8 6.8 22.9 12.4 20.5 21.6 24.9 26.1 25.8 24.7 26.4 24.4 28.1 26.2 4.0 17.4 21.1 16.6 25.7 24.9 14.4 20.5 23.3 20.9 14.2 13.9 17.0 20.5 16.1 16.9 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383528 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in many" 12 "U-2197: 123.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" 2400000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: " "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavourable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 22.4 10.2 4.9 7.7 6.7 3.8 28.6 1.6 6.5 19.9 5.1 5.6 6.4 5.1 14.3 13.6 16.2 9.9 10.2 12.9 4.4 1.8 21.6 14.1 17.2 5.2 2.7 2.9 21.0 9.8 1.7 5.9 30.2 4.8 12.9 2.0 33.6 7.9 13.1 7.0 16.0 4.0 9.4 3.6 7.9 6.5 14.7 3.5 0.0 15.2 5.5 8.2 16.6 19.0 0.3 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 2.7 3.1 1.1 5.2 5.1 1.6 2.6 0.3 0.5 0.0 1.9 3.4 0.0 0.0 0.1 0.2 1.1 0.1 0.1 1.4 1.6 9.9 0.0 0.0 3.2 0.0 3.9 0.1 0.0 0.2 0.0 0.2 1.8 0.0 0.4 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.1 0.9 2.4 4.1 0.0 0.9 0.2 0.0 4.8 1.2 123.8 0.6 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 6.7 1.6 6.5 4.4 1.8 2.7 2.9 4.8 3.5 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 38.1;pituitary gland: 70.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 24.3;HUVEC TERT2: 64.8;TIME: 38.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 2.2;pons and medulla: 5.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favourable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.5 16.0 0.3 0.2 0.3 1.1 1.4 2.2 3.5 1.9 0.4 0.7 2.0 0.2 0.4 12.1 0.2 3.4 1.1 0.4 0.8 0.5 20.7 0.6 38.1 0.1 0.7 0.1 1.1 8.6 0.7 70.3 1.6 5.5 1.2 0.3 17.7 6.9 4.9 0.2 0.7 0.2 0.1 0.3 2.3 0.6 1.7 0.2 0.1 1.1 0.5 0.6 0.5 0.8 0.0 0.0 1.5 0.7 0.0 0.0 5.1 1.8 0.2 4.2 0.0 2.5 9.3 0.0 11.0 24.3 3.2 4.8 0.3 1.7 0.0 4.3 11.8 0.0 0.1 0.2 18.2 0.0 0.0 1.8 0.2 0.0 0.8 0.0 0.0 2.7 0.1 13.9 2.8 64.8 0.6 0.0 8.8 0.2 0.0 0.0 1.7 1.6 0.0 0.3 0.0 1.6 0.9 0.1 0.0 0.3 0.5 4.3 18.8 0.0 38.5 13.0 0.4 4.5 15.0 0.0 0.0 0.0 10.4 0.0 3.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.1 0.3 0.3 2.2 0.4 0.8 0.5 0.7 0.1 5.5 0.2 VPS51 "ANG2, ANG3, C11orf2, C11orf3, FFR" ENSG00000149823 "VPS51, GARP complex subunit" Q9UID3 11 65089324-65111860 "Predicted intracellular proteins" "Lipid transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039650, HPA061447" Uncertain Approved "Nucleoli,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoli "HPA039650: AB_10673147, HPA061447: " "unprognostic (2.36e-2)" "unprognostic (7.58e-2)" "unprognostic (8.35e-2)" "unprognostic (1.56e-1)" "unprognostic (2.11e-2)" "unprognostic (1.64e-1)" "unprognostic (9.72e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (2.03e-3)" "unprognostic (1.56e-1)" "prognostic favourable (2.41e-9)" "unprognostic (7.77e-3)" "unprognostic (4.63e-2)" "unprognostic (2.85e-1)" "unprognostic (2.18e-1)" 22.1 19.5 17.5 19.4 24.3 30.3 21.7 29.8 33.8 23.4 30.9 16.9 22.4 31.2 27.7 15.5 22.9 20.9 25.0 27.7 15.9 13.0 18.5 24.7 16.6 35.0 14.5 19.2 53.2 77.6 22.9 14.5 21.7 15.9 22.0 15.7 17.2 54.2 18.4 39.4 32.0 27.7 24.4 13.2 20.5 30.3 17.5 12.6 36.5 34.7 24.4 21.9 24.6 22.4 15.6 14.8 9.9 10.5 21.8 19.8 10.5 21.7 24.0 11.8 14.4 5.3 13.1 22.0 8.6 17.6 17.5 13.0 17.4 28.8 38.0 24.7 16.6 18.7 12.4 19.3 6.4 22.1 18.8 22.6 24.4 16.7 17.3 24.4 20.7 22.6 13.2 13.0 10.8 19.2 23.0 27.3 7.1 29.6 32.7 24.4 19.1 18.4 20.4 5.7 45.8 11.9 24.4 19.7 27.1 6.4 36.6 21.3 29.8 12.2 15.5 11.9 10.4 14.7 12.3 34.9 27.0 21.3 13.2 8.9 8.4 7.0 10.0 9.9 13.3 10.5 15.5 15.3 18.5 19.8 14.8 15.6 16.9 14.7 6.3 21.8 10.3 13.4 11.9 10.5 17.5 24.3 29.8 33.8 15.9 13.0 14.5 19.2 15.9 12.6 VSIG4 Z39IG ENSG00000155659 "V-set and immunoglobulin domain containing 4" Q9Y279 X 66021738-66040125 "Plasma proteins, Predicted membrane proteins" "Complement alternate pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.0;U-937: 2.7" "Cancer enhanced" "Detected in all" "glioma: 88.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 26 "classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1" "Group enriched" "Detected in many" 30 "dendritic cells: 13.1;monocytes: 13.9" "Low region specificity" "Detected in many" "HPA003903, CAB026000" Enhanced Uncertain "Nucleoli,Plasma membrane,Cytosol" 41000000 "Plasma membrane, Cytosol" Nucleoli "CAB026000: , HPA003903: AB_1858776" "unprognostic (6.87e-3)" "unprognostic (4.79e-2)" "prognostic unfavourable (1.34e-4)" "unprognostic (3.19e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (9.37e-3)" "unprognostic (1.24e-1)" "unprognostic (3.10e-1)" "unprognostic (1.37e-3)" "unprognostic (1.06e-1)" "unprognostic (2.77e-1)" "prognostic unfavourable (1.95e-6)" "unprognostic (3.70e-2)" "unprognostic (5.45e-2)" "unprognostic (3.37e-2)" "unprognostic (3.47e-2)" 67.1 28.1 15.9 17.6 16.6 2.6 19.0 1.8 10.4 6.3 18.0 5.6 1.0 9.2 6.1 14.2 9.3 28.7 15.5 15.9 11.5 3.5 18.5 22.9 61.4 37.0 17.9 3.4 8.2 8.2 3.7 7.9 52.4 12.0 10.9 12.6 8.1 11.3 4.0 10.5 4.0 14.6 39.9 16.7 28.5 9.4 13.5 17.8 0.0 10.7 1.7 1.8 14.4 9.0 0.1 13.1 0.4 13.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.1 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.1 3.1 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.4 0.0 0.0 0.8 2.7 0.0 0.0 13.9 0.0 0.0 8.1 0.0 0.0 0.0 0.2 13.1 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 3.3 15.9 16.6 1.8 10.1 11.5 3.5 17.9 3.4 12.0 17.8 WASHC2A "bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824" ENSG00000099290 "WASH complex subunit 2A" Q641Q2 10 50067888-50133506 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol Vesicles "Nucleoli, Cytosol" "HPA047844: , HPA060975: , HPA061022: " "unprognostic (2.46e-1)" "unprognostic (1.11e-3)" "unprognostic (8.82e-2)" "unprognostic (3.28e-1)" "unprognostic (2.75e-1)" "unprognostic (6.51e-3)" "prognostic unfavourable (6.75e-5)" "unprognostic (4.60e-2)" "unprognostic (2.85e-2)" "unprognostic (2.37e-2)" "unprognostic (9.04e-2)" "unprognostic (2.73e-2)" "unprognostic (1.18e-1)" "unprognostic (2.57e-1)" "unprognostic (2.95e-1)" "unprognostic (1.85e-2)" "unprognostic (4.40e-2)" 24.0 21.0 15.8 31.4 19.3 24.7 27.1 22.5 18.3 19.1 21.2 16.2 12.6 19.4 22.8 15.3 15.7 15.5 14.4 42.9 17.6 13.9 26.1 12.1 20.7 20.2 15.3 15.8 22.5 14.0 21.2 27.0 17.7 22.0 16.7 23.0 13.1 17.5 16.5 15.5 19.2 21.3 16.8 14.6 27.4 16.2 9.4 14.8 27.0 21.4 9.8 20.2 18.4 27.4 6.6 9.0 11.7 13.9 9.0 12.5 8.8 10.9 5.3 9.1 10.6 37.1 20.8 7.4 12.9 27.4 19.2 20.6 12.4 16.5 9.7 8.1 19.2 12.0 13.1 10.9 19.0 9.2 9.5 6.9 10.7 12.4 25.9 11.7 12.0 21.3 13.7 21.0 13.3 14.5 11.2 9.8 23.1 7.8 6.4 19.2 7.4 25.2 9.8 13.2 5.7 13.2 12.7 3.1 9.8 12.0 11.2 17.2 13.8 8.1 21.3 9.8 8.3 27.8 10.6 10.1 20.1 8.3 21.6 21.6 3.9 1.2 10.7 11.7 12.0 13.9 12.5 6.6 10.2 11.0 9.0 6.5 10.2 7.4 5.1 9.0 8.2 5.3 10.4 8.8 15.8 19.3 22.5 18.3 17.6 13.9 15.3 15.8 22.0 14.8 WASHC2C "Em:AC012044.3, FAM21C, KIAA0592" ENSG00000172661 "WASH complex subunit 2C" Q9Y4E1 10 45727200-45792961 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA047844, HPA060975, HPA061022" Supported Supported Nucleoli,Vesicles,Cytosol Vesicles "Nucleoli, Cytosol" "HPA047844: , HPA060975: , HPA061022: " "unprognostic (7.50e-2)" "unprognostic (2.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.06e-1)" "unprognostic (4.51e-2)" "unprognostic (5.98e-3)" "prognostic unfavourable (1.35e-5)" "prognostic favourable (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (5.02e-2)" "unprognostic (1.00e-3)" "unprognostic (1.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.48e-1)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.00e-2)" 17.2 15.8 10.0 33.6 15.7 30.1 27.2 24.9 17.1 16.7 15.8 10.7 15.9 12.2 18.3 17.0 12.3 13.2 13.6 23.2 14.2 10.2 20.6 12.8 17.3 14.8 16.0 8.4 20.2 10.1 22.7 16.5 13.4 16.2 13.4 18.5 13.0 15.3 24.0 17.1 14.8 17.0 15.8 14.0 15.5 12.5 10.1 15.3 19.4 14.9 13.2 14.6 19.3 14.8 10.7 11.4 17.2 20.3 12.2 13.4 11.6 11.1 12.0 9.8 11.1 25.5 22.6 5.9 13.1 21.6 15.5 14.9 7.3 10.9 9.2 8.9 19.3 10.1 10.9 6.0 15.6 8.5 9.1 9.5 14.9 5.6 27.1 9.5 11.8 21.3 14.6 16.8 12.6 15.9 15.1 7.3 19.0 5.8 6.3 16.4 7.1 1.8 7.9 14.4 4.7 11.5 17.5 4.8 10.8 15.2 7.7 18.4 10.4 9.6 26.7 8.1 8.7 21.3 8.7 10.3 15.9 9.1 11.4 22.9 4.3 12.5 16.9 11.0 13.0 18.2 12.5 10.7 10.8 13.4 11.4 9.6 10.8 9.7 17.2 12.2 20.3 8.4 10.1 11.6 10.0 15.7 24.9 17.1 14.2 10.2 16.0 8.4 16.2 15.3 WDFY3 "ALFY, KIAA0993, ZFYVE25" ENSG00000163625 "WD repeat and FYVE domain containing 3" Q8IZQ1 4 84669610-84966391 "Disease related genes, Predicted intracellular proteins" Autophagy "Developmental protein" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.3" "Group enriched" "Detected in many" 23 "dendritic cells: 1.1;granulocytes: 4.3;monocytes: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042734, HPA048572" Approved Approved "Nucleoli,Plasma membrane,Cytosol" Cytosol "Nucleoli, Plasma membrane" "HPA042734: , HPA048572: " "unprognostic (7.14e-2)" "unprognostic (6.02e-2)" "unprognostic (7.68e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-2)" "unprognostic (2.48e-1)" "unprognostic (2.86e-2)" "unprognostic (3.36e-1)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "prognostic favourable (3.64e-5)" "prognostic unfavourable (9.35e-4)" "unprognostic (2.79e-1)" "unprognostic (4.41e-2)" "unprognostic (4.95e-2)" 10.1 15.2 17.2 7.5 18.7 13.1 9.0 17.9 18.6 9.6 8.3 17.6 4.8 3.6 11.5 6.9 9.4 9.3 9.0 7.3 17.3 6.5 21.3 5.8 7.9 2.4 22.8 9.5 14.7 9.0 24.0 14.6 11.8 17.0 9.2 5.9 8.6 9.8 8.1 13.7 10.9 5.6 8.7 14.8 7.5 7.8 8.0 21.4 0.4 12.1 3.2 2.6 14.2 6.6 0.0 1.1 4.3 1.5 0.0 0.0 0.3 6.3 4.4 8.0 4.4 14.2 11.1 5.0 6.1 6.5 6.4 5.8 4.9 5.3 0.0 6.4 10.2 3.2 8.5 6.7 8.2 4.4 2.7 4.0 4.8 2.9 5.3 3.1 7.6 8.1 6.1 8.4 8.5 20.4 4.1 19.6 11.8 4.6 3.0 0.7 4.1 2.2 4.5 6.4 0.9 11.1 8.5 9.4 4.4 7.6 8.4 4.2 4.3 7.8 31.0 8.5 8.5 4.7 7.7 0.0 0.0 0.0 5.8 2.7 9.3 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.3 0.0 0.5 0.0 0.0 0.3 17.2 18.7 17.9 18.6 17.3 6.5 22.8 9.5 17.0 21.4 WDR12 "FLJ10881, YTM1" ENSG00000138442 "WD repeat domain 12" Q9GZL7 2 202874782-203014798 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036389 Uncertain Approved "Nucleoli,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoli "HPA036389: AB_10670716" "unprognostic (1.08e-2)" "unprognostic (3.59e-1)" "unprognostic (8.17e-2)" "unprognostic (3.59e-3)" "unprognostic (1.24e-2)" "unprognostic (9.40e-3)" "prognostic unfavourable (2.57e-6)" "unprognostic (1.52e-1)" "unprognostic (6.14e-2)" "unprognostic (4.78e-2)" "unprognostic (4.58e-2)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.66e-1)" "unprognostic (9.69e-3)" "unprognostic (4.48e-2)" 5.8 9.7 7.2 5.5 16.1 6.7 7.6 11.5 15.2 5.9 6.2 6.5 3.7 8.9 7.1 7.0 8.0 6.7 5.0 8.4 6.8 8.6 11.1 8.7 4.2 6.4 7.4 8.9 7.3 5.7 6.7 8.0 6.6 12.6 4.9 8.7 6.7 5.4 5.2 11.0 7.7 6.0 7.4 6.2 5.3 5.6 17.1 8.2 9.6 7.1 5.1 7.5 5.8 5.6 5.4 6.9 3.6 5.0 3.6 5.9 3.0 4.3 4.6 5.3 10.0 10.0 8.6 9.7 6.6 5.3 8.2 8.0 11.6 6.1 7.9 6.1 5.3 5.5 14.3 10.6 13.2 4.0 8.9 13.4 7.4 13.7 6.5 17.4 8.2 7.8 7.7 9.7 19.4 8.5 20.9 5.2 9.0 5.0 11.9 10.2 12.1 11.7 8.7 8.3 12.4 9.0 5.2 9.3 8.2 5.2 6.8 8.1 4.0 11.5 6.8 7.4 6.0 6.1 7.3 6.8 10.3 13.3 7.3 11.9 7.3 3.6 4.7 2.0 4.2 5.0 5.9 5.3 4.0 4.3 6.0 5.4 5.2 5.0 2.1 3.6 4.5 6.9 4.3 3.0 7.2 16.1 11.5 15.2 6.8 8.6 7.4 8.9 12.6 8.2 WDSUB1 "FLJ36175, UBOX6, WDSAM1" ENSG00000196151 "WD repeat, sterile alpha motif and U-box domain containing 1" Q8N9V3 2 159235793-159286799 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036840, HPA058172" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA036840: AB_10670926, HPA058172: " "unprognostic (1.37e-2)" "prognostic favourable (3.35e-4)" "unprognostic (2.56e-1)" "unprognostic (7.33e-3)" "unprognostic (3.44e-2)" "unprognostic (9.65e-2)" "prognostic unfavourable (2.67e-4)" "unprognostic (2.76e-3)" "unprognostic (4.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (6.75e-2)" "unprognostic (3.46e-3)" "unprognostic (8.49e-2)" "unprognostic (1.72e-1)" "unprognostic (1.00e-2)" "unprognostic (2.87e-2)" 10.3 14.2 9.7 6.6 12.7 10.9 14.8 18.9 14.0 10.3 8.5 8.9 10.6 5.8 9.8 22.1 11.1 11.8 9.9 11.5 9.7 10.6 27.7 8.2 10.7 16.1 11.5 7.0 16.4 15.5 19.4 23.8 15.7 9.2 11.3 9.2 16.0 11.8 8.7 7.7 8.2 7.7 9.9 9.5 10.5 9.0 7.7 10.2 8.5 22.2 6.1 9.2 10.0 15.0 9.8 10.3 2.8 9.3 16.2 13.0 6.2 6.6 4.9 4.5 7.1 8.2 9.5 15.3 5.2 10.2 9.5 16.7 10.7 10.8 8.8 5.5 7.8 4.0 12.6 4.7 13.4 3.4 10.5 9.1 5.7 10.7 10.0 7.7 12.6 5.5 17.6 11.6 9.6 7.8 12.0 6.7 8.9 6.8 5.5 14.2 6.1 10.7 8.7 6.6 4.8 10.9 9.5 8.4 5.5 5.4 7.0 12.0 5.4 13.5 3.2 6.7 5.0 9.4 4.9 3.4 5.7 8.1 11.9 9.6 4.2 2.7 9.3 2.8 13.0 7.0 9.8 9.8 5.2 8.1 10.3 8.9 6.3 7.4 0.6 16.2 6.3 9.7 2.6 6.2 9.7 12.7 18.9 14.0 9.7 10.6 11.5 7.0 9.2 10.2 YWHAB YWHAA ENSG00000166913 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta" P31946 20 44885676-44908532 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003759, HPA007925, HPA011212, HPA061603" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol 210000000 Cytosol "Nucleoplasm, Nucleoli" "CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334, HPA061603: " "prognostic unfavourable (9.18e-4)" "unprognostic (1.48e-1)" "unprognostic (9.06e-2)" "prognostic unfavourable (5.46e-4)" "unprognostic (3.80e-1)" "prognostic unfavourable (6.14e-4)" "prognostic unfavourable (1.91e-6)" "prognostic unfavourable (6.01e-4)" "unprognostic (8.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.53e-2)" "unprognostic (2.35e-1)" "prognostic favourable (2.52e-5)" "unprognostic (6.72e-2)" "unprognostic (2.40e-1)" "unprognostic (6.60e-3)" "unprognostic (8.59e-2)" 39.3 38.6 65.5 39.4 79.2 28.6 33.0 60.1 87.9 34.0 47.5 27.7 28.7 37.9 35.2 26.4 48.1 30.2 29.6 40.3 68.7 63.4 47.3 36.5 37.4 46.8 49.8 76.2 25.8 18.9 41.1 18.4 36.7 50.1 31.4 53.4 22.9 30.7 43.2 28.3 38.4 39.3 43.3 38.4 53.7 36.7 16.8 33.6 48.2 36.1 31.8 60.2 41.2 34.9 30.9 41.9 37.3 58.4 26.8 43.5 26.6 51.8 39.3 31.7 30.4 52.8 46.7 43.0 47.2 46.0 58.2 51.1 81.8 58.8 55.4 49.5 62.3 55.2 44.7 87.8 69.6 21.2 27.3 41.2 34.6 48.5 35.0 66.7 39.9 36.5 65.7 45.6 58.9 58.2 44.4 26.8 59.7 61.3 52.0 55.0 29.9 61.2 40.9 46.0 43.0 62.3 58.0 33.9 36.1 80.0 85.6 55.1 62.3 64.2 66.0 90.5 46.5 51.0 48.0 17.9 32.6 50.8 66.1 44.7 46.0 34.8 40.1 34.4 29.7 52.2 30.2 30.9 37.7 36.3 41.9 28.6 30.8 36.6 37.3 26.8 58.4 26.5 43.5 26.6 65.5 79.2 60.1 87.9 68.7 63.4 49.8 76.2 50.1 33.6 YWHAE FLJ45465 ENSG00000108953 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon" P62258 17 1344272-1400378 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008445, CAB016200, CAB021109, CAB047350, HPA061603" Approved Supported Nucleoplasm,Nucleoli,Cytosol 160000000 Cytosol "Nucleoplasm, Nucleoli" "CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336, HPA061603: " "unprognostic (1.29e-1)" "unprognostic (1.50e-1)" "unprognostic (3.99e-2)" "prognostic favourable (6.48e-6)" "unprognostic (1.59e-1)" "unprognostic (2.91e-2)" "unprognostic (2.73e-2)" "unprognostic (4.77e-3)" "unprognostic (4.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.92e-3)" "unprognostic (8.33e-2)" "unprognostic (2.57e-1)" "unprognostic (3.24e-2)" "unprognostic (8.94e-2)" 55.2 54.3 107.5 35.3 87.1 32.7 37.3 71.5 118.4 28.4 40.2 60.9 23.8 40.2 35.9 54.1 43.1 44.2 23.4 57.7 92.3 81.9 64.5 50.9 32.8 25.4 94.1 77.9 40.2 40.2 41.0 37.9 45.1 73.7 35.0 42.5 27.9 42.4 27.7 135.9 36.8 36.2 32.2 101.1 26.2 38.5 46.0 53.6 30.9 47.5 36.5 37.2 31.6 32.1 19.2 41.5 17.2 36.2 15.0 23.3 31.5 77.8 58.2 70.5 59.3 31.2 36.1 67.8 50.4 29.7 45.0 34.9 104.0 32.0 52.9 59.2 41.7 54.1 59.7 50.9 63.8 36.5 111.3 36.9 48.6 44.5 37.3 35.3 37.8 32.7 37.6 45.0 69.0 54.1 42.3 38.2 57.8 37.9 46.7 28.2 64.6 37.8 56.8 33.3 37.5 45.8 45.1 39.3 59.7 60.6 24.9 39.4 47.2 32.7 51.1 43.7 37.1 55.1 88.9 24.0 44.3 44.4 52.4 42.3 63.1 17.2 31.8 8.6 12.4 36.2 15.6 19.2 18.7 13.9 41.5 16.1 17.0 14.3 10.8 15.0 30.9 28.8 23.3 31.5 107.5 87.1 71.5 90.2 92.3 81.9 94.1 77.9 73.7 53.6 YWHAG PPP1R170 ENSG00000170027 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma" P61981 7 76326794-76359031 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 117.8;skeletal muscle: 91.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013274, CAB018389, HPA026918, HPA061603" Approved Approved Supported Nucleoplasm,Nucleoli,Cytosol 160000000 Cytosol "Nucleoplasm, Nucleoli" "CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: " "unprognostic (3.71e-2)" "prognostic unfavourable (4.53e-4)" "unprognostic (3.88e-2)" "unprognostic (1.25e-2)" "unprognostic (6.28e-3)" "unprognostic (2.40e-3)" "unprognostic (8.98e-3)" "prognostic unfavourable (5.34e-4)" "unprognostic (1.63e-1)" "unprognostic (1.64e-1)" "prognostic unfavourable (7.44e-4)" "unprognostic (3.03e-2)" "prognostic unfavourable (4.01e-4)" "unprognostic (9.31e-2)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (1.70e-1)" 52.4 31.2 46.3 17.7 54.6 7.3 17.2 36.2 117.8 13.4 14.2 13.3 4.6 14.4 15.0 7.0 18.6 9.0 17.0 33.1 50.2 56.2 15.9 22.0 12.9 12.1 45.9 49.8 13.3 18.0 14.8 7.8 16.6 74.6 14.7 14.0 8.6 10.0 13.3 91.8 11.7 12.5 20.2 22.8 12.7 11.2 8.9 13.5 6.8 8.8 13.8 14.3 14.7 13.2 3.1 5.9 3.2 5.0 1.1 3.3 1.7 37.1 46.7 41.4 52.5 42.4 24.5 18.7 43.2 21.4 26.8 29.2 29.3 40.0 52.4 14.9 38.3 34.8 51.8 47.7 37.8 35.5 22.6 49.6 32.0 32.5 38.7 60.5 48.6 26.8 45.8 31.3 64.9 42.6 68.1 59.3 40.0 35.0 43.2 44.7 45.9 32.8 50.7 41.9 57.9 42.1 25.4 22.2 61.7 47.9 61.4 30.6 42.7 36.7 44.9 52.4 30.5 46.4 57.7 19.7 36.9 80.7 47.1 57.3 55.8 3.2 5.0 1.1 2.1 4.6 3.3 3.1 2.4 2.6 5.2 1.8 1.8 2.0 1.1 1.1 3.8 5.9 2.0 1.7 46.3 54.6 36.2 88.9 50.2 56.2 45.9 49.8 74.6 13.5 YWHAQ "14-3-3, HS1" ENSG00000134308 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta" P27348 2 9583972-9631014 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007925, CAB010286, HPA061603" Approved Supported Nucleoplasm,Nucleoli,Cytosol 120000000 Cytosol "Nucleoplasm, Nucleoli" "CAB010286: AB_2218221, HPA007925: AB_1844340, HPA061603: " "unprognostic (2.65e-2)" "unprognostic (3.99e-2)" "unprognostic (2.78e-2)" "prognostic unfavourable (8.20e-4)" "unprognostic (1.53e-1)" "unprognostic (5.78e-3)" "prognostic unfavourable (9.83e-6)" "unprognostic (4.90e-3)" "unprognostic (2.98e-2)" "unprognostic (5.51e-2)" "unprognostic (6.18e-2)" "unprognostic (1.45e-1)" "unprognostic (2.95e-2)" "unprognostic (6.74e-2)" "unprognostic (9.75e-2)" "unprognostic (1.63e-1)" "unprognostic (4.39e-3)" 40.5 47.3 77.8 32.1 60.8 48.0 50.8 88.5 82.5 52.2 44.0 82.5 25.0 37.9 60.5 48.2 57.6 45.3 40.0 68.5 73.7 76.2 45.9 37.2 35.0 38.2 74.3 54.8 55.9 64.4 39.2 39.0 39.3 69.8 54.2 44.1 31.2 38.9 48.8 17.6 33.3 36.5 57.9 72.2 29.8 36.9 44.3 63.5 58.8 45.4 56.7 43.3 47.7 46.3 31.5 30.9 24.8 28.9 51.4 58.4 60.9 42.7 64.5 58.5 56.5 46.1 63.8 55.0 58.8 57.9 61.8 51.9 48.5 37.7 55.4 30.7 84.2 40.3 64.9 64.1 79.8 136.3 52.8 51.8 42.1 51.8 35.3 49.8 31.4 43.1 37.7 67.4 44.0 69.3 50.8 33.5 75.9 29.8 88.2 50.9 99.3 74.4 64.6 75.9 67.8 68.0 38.3 55.7 94.4 53.5 55.5 42.5 34.5 25.7 63.1 77.7 55.1 67.2 89.6 34.2 46.8 73.1 66.4 52.1 64.4 17.1 22.2 24.8 47.8 28.9 58.4 31.5 45.1 50.8 30.9 28.8 24.7 39.9 6.8 51.4 27.2 15.7 43.1 60.9 77.8 60.8 88.5 69.0 73.7 76.2 74.3 54.8 69.8 63.5 YWHAZ "14-3-3-zeta, KCIP-1, YWHAD" ENSG00000164924 "Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta" P63104 8 100916525-100953388 "Plasma proteins, Predicted intracellular proteins, Transporters" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "CAB005065, HPA061603" Approved Approved Nucleoplasm,Nucleoli,Cytosol 760000000 Cytosol "Nucleoplasm, Nucleoli" "CAB005065: AB_2218378, HPA061603: " "unprognostic (4.70e-3)" "unprognostic (7.38e-3)" "unprognostic (8.09e-2)" "prognostic unfavourable (3.91e-4)" "unprognostic (1.83e-3)" "unprognostic (2.00e-2)" "prognostic unfavourable (2.28e-5)" "prognostic unfavourable (3.93e-4)" "unprognostic (1.65e-1)" "unprognostic (3.72e-1)" "prognostic unfavourable (1.20e-5)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.03e-6)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" 54.6 40.9 89.9 51.8 104.6 70.8 39.6 55.8 117.7 52.4 69.6 38.7 25.3 47.4 43.5 37.6 141.8 38.3 51.9 29.1 81.7 67.0 44.1 32.9 40.7 60.0 50.1 66.7 46.4 27.5 37.8 25.2 69.0 78.2 42.5 70.3 31.7 55.2 47.2 19.7 63.0 71.4 53.5 43.8 56.3 51.5 34.1 31.5 89.4 46.0 74.9 83.2 53.6 70.2 58.6 57.2 129.4 77.9 57.0 78.4 104.9 138.9 67.6 129.0 37.0 32.1 40.8 63.9 65.3 85.0 88.5 86.2 47.0 91.2 62.5 70.9 103.7 60.5 81.1 93.1 134.8 55.3 32.0 59.0 51.2 30.4 42.3 24.6 67.7 37.8 126.9 73.1 116.5 79.4 67.0 61.3 75.6 50.5 101.6 43.7 43.6 70.9 43.3 37.6 42.9 85.1 78.5 72.2 51.5 49.7 49.3 103.4 71.4 29.1 64.6 44.9 65.9 54.1 58.5 39.1 46.4 76.7 74.3 46.5 183.7 129.4 45.0 81.2 69.1 66.5 70.3 58.6 59.0 66.5 57.2 48.0 44.8 56.4 74.6 57.0 77.9 35.4 78.4 104.9 89.9 104.6 55.8 117.7 81.7 67.0 50.1 66.7 78.2 31.5 Z82206.1 ENSG00000225528 22 39960397-39964718 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3" "Cell line enhanced" "Detected in some" "HEL: 4.0;K-562: 15.9;MOLT-4: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" Nucleoli "Nucleoplasm, Nuclear bodies" "HPA047397: " "unprognostic (8.48e-4)" "unprognostic (2.95e-6)" "unprognostic (3.67e-1)" "unprognostic (5.90e-2)" "unprognostic (4.27e-1)" "unprognostic (6.95e-3)" "unprognostic (3.74e-1)" "unprognostic (5.41e-4)" "unprognostic (2.33e-1)" "unprognostic (2.13e-2)" "unprognostic (1.18e-3)" "unprognostic (8.77e-2)" "unprognostic (6.53e-5)" "unprognostic (1.89e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (6.58e-3)" 0.0 0.0 0.5 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.0 0.1 0.0 0.0 1.1 0.3 3.6 3.0 5.7 2.2 2.2 8.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 1.8 4.4 5.2 2.2 4.5 3.6 6.5 5.7 2.7 3.2 6.7 8.1 4.3 2.2 1.9 3.0 4.2 7.6 ZBED9 "Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452" ENSG00000232040 "Zinc finger BED-type containing 9" Q6R2W3 6 28570535-28616212 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 13.2;testis: 17.6" "Cell line enhanced" "Detected in many" "EFO-21: 7.7;hTCEpi: 7.0;K-562: 12.3;U-266/84: 5.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA007246 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" Nucleoli "Nucleoplasm, Golgi apparatus" "HPA007246: AB_1080727" "unprognostic (1.01e-1)" "unprognostic (5.16e-5)" "unprognostic (1.88e-1)" "unprognostic (1.27e-4)" "unprognostic (3.96e-2)" "unprognostic (9.46e-3)" "unprognostic (3.40e-1)" "unprognostic (2.73e-2)" "unprognostic (4.24e-2)" "unprognostic (2.34e-3)" "unprognostic (8.21e-3)" "unprognostic (4.31e-1)" "unprognostic (2.42e-2)" "unprognostic (1.14e-2)" "unprognostic (7.66e-3)" "unprognostic (3.92e-2)" "unprognostic (1.59e-1)" 0.8 1.8 2.6 0.4 7.2 0.4 2.3 9.5 4.7 2.3 1.1 0.3 9.3 0.7 1.6 7.5 1.0 3.1 0.7 1.2 2.4 2.3 2.3 3.2 1.9 0.5 1.3 2.9 4.1 3.4 3.2 6.9 3.0 3.5 3.4 1.5 0.8 2.4 13.2 0.5 0.7 0.8 1.1 0.8 0.6 1.0 17.6 0.7 0.0 4.1 0.0 0.6 1.4 1.2 0.5 0.7 1.1 0.7 0.4 1.4 0.2 1.8 1.8 1.8 0.0 0.0 0.0 2.2 0.4 0.0 0.4 1.1 0.0 1.2 0.0 7.7 0.1 1.0 0.0 2.1 0.4 0.0 5.1 0.4 1.2 1.8 1.2 0.0 0.0 1.1 7.0 0.1 3.5 0.0 12.3 0.0 0.1 1.3 0.0 0.1 1.8 0.9 0.6 0.8 0.1 2.0 2.1 2.0 4.8 0.0 1.9 0.0 0.0 0.6 0.0 0.0 2.2 0.0 1.2 0.0 5.9 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.3 0.4 0.1 0.2 0.4 0.4 0.2 0.5 1.4 1.0 1.1 0.4 0.7 0.7 0.1 0.2 2.6 7.2 9.5 4.7 2.4 2.3 1.3 2.9 3.5 0.7 ZCCHC2 "C18orf49, FLJ20222, FLJ20281, KIAA1744" ENSG00000141664 "Zinc finger CCHC-type containing 2" Q9C0B9 18 62523007-62587709 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 99.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040943 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol "Nucleoli, Cytosol" Nucleoplasm "HPA040943: AB_10795496" "unprognostic (9.32e-2)" "unprognostic (1.68e-1)" "unprognostic (1.17e-1)" "unprognostic (2.84e-3)" "unprognostic (1.40e-1)" "unprognostic (4.07e-2)" "unprognostic (4.79e-2)" "unprognostic (2.60e-1)" "unprognostic (1.93e-1)" "unprognostic (8.25e-2)" "unprognostic (2.32e-2)" "unprognostic (1.30e-1)" "unprognostic (5.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.72e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" 12.6 5.0 6.8 7.0 7.5 22.8 16.0 8.0 6.8 7.5 8.5 6.0 5.3 6.8 6.9 7.1 6.5 7.4 9.0 8.5 5.3 5.7 5.8 23.0 10.1 7.6 8.1 5.7 8.8 6.3 7.8 8.5 8.2 5.5 8.1 5.8 4.5 99.1 5.9 16.8 11.3 7.5 7.6 5.6 8.9 6.5 13.4 8.9 10.8 7.8 4.3 6.4 11.0 19.3 1.6 1.0 4.9 1.6 0.6 2.0 0.4 5.8 5.1 4.4 8.7 13.5 5.8 8.4 3.4 5.1 8.1 8.1 2.7 3.6 16.6 4.5 5.6 10.0 14.2 7.5 3.4 11.4 6.7 4.4 11.8 18.6 4.6 8.3 6.4 5.7 9.7 5.1 9.6 15.2 4.6 5.6 2.6 4.8 5.4 3.5 2.8 5.1 7.2 4.7 0.1 5.6 6.0 5.6 3.5 5.7 12.8 5.0 4.5 6.6 6.4 8.0 5.5 3.1 4.8 2.2 4.2 7.1 6.0 3.5 2.9 0.0 1.0 2.4 1.7 1.6 1.2 0.5 1.1 1.5 0.3 1.6 2.0 1.3 4.9 0.6 0.3 1.0 1.2 0.4 6.8 7.5 8.0 6.8 5.3 5.7 8.1 5.7 5.5 8.9 ZEB2 "KIAA0569, SIP-1, SIP1, ZFHX1B" ENSG00000169554 "Zinc finger E-box binding homeobox 2" O60315 2 144364364-144524583 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 76.6" "Cell line enhanced" "Detected in many" "HEL: 38.4;THP-1: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003456 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA003456: AB_10603840" "unprognostic (1.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.12e-1)" "unprognostic (2.42e-1)" "unprognostic (4.12e-1)" "unprognostic (4.17e-2)" "unprognostic (3.69e-1)" "unprognostic (3.77e-2)" "unprognostic (5.83e-2)" "unprognostic (7.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "prognostic unfavourable (6.04e-5)" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (7.45e-2)" "unprognostic (1.32e-2)" 30.2 23.7 48.0 27.8 42.4 55.5 16.6 6.7 36.6 29.4 12.3 72.9 3.4 11.3 15.6 11.1 14.4 11.1 22.6 22.5 52.5 28.8 9.9 11.6 20.7 19.6 54.4 26.4 37.5 3.6 5.0 3.1 31.5 37.6 10.9 16.3 15.7 5.7 12.5 9.6 7.7 12.8 17.2 76.6 32.6 9.3 8.2 38.7 1.9 8.3 7.5 12.4 21.5 14.8 5.0 12.7 9.7 21.6 3.6 10.7 7.4 0.4 0.5 22.1 0.0 26.4 13.5 0.0 9.1 9.2 10.2 9.9 0.0 0.2 1.6 0.0 9.8 0.1 3.7 0.0 12.8 9.4 2.6 38.4 1.6 0.0 5.9 6.6 30.5 11.0 0.2 12.6 6.1 7.7 10.7 1.1 12.0 0.0 0.0 20.1 3.2 0.5 11.3 15.2 0.0 0.1 0.2 0.1 5.8 1.1 0.0 23.9 0.0 45.7 11.9 11.7 0.2 22.8 2.8 12.5 0.0 1.9 17.6 19.9 31.6 9.7 21.6 5.7 10.7 20.8 1.0 4.4 1.4 5.3 12.7 5.0 1.1 4.0 7.5 3.6 19.5 10.2 0.3 7.4 48.0 42.4 6.7 35.6 52.5 28.8 54.4 26.4 37.6 38.7 ZFAND2B AIRAPL ENSG00000158552 "Zinc finger AN1-type containing 2B" Q8WV99 2 219195237-219209651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035159, HPA035160" Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA035159: , HPA035160: AB_10670697" "unprognostic (3.71e-1)" "unprognostic (5.49e-3)" "unprognostic (2.77e-3)" "unprognostic (2.59e-1)" "unprognostic (2.97e-1)" "unprognostic (6.85e-3)" "unprognostic (1.40e-2)" "unprognostic (2.27e-1)" "unprognostic (7.36e-2)" "unprognostic (1.20e-1)" "prognostic favourable (9.38e-4)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.69e-3)" "unprognostic (1.32e-1)" "unprognostic (6.21e-2)" "unprognostic (7.02e-2)" 13.4 12.9 16.4 14.6 16.9 23.8 13.5 22.3 24.6 14.8 30.0 20.2 15.9 30.5 15.3 14.2 22.2 13.1 22.2 11.6 16.2 13.3 20.0 28.5 15.2 27.3 18.8 17.9 14.1 29.1 18.6 18.0 22.2 15.6 14.7 18.5 11.3 17.3 14.2 15.9 23.4 34.7 24.5 17.5 22.6 21.8 9.5 13.9 23.0 30.0 12.9 19.3 14.7 16.6 29.1 20.5 36.6 27.8 30.7 32.5 25.4 10.4 7.1 8.2 11.5 8.7 9.2 11.4 10.6 12.5 15.3 15.2 16.0 9.0 8.5 11.3 18.1 7.2 7.6 13.5 12.2 13.1 11.8 19.4 11.8 13.8 17.9 10.3 22.5 7.6 29.7 15.1 36.0 10.2 11.3 24.2 14.9 18.1 17.0 21.7 4.2 8.2 10.6 4.9 14.6 14.5 8.9 17.9 8.1 5.1 8.7 11.8 7.4 21.9 10.8 15.5 14.5 17.8 15.1 10.0 3.2 15.3 15.2 20.5 12.0 17.7 21.7 28.6 32.1 27.8 28.0 25.4 29.3 31.3 16.4 29.1 26.7 32.5 36.6 30.7 21.9 20.5 30.2 25.4 16.4 16.9 22.3 24.6 16.2 13.3 18.8 17.9 15.6 13.9 ZFP41 "FLJ00028, FLJ38705, ZNF753" ENSG00000181638 "ZFP41 zinc finger protein" 8 143246821-143262705 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA047232, HPA056268" Uncertain Approved "Nucleoplasm,Nucleoli,Plasma membrane" Nucleoli "Nucleoplasm, Plasma membrane" "HPA047232: , HPA056268: " "unprognostic (9.16e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-1)" "unprognostic (1.47e-2)" "unprognostic (1.10e-1)" "unprognostic (1.45e-2)" "prognostic unfavourable (3.46e-5)" "unprognostic (4.92e-2)" "unprognostic (7.18e-2)" "unprognostic (3.53e-2)" "unprognostic (4.16e-3)" "unprognostic (2.98e-1)" "unprognostic (1.55e-2)" "unprognostic (6.89e-2)" "unprognostic (1.59e-1)" "unprognostic (3.44e-2)" "unprognostic (3.20e-1)" 7.8 6.6 10.3 6.5 9.0 4.1 5.6 12.6 13.7 8.0 8.8 10.7 6.5 9.4 12.5 6.8 5.7 9.2 5.6 6.3 10.8 14.3 6.5 5.8 6.3 6.7 10.7 7.4 13.1 9.1 11.4 10.2 3.5 9.6 7.7 4.5 8.9 12.6 9.1 8.1 12.1 9.1 7.3 7.4 8.5 7.2 10.6 8.6 4.6 8.0 4.6 6.7 6.7 10.0 0.9 3.7 0.1 0.9 0.7 2.2 0.8 7.1 11.3 4.9 6.6 5.7 4.5 5.8 4.3 2.3 8.5 5.8 5.6 5.9 3.9 6.4 5.6 5.8 5.4 5.6 4.2 6.2 6.5 5.0 5.5 4.3 8.0 1.9 3.1 4.7 8.0 5.4 8.1 3.9 10.5 3.9 4.0 12.7 5.2 2.1 7.3 11.3 2.8 4.0 1.4 3.7 6.4 6.3 8.7 12.1 3.3 6.4 8.5 3.9 4.1 6.4 11.5 5.0 6.8 6.3 4.7 1.9 5.7 4.8 8.4 0.0 0.6 0.1 1.3 0.9 2.2 0.4 1.1 0.9 0.5 0.9 1.9 1.2 0.0 0.7 0.1 3.7 0.9 0.8 10.3 9.0 12.6 13.7 10.8 14.3 10.7 7.4 9.6 8.6 ZMYM4 "KIAA0425, MYM, ZNF198L3, ZNF262" ENSG00000146463 "Zinc finger MYM-type containing 4" Q5VZL5 1 35268967-35422058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051301, HPA054802" Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA051301: , HPA054802: " "unprognostic (8.95e-2)" "unprognostic (6.80e-2)" "unprognostic (1.51e-2)" "unprognostic (1.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" "prognostic unfavourable (9.75e-9)" "unprognostic (9.76e-2)" "unprognostic (4.35e-3)" "unprognostic (4.44e-2)" "unprognostic (6.70e-2)" "unprognostic (4.98e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (1.18e-1)" "unprognostic (2.04e-1)" "unprognostic (9.18e-2)" "unprognostic (2.21e-1)" 16.6 15.9 17.9 17.3 22.1 13.6 19.7 28.1 24.7 22.0 14.8 17.1 18.3 10.2 19.8 18.2 15.0 17.9 15.7 13.1 17.6 19.0 15.8 14.4 14.1 15.0 15.8 14.6 27.0 15.7 26.1 22.6 19.6 22.2 21.0 13.6 18.2 18.0 26.8 15.9 12.9 12.5 16.6 15.2 16.0 15.4 36.3 13.6 26.7 21.6 13.0 18.8 17.2 14.7 4.2 9.8 3.5 8.2 9.6 4.4 2.5 12.7 10.4 31.9 16.1 9.3 20.3 11.8 15.2 23.0 18.6 24.3 11.2 12.8 23.8 9.4 19.0 8.3 22.1 11.2 26.9 13.4 15.3 29.0 12.1 9.5 17.0 24.8 13.2 15.3 10.1 18.0 17.1 20.6 31.6 6.5 22.5 7.7 21.0 13.8 26.6 9.9 23.6 20.5 11.5 13.3 16.9 18.4 17.9 18.3 13.4 20.8 10.9 18.9 24.8 17.3 18.0 7.6 16.3 7.2 13.3 18.3 12.5 19.0 16.5 2.4 5.0 3.5 4.3 7.1 4.4 4.2 4.2 3.8 4.8 3.7 4.1 3.9 1.0 9.6 8.2 9.8 3.1 2.5 17.9 22.1 28.1 24.7 17.6 19.0 15.8 14.6 22.2 13.6 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491123 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 64.8;skeletal muscle: 111.1" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 48.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol Nucleoli "Nucleoplasm, Cytosol" "HPA054267: " "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 14.9 5.4 8.8 6.6 10.4 9.0 10.3 6.3 9.1 7.1 7.8 4.5 4.5 3.9 7.4 6.3 12.7 5.4 6.1 64.8 9.2 6.3 6.4 3.7 7.8 6.0 7.6 6.4 6.6 4.4 8.4 7.1 5.0 11.9 7.8 5.6 11.3 6.0 5.7 111.1 4.3 5.9 10.9 8.0 6.3 6.0 5.7 7.2 3.4 5.7 46.9 6.8 7.0 17.7 8.3 10.8 48.5 19.6 3.9 5.1 4.5 14.1 8.2 14.4 15.9 36.4 32.1 8.8 11.5 11.0 10.1 10.8 19.3 4.1 9.5 10.3 14.1 16.2 14.9 11.8 15.5 15.4 7.2 18.2 19.2 6.9 10.5 21.8 10.9 24.1 7.9 15.3 17.1 16.2 21.6 1.3 16.4 5.6 8.3 5.3 6.1 8.4 8.0 26.2 5.2 5.3 16.0 9.2 4.9 23.3 11.0 13.0 10.1 14.2 24.4 10.9 16.8 14.4 16.8 7.9 15.2 35.6 9.7 17.4 18.8 19.9 19.6 7.6 5.1 15.9 4.5 6.7 4.2 4.2 10.5 8.3 3.8 3.4 48.5 3.9 18.5 10.8 3.8 4.5 8.8 10.4 6.3 9.1 9.2 6.3 7.6 6.4 11.9 7.2 ZNF121 "D19S204, ZHC32, ZNF20" ENSG00000197961 "Zinc finger protein 121" P58317 19 9560353-9584533 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA054961 Uncertain Approved Nucleoplasm,Nucleoli,Centrosome "Nucleoplasm, Centrosome" Nucleoli "HPA054961: " "unprognostic (3.06e-1)" "unprognostic (9.38e-3)" "unprognostic (9.51e-2)" "unprognostic (7.49e-2)" "unprognostic (3.07e-2)" "unprognostic (3.91e-3)" "unprognostic (3.68e-2)" "unprognostic (1.76e-1)" "unprognostic (6.80e-3)" "prognostic favourable (6.59e-5)" "unprognostic (9.36e-2)" "unprognostic (1.76e-3)" "prognostic unfavourable (1.01e-4)" "unprognostic (8.75e-3)" "unprognostic (2.83e-1)" "unprognostic (1.06e-1)" "prognostic favourable (5.75e-5)" 13.8 8.9 10.4 11.0 12.3 21.0 14.0 16.1 11.8 10.6 8.9 6.2 12.5 6.7 9.4 10.0 16.5 12.4 7.6 10.3 10.3 5.0 9.2 13.2 14.6 13.0 13.6 6.3 13.8 12.5 22.3 20.2 8.3 11.0 11.8 10.6 5.3 14.1 13.7 9.4 18.6 12.3 12.3 14.8 12.4 11.1 6.2 13.0 12.2 11.3 10.4 12.1 15.8 12.7 6.0 4.6 2.9 4.5 7.1 6.8 1.8 7.6 4.9 5.9 12.3 2.7 3.3 9.1 2.6 2.4 4.0 5.0 8.5 3.4 8.7 7.6 2.1 7.6 12.1 7.0 5.6 4.2 19.6 27.2 12.2 7.6 3.4 13.4 13.6 4.5 6.2 3.9 10.3 2.9 9.7 14.8 2.9 6.4 9.9 30.9 14.6 8.6 6.4 8.1 6.0 3.8 32.5 10.6 5.4 5.2 5.2 3.0 4.2 4.3 4.2 12.7 7.1 4.3 6.8 15.7 8.6 10.3 3.4 7.9 4.3 2.9 3.6 2.1 5.5 4.4 6.8 4.0 4.9 5.1 4.1 6.0 6.1 6.8 2.8 7.1 4.5 4.6 4.3 1.8 10.4 12.3 16.1 11.8 10.3 5.0 13.6 6.3 11.0 13.0 ZNF300 ENSG00000145908 "Zinc finger protein 300" Q96RE9 5 150894392-150904983 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 17.2;HeLa: 18.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 3.8" "Low lineage specificity" "Detected in all" "HPA028975, HPA051777" Uncertain Supported "Nucleoplasm,Nucleoli,Nuclear bodies" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA028975: , HPA051777: " "unprognostic (5.06e-2)" "unprognostic (1.05e-2)" "unprognostic (8.41e-2)" "unprognostic (2.31e-1)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.15e-1)" "unprognostic (6.23e-3)" "unprognostic (4.21e-2)" "unprognostic (3.23e-1)" "unprognostic (8.62e-2)" "unprognostic (6.85e-3)" "prognostic unfavourable (3.21e-6)" "unprognostic (3.62e-3)" "unprognostic (2.99e-1)" "unprognostic (3.46e-1)" "unprognostic (1.50e-2)" 4.5 1.3 4.8 4.0 12.0 3.6 7.2 12.5 6.4 7.4 4.3 5.4 4.1 4.1 11.7 5.3 7.5 5.4 5.4 4.0 7.5 3.2 7.3 1.5 3.0 4.4 8.2 2.4 16.6 7.3 1.0 7.3 2.4 7.4 7.0 4.4 3.6 3.8 3.9 1.5 6.9 5.8 6.4 9.2 5.1 7.1 14.9 9.1 1.5 9.3 2.7 4.4 5.5 6.2 3.8 1.2 1.1 1.5 1.7 1.0 0.8 1.2 2.8 17.2 0.0 1.5 3.6 0.0 4.2 3.3 3.7 5.4 1.4 2.1 0.0 3.7 3.5 2.5 0.0 9.6 5.8 0.0 5.6 0.0 18.9 2.2 3.1 0.1 0.0 5.5 3.0 7.7 9.1 6.3 0.0 9.1 3.6 0.0 0.0 0.8 16.5 0.0 0.0 2.5 4.9 2.7 3.1 9.7 16.1 9.9 8.6 5.7 5.7 0.0 2.7 5.0 2.1 3.6 7.6 0.3 0.1 0.0 0.5 0.1 10.3 0.0 0.6 1.1 0.7 1.5 0.1 0.9 1.0 0.0 1.2 3.8 0.7 0.4 0.2 1.7 0.1 0.1 0.0 0.8 4.8 12.0 12.5 6.4 7.5 3.2 8.2 2.4 7.4 9.1 ZNF354A "EZNF, HKL1, KID-1, KID1, TCF17" ENSG00000169131 "Zinc finger protein 354A" O60765 5 178694605-178730702 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052043 Approved Supported Nucleoplasm,Nucleoli,Cytosol "Nucleoplasm, Nucleoli" Cytosol "HPA052043: " "unprognostic (2.79e-1)" "unprognostic (3.44e-2)" "unprognostic (7.06e-3)" "unprognostic (1.78e-3)" "unprognostic (1.38e-1)" "unprognostic (1.32e-1)" "unprognostic (3.25e-2)" "unprognostic (1.41e-1)" "unprognostic (7.66e-3)" "prognostic favourable (8.28e-4)" "unprognostic (4.06e-2)" "unprognostic (4.55e-2)" "prognostic unfavourable (3.45e-6)" "unprognostic (8.71e-2)" "unprognostic (4.13e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" 14.0 7.0 13.0 12.1 13.6 14.2 14.2 13.3 14.4 12.6 15.0 6.7 11.4 7.1 13.7 13.3 10.4 11.7 9.8 14.5 13.2 9.3 18.0 6.2 10.8 12.7 16.7 16.1 10.9 15.0 11.7 14.1 14.0 13.4 13.3 10.0 7.1 8.8 15.1 11.9 12.3 10.6 13.6 12.9 17.1 10.4 14.0 14.4 13.1 15.1 8.6 14.2 17.0 25.1 5.7 5.3 15.0 5.8 6.0 6.4 3.6 4.2 3.3 7.0 18.5 12.2 9.9 29.0 4.9 6.6 6.9 7.4 4.9 7.2 5.7 6.5 4.5 8.5 2.6 21.0 10.6 7.6 8.0 1.7 4.2 0.6 9.3 0.0 4.8 7.7 13.5 6.0 12.4 6.5 1.4 0.0 9.9 8.6 8.5 5.7 6.1 8.7 6.4 1.2 3.6 6.4 4.3 7.7 8.4 6.2 7.1 9.5 5.8 8.4 5.0 7.8 5.1 4.4 4.2 1.9 3.9 3.6 0.2 1.3 9.7 4.4 5.8 14.5 5.1 3.8 6.4 5.7 4.6 5.7 5.3 3.6 5.3 3.8 15.0 6.0 3.9 1.9 4.1 3.6 13.0 13.6 13.3 14.4 13.2 9.3 16.7 16.1 13.4 14.4 ZNF461 "GIOT-1, MGC33911" ENSG00000197808 "Zinc finger protein 461" Q8TAF7 19 36637192-36666853 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021139 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA021139: AB_10961418" "unprognostic (8.37e-3)" "unprognostic (2.23e-1)" "unprognostic (1.74e-1)" "prognostic unfavourable (3.64e-4)" "unprognostic (2.08e-2)" "unprognostic (6.32e-2)" "unprognostic (5.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-3)" "unprognostic (2.11e-1)" "unprognostic (7.01e-3)" "unprognostic (2.43e-2)" "unprognostic (1.51e-1)" "unprognostic (4.21e-2)" "unprognostic (4.54e-2)" "unprognostic (5.86e-2)" "unprognostic (5.11e-3)" 6.0 8.7 8.1 5.6 12.3 6.3 7.2 13.5 12.0 7.1 5.9 8.5 4.7 1.5 10.2 7.1 5.2 7.6 5.8 5.0 6.9 7.5 6.8 5.1 5.4 6.9 7.0 8.6 10.8 4.0 7.9 12.1 8.7 8.7 6.7 4.7 5.7 4.8 6.3 4.1 5.9 5.4 8.5 7.4 7.9 5.4 8.1 9.2 5.9 10.6 3.1 7.6 6.2 7.3 3.3 2.3 1.0 2.3 2.2 6.2 1.6 2.8 5.3 4.0 5.1 2.8 6.2 2.4 3.1 3.5 4.8 6.8 0.9 1.3 0.4 6.6 4.3 0.5 2.8 3.4 5.2 5.4 3.9 4.6 0.7 1.9 4.5 3.9 5.5 3.9 6.2 1.5 4.3 3.0 0.2 0.4 4.8 3.1 6.0 1.0 2.2 2.0 0.4 3.8 0.9 1.5 6.6 4.6 6.6 0.2 2.3 4.1 2.4 1.5 3.0 2.9 3.8 1.9 3.7 8.7 12.8 1.6 0.0 0.7 3.8 0.0 0.8 1.0 2.5 2.3 3.1 2.8 4.1 6.2 2.3 3.3 3.1 2.2 0.1 2.2 0.4 0.7 3.5 1.6 8.1 12.3 13.5 12.0 6.9 7.5 7.0 8.6 8.7 9.2 ZNF571 HSPC059 ENSG00000180479 "Zinc finger protein 571" Q7Z3V5 19 37554782-37594790 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 61.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA054762 Approved "Nucleoplasm,Nucleoli,Plasma membrane" "Nucleoplasm, Nucleoli" "Plasma membrane" "HPA054762: " "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (3.92e-2)" "unprognostic (1.19e-1)" "unprognostic (5.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.19e-1)" "unprognostic (9.03e-4)" "unprognostic (5.77e-2)" "unprognostic (9.82e-2)" "unprognostic (1.22e-3)" "unprognostic (3.90e-2)" "unprognostic (2.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.62e-1)" "unprognostic (4.89e-2)" "unprognostic (2.71e-4)" 6.5 6.7 8.6 3.2 12.9 6.1 12.5 12.5 12.8 5.9 4.2 9.8 4.4 2.3 6.7 8.7 3.9 6.0 4.5 4.2 10.4 7.2 6.4 4.2 4.1 4.4 15.3 9.4 8.5 3.8 11.5 12.2 4.8 13.4 7.1 3.4 5.1 3.6 4.5 3.5 7.1 3.7 7.7 14.3 4.8 3.5 8.5 15.8 3.7 61.8 3.3 5.0 6.6 5.3 9.4 4.1 4.9 1.3 3.7 8.4 3.2 1.8 1.0 6.3 9.1 4.7 4.7 2.0 2.7 4.4 6.6 8.2 1.9 1.7 9.6 8.6 2.8 2.4 2.0 2.9 11.0 2.1 7.9 5.1 2.7 1.1 5.4 1.9 5.8 2.6 5.2 6.3 5.7 1.3 2.4 0.8 5.3 1.7 9.5 2.1 15.8 3.5 4.8 3.0 5.0 9.0 11.6 13.6 9.5 6.4 2.1 3.2 9.7 1.3 0.8 3.0 3.9 3.2 6.9 7.7 15.8 13.2 0.5 0.8 6.5 1.8 0.8 4.9 6.7 1.3 6.1 8.7 6.3 6.5 2.7 9.4 7.8 8.4 1.5 3.7 1.2 4.1 4.2 3.2 8.6 12.9 12.5 12.8 10.4 7.2 15.3 9.4 13.4 15.8 ZNF678 MGC42493 ENSG00000181450 "Zinc finger protein 678" Q5SXM1 1 227563543-227677443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA028507 Uncertain Approved Nucleoli,Mitochondria,Cytosol "Mitochondria, Cytosol" Nucleoli "HPA028507: AB_10603567" "unprognostic (1.76e-2)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (4.42e-3)" "unprognostic (3.92e-2)" "unprognostic (4.64e-2)" "unprognostic (1.59e-2)" "unprognostic (2.19e-2)" "unprognostic (2.50e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-6)" "unprognostic (1.39e-1)" "unprognostic (4.18e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-4)" 9.0 7.6 8.2 6.6 16.2 7.1 8.8 19.4 10.8 9.3 7.2 6.7 7.1 5.4 9.2 6.2 6.1 7.7 7.4 7.4 8.9 6.3 6.4 5.3 7.8 9.8 12.7 8.2 9.9 12.6 7.2 19.4 9.7 8.9 10.6 10.8 4.6 7.6 6.3 6.2 5.2 6.6 7.5 14.2 9.5 7.6 8.7 15.5 12.0 12.7 5.1 9.1 8.2 9.4 6.6 3.2 7.1 1.1 2.2 3.2 1.5 2.0 3.2 11.8 13.4 1.4 3.4 7.1 2.7 2.7 4.0 4.3 2.5 2.5 8.2 7.1 1.2 3.9 6.9 1.8 6.7 3.4 13.2 3.9 2.5 1.6 2.6 6.5 10.5 2.9 3.3 2.4 5.3 3.8 9.7 13.0 4.4 1.7 9.0 2.3 10.3 5.4 7.0 7.6 3.2 3.0 6.4 5.0 9.8 4.1 4.8 2.0 6.7 8.3 2.5 5.1 4.8 4.5 5.5 4.2 9.5 9.0 2.1 1.2 5.2 7.1 1.1 1.3 2.5 0.3 3.0 6.6 2.5 1.4 2.1 4.5 2.2 3.2 0.2 2.2 0.7 3.2 2.7 1.5 8.2 16.2 19.4 10.8 8.9 6.3 12.7 8.2 8.9 15.5 ZNF691 Zfp691 ENSG00000164011 "Zinc finger protein 691" Q5VV52 1 42846573-42852477 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062527 Approved Approved Nucleoplasm,Nucleoli,Vesicles Nucleoplasm "Nucleoli, Vesicles" "HPA062527: " "unprognostic (4.34e-2)" "unprognostic (4.05e-2)" "unprognostic (1.09e-1)" "unprognostic (4.32e-2)" "unprognostic (4.86e-2)" "unprognostic (5.50e-2)" "prognostic unfavourable (7.33e-6)" "unprognostic (1.40e-3)" "unprognostic (2.65e-3)" "unprognostic (5.12e-2)" "prognostic favourable (6.25e-5)" "unprognostic (1.24e-1)" "unprognostic (1.06e-2)" "unprognostic (1.41e-1)" "unprognostic (1.78e-1)" "unprognostic (1.00e-1)" "unprognostic (1.05e-1)" 7.8 14.6 13.6 11.2 15.5 2.9 15.6 10.8 14.4 12.9 12.6 18.3 14.1 8.8 16.9 21.8 9.1 14.2 8.4 11.4 11.9 9.8 14.2 24.1 9.9 16.0 12.2 12.1 18.6 13.4 19.2 17.3 12.7 12.3 16.8 10.2 12.3 15.2 18.5 10.9 12.8 10.6 13.5 11.9 17.7 10.8 13.9 14.8 17.9 19.3 6.4 16.8 11.8 10.0 20.5 12.5 18.2 11.2 18.4 19.3 12.8 4.5 6.4 13.1 10.8 11.8 9.1 1.7 5.5 6.7 9.0 9.0 4.5 6.8 11.3 8.6 5.1 8.1 12.5 7.2 7.8 20.2 12.7 11.8 17.6 8.1 8.8 4.5 2.5 7.8 8.9 11.2 9.3 9.1 11.4 4.9 8.7 3.6 13.4 6.0 19.5 4.8 9.2 16.4 7.7 8.3 4.4 9.4 9.3 5.6 10.2 9.4 5.6 15.5 4.7 9.0 9.5 5.0 5.9 11.9 9.4 3.3 6.3 5.5 7.5 18.2 11.2 16.0 12.2 9.7 15.7 15.9 16.4 16.4 11.1 20.5 15.8 15.7 6.3 18.4 10.0 12.5 19.3 12.8 13.6 15.5 10.8 14.4 11.9 9.8 12.2 12.1 12.3 14.8 ZNF787 ENSG00000142409 "Zinc finger protein 787" 19 56087366-56121280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035140 Supported Approved Nucleoplasm,Nucleoli,Mitochondria Nucleoplasm "Nucleoli, Mitochondria" "HPA035140: AB_10602358" "unprognostic (1.97e-2)" "unprognostic (5.86e-2)" "unprognostic (8.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.26e-1)" "unprognostic (1.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.96e-3)" 7.4 8.0 4.3 7.8 5.2 18.8 7.1 4.7 7.0 8.0 9.8 5.1 8.5 12.8 5.8 6.5 9.8 8.7 8.7 10.2 4.0 4.3 6.4 18.0 6.9 7.7 4.8 4.0 8.7 13.9 3.3 6.6 4.8 4.6 10.0 3.9 7.9 9.6 7.2 28.2 9.3 10.5 6.8 3.1 14.9 11.0 6.8 4.6 4.8 10.0 8.2 5.7 8.7 10.1 3.0 5.5 4.9 2.1 1.2 1.6 0.7 11.8 11.7 3.8 8.0 1.1 2.4 10.0 6.2 2.4 4.2 4.8 6.9 7.4 8.5 0.4 2.6 9.4 2.4 5.0 1.9 11.2 43.4 13.5 5.9 10.4 6.2 12.9 11.9 3.2 4.9 3.5 6.1 3.1 16.1 9.6 2.4 7.5 8.0 16.3 12.1 22.2 10.0 5.6 10.8 4.3 7.9 14.7 14.3 6.5 12.8 11.4 7.9 18.4 6.6 16.0 11.4 6.7 16.9 20.4 14.9 8.2 9.2 8.7 7.4 1.7 2.1 2.6 1.2 1.5 1.6 2.3 0.8 1.0 2.2 3.0 1.3 0.7 4.9 1.2 1.4 5.5 1.3 0.7 4.3 5.2 4.7 7.0 4.0 4.3 4.8 4.0 4.6 4.6 ZNF793 ENSG00000188227 "Zinc finger protein 793" Q6ZN11 19 37506939-37548762 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4;RT4: 9.7;U-266/70: 16.9;U-266/84: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA034781 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol Nucleoplasm "Nucleoli, Cytosol" "HPA034781: AB_10602784" "unprognostic (4.80e-2)" "unprognostic (4.70e-2)" "unprognostic (3.26e-1)" "unprognostic (7.13e-2)" "unprognostic (4.08e-2)" "unprognostic (5.72e-2)" "unprognostic (1.05e-2)" "unprognostic (3.80e-2)" "unprognostic (2.22e-1)" "unprognostic (2.69e-3)" "unprognostic (4.16e-3)" "unprognostic (1.03e-4)" "unprognostic (4.94e-3)" "unprognostic (1.38e-1)" "unprognostic (4.62e-1)" "unprognostic (1.24e-2)" "unprognostic (8.12e-3)" 3.1 7.7 12.5 4.9 11.9 2.1 6.4 22.1 14.0 6.4 4.2 12.8 4.6 3.0 9.3 6.9 5.2 6.7 4.6 6.8 10.3 8.0 6.2 1.1 3.3 5.6 8.3 10.0 14.1 4.0 15.7 18.4 4.5 11.2 7.5 6.0 8.1 3.6 5.8 3.7 10.7 3.6 6.1 10.1 5.6 5.3 12.3 9.6 2.1 11.0 3.2 4.9 4.9 5.7 4.0 2.1 7.2 1.6 4.0 2.8 1.4 0.1 0.2 4.2 11.4 0.9 0.9 0.2 3.3 0.2 0.7 0.3 0.2 1.3 2.9 5.5 1.7 0.4 0.3 2.8 0.3 0.8 4.2 0.3 0.4 0.3 2.1 0.2 2.6 3.4 2.5 0.6 0.1 0.1 0.1 0.5 0.5 3.2 0.3 0.4 6.9 0.3 0.1 0.1 0.6 2.8 9.7 3.1 6.7 0.2 0.2 0.0 6.4 0.3 0.4 0.1 1.8 0.2 3.2 16.9 11.3 0.2 0.0 0.2 0.5 7.2 1.6 1.2 1.5 0.6 2.3 2.0 2.8 2.5 1.2 4.0 1.9 2.4 4.2 4.0 0.6 2.1 2.2 1.4 12.5 11.9 22.1 14.0 10.3 8.0 8.3 10.0 11.2 9.6